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1 INTRODUCTION 
1.1 Basic aspects of positron emission tomography (PET) 
In contrast to the imaging techniques of magnetic resonance tomography (MRT) and 
X-ray computed tomography (CT), emission tomography technology shows the 
special advantage of visualising pathophysiological, physiological and metabolic 
processes. Emission tomography is possible as single photon emission tomography 
(SPECT) and positron emission tomography (PET). Both are routinely used in 
nuclear medicine and pharmacological research.1 Although SPECT has become 
more developed in the past several years, PET is the more advanced technology, as 
PET shows a high sensitivity (more than 100-fold of SPECT) and its most important 
quantitation methods are well-elaborated.  
Around the year 2000, PET had its international breakthrough as a method. This can 
clearly be seen by the broad application of PET/CT in clinical research and 
healthcare.2-4 Moreover, during the last three years animal PET has become 
available, allowing the determination of biochemical processes and biokinetics within 
small animals.5 In this unique international situation, radiopharmaceutical methods 
play a key role in PET applications since the spectrum of applications directly 
depends on the availability of compounds labeled with radionuclides appropriate for 
PET studies. 
For labeling PET radiotracers, short-lived neutron-deficient positron emitters are of 
primary interest. The radioactive decay of the PET radionuclides gives rise to the 
emission of a positron. The positron loses its kinetic energy by collisions and 
interacts with matter over a short distance. The range depends on the β+-energy, 
which is specific for the employed isotope (Table 1-1),6, 7 and reaches from less than 
1 mm to several millimetres. When the positron is near rest, it interacts with an 
electron, its anti-particle. A positron and an electron compose an intermediary 
positronium, an exotic atom showing similarities to hydrogen. In the positronium, the 
particles “spiral” closer to each other until they are terminated by annihilation 
radiation. In a few microseconds, two gamma photons are released from the singlet 
state and show a nearly 180° emission. Each of them carries a characteristic energy 
of 511 keV (Figure 1-1).8  
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Table 1-1. Position emitters used for PET and their important nuclear data  
Nuclide Half-life Decay mode (%) E β+, max (keV) 
11C 20.4 min β+ (99.8), EC (0.2) 960 
13N 9.96 min β+ (100) 1190 
15O 2.03 min β+ (99.9), EC (0.1) 1720 
30P 2.5 min β+ (99.8), EC (0.2) 3250 
18F 109.6 min β+ (97), EC (3) 635 
75Br 98 min β+ (75.5), EC (24.5) 1740 
76Br 16.1 h β+ (57), EC (43) 3900 
73Se 7.1h β+ (65), EC (35) 1320 
120I 1.35 h β+ (64), EC (36) 4100 
124I 4.18 d β+ (25), EC (75) 2140 
38K 7.6 min β+ (100) 2680 
62Cu 9.7 min β+ (98), EC (2) 2930 
64Cu 12.7 h β+ (18), β- (37), EC (45) 655 
68Ga 68.3 min β+ (90), EC (10) 1900 
82Rb 1.3 min β+ (96), EC (4) 3350 
86Y 14.7 h β+ (34), EC (66) 1300 
94mTc 52 min β+ (72), EC (28) 2470 
72As 26 h β+ (88), EC (12) 2515 
These resulting two body-penetrating gamma photons provide the basis for 
measurement by PET (Figure 1-1). The PET scanner (PET camera) consists of 
circular arrangement of scintillation detectors. In these rings of detectors, pairs of 
opposite detectors are connected for coincidence measurements. As a result, the two 
γ-rays of the annihilation process are detected if they hit both of the opposite 
detectors within a timeframe of a few nanoseconds. The visual field of the 
tomographic system is defined by the central area covered by all fan-shaped areas of 
coincidence. The body of the patient is placed in that visual field. If compounds 
labeled with positron-emitting isotopes are accumulated in certain regions of the body, 
an image of this region can be reconstructed with tomographic slices from the 
detected annihilation events. Computer-aided image reconstruction of the data from 
several transverse measurement planes allows the output of a 3D-image of the 
region of interest. The latest innovation is that modern scanners combine PET and 
MRT in one instrument, which leads to 3D-images with exact morphologic 
information as well as a physiological and biochemical assessment.9 Those 
procedures are highly relevant in the clinical management of oncologic therapy. 
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Figure 1-1. Radioactive decay by positron emission and annihilation coincidence detection 
in PET device 10 
1.2 Radionuclides and tracers for PET registration 
As mentioned before, PET is an excellent imaging technique with the advantages of 
very high sensitivity, good spatial resolution and the ability to assess (patho) 
physiological processes and functions in a highly-quantitative way. Therefore, the 
continuous improvement and advanced development of suitable and highly-specific 
radiotracers has been necessary for performing any type of PET investigation. The 
development of a radiotracer begins with the selection of an appropriate radionuclide 
(Table 1-1). 
In general, radionuclides can be divided into three types: organic, analogous and 
metallic. The so-called “organic” PET nuclides, i.e. 11C, 15O, 13N and 30P, allow 
authentic labeling without any changes in the (bio)-chemical and physiological 
behaviour or properties of the labeled compounds. However, extremely short 
half-lives of those isotopes, from two to twenty minutes, limit their applicability. Only 
the half-life of 11C (t1/2 = 20.4 min) provides the possibility of multi-step 
radiosyntheses and allows PET measurements of slower physiological processes. 
The so-called “analogous” radiotracers are commonly labeled with 18F, 75,76Br, 73Se 
and 120,124I. Their longer half-lives range from 1.35 h to 4.15 d, and allow more 
extensive radiosyntheses as well as PET studies of slower biochemical processes. 
Generally, analogous tracers make use of similarities in steric demand and/or in 
electronic character of the substituted atom or function. A third group of suitable 
positron emitters for PET is represented by the metallic isotopes. In contrast to the 
“organic” and “analogous” PET nuclides, a few metallic isotopes are achievable by 
generator systems (i.e. 82Rb, 62Cu and 68Ga), so that they are available in places 
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without an on-site cyclotron.11 For in vivo studies, they are applied as free cationic 
tracers or as metal complexes. 
In the selection of the radionuclide, the following considerations are compulsory. The 
first is whether the physical half-life of the radioisotope matches the biological half-life 
of the process under investigation. The final radiotracer’s achievable specific activity 
(see paragraph 1.3.2) is also a crucial point. In addition, the time necessary to 
perform the radiochemical reaction, manipulation through the subsequent synthetic 
pathways and/or purifications are influential in the decision. Furthermore, the type of 
information to be obtained from the PET measurement is also important in the 
selection of the radioisotope. Finally, the spatial distribution and regional 
concentrations of a target substance or neurotransmitter uptake site are also taken 
into consideration. 
1.3 Fluorine-18 as a nuclide for radiotracers 
At present, in the clinical application of PET, fluorine-18 is one of the most suitable 
nuclides for the syntheses of radiotracers, although it is not a significant element in 
the living system. As fluorine-18 (1.35 Å) has a very sterically similar size to 
hydrogen (1.20 Å) and shows extremely electronegative charater, such substitution 
can often produce significant and useful changes in physiochemical and biological 
properties of radiopharmaceutical compounds. The most famous and most 
widely-used PET radiopharmaceutical is 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG). 
For the first metabolic steps, [18F]FDG is accepted as a glucose analogue. It is taken 
up into cells by glucose transporters. In cells, it is metabolised by the enzyme 
hexokinase to 2-[18F]fluorodeoxyglucose-6-phosphate, but 18F- for -OH substitution in 
the original glucose molecule leads to an blockage of the metabolism and leaves the 
phosphorylated FDG in the cell unaltered. Thus, FDG accumulates and gives rise to 
a PET signal which can very well be registered. Active cancer tissue can be detected 
because of its elevated glucose metabolism.12 On the other hand, the success of 
cancer chemotherapy results in the death of the cancer cells and, consequently, in 
low or no accumulation of [18F]FDG. Another typical application of [18F]FDG is the 
investigation of the biodistribution of drugs in the body or the detection of receptors 
for certain biomolecules. In recent years, the number of newly-developed 18F-labeled 
pharmaceuticals has increased rapidly, such as 6-[18F]FluoroDOPA, [18F]Fluoro-α-
methyltyrosine and [18F]Fluoromisonidazole. They are widely used in research on 
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dopamine metabolism, tumor imaging and hypoxia imaging. Table 1-2 shows a list 
including a couple of important 18F-labeled radiotracers and their applications.13 
Table 1-2. Fluorine-18 labeled radiopharmaceuticals in clinical use13 
Compound Common synthesis Clinical utility 
6-[18F]FluoroDOPA Electrophilic fluoro-
demetallation; nucleophilic 
aromatic substitution 
Dopamine metabolism 
6-[18F]Fluoro-m-tyrosine Fluorodestannylation Dopamine metabolism 
6-[18F]Fluorophenylalanine Electrophilic fluorination with 
[18F]AcOF 
Neutral amino acid transport 
2-[18F]Fluoro-4-
boronophenylalanine 
Electrophilic fluorination with 
[18F]AcOF 
Neutron capture therapy 
titration 
[18F]Fluoroethyltyrosine O-alkylation with 
[18F]fluoroethyl tosylate 
Tumor imaging 
[18F]Fluoro-α-methyltyrosine Electrophilic fluorination with 
[18F]AcOF 
Tumor imaging 
6-[18F]Fluorodopamine Nucleophilic aromatic 
substitution 
Cardiac sympathetic 
innervation 
(-)-6-[18F]Fluoronorepinephrine Nucleophilic aromatic 
substitution 
Cardiac sympathetic 
innervation 
6-[18F]Altanserin Nucleophilic aromatic 
substitution 
5HT2A receptors 
[18F]Fluoroethylspiperone N-alkylation with 
[18F]fluoroethyltosylate 
D2 receptor 
[18F]Fluoromisonidazole N-alkylation using 
[18F]epifluorohydrin 
Hypoxia imaging 
5-[18F]Fluorouracil Direct electrophilic 
fluorination with [18F]F2 
Tumor imaging 
16α-[18F]Fluoroestradiol Nucleophilic displacement of 
aliphatic cyclic sulfone 
Estrogen receptor positive 
tumors 
[18F]Fleroxacin Nucleophilic displacement of 
mesylate 
Antibiotic pharmacokinetics 
[18F]CFT Fluorodestannylation with 
high spec. act. [18F]AcOF 
Dopamine transport 
The success of fluorine-18 as a routine PET nuclide in diagnosis and 
pharmacological research is based on its chemical and nuclear properties. 
Fluorine-18 can be produced in good yields, even with low-energy cyclotrons. As 
mentioned above, the half-life of 109.7 min allows both time-consuming multi-step 
radiosyntheses up to 3 h and extended PET studies of slower biochemical processes. 
In addition, this half-life makes shipment within a range of at least 200 km possible. 
In the so-called satellite concept, the supply of clinics without an on-site cyclotron can 
be ensured.14 The 18F has a low β+-energy of 635 keV that provides a very high 
resolution for PET images and guarantees minor radiation doses to the patients. In 
terms of chemistry, several facile labeling reactions and methods are known for 
18F-introduction into organic molecules. 
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1.3.1 Production pathway of fluorine-18 
The PET nuclides are generally produced by the bombardment of stable isotopes by 
small charged particles in accelerators. Protons, deuterons and alphas are 
predominately employed. The final chemical form of the product depends on the type 
of nuclear reaction and even more on the target, the aggregate state (i.e. gas, liquid, 
solid) and the chemical form of the target material. 
Fluorine-18 can be produced for nucleophilic and electrophilic labeling reaction by 
using various types of nuclear reactions. The most common forms of fluorine-18 are 
listed in Table 1-3.6, 15-17 Currently, the use of the 18O(p,n)18F reaction on 
18O-enriched water is the most effective and reliable for the production of [18F]fluoride 
ion with high specific activity. Thus, under optimised conditions, high amounts of 
[18F]fluoride ion can easily be achieved from cyclotrons, even with low-energy 
machines, within less than one hour of irradiation time. In the case of electrophilic 
radiolabeling reactions, fluorine-18 can be produced as [18F]F2 or 
[18F]acetylhypofluorite in a neon target. In that method, the major problem is the 
deposition of the produced fluorine-18 on the target walls. Therefore, the target has 
to be treated in advance with a 1 % fluorine/neon gas mixture in order to coat the 
target walls with F2. The fluorine acts as a kind of “carrier gas” by facilitating the 
transport of fluorine-18 from the target to the laboratory. The addition of 
non-radioactive fluorine to the target results in a lower specific activity of the 
produced fluorine-18, so this production method is not applicable for the syntheses of 
radiotracers that require a high specific activity.  
Table 1-3. Most common nuclear reactions for production of fluorine-186, 15-17 
Reaction 18O(p,n)18F 16O(3He,p)18F 20Ne(d,α)18F 18O(p,n)18F c 
Target H218O a H2O Ne(0.1-0.2 % F2) b 18O2, Kr(1 % F2) b 
Particle energy [MeV] 16→3 36→0 14→0 10→0 
Main product form 18F-aq 18F-aq [18F]F2 [18F]F2 
Yield [GBq/µAh] 2.22 0.26 0.37-0.44 ~0.37 
Specific activity [Bq/mmol] ≤ 3.7×1015 ≤ 3.7×1015 ≤ 3.7×1010-11 ≤ 3.7-185×1010 
a Ti-target with Ti-window. b passivated Ni-target. c two steps process. 
1.3.2 Type of radiosyntheses and specific activity of the radioactive 
product  
In principle, radiosyntheses can be classified as: carrier-free, no-carrier-added (n.c.a.) 
and carrier-added (c.a.). Ideally, carrier-free systems are only achieved when artificial 
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radioelements (i.e. astatine) are used and the presence of non-radioactive isotopes 
of the element is excluded. Nevertheless, in radiosyntheses with cyclotron-produced 
radionuclides of naturally-occurring elements, tracers of stable isotopes of these 
elements are omnipresent and act as isotopic carriers. Even the most accurate 
operation methods can not circumvent this effect. Under those conditions 
radiosyntheses are referred to be performed as no-carrier-added (n.c.a.) processes. 
In contrast, some circumstances require the addition of weighable quantities of stable 
isotopes. In the case of [18F]F2 production, fluorine gas is added because n.c.a. 
[18F]F2 is too reactive to be removed from the walls of targets and tube lines. These 
methods are termed as carrier-added (c.a.).  
The extent to which a compound labeled with a radionuclide is diluted with the 
non-radioactive isotopic compound is referred to as the specific activity. The specific 
activity is calculated from the ratio of the amount of radioactive compound (Becquerel, 
Bq or Curie, Ci) and the molar concentration of the compound (mol), and is usually 
expressed in GBq/µmol or Ci/mmol.18 The maximum theoretical specific activity of 
fluorine-18, with a half-life of 110 min, is 63,000 GBq/µmol (1.7 × 106 Ci/mmol). In 
practice, much lower specific activities are obtained due to the unavoidable dilution 
with the ubiquity of the stable element (i.e. 19F). PET investigations using labeled 
biomolecules with very low concentrations in the destined tissue (i.e. substrates of 
enzymes, receptor ligands and reuptake inhibitors) demand radiotracers of very high 
specific activities. Therefore, n.c.a. 18F-fluorination has been taken under more 
intensive consideration for the radiosyntheses of 18F-labeled radiopharmaceuticals. 
1.4 Radiochemical syntheses for incorporating 18F into molecules 
In general, fluorination is more difficult than other halogenations, because most 
fluorinating reagents are either very toxic, corrosive to glass and metals or too 
reactive. Fluorination with fluorine-18 is also different from fluorine-19. First, this work 
is related to the decay in the case of radioactive 18F and the need to conduct all of 
the work, including the syntheses of reagents in situ and the fluorination reaction, 
within a limited time. In addition, in 19F-fluorination reactions, the product can be 
identified by the usual spectroscopic techniques (1H NMR, 13C NMR, 19F NMR, MS, 
etc.), but it is difficult in 18F-fluorination reactions unless a standard is available for 
quick comparison by TLC and HPLC. In contrast to equimolar ratios in classic 
reactions, radiochemical reactions on the n.c.a. scale are performed at a 
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subnanomolar level. Such reactions under non-equilibrium conditions generally 
proceed according to pseudo-first-order kinetics, since the concentration of the 
precursor to be labeled is in very high excess to the n.c.a. radionuclide and can 
approximately be considered to be constant. Therefore, many 18F-labeling reactions 
are successful, although the same 19F-fluorination reactions fail. 
Fluorine-18 can be incorporated into organic compounds using a variety of methods, 
which can generally be divided into direct methods (electrophilic substitution and 
nucleophilic substitution) and indirect methods (18F-fluorination via prosthetic groups 
or build-up procedures).19 Owing to the development of PET and the requirement for 
new radiopharmaceuticals (especially 18F-labeled aromatic amino acids), there has 
been extensive research on the field of aromatic fluorination. However, the 
introduction of fluorine atoms onto an aromatic ring can be realized by only a small 
number of reactions, and remains an active area of research.  
1.4.1 Electrophilic substitution 
These methods rely on [18F]F2 or reagents that can supply electrophilic fluorine.20 
The normally used 18F-sources in electrophilic fluorination are [18F]F2,21 [18F]CF3OF,22 
[18F]CH3COOF,23 [18F]FClO3,24 [18F]XeF225 and 18F-labeled N-flouropyridinium 
triflate.26 These reagents create a chemical environment in which the fluorine atom is 
highly polarized with a partial positive charge.13 Hence, it is possible to fluorinate a 
variety of electron-rich substrates (e.g. alkenes, aromatic molecules, carbanions, 
etc.). On the basis of the high reactivity of the electrophilic 18F-labeling reagents, the 
selectivity is rather low, so that undesired radical side reactions and reactions with 
the solvent can take place. To increase the regioselectivity on arenes, demetallation 
reactions of organometallic precursors can be used (Figure 1-2). The substituent X 
deactivates the arene, but for the 18F-fluorodemetallation reaction, the effect is less 
strong than in direct electrophilic 18F-labeling reactions. Thus, side reactions and 
consecutive fluorination are decreased and the purification is simplified. However, 
due to carrier addition in [18F]F2 production, only half of the fluorine atoms are 
radioactive, hence the theoretical achievable maximum RCY in electrophilic 
18F-labeling reactions is limited to 50 %. Recent attempts were made to reduce the 
amount of fluorine-19 carriers in the syntheses of electrophilic 18F-species in order to 
get higher specific activities, but lower radiochemical yields were an undesired 
drawback of this work.27 As a result, electrophilic 18F-labeling routes are restricted to 
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radiopharmaceuticals, where high specific activities are not compulsory and the 
chemical species in question are not toxic.  
X
M(CH3)3
X
F18
M = Sn, Ge, Si; X = OCH3, CH3, H, F, CF3, NO2
 
Figure 1-2. Regioselective 18F-labeling via electrophilic fluorodemetallation reactions28 
1.4.2 Nucleophilic substitution 
In general, the most important route to synthesize 18F-labeled compounds is 
nucleophilic substitution based on n.c.a. [18F]fluoride ion, which is directly available 
from the target without any carrier addition. Thus far, this is the only method to obtain 
n.c.a. 18F-radiopharmaceuticals with high specific activity. [18F]Fluoride ion is mainly 
obtained as an aqueous solution and, due to its high electronegativity, it is strongly 
hydrated and inactivated for nucleophilic reactions. In the presence of proton donors, 
the fluoride anion is deactivated by solvation effects or even the formation of 
[18F]hydrogen fluoride. Therefore, some simple but very important manipulations are 
required to provide a reactive nucleophilic reagent. The steps in preparing for 
reactive [18F]fluoride ion follow.13 
1.4.2.1 Addition of a cation  
After irradiation of an [18O]H2O target, the [18F]fluoride ion must be accompanied by a 
positively charged counterion. This is mainly solved by the addition of a cationic 
counterion (mostly potassium complexed by a cryptand such as Kryptofix 222 or 
tetraalkylammonium salts) prior to the evaporation of the water. Many syntheses now 
utilize the potassium/Kryptofix system, although examples of the use of 
tetraalkylammonium salts are frequently encountered in the literature.29 The 
carbonate ion CO32- is mostly used as the counter ion because it has low 
nucleophilicity and moderate basicity. 
1.4.2.2 Water evaporation 
Water is removed by the use of a relatively volatile solvent such as acetonitrile 
(azeotropic distillation) under a mild stream of an inert gas like argon at 140 °C. This 
method provides practically anhydrous and, thus, reactive [18F]fluoride ion.  
[18F]CH3COOF, [18F]F2
CFCl3, -78 °C
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1.4.2.3 Addition of the precursor solution 
After the two steps described above, [18F]fluoride ion is provided in a dry and “naked” 
form, suitable for substitution reactions. Because of the strong basicity of fluoride ion, 
all reactions performed in polar protic solvents (such as methanol and ethanol) fail. In 
general, nucleophilic substitution reactions are favourable in dipolar aprotic solvents 
such as acetonitrile (ACN), dimethyl sulphoxide (DMSO), N,N-dimethylformamide 
(DMF) and dimethylacetamide (DMAA), which are inert towards [18F]fluoride ion. In 
addition, organic compounds and [18F]fluoride ion (particularly the K+/Kryptofix pair) 
show good solubility in these dipolar aprotic solvents. The choice of solvent also 
depends on the type of chemical reaction being performed, potential side reactions 
with the precursor and the simplification of the subsequent workup and product 
isolation. 
In the last few years, ionic liquids have been successfully applied30 as a medium to 
carry out nucleophilic fluorination. The big advantage of ionic liquids is the fact that 
they tolerate the presence of water up to 20 % in solution. The use of ionic liquids as 
a media for 18F-fluorinations31-33 has been extended to the important tracers like 
[18F]FDG and [18F]FLT. 
1.4.3 Nucleophilic aromatic 18F-fluorination  
Nucleophilic aromatic 18F-fluorination is of great importance in the development of 
18F-labeled radiopharmaceuticals, which generally show good stability in the 
metabolic pathways of organisms. This reaction is activated by electron withdrawing 
groups ortho and/or para to the leaving group (Figure 1-3) 
F18
o-,p-Y
X
o-,p-Y
X = NO2, N(CH3)3
+, Br, Cl, I;
Y = NO2, CN, CHO, COR, COOR, Cl, Br, I;
PTC = K2.2.2 / CO3, R4N
+, Cs+, Rb+
 
Figure 1-3. Nucleophilic 18F-fluorination with activated arenes19 
A good leaving group on the benzene ring is needed, and nitro (-NO2) and 
trimethylammoniumtriflate (-NMe3OTf) groups are widely used in SNAr reactions. 
Halogens are used less frequently. A recent study shows that the diphenyliodonium 
n.c.a. [18F]fluoride ion
PTC
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(Ar-I+-Ar') group has the advantage of unnecessary electron withdrawing groups on 
the ring, but problems are associated with undesired radioactive byproducts.34 
Simple isotopic substitution, 18F for 19F, mostly shows very high radiochemical yield. 
However, the lower specific activity from these isotopic substitutions makes this 
process less practiced.  
As an activating group, functions with high positive Hammett constants, such as nitro, 
cyano and carbonyl groups, are suitable for activating SNAr reactions. The choice of 
activating group depends on the structure of the desired final product, or the 
sequence of synthetic steps to be followed after the introduction of 18F. The best case 
is that the activating group is a part of the desired product. Otherwise, the activating 
group needs to be conveniently transformed into the structural component after 
18F-fluorination. In some cases, such a group can temporarily be placed on the aryl 
ring and subsequently removed. An example here is the aldehydic function, which 
can be removed by catalytic decarbonylation (using Wilkinson’s catalyst i.e. 
Rh[PPh3]3Cl).35  
1.4.4 Indirect 18F-labeling method 
The methods mentioned above are direct 18F-labeling methods. In some cases, 
indirect 18F-labeling methods are applied. These methods mean that a primary 
18F-labeled prosthetic group or synthon is coupled with a second molecule to form 
the product. Important procedures via prosthetic groups are 18F-fluoroalkylation,36, 37 
18F-fluoroacylation38, 39 and 18F-fluoroamidation.40 (Figures 1-4) 
X
Y
F18
Y
F18
Z-R
n n n
[18F]Fluoride ion 
X
NH2
F18
NH2
F18
NH R
O
n n n
[18F]Fluoride ion 
[18F]Fluoride ion 
R-Z-H
R-Z-H
CH3
OR
O
X
CH3
OR
O
F18
CH3
Z-R
O
F18
R OR
O
18F-fluoroacylation  
18F-fluoroamidation  
18F-fluoroalkylation 
 
Figure 1-4. 18F-fluorination via prosthetic groups 
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In addition, the various 18F-synthons used for indirect 18F-labeling methods are 
4-[18F]fluorophenyl lithium,41 1-[18F]fluoro-4-haloarenes,42 4-cyano-1-
[18F]fluorobenzene,43 4-[18F]fluorophenol44 and 4-[18F]fluorobenzaldehyde.45 
1.5 Automatic technology in PET radiopharmaceuticals 
In order to produce reliable, cost-effective commercially available PET 
radiopharmaceuticals and to facilitate the application of these radiotracers, the 
development of automated systems has been an important focus for researchers.  
In principle, the design and development of automated radiotracer synthesis systems 
follow the organic synthetic practices, but there is clear difference between the 
development of automated machines for PET radiotracer synthesis and organic 
synthesis. Radiotracer synthesis is more often carried out in volume range of 5 µL to 
5 mL (comparing with 50 mL to 5 L in organic synthesis), and has special time 
constraints (often limited to 2 or 3 half-lives of the radioactive isotope) and schielding 
requirements defined by the short-lived isotopes that PET exploits. All these limitation 
make automatic radiochemical processes and equipment difficult or impossible.  
In radiotracer syntheses, an automatic system is composed of the modular design 
concept of laboratory unit operations and feedback control.46, 47 Those general-
purpose unit operations include manipulations common to the organic chemist like 
transferring reagents, evaporating solvents, regulating vessel temperature and solid 
phase extraction (SPE). In addition, the use of appropriate sensors and feedback 
controls are necessary for building more robust, general-purpose modules. 
The earliest fully automated production systems for PET radiotracers appeared in the 
early 1980’s. These pioneering systems included hard-wired automatic syntheses of 
11C-glucose48 and 13NH3,49 a microprocessor based syntheses of 13NH3 and L-[13N]-
glutamate50 and an automatic production system for syntheses of 75Br-labeled 
radiopharmaceuticals.51 By 1990, automated systems were common in many PET 
research facilities due to the reliable, high yield, one-pot syntheses of [18F]FDG 
reported by Hamacher et al..52 This synthesis of [18F]FDG by nucleophilic substitution 
using Kryptofix 222 not only provided a simple, efficient, stereospecific route for 
radiotracer production, but also allowed the utilization of new high yield cyclotron 
targets for the production of [18F]fluoride ion from H218O.53, 54 
Currently, due to the rapid development of radiochemistry and PC technology, more 
and more examples illustrate the diversity of engineering solutions to the problem of 
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automated PET radiotracer syntheses, such as automated syntheses of 6-[18F]fluoro-
L-DOPA by electrophilic substitution55 and robot syntheses of [11C]flumazenil.56 
Except for the automated syntheses of PET radiotracers, the automatic application of 
PET radiotracers is also important in basic and drug research and development. 
These systems include automated quality control of radiotracers,57 computer 
controlled infusion systems for the automated injection of radiopharmaceuticals,58 
automated dose dispensing systems59 and the automated delivery of radiotracers 
using pneumatic transport systems.60 
Along with the rapid development of PET technology, more and more new strategies 
for the radiolabeling, purification and formulation of PET radiopharmaceuticals are 
likely to be utilized in automated systems. In particular, PET radiochemists have 
exploited captive solvent techniques and solid phase reactions to create very simple 
high yielding radiochemical systems that are amendable to automation.61, 62 The 
development trend of automation in PET technology is that the latest technologies in 
personal computers, industrial controls, and laboratory robots will be used to 
implement more reliable and flexible automated radiosynthesis systems. 
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2 PROBLEM 
The successful application of molecular imaging with positron emission tomography 
(PET) directly depends on the availability of selective molecular probes labeled with 
positron-emitters, i.e. radiotracers. The crucial role of the radiotracers is due to the 
fact that the primarily-registered physical signal can be selectively correlated to a 
particular metabolic function. For imaging dopamine metabolism and neutral amino 
acid transport, new interest in 18F-labeled phenolic amino acids (i.e. [18F]FDOPA, 
[18F]fluoro-m-tyrosine) is apparent in PET and recent PET/MRI studies.  
Commonly, fluorinated aromatic amino acids are synthesized by electrophilic 
substitutions using [18F]F2, 18F-acetylhypofluorite etc. as reagents. The limitation of 
these electrophilic methods is the low specific activity (ratio of 18F-compound (in Bq) 
to 18F- plus 19F-compound (in mol)) of the radiotracer. This is due to the type of 
nuclear process that is used at the cyclotron. However, high specific activities are 
important for following metabolic processes without altering the biochemical 
processes that are on-going in vivo. Therefore, the incorporation of 18F into the tracer 
is to be carried out with no-carrier-added fluorination reagents. Since [18F]fluoride ion 
can be produced at a cyclotron efficiently and, most importantly, without any carrier 
addition, fluorination by nucleophilic substitution results in high specific activities.  
For this reason, nucleophilic aromatic substitution (SNAr) is considered to be the 
reaction type of choice in order to introduce 18F at aryl carbons. However, due to high 
electron density of aromatic compounds, that approach has become a challenging 
task to radiopharmaceutical research groups.63  
Aiming at syntheses of 18F-labeled aromatic amino acids via SNAr, two different 
synthetic strategies were studied in this work. One of them is an existing synthetic 
strategy for [18F]FDOPA that includes four steps: fluorination, reductive iodination, 
alkylation and hydrolysis (Figure 2-1). It has been developed by several groups.64-66 
However, this complicated multi-step synthesis is not suitable for routine production. 
Therefore, in order to realize the reliable automated synthesis of [18F]FDOPA for the 
multi-patient-dose routine production, the reaction conditions and operating system 
for the entire synthesis should be improved. 
PROBLEM  15 
 
O
CH3
O
CH3
O
N
+
O
-
O
O
CH3
O
CH3
O
F18
O
CH3
O
CH3
I
F18
O
CH3
O
CH3
F18
COOMe
N C6H5
C6H5
OH
OH F18
COOH
NH2
 
Figure 2-1. An existing synthetic strategy for [18F]FDOPA 
(18F-labeling and subsequent addition of the amino acid residue)64 
Another synthetic process with less and more simple radioactive synthesis steps has 
been under consideration for a long time. In this work, a three-step synthetic strategy 
is developed. The precursor would contain a protected glycine residue and, thus, 
would be ready for 18F-labeling by nucleophilic substitution followed by removal of the 
assisting electron withdrawing group and the protective groups (Figure 2-2). 
LG
R1
R2
PAA
O
PAA
O
R1
R2 F
18
PAAR1
R2 F
18
R3
R4 F
18
O
OH
NH2
PAA = Protected amino acid residue 
R1, R2, R3, R4 = H, [18F]fluorophenylalanine 
R1, R3 = H, R2,= OMe, R4 = OH, [18F]fluoro-p-tyrosine 
R2, R4 = H, R1,= OMe, R3 = OH, [18F]fluoro-m-tyrosine 
R1, R2= OMe, R3, R4 = OH, [18F]FDOPA  
Figure 2-2. The synthetic strategy to be developed for syntheses of 18F-labeled 
aromatic amino acids via SNAr  
For both strategies, it is essential to gain more information about nucleophilic 
aromatic 18F-fluorination with model compounds. Therefore, a systematic 
investigation of SNAr with a broad variation of the substitution pattern (modeling 
18F-labeled aromatic amino acids, Figure 2-3) has to be performed. When both 
electron donating groups and electron withdrawing groups exist in the precursor 
molecule, the contradictive influence of these substituents on the SNAr reaction will 
be discussed.  
In order to understand the SNAr reaction in more detail, the labeling reaction must be 
monitored by sensitive and precise analytic methods (i.e. HPLC, LC/MS), and the 
potentially competitive side reactions during SNAr should be checked. 
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Additionally, one of the goals in this work is to prove the feasibility of the newly-
developed synthetic strategy (Figure 2-2). Therefore, the crucial intermediate step 
(decarbonylation) should be tested with model compounds and a suitable protected 
glycine residue (stable against the synthesis conditions) should be chosen. 
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Figure 2-3. Model compounds for systematic study on SNAr reaction with [18F]fluoride ion 
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3 RESULTS AND DISCUSSION 
3.1 Organic syntheses of precursors for modeling 18F-labeled 
aromatic amino acids 
For the systematic study on nucleophilic aromatic substitution aiming at 18F-labeled 
aromatic amino acids, a series of model compounds had to be synthesized. These 
compounds can be divided into four groups.  
1) Model compounds that can be used as building blocks for 18F-labeled aromatic 
amino acids (see paragraph 3.1.1). 
2) Model compounds with methyl substituents that mimic 18F-labeled aromatic amino 
acids (see paragraph 3.1.2). In these precursors, the methyl group is in the position 
of the glycine residue.  
3) A series of precursors multi-substituted with methoxy groups, two formyl 
substituents or differentially-protected hydroxyl groups that is used for a broad 
investigation of SNAr (see paragraph 3.1.3). 
4) Compounds with protected glycine derivatives that are suitable for the synthesis of 
[18F]fluoro-m-tyrosine via SNAr (Figure 2-2) (see paragraph 3.1.4).  
In the following, the organic synthetic paths are shown, and the details of the 
available compounds, synthetic procedures and the characterization data of products 
are included in the experimental section. 
3.1.1 Model compounds as building blocks  
In this work, model compounds that can be building blocks for 18F-labeled aromatic 
amino acids have five basic substitution patterns (Figure 3-1). 
LG
O
LG
O
1 2
LG = F, NO2, Cl, Br, I, N
+Me3TfO
-
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O
CH3
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CH3
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3 4 5
 
Figure 3-1. Model compounds as building blocks for 18F-labeled aromatic amino acids 
In case of substitution patterns 1 and 2, most model compounds are commercially 
available except 4-formylphenyl-trimethylammonium triflate (2-N+Me3TfO-). 
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Compounds with substitution pattern 5 were synthesized in a previous work,67 while 
all of the other compounds were synthesized. 
4-Formylphenyl-trimethylammonium triflate (2-N+Me3TfO-) 
Following the method in the literature,68 2-N+Me3TfO- was synthesized by 
quaternisation of p-dimethylaminobenzaldehyde with methyl 
trifluoromethanesulfonate (Y = 39 %). 
N
O
CH3
CH3
N
+
O
CH3
CH3
CH3
CF3SO3
-
CF3SO3CH3, DCM
2-N+Me3TfO
-
r.t., 3 h
 
5-Methoxy-2-nitrobenzaldehyde (3-NO2) 
3-NO2 was synthesized by methoxylation according to the literature.69 Treatment of 
5-hydroxy-2-nitrobenzaldehyde with methyl iodide under basic conditions afforded 
3-NO2 (Y = 87 %).  
OH
O
N
+
O
-
O
O
N
+
O
-
O
O
CH3MeI, K2CO3, DMF
r.t., 3 h
3-NO2
 
2-Bromo-5-methoxybenzaldehyde (3-Br) 
Following the literature,70 3-Br was synthesized by bromination of 
3-methoxybenzaldehyde with bromine in CHCl3. A mixture of monobromo compound 
and dibromo compound was obtained and 3-Br was isolated by using flash 
chromatography (Y = 82 %).  
 
2-Chloro-5-methoxybenzaldehyde (3-Cl)  
2-Chloro-5-methoxytoluene was brominated with NBS (N-bromosuccinimide) and a 
catalytic amount of AIBN in CCl4 to provide 4-chloro-3-bromomethylanisole, and this 
intermediate product was oxidized in DMSO in presence of potassium carbonate to 
3-Cl (Y = 36 % based on 2-chloro-5-methoxytoluene). 
O
CH3
O
O
CH3
O
Br
Br2, CHCl3
r.t., 0.5 h
3-Br
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2-Iodo-5-methoxybenzaldehyde (3-I) 
Following the literature,71 3-methoxybenzyl alcohol was iodinated with iodine and 
silver trifluoroacetate in CHCl3, and 2-iodo-5-methoxybenzyl alcohol was formed in 
48 % yield. This intermediate product was oxidized by using PDC in DCM to 3-I 
(Y = 84 %).  
O
CH3 OH
I
O
CH3 OH
O
CH3
I
O
CF3COOAg, I2, CHCl3 PDC, DCM
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3-I
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5-Methoxy-2-trimethylammoniobenzaldehyde triflate (3-N+Me3TfO-) 
According to the literature,72 5-methoxy-2-dimethylaminobenzaldehyde was prepared 
by nucleophilic substitution with NH(CH3)2·HCl and potassium carbonate on 
2-fluoro-5-methoxybenzaldehyde. The reaction proceeded under reflux in a mixture 
of DMSO and water (Y = 59 %). After quaternisation of this dimethylamino compound 
with methyl trifluoromethanesulfonate in DCM, 3-N+Me3TfO- was obtained (Y = 78 %). 
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4-Methoxy-2-nitrobenzaldehyde (4-NO2) 
4-Bromo-3-nitroanisole was lithiated with phenyllithium at -78 °C for 2 h and 
consecutively formylated by the addition of DMF to give 4-NO2 (Y = 65 %). 
O
CH3
Br
N
+
O
-
O
O
CH3
N+
O-
O
O
PhLi, -78 oC, THF
DMF
4-NO2
 
RESULTS AND DISCUSSION 21 
 
3.1.2 Model compounds with a methyl substituent 
Similar to compounds (see paragraph 3.1.1), the methyl-substituted compounds had 
five different basic substitution patterns (Figure 3-2), which can also be used to mimic 
[18F]fluorophenylalanine (substitution patterns 6 and 7), [18F]fluoro-m-tyrosine 
(substitution pattern 8), [18F]fluoro-p-tyrosine (substitution pattern 9) and [18F]FDOPA 
(substitution pattern 10).  
LG
O
CH3
LG = F, NO2, Cl, Br, N
+Me3TfO
-
LG
CH3
O
LG
O
CH3
O
CH3
LG
CH3
O
O
CH3
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O
CH3
O
CH3
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O
CH3
O
CH3
O
CH3
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9 10 11
 
Figure 3-2. Methyl-substituted compounds mimicking 18F-labeled aromatic amino acids 
In case of substitution patterns 9, 10 and 11, all of these compounds were 
synthesized elsewhere.73 For the substitution patterns 6 and 7, all compounds were 
synthesized by the following pathways. 
3-Methyl-2-nitrobenzaldehyde (6-NO2) 
6-NO2 was prepared in the same manner as 4-NO2. 1-Bromo-3-methyl-2-
nitrobenzene was lithiated with phenyllithium and consecutively formylated by the 
addition of DMF to give 6-NO2 (Y = 66 %).  
Br
CH3
N
+
O
-
O
O
CH3
N
+
O
-
O
DMF
PhLi, -78 oC THF
6-NO2
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2-Chloro-3-methylbenzaldehyde (6-Cl) and 
2-bromo-3-methylbenzaldehyde (6-Br) 
6-Cl and 6-Br were synthesized analogous to the way described in the preparation of 
3-Cl. The starting compound (2-chloro-1,3-dimethylbenzene or 2-bromo-1,3-
dimethylbenzene) was brominated with NBS in CCl4 to afford the intermediate 
product, which was oxidized to 6-Cl (Y =33 % based on 2-chloro-
1,3-dimethylbenzene) and 6-Br (Y = 53 % based on 2-bromo-1,3-dimethylbenzene). 
LG = Cl, Br
CH3
CH3
LG
CH3
LG
Br
CH3
LG
O
NBS, AIBN, CCl4
reflux, 1 h
6-Cl or 6-Br
50 oC, 12 h
Na2CO3, DMSO
 
2-Fluoro-3-methylbenzaldehyde (6-F) 
6-F was synthesized from 1-fluoro-2-methylbenzene by formylation with n-BuLi and 
DMF (Y = 62 %).  
F
CH3
F
CH3
O
DMF
n-BuLi, t-BuOK, -78 oC, THF
6-F
 
3-Methyl-4-nitrobenzaldehyde (7-NO2) and 
4-bromo-3-methylbenzaldehyde (7-Br) 
3-Methyl-4-nitrobenzoic acid or 4-bromo-3-methylbenzoic acid was stirred in a 
BH3·THF solution to yield 3-methyl-4-nitrobenzyl alcohol or 4-bromo-3-methylbenzyl 
alcohol, and these intermediate products were the directly oxidized with PDC to the 
final products. (7-NO2, Y =76 % based on 3-Methyl-4-nitrobenzoic acid; 7-Br, 
Y = 58 % based on 4-bromo-3-methylbenzoic acid).  
CH3
LG
O
OH
CH3
LG
OH
CH3
LG
O
LG = NO2, Br
BH3THF PDC, DCM
r.t., 36 h r.t., 12 h
7-NO2 or 7-Br
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3-Methyl-4-trimethylammoniumbenzaldehyde triflate (7-N+Me3TfO-) 
The synthesis of 7-N+Me3TfO- was the same as for 3-N+Me3TfO-. The dimethylamino 
compound was prepared by a nucleophilic substitution with NH(CH3)2HCl on 4-fluoro-
3-methylbenzaldehyde (Y = 68 %). The ammonium triflate 7-N+Me3TfO- was obtained 
by quaternisation of the dimethylamino compound (Y = 74 %). 
N
CH3
CH3
CH3
O
N+
CH3
CH3
CH3
CH3O
CF3SO3
-
F
CH3
O
reflux, 12 h
CF3SO3Me, DCM
r.t., 3 h
7-N+Me3TfO
-
NH(CH3)2HCl, K2CO3
DMSO, Water
 
2-Fluoro-5-methoxy-3-methylbenzaldehyde (8-F) 
8-F was synthesized by formylation of 2-fluoro-5-methoxytoluene with n-BuLi and 
DMF (Y = 70 %). 
O
CH3
CH3
F
O
CH3
CH3
F
O
DMF
8-F
n-BuLi, t-BuOK, THF, -78 °C
 
In the first phase of this reaction, the lithium ion could be introduced in the ortho 
position to the methoxy substituent or ortho to the fluoro substituent. However, when 
the n-BuLi and t-BuOK (or TMEDA) are used as reagents in the reaction, lithiation 
ortho to the fluoro substituent is the predominant reaction.74  
5-Methoxy-3-methyl-2-nitrobenzaldehyde (8-NO2) 
In order to reduce the risk of unknown impurities in 8-NO2 by organic synthesis, this 
compound was prepared by three different synthetic pathways. In the preparation, 
the synthetic pathway 1 needed less synthetic steps and had the highest overall 
yield compared to the other two synthetic pathways. 
Synthetic pathway 1 
Reaction of 5-methoxy-2-nitrobenzaldehyde in presence of toluene-4-sulfonic acid 
with ethylene glycol provided 2-(5-methoxy-2-nitrophenyl)-1,3-dioxolane (Y = 71 %). 
This intermediate product was treated with MeMgBr at -78 °C in THF to form a 
meisenheimer adduct, which was oxidized with KMnO4 to 2-(5-methoxy-3-methyl-2-
nitrophenyl)-1,3-dioxolane (Y = 39 %). In this nucleophilic alkylation of nitroarenes, 
the methyl group is selectively introduced at the ortho position of the nitro group.75 
24 RESULTS AND DISCUSSION 
 
After cleavage of the 1,3-dioxolane group under acidic conditions, 8-NO2 was 
obtained (Y = 70 %).  
N+
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O
CH3
O
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O
CH3
O
O
CH3
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O-
O
O
CH3
O
CH3
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O
CH3
O
O
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, Toluene
 KMnO4
HCl, THF
reflux, 6 h
r.t., 12 h
MeMgBr, THF, -78 oC, 0.5 h
8-NO2
 
Synthetic pathway 2 
Methoxylation of 3,5-dimethylphenol afforded 3,5-dimethylanisole, which was 
brominated with NBS and consecutively oxidized in DMSO (Y = 30 %) to provide 
3-methoxy-5-methylbenzaldehyde. Following, it was nitrated by using 90 % HNO3 at 
0 °C and three different isomers were obtained. The desired product 8-NO2 was 
obtained by using flash chromatography (Y = 30 %). 
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CH3OH OCH3
CH3
CH3 OCH3
CH3
Br
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CH3
CH3
O
O
CH3
CH3
O
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+
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O
O
CH3
CH3
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-
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O
CH3
CH3
O
N
+O
-
O
+ +
MeI, K2CO3
DMF, r.t., 3 h
NBS, AIBN
CCl4, reflux, 12 h
Na2CO3, DMSO
90 % HNO3
8-NO2
r.t., 12 h
0 oC, 1 h
 
Synthetic pathway 3 
According to the method described in the literature,76 3,5-dimethylphenol was nitrated 
with NaNO3 and 11 N HCl in the mixture of water and diethylether (1:1, v/v) to furnish 
3,5-dimethyl-4-nitrophenol (Y = 29 %). Following, this was methoxylated to 
3,5-dimethyl-4-nitroanisole (Y = 81 %). After bromination with NBS and oxidation in 
DMSO, 8-NO2 was obtained (Y = 30 % based on 3,5-dimethyl-4-nitroanisole). 
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reflux, 12 h
Na2CO3, DMSO
r.t., 12 h
8-NO2
DEE/Water, r.t., 12 h
2-Bromo-5-methoxy-3-methylbenzaldehyde (8-Br) 
8-Br was synthesized from 3,5-dimethylphenol. Methoxylation of 3,5-dimethylphenol 
yielded 3,5-dimethylanisole, which was brominated with bromine in CHCl3 to 
2-bromo-5-methoxy-1,3-dimethylbenzene (Y = 85 % based on 3,5-dimethylphenol). 
This intermediate product was subjected to bromination with NBS and oxidation in 
DMSO to afford 8-Br (Y = 39 % based on 2-bromo-5-methoxy-1,3-dimethylbenzene).  
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CH3OH O
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CH3
CH3
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CH3
Br
CH3
CH3
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CH3
O
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CH3
O
CH3
Br
CH3
Br
MeI, K2CO3, DMF
r.t., 3 h
NBS, AIBN, CCl4
reflux, 12 h
Na2CO3, DMSO
r.t., 0.5 h
r.t., 12 h
8-Br
Br2, CHCl3
 
2-Chloro-5-methoxy-3-methylbenzaldehyde (8-Cl) 
8-Cl was synthesized from 3,5-dimethyl-4-chlorophenol, and the synthetic route was 
similar to that described in the synthesis of 8-Br. After methoxylation of the hydroxyl 
group (Y = 94 %), bromination of the methyl group and oxidation of bromomethyl 
group, 8-Cl was obtained (Y = 15 % based on 2-chloro-5-methoxy-1,3-
dimethylbenzene).  
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3.1.3 The other precursors for systematic study of SNAr reaction  
In order to perform the systematic study on SNAr for the syntheses of 18F-labeled 
aromatic amino acids, a broad variety of model compounds with different ether 
functions as a protection for phenol, varying numbers of methoxy substituents or 
dialdehydic functions were synthesized. 
3.1.3.1 Precursor with differentally-protected hydroxyl group 
The 18F- ion is deactivated by proton donors, therefore the phenolic hydroxyl group in 
the precursor molecule has to be protected. In this work, based on the structure of 
5-hydroxy-2-nitrobenzaldehyde, -OH group was protected as different types of ethers, 
and these derivatives were used for studying the influence of different alkyl groups on 
the RCY (see paragraph 3.2.2.1). For substitution pattern 12, all compounds were 
synthesized by the following pathways.  
O
R
O
N
+
O
-
O
R = C2H5, C3H7, C4H9, CF3, Bn
12
 
Compounds 12-C2H5, 12-C3H7, 12-C4H9, 12-Bn 
5-Hydroxy-2-nitrobenzaldehyde, K2CO3 and the iodoalkane (or BnBr) were stirred in 
DMF (or mixture of MeOH and CHCl3). The products were produced in good yields 
(12-C2H5, Y = 95 %; 12-C3H7, Y = 72 %; 12-C4H9, Y = 70 %; 12-Bn, Y = 70 %).   
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2-Nitro-5-(trifluoromethoxy)benzaldehyde (12-CF3) 
3-(Trifluoromethoxy)benzaldehyde was nitrated with 100 % HNO3 at room 
temperature to yield 12-CF3 (Y = 81 %). 
O
F3CO
O
F3CO
N
+
O
-
O
100 % HNO3
12-CF3
r.t.
 
3.1.3.2 Precursors with various numbers of methoxy substituents 
In this work, a study was also performed to determine the dependency of the RCY on 
the number and positions of methoxy groups present in o-nitrobenzaldehydes or 
o-bromobenzaldehydes (Figure 3-3) (see paragraph 3.2.2.2).  
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Figure 3-3. Precursors with different number of methoxy substituents 
In Figure 3-3, 14-NO2 and 14-Br are commercially available; 15-NO2 and 15-Br were 
prepared previously,67 in addition, 3-NO2, 4-NO2 and 5-NO2 have already been 
synthesized as model compounds (see paragraph 3.1.1). All the other 
o-nitrobenzaldehyde or o-bromobenzaldehyde derivatives were synthesized by the 
following methods. 
2-Methoxy-6-nitrobenzaldehyde (13-NO2) 
Following the method in the literature,77 formylation of 3-nitrophenol by the DUFF 
reaction led to a mixture of 2-hydroxy-6-nitrobenzaldehyde and 2-hydroxy-4-
nitrobenzaldehyde. These crude intermediate products were directly methoxylated by 
the same method used in the synthesis of 3-NO2, and 13-NO2 was isolated by using 
flash chromatography (Y = 16 % based on 3-nitrophenol). 
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3,6-Dimethoxy-2-nitrobenzaldehyde (16-NO2) 
2,5-Dimethoxybenzaldehyde was nitrated with a mixture of AcOH and 70 % HNO3 at 
room temperature for 1 h, and 16-NO2 was formed (Y = 42 %). 
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3,5-Dimethoxy-2-nitrobenzaldehyde (17-NO2) 
3,5-Dimethoxybenzaldehyde was treated with 90 % HNO3 at 0 °C to give 17-NO2 
(Y = 17 %).   
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O
CH3
O
CH3
90 % HNO3
17-NO2
r.t.
 
2-Bromo-3,5-dimethoxybenzaldehyde (17-Br) 
In the bromination of 3,5-dimethoxybenzaldehyde with bromine in CH3Cl, 17-Br was 
obtained after purification by using flash chromatography (Y = 84 %). 
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3,4-Dimethoxy-2-nitrobenzaldehyde (18-NO2) 
The synthesis of 18-NO2 started from phenyl-4-formyl-2-methoxy-
3-nitrobenzenesulfonate, which was readily obtained in previous work.67 It was 
hydrolyzed under basic conditions to give 4-hydroxy-3-methoxy-2-nitrobenzaldehyde. 
Methoxylation of this intermediate product afforded 18-NO2 (Y = 46 % based on 
phenyl-4-formyl-2-methoxy-3-nitrobenzenesulfonate). 
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2,3,4-Trimethoxy-6-nitrobenzaldehyde (19-NO2) 
19-NO2 was directly synthesized by nitration with a mixture of 100 % AcOH and 
100 % HNO3 at 0 °C for 10 min (Y = 66 %). 
O
CH3
O
CH3
O
CH3
O
O
CH3
O
CH3
O
CH3
O
N
+
O
-
O
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6-Bromo-2,3,4-trimethoxybenzaldehyde (19-Br) 
The synthesis of 19-Br was started from 5-bromo-2,3-dimethoxybenzaldehyde, which 
was prepared in previous work.67 This compound was converted to 5-bromo-2,3-
dimethoxyphenol by a Baeyer-Villiger reaction. Following, the formyl group was 
introduced into the molecule by the DUFF reaction. Finally, 19-Br was obtained after 
methoxylation (Y = 13 % based on 5-bromo-2,3-dimethoxybenzaldehyde). 
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6-Fluoro-2,3,4-Trimethoxybenzaldehyde (19-F) 
19-F was synthesized by fluorination of 19-NO2 with KF in DMF in presence of K2.2.2, 
and the synthetic procedure was analogous to that described in fluorination with the 
18F nucleophile (Y = 1.3 %). 
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2,3,4,5-Tetramethoxy-6-nitrobenzaldehyde (20-NO2) 
2,3,4-Trimethoxybenzaldehyde was converted into 2,3,4-trimethoxyphenol by the 
Baeyer-Villiger reaction. Following, formylation of 2,3,4-trimethoxyphenol by the 
DUFF reaction afforded 2-hydroxy-3,4,5-trimethoxybenzaldehyde (Y = 51 %), which 
was methoxylated to 2,3,4,5-tetramethoxybenzaldehyde (Y = 80 %). This 
intermediate was nitrated with a mixture of 100 % AcOH and 70 % HNO3 to give 
20-NO2 (Y = 39 %). 
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2-Bromo-3,4,5,6-tetramethoxybenzaldehyde (20-Br) 
20-Br was prepared by the bromination of 2,3,4,5-tetramethoxybenzaldehyde 
(intermediate product in the synthesis of 20-NO2) with trifluoroacetic acid and NBS 
(Y = 75 %).  
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3.1.3.3 Precursors with two formyl substituents 
In order to improve the RCY of precursors modeling 18F-labeled aromatic amino 
acids, the model compounds with two aldehydic functions (Figure 3-4) were 
synthesized.  
Substitution patterns 25 and 26 used in this work were synthesized elsewhere.73 All 
of the other compounds were synthesized by the following synthetic pathways. 
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Figure 3-4. Model compounds with two formyl substituents 
2-Nitroisophthalaldehyde (21-NO2) 
The synthesis of 2-nitroisophthalaldehyde began with the oxidation of 
1,3-dimethyl-2-nitrobenzene with KMnO478 to provide 2-nitroisophthalic acid 
(Y = 63 %). Following, it was reduced using BH3·THF to 1,3-dihydroxymethyl-2-
nitrobenzene (Y = 90 %). The oxidation of this benzyl alcohol led to the mixed 
products (monoaldehyde and dialdehyde), which were isolated by using flash 
chromatography (21-NO2, Y = 23 %; 3-(hydroxymethyl)-2-nitrobenzaldehyde, 
Y = 54 %).  
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2-Fluoroisophthalaldehyde (21-F) 
2-Fluorobenzaldehyde was treated with ethylene glycol in toluene to provide 
2-(2-fluorophenyl)-1,3-dioxolane (Y = 81 %), which was subjected to formylation with 
n-BuLi and DMF to give 3-(1,3-dioxolan-2-yl)-2-fluorobenzaldehyde (Y = 37 %). This 
intermediate was deprotected under acidic conditions to yield 21-F (Y = 61 %). 
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2-Nitroterephthalaldehyde (22-NO2) 
This synthesis of 22-NO2 started from 2-nitroterephthalic acid, and the synthetic 
procedure was the same as described in the preparation of 21-NO2. After reduction 
with BH3·THF (Y = 96 %) and oxidation with PDC (Y = 64 %), 22-NO2 was produced. 
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2-Fluoroterephthalaldehyde (22-F) 
4-Bromo-3-fluorobenzaldehyde was treated with ethylene glycol in toluene to provide 
2-(4-bromo-3-fluorophenyl)-1,3-dioxolane (Y = 92 %). This intermediate was 
converted to 4-(1,3-dioxolan-2-yl)-2-fluorobenzaldehyde by formylation with 
phenyllithium and DMF. The crude product was directly subjected to the deprotection 
to afford 22-F (Y = 77 % based on 2-(4-bromo-3-fluorophenyl)-1,3-dioxolane). 
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5-Methoxy-2-nitroisophthalaldehyde (23-NO2) 
The synthesis of 23-NO2 began with 1,3-dimethyl-5-methoxy-2-nitrobenzene 
(intermediate product in the synthesis of 8-NO2), and the synthetic procedure was the 
same as described in the preparation of 21-NO2. After oxidation with KMnO4 
(Y = 41 %), reduction with BH3·THF (Y = 53 %) and oxidation with PDC, a mixture of 
5-methoxy-2-nitroisophthalaldehyde and 3-(hydroxymethyl)-5-methoxy-
2-nitrobenzaldehyde was obtained. 23-NO2 was isolated by using flash 
chromatography (Y = 22 % based on 5-methoxy-1,3-dihydroxymethyl-
2-nitrobenzene).  
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2-Fluoro-5-methoxyisophthalaldehyde (23-F) and 
2-fluoro-5-methoxyterephthalaldehyde (24-F) 
2-Fluoro-5-methoxybenzaldehyde was treated with ethylene glycol in toluene to 
provide 2-(2-fluoro-5-methoxyphenyl)-1,3-dioxolane (Y = 90 %). The formylation of 
this protected aldehyde with sec-BuLi and DMF led to a mixture of two important 
intermediates, which were isolated by using flash chromatography 
(4-(1,3-dioxolan-2-yl)-5-fluoro-2-methoxybenzaldehyde, Y = 10 %; 3-(1,3-dioxolan-
2-yl)-2-fluoro-5-methoxybenzaldehyde, Y = 37 %). After deprotection under acidic 
conditions, 23-F (Y = 88 %) and 24-F (Y = 80 %) were obtained. 
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5-Methoxy-2-nitroterephthalaldehyde (24-NO2) 
2,5-Dimethylphenol was nitrated with NaNO3 and 11 N HCl (Y = 36 %), and 
consecutively methoxylated with MeI to give 2,5-dimethyl-4-nitroanisole (Y = 85 %). 
This intermediate product was subjected to oxidation with KMnO4 to provide 
2-methoxy-5-nitroterephthalic acid (Y = 40 %). The following synthesis was 
analogous to that used in the preparation of 22-NO2. After reduction with BH3·THF 
and oxidation with PDC, 24-NO2 was obtained (Y = 44 % based on 2-methoxy-5-
nitroterephthalic acid). 
OH CH3
CH3
N+
O-
O
O
CH3
O
OH
O
OH
N+
O-
O
O
CH3
OH
OH
N+
O-
O
O
CH3
O
O
N+
O-
O
O
CH3
CH3
CH3
KMnO4, KOH
reflux, 24 h
BH3 THF PDC, DCM
OH
N+
O-
O
CH3
CH3
r.t., 12 h
MeI, K2CO3, DMF
r.t., 12 hr.t., 36 h
r.t., 12 h
NaNO3, 11 N HCl
24-NO2
 
3.1.4 The precursors of [18F]fluoro-m-tyrosine containing protected 
2-carboxy-2-aminoethyl substituents  
For the preparation of [18F]fluoro-m-tyrosine via a newly-developed strategy 
(Figure 2-2), precursors with protected glycine residues were synthesized by the 
following routes. 
CH2
F
O
O
CH3
MeOOC
NH5C6
C6H5
CH2
F
O
O
CH3
N
N
CH3
CH3
O
CH3
O
CH3
27-F 28-F
 
Methyl N-(diphenylmethylene)-2-fluoro-3-formyl-5-methoxyphenylalaninate 
(27-F) 
The synthesis of 27-F was started from 3-(1,3-dioxolan-2-yl)-2-fluoro-5-
methoxybenzaldehyde (see synthesis of 23-F). It was reduced with NaBH4 (Y = 76 %) 
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and deprotected under acidic conditions to provide 2-fluoro-3-(hydroxymethyl)-5-
methoxybenzaldehyde. This intermediate product was subjected to bromination with 
BMDAB,73, 79 and 3-(bromomethyl)-2-fluoro-5-methoxybenzaldehyde was obtained 
(Y = 76 % based on 3-(1,3-dioxolan-2-yl)-2-fluoro-5-methoxybenzyl alcohol). After 
incorporation of N-(diphenylmethylene)glycine methylester into this benzyl bromide 
by a coupling reaction, 27-F was prepared in a yield of 44 %. 
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H
H
 
2-Fluoro-3-[(5-isopropyl-3,6-dimethoxy-2,5-dihydropyrazin-2-yl)methyl]-5-
methoxybenzaldehyde (28-F) 
4-Fluoro-3-methylanisole was brominated by the method used in the synthesis of 
3-Cl to afford 3-(bromomethyl)-4-fluoroanisole (Y = 55 %). Following, it was coupled 
with (2R)-(-)-2,5-dihydro-3,6-dimethoxy-2-isopropylpyrazine in presence of n-BuLi in 
THF to provide 2-(2-fluoro-5-methoxybenzyl)-5-isopropyl-3,6-dimethoxy-2,5-
dihydropyrazine (Y = 91 %). 
The last step was to introduce the formyl group ortho to the fluoro substituent by 
formylation with BuLi and DMF. However, several attempts failed. The reaction was 
performed in the presence of n-BuLi or sec-BuLi in the range of -78 °C to -60 °C. 
After the addition of DMF, the reaction solution was monitored by LC/MS. When 
using sec-BuLi, a new compound with the correct mass peak of 28-F (ACPI (+) mode, 
[M+H]+ , m/z 351) was observed, but the NMR analysis of the raw product showed 
that the formyl group was introduced on the dihydropyrazine ring, so that particular 
synthesis remains under development. 
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3.2 The systematic study on the nucleophilic aromatic 
18F-fluorination 
3.2.1 The principle of nucleophilic aromatic substitution 
In aromatic compounds such as phenolic derivatives, nucleophilic substitution cannot 
occur because the electron density on the ring is too high so that a nucleophile is 
repulsed. In order to realize this reaction with a nucleophile such as [18F]fluoride ion, 
different factors have to be taken into consideration. Most importantly, the aromatic 
compounds should have a type of chemical structure in which the electron density of 
the reactive center is decreased. For that reason the compound must have a leaving 
group (LG) with an electron withdrawing effect. To achieve a good substitution yield, 
another electron withdrawing substituent (EWG) is necessary as an auxiliary 
activating group. Moreover, these substitution reactions exhibit strong dependencies 
on solvent, reaction temperature, reaction time, amount of base and precursor 
concentration. In this paragraph, all these effects on the SNAr reaction are discussed 
on the basis of compounds modeling aromatic amino acids. Additionally, two more 
different methods are developed for analyzing the 18F-labeled products.  
3.2.1.1 Substitution pattern effect on RCY in the case of nitrobenzene 
derivatives 
In the nucleophilic aromatic 18F-fluorination, the effect of the substitution pattern on 
the radiochemical yield was studied with nitrobenzene and its derivatives (only 
including one EWG or one EDG). The results are presented in Figure 3-5. 
The effect of substitution pattern can be illustrated starting with nitrobenzene, which 
showed a low RCY of 1 %. This is due to the electron withdrawing ability of the nitro 
group, which can reduce the electron density of the reactive center to a certain extent. 
Based on this structure, if one electron donating group (-MeO) was introduced in the 
para position to the leaving group (4-nitroanisole), the electron density of the reactive 
center would be increased by the +M-effect. Therefore, an RCY of 0 % was observed 
after 30 min. If an electron withdrawing group (-CHO) was introduced onto the ring, 
RCYs were improved (3-nitrobenzaldehyde, 7 ± 1 %; 1-NO2, 84 ± 0.3 %; 2-NO2, 
81 ± 5 %). This RCY increase was the result of two different effects, the I-effect and 
M-effect. In the case of 3-nitrobenzaldehyde, the electron density of the reactive 
center was decreased by the inductive effect, which slightly improved the RCY but 
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not remarkably. In the case of 1-NO2 and 2-NO2, the carbon bearing the leaving 
group had a relatively low electron density because of the direct -M-effect and I-effect 
in the ortho or para positions. This results in an easier replacement of the LG by a 
nucleophile, hence the RCY was increased significantly.  
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 
140 °C, within 30 min.  
Maximum RCY is presented. 
Figure 3-5. The effect of substitution pattern of nitrobenzene derivatives on RCY in SNAr 
In summary, the radiochemical yield in the nucleophilic aromatic 18F-fluorination is 
strongly dependent on the substitution pattern of the precursor. When the LG and 
EWG are ortho or para to each other, the nucleophilic substitution reaction is 
accelerated. In this study, the model compounds for the 18F-labeled aromatic amino 
acids were designed to contain an EWG ortho or para to the LG. 
3.2.1.2 Formyl substituent as an EWG 
In this work, the choice of EWG was dependent on the structure of the desired final 
product or the sequence of synthetic steps following the introduction of 18F. The 
formyl substituent was chosen as an activating group in the syntheses of 18F-labeled 
aromatic amino acids because it can easily be removed in a decarbonylation reaction 
(see paragraph 3.3), or in the further steps of the synthesis, this formyl substituent 
can be used as starting point for the connection of the amino acid residue to the 
aromatic part (see paragraph 3.5). 
NO 2NO 2
MeO
NO 2
CHO
OHC
NO 2NO 2
CHO
EDG
EW
G m
eta
 to
 LG
EW
G ortho  
or para  to LG
1-NO2 2-NO2
RCY 7 ± 1 % 
RCY 84 ± 0.4 % 
RCY 1 ± 0.1 % 
RCY 81 ± 5 % 
RCY 0 % 
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3.2.1.3 Effect by LG 
The leaving group quality has an effect on the RCY in the SNAr reaction. In the case 
of model compounds with different substitution patterns, the RCY dependence on the 
leaving group quality was studied (Table 3-1). 
In all of the structures, 18F/19F isotopic exchange always gave high RCY (> 75 %); 
however, only low specific activity can be reached by this isotopic exchange, which 
limits its utility in clinical applications.  
For no-carrier-added SNAr reactions, the nitro group or the trimethylammonium triflate 
group are usually used as LGs. In Table 3-1, high RCYs (substitution 
patterns 1, 2 and 5) were obtained for both LGs. However, due to the difficult 
syntheses of trimethylammonium triflate precursors, especially for the precursor 
including the amino acid residue, this LG is not the first option. Interestingly, in the 
case of 2-NO2, when the scale of [18F]fluoride ion in the labeling reaction was 
increased from 300 MBq to 60 GBq, the RCY was decreased from 81 % to 0 %; 
however, this unusual result was not observed for 1-NO2.  
As a general tendency, bromo and chloro precursors give similar RCYs, and are 
usually lower than the nitro precursor. However, this is not always observed. In 
Table 3-1, when the precursor molecule did not include electron donating groups, the 
RCYs of bromo and chloro precursors were close to that of nitro precursors 
(substitution patterns 1 and 2). On the contrary, the bromo and chloro precursors 
showed lower RCYs than nitro precursors when methoxy groups were present 
(substitution patterns 3 and 5). In addition, in the case of substitution pattern 6, the 
RCYs of bromo and chloro precursors were even a little bit higher than that of the 
nitro precursors because there was a side reaction competing with SNAr during the 
labeling reaction for the nitro-precursor. An approach to explain this result is given in 
paragraph 3.2.3. The iodo precursor, as the most inactive LG mentioned in the 
literature, showed the lowest RCY. 
As expected, the leaving group quality in SNAr reaction generally follows the order: 
F > [N+Me3OTf-] ≈ NO2 > Br ≈ Cl > I. However, this order is not always mirrored by 
the detected RCYs, because competitive reactions coexist during the nucleophilic 
aromatic substitution reaction. Even though, the nitro derivatives are the most 
promising precursors because they show good RCYs in most cases and can easily 
be separated from the 18F-labeled products to give products with high specific activity. 
Furthermore, the synthesis of the nitro precursors is usually straightforward. 
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Therefore, the precursors in the further work, modeling different aromatic amino 
acids, derive from 2-nitrobenzaldehyde or 4-nitrobenzaldehyde. 
Table 3-1. RCYs in model compounds with different LGs 
RCY (%) Substituion 
pattern F NO2 Cl Br I N+Me3OTf- 
1 
LG
O
 
75 ± 167 84 ± 0.3 65 ± 167 73 ± 0.267 -- -- 
2 
LG
O
 
78 ± 0.567 81 ± 567 67 ± 367 75 ± 0.567 -- 88 ± 1 
3 
LG
O
CH3
O
 
83 ± 3 57 ± 1 31 ± 4 28 ± 4 18 ± 2 35 ± 4 
5 
LG
O
CH3
O
O
CH3  
88 ± 1*, 67 87 ± 2 57 ± 6*, 67 36 ± 2 -- -- 
6 
O
CH3
LG
 
79 ± 3 48 ± 5 62 ± 8 52 ± 2 -- -- 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 
140 °C, within 30 min.  
*: precursor (20 mg). 
Maximum RCY is presented. 
3.2.1.4 Solvent dependence 
Solvents have great effects on the nucleophilic aromatic fluorination reaction. This 
type of reaction is favoured in dipolar aprotic solvents, where the suppression of the 
nucleophilicity of the 18F- ion by solvation is smallest. A commonly used solvent is 
DMSO.80, 81 However, in a previous report82, 83 (Table 3-2), compounds presenting 
substitution pattern 5 with different leaving groups were labeled in different solvents 
(DMSO, DMF, DMAc, Sulfolane). The results showed that the best RCY was always 
obtained in DMF, whereas with bromo or chloro as the LG, the RCYs in DMSO were 
extremely low. 
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Table 3-2. Dependence of the RCY on Solvent for substitution pattern 582, 83 
RCY (%) 
O
CH3
O
CH3
LG
O
5
 
LG = NO2 LG = Br LG = Cl 
Solvent = DMF 89 ± 2 45 ± 4* 57 ± 6* 
Solvent = DMAc 76 ± 2 27 ± 0.2* 12 ± 4* 
Solvent = Sulfolane 40 ± 2 13 ± 3* 9 ± 0.3* 
Solvent = DMSO 71 ± 2 4 ± 1* 4 ± 1* 
Labeling condition: precursor (20 mg), solvent (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 
140 °C, within 30 min.  
*: at 160 °C. 
Maximum RCY is presented. 
For better monitoring of the labeling reaction, model compounds which have fewer 
substituents on the benzene ring were used (Table 3-3). Similar to the previous 
results of substitution pattern 5, the influence of the solvent on the radiochemical 
yields was strongly dependent on the leaving group. With the fluoro or nitro group as 
a substituent (1-F, 2-F, 1-NO2, 2-NO2), the radiochemical yield was reduced from 
75 ~ 82 % in DMF to 40 ~ 68 % in DMSO. In the case of the chloro or bromo 
precursors (1-Cl, 2-Cl, 1-Br, 2-Br), in DMSO the radiochemical yield decreased to 
less than 2 %, whereas yields of 65 ~ 75 % were obtained in DMF. 
  
Table 3-3. RCY for benzaldehydes only with one leaving group in DMF or DMSO 
LG
O
 
1 
O
LG 
2 
RCY (%) RCY (%) 
DMSO DMSO 
Leaving group 
DMF This study Literature DMF This study Literature 
F  75 ± 1  64 ± 4 -- 78 ± 0.5  56 ± 4 -- 
NO2  84 ± 0.3  68 ± 0.4 53-7835, 80, 84-88 81 ± 5  40 ± 3 53-7535, 80, 85-89 
Cl  65 ± 1  0.6 ± 0.3 -- 67 ± 3  1 ± 0.8 1-680, 89 
Br  73 ± 0.2  1 ± 0.5 -- 75 ± 0.5  1 ± 0.6 3-780, 89 
Labeling condition: precursor (10 mg), solvent (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 140 °C, within 30 min.  
Maximum RCY is presented. 
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In order to better understand the labeling reactions in DMF and DMSO, the case of 
1-Br versus a possible effect of oxidation was examined. HPLC analysis showed the 
formation of the corresponding substituted benzoic acid as result of the oxidation of 
the aldehydic group (Figure 3-6). In DMSO, more than 90 % of 1-Br was oxidized 
within 3 min. In DMF, less than 5 % of benzoic acid was formed and after 1 min the 
amount of benzoic acid did not change. These results show oxidation proceeds 
rapidly in DMSO resulting in low labeling yields. Interestingly, no 18F-labeled benzoic 
acid derivatives were observed. 
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Figure 3-6. Oxidation of 1-Br to 2-bromobenzoic acid during labeling reactions in DMF or DMSO 
The effect of the carbonyl group para or ortho to the LG should be similar when 
substituent effects are considered on the basis of mesomeric interactions. In DMF, 
ortho and para isomers were similarly substituted by [18F]fluoride ion independent of 
the LG (Table 3-3). In DMSO, no differences between ortho and para isomers were 
noted except in the case of the nitro group as the LG. The ortho isomer (1-NO2) 
showed a radiochemical yield of 68 ± 0.4 %, the para isomer (2-NO2) only 40 ± 3 %. 
For 1-NO2 and 2-NO2, the labeling reactions in both solvents were also analyzed by 
HPLC. 
In DMF, the formation of oxidation products was always much slower and the 
concentration of benzoic acid remained below 10 % (Figure 3-7 and Figure 3-8) and 
good labeling yields, i.e. 84 ± 0.3 % and 81 ± 5 %, for 1-NO2 and 2-NO2 were 
observed, respectively. 
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Figure 3-7. Formation of 2-nitrobenzoic acid by oxidation of 1-NO2 during labeling reactions 
in DMF or DMSO 
0 5 10 15 20 25 30
0
20
40
60
80
100
S
ub
st
ra
te
 / 
%
Time / min
 4-nitrobenzaldehyde (2-NO2) in DMF
 4-nitrobenzaldehyde (2-NO2) in DMSO
 4-nitrobenzoic acid in DMSO
 4-nitrobenzoic acid in DMF
 
Figure 3-8. Conversion of 2-NO2 during labeling reactions in DMF or DMSO 
In DMSO, almost 40 % of 1-NO2 was oxidized to benzoic acid within 30 min. The 
oxidation proceeded faster than in DMF without giving rise to any other by-products 
(Figure 3-7). Therefore, the radiochemical yield (68 ± 0.4 %) was lower than in DMF 
(84 ± 0.3 %). Labeling of 2-NO2 in DMSO was accompanied by a high degree of 
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oxidation. After 30 min there was almost no precursor left due to the conversion to 
benzoic acid (ca. 50 % of the precursor) and an unidentified by-product (Figure 3-8), 
but the radiochemical yield (40 ± 3 %) did not decrease significantly. Neither benzoic 
acid nor the other by-product were detected as radioactively labeled products. 
The small amount of oxidation of bromo and nitrobenzaldehyde (Figure 3-6 –
 Figure 3-8) in DMF observed at the beginning of the reaction may be due to 
dissolved oxygen. The high oxidation rates observed in DMSO, however, seem to be 
the result of an oxidation process mediated by this solvent. DMSO is known to be a 
superior reagent for the oxidation of alcohols to carbonyl compounds when it is 
activated by an electrophile.90-92 The oxidation of benzaldehydes substituted with 
electron-withdrawing groups by DMSO in the presence of K2CO3 can be rationalized 
as an electrophilic addition of the aldehyde to the nucleophilic oxygen in DMSO, 
followed by deprotonation of the resulting sulfonium intermediate. The sulfur ylide, 
thus formed, may finally decompose under internal hydrogen abstraction into the 
anion of the benzoic acid and dimethylsulfide (Figure 3-9). In this study, benzoic acid 
was detected by HPLC and dimethylsulfide by GC/MS analysis. 
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Figure 3-9. Suggested mechanism for the oxidation of substituted benzaldehydes in DMSO 
In the case of isomers 1 and 2, substitution by [18F]fluoride ion was reduced because 
the Cl and Br groups are poorer LGs (Table 3-3). In these cases, the competing 
oxidation prevailed. As already pointed out, the radiolabeled benzaldehydes formed 
by nucleophilic displacement by [18F]fluoride ion did not suffer from subsequent 
oxidation by DMSO. In all cases the fluorine was introduced either ortho or para to 
the aldehydic function. Despite its strong electron-withdrawing character, fluorine is 
also a strong +M-donor. This mesomeric effect lowers the electrophilic character of 
the aldehydic carbon and may protect the aldehyde from oxidation. 
48 RESULTS AND DISCUSSION 
 
In conclusion, DMF is superior to DMSO as a solvent in the labeling reaction of 
benzaldehydes by SNAr. Benzaldehydes with bromo or chloro substituents as leaving 
groups give very low radiochemical yields in DMSO due to rapid oxidation. 
3.2.1.5 Effects of [18F]nucleophile, concentration of precursor, 
temperature and reaction time  
In order to achieve “naked” [18F]fluoride ion of high nucleophilicity, the 
tetraalkylammonium carbonates (hydrogen carbonates) or the aminopolyether 
Kryptofix 222 in combination with potassium carbonates or oxalate (TBA+18F- or 
[K2.2.2-K]+18F-) are widely adapted in the literature.10, 13, 19 In this work, the Kryptofix 
system was used for all radiofluorination reactions. 
In a previous report,82 the influence of the concentration of the precursor and reaction 
temperature effects were studied in detail with substitution pattern 5. It was found 
that the RCY was improved by increasing the concentration of the precursor, but 
when this concentration was higher than 10 mg/mL, the RCY reached a plateau. In 
addition, the optimum temperature for labeling with [18F]fluoride ion was 140 °C (tests 
were carried out in the range of 100 - 160 °C). 
In this study, the RCY for the labeling reaction was investigated at different time 
points, and kinetic curves were plotted. In most cases, the nucleophilic aromatic 
fluorination proceeded quickly and the maximum RCY was reached after 10 - 20 min.  
In order to systematically study the nucleophilic aromatic 18F-fluorination, the 
following experiments were carried out under optimized conditions which were 
determined as: 10 mg precursor is labeled with [K/2.2.2-K]+ 18F- in DMF (1 mL) at 
140 °C within 30 min. 
3.2.1.6 Analytical assay of 18F-labeled product 
In analytical radiochemistry, the standard protocol for checking the identity and purity 
of 18F-labeled products is carried out by radio-TLC and radio-HPLC (Method 1).93 In 
this work, however, a few of the fluoro reference compounds were not available and 
could not be synthesized. In this case, only the purity of product could be checked by 
Method 1, and the identity of product was assured by Method 2 or Method 3.  
Method 1: The solutions of labeling reactions are analyzed by TLC and an 
Instantimager using the fluoro reference compounds as standards. Due to the lower 
resolution of TLC or the volatility of 18F-labeled products (i.e. [18F]fluorobenzene, 
[18F]fluoroanisole), HPLC equipped with a NaI(Tl)-scintillation detector is used for 
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additional identification. 18F-labeled products are identified in the radio-HPLC by the 
nonradioactive reference standards via comparison of their UV signal with the 
radioactive signal. The fraction of radioactive product is collected and measured by a 
gamma-counter to give the RCY in the labeling reaction. In order to avoid error by 
coincidence in the HPLC retention time, the 18F-labeled product could be verified by 
using another different characteristic column i.e. a reverse phase C18 column and a 
phenyl hexyl column. In this study, most precursors (in the case of availability of 
reference standards) were analyzed by this standard method (radio-TLC 
accompanied by radio-HPLC analysis). 
Method 2: Labeling reactions are performed in the presence of a K19F (spray-dried) 
carrier (c.a. reaction, see paragraph 5.3.2). In this case, the carrier-added 
nucleophilic fluorination allows analyses by LC/MS in addition to detection by 
Radio-HPLC. Thus, by finding the mass of the 19F-product within the fraction of the 
eluted 18F-labeled product characterised by the retention time, the identification is 
independently assured.  
Because the concentration of the 18F-labeled product is much lower than the 
detection limit of the LC/MS, the K19F carrier is added to increase the concentration 
of fluorinated product. However, the addition of the carrier decreases the fluorination 
yield in the labeling reaction. A different approach to reach the detection limit by 
concentrating the labeling solution is not feasible. Therefore, an appropriate amount 
of carrier, 8.6 µmol K19F, was added in the labeling reaction. 
Method 3: Precursors are chosen having the same chemical structure, except for a 
different leaving group, so that they result in the same product, i.e. substitution of the 
bromo and nitro group leads to the same 18F-labeled product, which is identified by 
the corresponding retention time on HPLC.  
In this work, verification of the 18F-labeled products (some methoxy- or 
methyl-substituted compounds) were carried out by Method 2 and Method 3. 
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3.2.2 The effect of methoxy substituents on the SNAr reaction 
3.2.2.1 Selection of protective groups for the hydroxyl group 
In the case of the nucleophilic aromatic substitution used for radiofluorination, it is 
particularly important to avoid free –OH or –NH2 groups by means of appropriate 
protecting groups. The reason is that the reactivity of the [18F]fluoride ion is 
decreased due to strong interactions of the [18F]fluoride ion with the acidic hydrogens. 
Acidic hydrogens can be present as impurities i.e. protic solvent residues or traces of 
unprotected precursor. Because of the fact that the concentration of precursor 
(0.03 – 0.07 mmol/mL) is much higher than the concentration of the [18F]fluoride ions 
(0.5 – 1.6 pmol/mL) in the labeling reaction, even an impurity of 0.1 % or less acidic 
hydrogens is still in large excess with respect to the amount of [18F]fluoride ion. 
Therefore, the presence of acidic hydrogens has to be avoided in SNAr with great 
care. To produce 18F-labeled phenolic amino acids, protection of the phenolic 
hydroxyl group is essential. 
According to the literature, many protective groups are applicable to protect phenol. 
In this work the protective groups should match the following demands. First, they 
should be stable towards the labeling reaction conditions (temperature: 100 - 160 °C, 
pH: 8 - 12) and the conditions used during subsequent synthetic steps. In addition, 
they should also allow relatively easy deprotection at the last synthetic step. In 
previous work,67 phenol ethers were chosen as protected phenols because of the 
relatively high stability and selective deprotection under acidic conditions (conc. HI, 
150 °C).94  
Table 3-4. The influence of different ether as protected phenol 
R =  O
O
R
N
+
O
-
O
 
-CH3 
(3-NO2) 
-C2H5 
(12-C2H5) 
-C3H7 
(12-C3H7) 
-C4H9 
(12-C4H9) 
-Bn 
(12-Bn) 
-CF3 
(12-CF3) 
RCY (%) 57 ± 1 63 ± 3 60 ± 2 60 ± 2 50 ± 1 60 ± 1 
δ Carom-NO2  
in 13C NMR (ppm) 
141.8 141.6 141.6 141.6 141.9 147.9 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 
140 °C, within 30 min.  
Maximum RCY is presented. 
As shown in Table 3-4, based on the structure of 5-hydroxy-2-nitrobenzaldehyde, the 
dependence of RCY on differentially-protected phenol hydroxyl was studied. Since 
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the angle between the benzene ring and the plane of the protective group influences 
overlap between the lone pairs on the oxygen atom and the π-system of the aromatic 
ring, the size of alkyl part in the ether could have an effect on this overlap, hence, 
there will be a changing of the π-electron densities at the para carbon atoms, a 
phenomenon which is verified by 13C NMR chemical shift. However, in Table 3-4, the 
13C chemical shift of NO2-Carom showed no significant difference for compounds 
3-NO2, 12-C2H5, 12-C3H7, 12-C4H9 and 12-Bn (141.6 - 141.9 ppm). Consequently, 
RCYs were also not markedly influenced by different type of phenol ether 
(50  ~ 61 %). 
In addition, in the phenol ether, the electron density on the oxygen can be decreased 
by strong electron-withdrawing –I-effects of alkyl part, such as the trifluoromethyl 
group. As a consequence, the +M resonance effect on the para carbon atoms is 
reduced. Indeed, in compound 12-CF3, the electron density of the para carbon atoms 
bearing the LG was decreased (13C NMR chemical shift of NO2-Carom = 147.2 ppm). 
However, the RCY was at the same level (60 %) when compared to the RCYs of the 
other phenol ethers. It is noteworthy that there was a radioactive by-product 
(RCY = 15 %) in the first 3 minutes of the reaction. This product was proposed to 
arise from the isotopic exchange (18F for 19F) on the trifluoromethyl group, but was 
not additionally analyzed. 
All of those results indicated that modifying the phenolic precursor with different types 
of phenol ethers did not clearly increase the RCY. Finally, the methyl ether was 
chosen as the protection of the phenolic substrate in this study because methoxy 
compounds are most commonly available or are conveniently synthesized. 
3.2.2.2 Effect of methoxy groups  
In the case of 5-methoxy-2-nitrobenzaldehyde (3-NO2), a radiochemical yield of 5 % 
was reported for the substitution of NO2 by 18F.84 This poor RCY may be understood 
in terms of the strong +M-effect of the -OCH3 substituent p-oriented to the LG. 
Compared to this result, the radiochemical yields (25 ~ 55 %) obtained for 
4,5-dimethoxy-2-nitrobenzaldehyde (5-NO2) as precursor95, 96 may be considered to 
be high. These results prompted a systematic study on the dependency of the RCYs 
on the number and positions of methoxy groups present in o-nitrobenzaldehydes.  
The investigations were performed on 11 methoxylated o-nitrobenzaldehydes and 
compared with the RCY of 2–nitrobenzaldehyde (1-NO2) in the nucleophilic 
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fluorination reaction. The labeling results (time dependence curve) are presented in 
Figures 3-10. 
In all cases, the maximum RCY was normally reached within 5 - 10 min. In 
substitution patterns 3, 5, 13, 18, 19 and 20, carrier (K19F) added reactions were 
carried out. For both reactions (n.c.a. and c.a. nucleophilic fluorination), similar trends 
of yield curves were observed indicating both reactions proceeded by principally the 
same substitution mechanism. For compounds 13-NO2 and 18-NO2, only the 
maximum RCY was checked in this c.a. labeling reaction. In addition, in compounds 
3-Br, 5-Br, 15-Br, 17-Br, 19-Br and 20-Br, the nitro substituent was replaced with 
bromine. Results similar to the nitro compounds were observed; however, due to the 
poorer qualities of the bromo substituent as a LG, the radiochemical yields were 
generally much lower. 
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140 °C, within 30 min.  
Maximum RCY is presented. 
Figure 3-10. The dependence of RCY on reaction time for differentially-methoxylated 
o-nitrobenzaldehydes 
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With 1-NO2, a maximum radiochemical yield of 84 % was observed. The derivatives 
obtained by introduction of an increasing number of methoxy groups to the aromatic 
ring of 1-NO2 can be roughly divided in three groups with respect to the maximum 
incorporation yield of 18F (Figure 3-11). 
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Figure 3-11. Classification of ortho nitrobenzaldehyde derivatives by Maximum RCYs 
Remarkably high yields close to, or even above, the value for 1-NO2 were noted for 
compounds 4-NO2 (89 %), 13-NO2 (79 %), 5-NO2 (87 %), 18-NO2 (86 %) and 19-NO2 
(82 %). These compounds have a methoxy group at C–4 (meta oriented with respect 
to NO2) in common. Lower, although still satisfactory, radiochemical yields were 
found for the fluorination reaction of 16-NO2 (70 %), 14-NO2 (70 %), 3-NO2 (57 %) 
and 20-NO2 (48 %). Compound 17-NO2, which is substituted with two methoxy 
groups in the o– and p–position to the LG showed a significantly lower maximum 
yield of only 13 %. Similarly, the yield of 15-NO2 was low (22 %). In this case, the 
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reason could be the formation of a radioactive by–product of unknown structure 
accounting for a yield of 15 %. 
The electronic influence of methoxy groups on aromatic rings is described by a 
combination of the electron-donating +M-effect and the electron-withdrawing –I-effect. 
With respect to the ortho and para positions relative to the methoxy-substituted 
carbon atom, the mesomeric effect dominates, and therefore renders nucleophilic 
attack more difficult. Indeed, both, the 3-methoxy-(14-NO2) and the 5-methoxy-
substituted derivative (3-NO2) gave lower yields in comparison to the reference 
compounds 1-NO2. The lowest yield was observed when both positions were 
simultaneously methoxylated (17-NO2). In contrast, introducing the -OCH3 group in 
position 4 (4-NO2) and 6 (13-NO2) (both in the meta position to NO2) did not result in 
a larger change of the radiochemical yields. For meta positions, the electron-
withdrawing –I-effect becomes more important, which should result in an increase of 
the reactivity of the nitro-substituted carbon towards nucleophilic attack. On the other 
hand, in this substitution pattern the methoxy group suppresses to some extent the 
activating effect of the ortho-formyl substituent by +M-donation (Figure 3-12).  
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Figure 3-12. Effect of the methoxy group in para position to the formyl group 
The combined action of both effects may be the reason why such derivatives give 
more or less the same radiochemical yield as the reference compound 1-NO2.  
The overall effect of the presence of both o/p- and m-methoxy groups is difficult to 
predict because steric effects may additionally become superimposing to the 
electronic effects.84 In particular, steric hindrance works against the +M-effect 
because the orbital overlap between the lone pair on the oxygen atom and the 
aromatic π-system becomes disturbed. The total effect of all substituents and the 
electron density of the carbon atom bearing the leaving group may be derived from 
the 13C NMR chemical shifts of this carbon position.  
The 13C NMR chemical shift of the nitro-substituted C-atom in the 
o-nitrobenzaldehydes studied (Table 3-5) were in the range between δ = 132 ppm 
(17-NO2) and 151 ppm (4-NO2). 
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Table 3-5. 13C NMR chemical shifts of the nitro–substituted carbon and rate constants 
(k*, at 1 min) of methoxy–substituted 2–nitrobenzaldehydes 
Compounds δ CArom-NO2 k* min-1 RCY at 1 min 
4-NO2 151.0 2.00 87 ± 0.6 
1-NO2 149.1 1.62 80 ± 2 
13-NO2 148.1 1.19 70 ± 0.4 
19-NO2 143.8 1.09 66 ± 2 
5-NO2 143.6 1.32 73 ± 2 
18-NO2 142.3 1.11 67 ± 6 
3-NO2 141.8 0.62 46 ± 1 
15-NO2 139.0 0.09 9 ± 0.5 
20-NO2 137.8 0.48 38 ± 2 
14-NO2 137.2 0.61 46 ± 3 
16-NO2 137.1 0.65 48 ± 2 
17-NO2 131.9 0.01 1 ± 0.2 
In the reports of Rengan et al.87 and Ding et al.,84 a correlation of the RCY with the 
deshielding of the carbon atom bearing leaving group was studied (R2 = 0.87;87 
R2 = 0.5384). However, the compounds involved in both reports had different ethers 
as protected phenols. In addition, DMSO was used as the labeling solvent, which can 
cause strong competition reactions due to oxidation of aldehydic functions (see 
paragraph 3.2.1.4). In this work, only the methoxy substituent was used as a 
protected phenol, and DMF was applied instead of DMSO to avoid oxidative side 
reactions. The correlation of maximum RCY with the 13C NMR chemical shift of the 
nitro-substituted C-atom showed a trend but not a good fit (R2 = 0.62) (Figure 3-13). 
The deshielding of the nitro-substituted carbon atom is considered to be a measure 
of its electrophilicity. The question is whether such a reactivity parameter may 
correlate with maximum radiochemical yields or not. In radiofluorination experiments 
the [Precursor] / [18F]F- ratios applied are very high. If no product decomposition and 
side reactions consuming or deactivating 18F- ion intervene, this should result in 
complete incorporation of 18F into the reaction product. Only the time needed for the 
completion of the reaction should vary according to the electrophilicity of the 
precursor. In reality, however, side reactions and product decomposition contribute to 
the outcome of a labeling reaction and decrease the yield. These side effects should 
become more influential as the precursor becomes less reactive. This may explain 
why the maximum radiochemical yields correlate to some extent with the 13C NMR 
chemical shift values as reactivity parameter. 
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Compound 15-NO2 has been omitted because a radioactive by–product (15 %) of unknown 
structure was detected.  
Figure 3-13. Correlation of maximum RCY with 13C NMR chemical shift values 
At the beginning of a labeling experiment any competing side effect lowering the yield 
should be less disturbing. In our experiments, the course of the radiochemical yields 
was determined over 30 min (Table 3-5, Figure 3-10). The strongest yield increase 
was generally observed within the first minute. Provided that the 13C NMR chemical 
shifts are reliable measures of the electrophilicities, these values should give a 
satisfactory correlation with the rate constants (k*) in this reaction interval. Because 
only the measurements after 1 min were available, the pseudomonomolecular rate 
constants derived from the radiochemical yields after 1 min can only be considered 
as estimates. Yet, the k* values showed a satisfactory correlation with 13C-chemical 
shifts (R2 = 0.89). (Figure 3-14).  
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Compound 15-NO2 has been omitted because a radioactive by–product (15 %) of unknown 
structure was detected. 
Figure 3-14. Correlation between k* and 13C NMR chemical shift values 
As outlined before, the more reactive o-nitrobenzaldehyde derivatives with respect to 
the SNAr reaction should have a better chance to escape unwanted side reactions 
and, therefore, attain higher yields in the radiofluorination steps. The precursor 
molecules 19-NO2 and 20-NO2 may illustrate this. 19-NO2 (δ (C-6) = 144 ppm) was 
ca. twofold as reactive as 20-NO2 (δ (C-6) = 138 ppm). The corresponding maximum 
radiochemical yields were 82 % (19-NO2) and 48 % (20-NO2). It should be 
emphasized that the yield obtained from the fully substituted derivative 20-NO2 was 
still acceptable from a practical point of view, and higher than expected when 
comparing with 17-NO2 (13 %, δ (C-6) = 132 ppm).  
From the data compiled in Table 3-5 it can be seen that the precursors with chemical 
shifts of the nitro-substituted carbon atom close to the corresponding value found in 
1-NO2 (δ (C-6) = 149 ppm) give high maximum radiochemical yields, e.g. 4-NO2 
(δ (C-6) = 151 ppm), 89 %; 19-NO2 (δ (C-6) = 144 ppm), 82 %.  
In these cases, because of the high reactivities of the precursors towards the SNAr 
reaction, side reactions did not play an important role, and high yields (≥ 80 %) 
resulted in the radiofluorination. However, for the less reactive precursors exhibiting 
δ-values in the range of 132 to 137 ppm, a decrease in the radiofluorination yields 
(13 ~ 70 %) was observed. Because the yields went through a maximum within the 
reaction interval of 30 min, the reduced yields could not be explained by insufficiently 
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long reaction times. Obviously, with compounds less prone to the SNAr reaction, 
other processes consuming 18F- ion became important.  
In the course of our experiments with methoxylated o-nitrobenzaldehydes, indications 
of possible side reactions were indeed obtained. LC/MS measurements revealed the 
formation of phenolates which could be formed in an SN2-like demethylation by attack 
of F- at the methoxy group (Figure 3-15).  
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Figure 3-15. Demethylation of methoxy group by SN2 mechanism 
In all cases a HPLC-peak eluting faster than the starting compound with a mass 
corresponding to the [M-H]- ion of the phenolic demethylation product could be 
detected. In 19F-fluorination of 2,3,4-trimethoxy-6-nitrobenzaldehyde (see 
paragraph 5.2.3.12), the phenolic product was isolated and characterized.  
The proximity of a nitro and formyl group in the precursor molecules could give rise to 
an intramolecular redox process resulting in o–nitrosobenzoic acids. If 
o-nitrosobenzoic acids are formed as side products, they deactivate the nucleophilic 
power of [18F]fluoride ion by interacting with the acidic hydrogens, potentially ending 
up in strong hydrogen bonds. Such intramolecular redox-processes are well known in 
photochemistry97 and electron–impact induced fragmentation (mass spectrometric 
ortho–effect).98 Under these reaction conditions the intramolecular process is initiated 
by abstraction of the aldehydic hydrogen by an unpaired electron on a nitro oxygen 
formed by n-π* excitation and ionisation, respectively. An analogous thermal process 
could be started by intramolecular nucleophilic addition of a nitro oxygen atom to the 
neighbouring carbonyl group (Figure 3-16). 
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Figure 3-16. The intramolecular redox-processes in o-nitrobenzalhyde 
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To test a thermal intramolecular redox reaction as a possible side reaction 
intervening in our labeling experiments, o–nitrobenzaldehyde was heated under 
conditions identical with the labeling experiments except that no fluoride ion was 
present. On heating in DMF in the presence of the K2CO3–crown ether complex, a 
blueish colour built up. Subsequent LC/MS analysis indicated the formation of an 
isomeric compound eluting faster than the starting compound. The mass spectrum 
(ACPI (-) mode) exhibited strong [M–H]– (m/z 150) and [M–H–CO2]– (m/z 106) ions. 
In contrast, the negative ion mass spectrum of the starting compound was dominated 
by the radical anion M-• at m/z 151. The blue colour (typical for C–nitroso compounds) 
and the mass spectral data are in accordance with the formation of 
o-nitrosobenzoic acid. 
In summary, for the nucleophilic aromatic fluorination of methoxylated 
o-nitrobenzaldehydes by [18F]fluoride ion, a correlation has been found between the 
downfield shift of the nitro-substituted aromatic carbon atom in the 13C NMR 
spectrum and the reaction rate at the beginning of the reaction. Side reactions and 
product decomposition decrease the radiochemical yields to some extent as the 
reaction proceeds, and become relevant in the cases of less reactive precursor 
molecules.  
4-Methoxy-2-nitrobenzaldehyde (4-NO2), 4,5-dimethoxy-2-nitrobenzaldehyde (5-NO2) 
and 3,4-dimethoxy-2-nitrobenzaldehyde (18-NO2) are potential candidates for the 
syntheses of 18F-labeled tyrosine and DOPA, respectively, when the aldehydic 
function is utilized for connecting the aromatic substructure with the amino acid 
residue. All the three o-nitrobenzaldehyde precursors gave high maximum 
radiochemical yields (> 85 %). Even the threefold and fourfold methoxylated 
precursors 19-NO2 and 20-NO2 reacted in remarkably good yields to furnish the 
corresponding 18F-labeled products (82 % and 48 %, respectively).  
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3.2.3 The effect of methyl substituent on SNAr reaction 
In a further approach towards the final goal of synthesizing 18F-labeled aromatic 
amino acids, the radiofluorination of compounds having a methyl group to mimic the 
protected glycine residue was examined. 
3.2.3.1 Dependence of RCY on LG 
Methyl-substituted precursors, modeling [18F]fluorophenylalanine, [18F]fluorotyrosine 
and [18F]FDOPA, were labeled with 18F via SNAr. The radiochemical yields were 
dependent on different LGs such as nitro, fluoro, bromo and chloro groups 
(Table 3-6). 
Table 3-6. RCYs of the precursors modeling 18F-labeled aromatic amino acids 
(i.e. effect of different leaving groups) 
LG Substitution 
pattern NO2 F Cl Br 
Modeling 
6 LG
CH3
O  
48 ± 5 % a 79 ± 3 % a 62 ± 9 % a 52 ± 2 % a [
18F]fluoro 
phenylalanine 
8 
CH3
O
CH3
LG
O
 
3 ± 1 % a 75 ± 2 % a 14 ± 3 % a 10 ± 2 % a [
18F]fluoro-m-
tyrosine 
9 
LG
OO
CH3
CH3  
52 ± 6 % b 85 ± 5 % b 9 ± 2 % b 29 ± 2 % b [
18F]fluoro-p-
tyrosine 
10 O
CH3
O
LG
CH3
 
69 ± 8 % b 80 ± 8 % b 32 ± 3 % b 36 ± 5 % b 
[18F]fluoro-p-
tyrosine 
11 
CH3
O
CH3
LG
OO
CH3
 
1 ± 1 % b 76 ± 6 % b 3 ± 1 % b 3 ± 2 % b [18F]FDOPA 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), within 
30 min. a: 140 °C, b: 120 °C73. 
Maximum RCY is presented. 
For all of these compounds (Table 3-6), the RCYs were highest for the fluoro 
substituent as a LG. As a general tendency, the bromo and chloro substituent as the 
LG led to similar labeling results, which are usually lower than the RCYs in the 
precursor with a nitro substituent as a LG.83 However, in Table 3-6 the RCYs of the 
nitro compounds varied from high (10-NO2, 69 %) to low (11-NO2, 1 %). For 
substitution patterns 6, 8 and 11, the nitro precursors showed even lower RCYs than 
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the bromo or chloro precursors. In addition, the maximum RCY was normally 
reached within 5 min to 10 min, except for 11-F, where the maximum RCY was 
reached after 30 min. 
3.2.3.2 Influence of the methyl group 
In paragraph 3.2.2, for the precursors bearing a different number of methoxy groups 
in different substitution patterns, the correlation between the pseudomonomolecular 
rate constants k* (determined from the RCY at t = 1 min) and the 13C NMR chemical 
shifts of the carbon atom with the LG (-NO2) was described. 
Whereas for methoxylated o-nitrobenzaldehydes the plot exhibited a satisfactory fit 
(R2 = 0.89, Figure 3-14), this was not the case for the corresponding precursors 
bearing a methyl group (6-NO2, 7-NO2, 8-NO2, 9-NO2, 10-NO2 and 11-NO2). The 
data were plotted as (k* vs δ, R2 = 0.27) (Figure 3-17).  
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Figure 3-17. Correlation between k* (1 min) and (δ) 13C NMR chemical shifts of 
the carbon atom substituted by LG  
This poor correlation for the compounds with a methyl group seems to be caused by 
the influence of the methyl group. Kilbourn et al.87 suspected that the [18F]fluoride ion 
was deactivated by the methyl group, but did not propose a mechanism.  
In order to explain this observation, the problem was approached systematically by 
comparing methyl-substituted compounds with their analogues. Compounds carrying 
either a hydrogen atom or a methoxy group in the position of the methyl group were 
chosen for comparison. The radiochemical yields are presented in Table 3-7.  
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Table 3-7. RCYs of model compounds with hydrogen, methoxy or methyl ortho to NO2 
Substitution 
patterns 
R
N
+
O
-
O
O
 R
N
+
O
-
O
OO
CH3
O
CH3
O
R
N
+
O
-
O
R
O
CH3
N
+
O
-
O
O
 R
O
CH3
N
+
O
-
O
OO
CH3
R = H 84 ± 0.3 %
a 
(1-NO2) 
79 ± 4 % a 
(13-NO2) 
82 ± 2 % a 
57 ± 1% a 
(3-NO2) 
22 ± 2 % a 
(15-NO2) 
R = -OMe 70 ± 3 %
 a 
(14-NO2) 
70 ± 2 % a 
(16-NO2) 
-- 
13 ± 2 % a 
(17-NO2) 
-- 
R = Me 48 ± 5 %
 a 
(6-NO2) 
52 ± 6 % a 
(9-NO2) 
69 ± 8 % b 
(10-NO2) 
3 ± 1 % a 
(8-NO2) 
1 ± 1 % b 
(11-NO2) 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), within 
30 min. a: 140 ° C, b: 120 °C73 
Maximum RCY is presented. 
The introduction of a methyl group or a methoxy group in the ortho position to the 
nitro group always decreased the RCY, but the extent of yield decrease was different. 
This by itself is not surprising as the methyl group increases the electron density of 
the aromatic ring through a +I-effect, hence reducing its reactivity towards 
nucleophilic attack. However, a methoxy group exhibits a stronger electronic effect 
(+M-effect) and, hence, towards nucleophilic attack the reactivity of the reactive 
center should be reduced even more. Therefore, the reduction of the RCY by the 
methoxy group should be more than that by the methyl group. Surprisingly, the 
methoxy group in the position of the methyl group showed a much weaker negative 
effect on the RCY. Therefore, it can be concluded that electronic effects did not have 
the main influence in decreasing the RCY.  
Following the literature by Rengan et al.,87 competition experiments were carried out 
in order to determine which group or substitution pattern can be related to the 
decrease in RCY. 5-NO2 and 3-NO2 with a known RCY were labeled in the presence 
of competitive compounds bearing methyl, nitro and methoxy substituents, either one 
of them or in combination (Table 3-8).  
Neither the addition of toluene, nor that of nitrobenzene and nitro anisole, influenced 
the labeling results. However, compounds with a methyl group ortho to the nitro 
group, i.e. o-nitrotoluene and 5-methoxy-2-nitrotoluene, seemed to have a negative 
effect on the RCY.  
Since the RCY was not decreased in the presence of toluene and nitrobenzene, a 
particular intramolecular interaction between the methyl and nitro group was taken 
into consideration. 
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Table 3-8. 18F-substituion in the presence of toluene or nitrobenzene derivatives 
Competitive compounds 
Precursor for  
18F-substitution None 
CH3 N+
O
-
O 
O
CH3
N
+
O
-
O 
N
+
O
-
O
CH3
 
CH3
O
CH3
N
+
O
-
O
O
CH3
N
+
O
-
O
O
O
CH3
5-NO2
 
87 ± 2 % 82 ± 0.4 % 84 ± 1 % 85 ± 4 % 55 ± 5 % 69 ± 3 % 
O
CH3
N
+
O
-
O
O
3-NO2
 
57 ± 1% 58 ± 1 % 59 ± 1 % 59 ± 1 % 38 ± 1 % 26 ± 7 % 
Labeling condition: precursor (10 mg), DMF (1 mL),3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 
140 °C, within 30 min. 1 Molar eqv. competitive compound was added simultaneously with precursor. 
Maximum RCY is presented. 
For a better understanding of the reaction process, LC/MS analysis was used to 
monitor the labeling reaction. Interestingly, when the competitive compound 
o-nitrotoluene was used, the LC/MS analysis results showed that an unknown 
compound with the mass peak 302 (ACPI (+) mode) was detected in the case of 
5-NO2 and another compound with the mass peak 272 (ACPI (+) mode) was 
detected in the case of 3-NO2. 
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Figure 3-18. Condensation reaction of precursors containing o-nitrotoluene structure 
Similarly, in the LC/MS analysis of the labeling solution of precursors (with the 
o-nitrotoluene substitution pattern in Table 3-6), a compound hinting at a mass of 
(2×M(precursor)-47) was always observed. Two precursors (6-NO2 and 8-NO2) were 
chosen as an example in order to synthesize the detected by-product and 
characterize it. The results showed that this side reaction was a condensation 
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reaction between two precursor molecules (Figure 3-18, Figure 3-19), and details 
were described in another work.73  
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Figure 3-19. The mechanism for condensation reaction during SNAr 
Therefore, in the labeling reaction with the competitive compound o-nitrotoluene 
(Table 3-8), the formation of the unknown compounds can also be explained by the 
condensation side reaction (Figure 3-20) 
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Figure 3-20. Condensation reaction of precursors with competitive compound 
This condensation side reaction can reduce the RCY in the following ways:  
1) The concentration of precursor can be decreased by coupling between two 
precursor molecules.  
2) The acidic protons formed in the first step of the condensation reaction 
(Figure 3-19) can also deactivate the 18F- ion. 
Due to the mechanism of the condensation reaction,73 it can be also explained why 
the RCYs for 9-NO2 and 10-NO2 are better than for 8-NO2 and 11-NO2 (Table 3-6). In 
9-NO2 and 10-NO2, the methoxy substituent is para/ortho to the methyl substituent, 
thus, the ability of the methyl group to abstract a proton is decreased by the 
+M-effect and the nucleophilic substitution remains the dominating reaction. However, 
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in 8-NO2 and 11-NO2, the methoxy group in the p-position to the LG decreases the 
reactivity towards SNAr because of its strong +M-effect. Therefore, the condensation 
reaction becomes the dominant reaction. Moreover, this side reaction was only 
observed for methyl-substituted compounds with NO2 as the LG, not for precursors 
with Br, Cl and F as the LG.  
In summary, for compounds bearing a methyl group the RCY is clearly dependent on 
the LG and the substitution pattern. The isotopic exchange (18F/19F) always proceeds 
easily and in good yield, and the fluorodenitration is strongly influenced by the 
described condensation side reaction. In the case of the precursor with lower 
reactivity, this side reaction becomes dominant, hence resulting in low RCYs.  
3.2.3.3 Attempts to improve the RCY of methyl-substituted precursors 
As described above, in the labeling reaction of nitro substituted compounds (8-NO2 
modeling [18F]fluoro-m-tyrosine and 11-NO2 modeling [18F]FDOPA) the RCYs 
dropped significantly because of the strongly competitive side reaction. Due to the 
high interest in [18F]fluoro-m-tyrosine and [18F]FDOPA for clinical applications, 
attempts to improve the RCY of 8-NO2 and 11-NO2 (Table 3-6) have been made as 
follows. 
Changing the reaction parameters was taken into consideration for suppressing the 
side reaction, i.e. reaction solvents (DMF, DMSO, DMAc), temperature (120 - 160 °C) 
and the type of base (Ce2CO3, K2C2O4 or K2CO3/K2C2O4). The data presented in 
Table 3-9 showed that the change of reaction parameters had very little effect on 
RCY. Moreover, the condensation by-product was still observed by LC/MS analysis 
of reaction solution (at 1 min). All theses results indicate that the side reaction cannot 
be depressed by changing the reaction parameters.  
Table 3-9. Labeling reaction of 8-NO2 with different reaction parameters 
Solvent Temperature (°C) Base RCY (%) 
DMF 160 K2CO3  3 ± 0.1 
DMF 140 K2CO3  3 ± 1 
DMF 120 K2CO3  0.6 ± 0.2 
DMF 140 Ce2CO3  2 ± 0.6 
DMF 140 K2C2O4  2 ± 0.8 
DMF 140 K2CO3/K2C2O4=1/33  1 ± 0.1 
DMF 140 K2CO3/K2C2O4=1/1  0.8 ± 0.1 
DMSO 140 K2CO3  2 ± 0.2 
DMAc 140 K2CO3  2 ± 0.6 
Labeling condition: precursor (10 mg), solvent (1 mL), base (25 µmol) and K2.2.2 (15 mg).  
Maximum RCY is presented. 
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The side reaction takes place when –NO2 is used as the leaving group. In paragraph 
3.2.1.3, it was been mentioned that the trimethylammonium triflate group has a 
similar reactivity as the nitro group. Therefore, the effect of the trimethylammonium 
triflate as the LG was studied with substitution patterns 3, 7 and 10 (Table 3-10). 
Table 3-10. The comparison of NO2 and N+Me3TfO- as LG in substitution patterns 3, 6 and 7 
Substitution patterns LG = NO2 LG = N+Me3TfO- 
7 
LG
CH3
O
 
8 ± 1 % 69 ± 1 % 
10 LG
CH3
O
O
CH3  
69 ± 8 %73 92 %99 
3 
LG
O
CH3
O
 
57 ± 1 % 35 ± 4 % 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 
140 °C, within 30 min.  
Maximum RCY is presented. 
For substitution patterns 7 and 10, the RCYs were increased obviously when the 
trimethylammonium triflate substituent was used as a LG instead of the nitro 
substituent. However, in the case of substitution pattern 3, the trimethylammonium 
triflate substituent as the LG showed a lower RCY than the nitro substituent as the 
LG. In the LC/MS analysis of the labeling reaction solution (3-N+Me3TfO- and 
7-N+Me3TfO-), the condensation by-product was not observed, whereas another 
by-product, 4-(dimethylamino)-3-methylbenzaldehyde ((ACPI (+) mode), [M+H]+, 
m/z 163) or 2-(dimethylamino)-5-methoxybenzaldehyde ((ACPI (+) mode), [M+H]+, 
m/z 180), was detected. According to the literature,100 demethylation can take place 
for the trimethylammonium triflate precursor during the 18F-labeling reaction 
(Figure 3-21).  
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Figure 3-21. Demethylation of the precursor with N+Me3TfO- as LG 
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Nevertheless, high RCYs (69 % and 92 %) were obtained in the case of 7-N+Me3TfO- 
and 10-N+Me3TfO-. This indicated that nucleophilic substitution was still the dominant 
reaction, while the demethylation seemed to have little effect. In the case of 
3-N+Me3TfO-, the methoxy substituent para to the LG could accelerate the rate of 
demethylation reaction by the +M-effect (Figure 3-21). This may explain why 
3-N+Me3TfO- showed a lower RCY than 3-NO2 (35 % and 57 %, respectively). As 
discussed above, RCY was decreased from 57 % (3-NO2) to 3 % (8-NO2) by the 
effect of the condensation side reaction, which starts with the deprotonation of the 
methyl substituent. Comparing the RCY decrease from 3-NO2 to 3-N+Me3TfO- and 
from 3-NO2 to 8-NO2, it was found that the demethylation side reaction shows a less 
negative effect. Therefore, a promising RCY could be obtained by using the 
trimethylammonium triflate substituent as the LG in the model compounds for 
[18F]fluoro-m-tyrosine and [18F]FDOPA. 
During this work, the synthesis of 8-N+Me3TfO- failed because the intermediate 
product 2-(dimethylamino)-5-methoxy-3-methylbenzaldehyde cannot be synthesized 
by a nucleophilic substitution with dimethylamine on 2-fluoro-5-methoxy-
3-methylbenzaldehyde, whereas, this synthetic route works very well for compounds 
3-N+Me3TfO- and 7-N+Me3TfO-.  
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It is planned to synthesize 8-N+Me3TfO- by an alternative pathway (Figure 3-22) 
outside the scope of this thesis. 
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Figure 3-22. An alternative synthetic route for 8-N+Me3TfO- 
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3.2.4 The effect of a second formyl substituent on the SNAr reaction 
As described in paragraph 1.4.3, among many auxiliary substituents for activating 
SNAr, the aldehydic function is one of the best choices for the syntheses of 
18F-labeled aromatic amino acids. This is because the aldehydic function can be 
catalytically removed by decarbonylation or used as starting point for the synthetic 
addition of the amino acid residue to the aromatic part of the molecule. Moreover, the 
results in paragraph 3.2.1 showed that the aldehydic function is efficient for improving 
the RCY, especially when it is located ortho or para to the LG. Therefore, in this 
paragraph two aldehydic functions were introduced in the precursor molecule to 
improve the RCY further.  
3.2.4.1 Effect of a second formyl substituent on the maximum RCY 
In the syntheses of methyl-substituted model compounds for 18F-labeled aromatic 
amino acids, the second aldehydic function can be added on the benzene ring 
depending on the structure of the model compounds. In the case of 
[18F]fluorophenylalanine and [18F]fluoro-p-tyrosine, the second aldehydic group can 
be introduced para to the LG. In the case of [18F]fluoro-m-tyrosine and [18F]FDOPA, 
the second aldehydic group can be only introduced in the meta position to the LG 
(Figure 3-23). 
LG
CH3
O
LG
CH3
OO
CH3
LG
O
CH3
CH3
O
O
CH3
LG
CH3
OO
CH3
CHO CHO
CHO
CHO
CHO
 
Figure 3-23. Dialdehydic function substituted model compounds aiming at 
18F-labeled aromatic amino acids 
The discussion about the effect of aldehydic functions on the RCYs started from the 
compounds without the methyl substituent. Based on the structure of nitrobenzene, 
3-nitroanisole and 4-nitroanisole, the aldehydic functions were added ortho, meta or 
para to the nitro group (Table 3-11).  
The presented data in Table 3-11 showed that a maximum RCY of more than 80 % 
was achieved for compounds 21-NO2, 23-NO2 and 25-NO2, which had two aldehydic 
functions, both ortho to the LG. In the case of 1-NO2, 13-NO2 and 4-NO2, high 
maximum RCYs (79 ~ 89 %) were already observed, therefore the maximum RCY 
[18F]FDOPA [18F]fluorophenylalanine [18F]fluoro-m-tyrosine [18F]fluoro-p-tyrosinemodeling 
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was not improved further when the second aldehydic function was included (84 % for 
21-NO2 and 87 % for 23-NO2). However, in the case of 3-NO2 the maximum RCY 
(57 %) was not as high as 1-NO2, 13-NO2 and 4-NO2 because the reactivity of this 
precursor was decreased by the strong +M-effect of the methoxy substituent para to 
the nitro group. For this kind of substitution pattern, a second aldehydic function ortho 
to the nitro group enhanced the maximum RCY to 80 % (23-NO2). 
Table 3-11. The maximum RCY of the precursors with non, mono or dialdehydic function 
Nonaldehydic 
compound 
Monoaldehydic 
compound Dialdehydic compound 
 
N+
O-
O
 N
+
O-
O
O
 
N+
O-
O
O
O  
N+
O-
O
O
O  
RCY(%) 1 ± 0.1 84 ± 0.3  (1-NO2) 
84 ± 3  
(21-NO2) 
60 ± 3  
(22-NO2) 
 N+
O-
O
O
CH3
 N
+
O-
O
O
O
CH3
 
N+
O-
O
O
O
O
CH3
 
N+
O-
O
O
O
O
CH3
 
RCY(%) 0 57 ± 1  (3-NO2) 
80 ± 0.6  
(23-NO2) 
32 ± 1 
 (24-NO2) 
 N+
O-
O
O
CH3  N
+
O-
O
OO
CH3
 
N+
O-
O
O
CH3
O
 
N+
O-
O
O
O
CH3
O
 
RCY(%) -- 79 ± 4  (13-NO2) 
89 ± 2  
(4-NO2) 
85 ± 173  
(25-NO2) 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 
140 °C, within 30 min.  
Maximum RCY is presented. 
Interestingly, the dialdehydes 22-NO2 and 24-NO2 showed even lower maximum 
RCYs than monoaldehydes 1-NO2 and 3-NO2. This special RCY decrease might be 
caused by an oxidation reaction of the dialdehydic precursor, especially when both 
aldehydic functions are para to each other. That increases the risk of oxidation of the 
aldehyde to benzoic acid due to the strong electron withdrawing effect. Indeed, in the 
LC/MS analysis of the labeling solution of 22-NO2 (labeling condition was same as in 
Table 3-11 but in the absence of 18F- ion), a relative polar by-product was formed in 
the first minute of reaction time and the mass spectrum (ACPI (-) mode) exhibits 
strong ions [M–H]– (m/z 194) and [M–H–CO2]– (m/z 150). This information indicates 
that the by-product is a benzoic acid derivative. However, a source of oxygen for 
oxidation was not known in this experiment. In addition, in the same LC/MS analysis 
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of the labeling solution of 21-NO2, no benzoic acid derivative by-product was 
detected.  
In order to avoid this kind of oxidation in the case of 22-NO2, the labeling reaction 
was performed at a lower temperature (Figure 3-24). However, lower RCYs were 
observed at 120°C or 100 °C, and the benzoic acid derivative could still be detected 
within the first minute of the reaction time by LC/MS analysis.  
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Figure 3-24. 18F-labeling reaction of 22-NO2 at different temperature 
Therefore, the maximum RCY of the monoaldehydic compound can be improved by 
the introduction of a second aldehydic function, but this should meet the following 
conditions: 
1) The reactivity of the monoaldehyde is not very high (maximum RCY ≤ 60 %).  
2) The second aldehydic function should be introduced ortho or para to the LG.  
According to the above requirements, for improving RCYs of monoaldehyde with a 
methyl substituent and a halogen as the LG (9-Cl, 9-Br and 10-Cl, 10-Br), the 
second aldehydic function should be introduced para to the LG (26-Cl and 26-Br).73 
The RCY data presented in Table 3-12 showed that the maximum RCYs were 
enhanced by introduction of the second aldehydic function. 
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Table 3-12. Comparison of RCY in monoaldehydic and dialdehydic compounds with 
a methyl substituent and a halogen as leaving group73 
 
LG
CH3
OO
CH3
 
CH3
LGO
CH3
O
 
LG
CH3
O
OO
CH3
 
LG = Cl 9 ± 2 % (9-Cl) 32 ± 3 % (10-Cl) 85 ± 3 % (26-Cl) 
LG = Br 29 ± 2 % (9-Br) 36 ± 5 % (10-Br) 79 ± 4 % (26-Br) 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 
120 °C, within 30 min.  
Maximum RCY is presented. 
3.2.4.2 Reaction Kinetics in 18F-labeling of dialdehydic compounds 
For 22-NO2, the time dependence curves at 140 °C (Figure 3-25) showed that the 
RCY reached a maximum value (85 %) within the first minute, and then dropped to 
only 1 % after 20 min. This indicates that the labeled dialdehydic compounds are not 
stable under the labeling conditions. In order to avoid decomposition of the labeled 
product, the labeling reaction of 22-NO2 was performed at lower temperatures. It was 
found that the decomposition of the labeled product was depressed by decreasing 
the reaction temperature. At 60 °C the decomposition of the product was almost 
stopped (RCY = 80 % at 30 min), yet the substitution reaction proceeded very fast 
(maximum RCY = 85 % at 1 min). Surprisingly, even at room temperature the 
relatively high maximum RCY (78 %) was still observed at 7 min.  
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Figure 3-25. Time dependence curves in the radiolabeling of 22-NO2 at different temperatures 
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In contrast, for 1-NO2, the time dependence curves (25 - 140 °C) showed that the 
labeled product had a high stability under the labeling conditions, but the reactivity of 
the precursor and reaction rates were decreased at lower temperatures. At 25 °C, the 
RCY was only 10 % after the 30 min labeling reaction (Figure 3-26).  
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Figure 3-26. Time dependence curves in the radiolabeling of 1-NO2 at different temperatures 
This SNAr reaction was also performed at a lower temperature for methyl-substituted 
model compound 26-Cl.73 The time dependence curves are presented in Figure 3-27. 
Although the Cl substituent as the LG decreased the reactivity of the precursor, the 
maximum RCY (30 %) was still found at 25 °C after a 30 min labeling reaction. 
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Figure 3-27. Time dependence curves in the radiolabeling of 26-Cl73 at different temperatures 
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As generally expected, the introduction of a second aldehydic function in the o/p 
position to the LG improves the maximum RCY of precursors with low reactivity and 
accelerates the reaction rates significantly, i.e. even at room temperature 21-NO2 
was labeled in a good yield of 79 % within 10 min. However, introduction of a second 
aldehydic function in the meta orientation to the LG decreases the maximum RCY 
compared to the monoaldehyde, the reason is the rapid formation of a benzoic acid 
derivative in the radiolabeling. 
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3.3 Decarbonylation of the 18F-labeled benzaldehydes 
In order to realize the syntheses of 18F-labeled aromatic amino acids by the 
newly-developed synthetic strategy (see Figure 2-2), the electron withdrawing 
substituent that is able to activate the aromatic nucleophilic substitution should be 
removable after the introduction of the 18F. Among many EWGs, the formyl group 
was chosen due to the possibility of an easy catalytic removal as was principally 
demonstrated.35, 101 However, in these approaches, it was not pursued further, and 
the multi-substituted model compounds (similar to [18F]FDOPA) had not yet been 
studied. In this paragraph, the conditions of the decarbonylation reaction were 
studied with the model compounds for [18F]fluoro-m-tyrosine, and those conditions 
were applied in decarbonylations of multi-substituted monoaldehydes or dialdehydes 
modeling 18F-labeled aromatic amino acids. 
3.3.1 Decarbonylation of model compounds with monoaldehydic 
substituent 
Decarbonylation was tested on multi-substituted benzenes as model compounds, 
such as 8-F, 9-F, 9-NO2, 9-Cl, 9-Br and 11-F, aiming at the syntheses of 
[18F]fluoro-m-tyrosine, [18F]fluoro-p-tyrosine and [18F]FDOPA (Figure 3-28). The best 
reaction conditions were to be determined for an efficient and fast removal of the 
carbonyl function. 
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Figure 3-28. Radiochemical syntheses of model compounds for [18F]fluoro-m-tyrosine, 
[18F]fluoro-p-tyrosine and [18F]FDOPA 
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3.3.1.1 Selection of catalyst 
Decarbonylation reactions are usually performed by two kinds of catalysts: 
Wilkinson's catalyst RhCl(PPh3)3 or a palladium / carbon catalyst. It was found that in 
the syntheses of [18F]fluoroarenes using the corresponding fluorobenzaldehydes, the 
rhodium complex offered quite a few advantages with respect to reaction rates and 
mild conditions in comparison to the palladium / carbon catalyst.101 
The decarbonylation reaction by Wilkinson's catalyst RhCl(PPh3)3 has been 
established as an efficient method to remove the carbonyl function.102, 103  
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Figure 3-29. The mechanism of decarbonylation by rhodium catalyst 
According to the reported mechanism,104, 105 the rhodium-catalyzed decarbonylation 
comprises four elementary steps: (i) coordination of the aldehyde, (ii) oxidative 
addition of the aldehydic C-H to form a rhodium-acyl complex, (iii) migratory extrusion 
of carbon monoxide, (iv) reductive elimination of the product. (Figure 3-29). 
In the following text, RhCl(PPh3)3 was chosen for a systematic study to optimize the 
decarbonylation yields of compound 8-18F. 
3.3.1.2 Solvent dependence 
In the literature, dioxane, 1,2-dichloroethane, benzene and toluene are commonly 
recommended as solvents to achieve the decarbonylation of aldehydes with 
RhCl(PPh3)3.35, 106, 107 Sterically hindered aldehydes require higher temperatures for 
decarbonylation by the rhodium complex. However, at higher temperatures, large 
amounts of the catalyst are transformed to a precipitating brick red dimeric complex 
of di-µ-chloro-tetrakis(triphenylphosphine)dirhodium. According to Ohno and Tsuji, 
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the active rhodium species is stabilized sufficiently in benzonitrile to suppress dimer 
formation.107 Therefore, particular interest was now focused on the application of 
benzonitrile as the solvent for the decarbonylation. 
The decarbonylation of 8-18F was performed in DMSO, dioxane, toluene, DMF and 
benzonitrile with 2 molar equivalents of the rhodium complex (with regard to the 
precursor) at 150 °C (Figure 3-30). After 20 min of reaction time, the following yields 
ware obtained: 65 ± 1 % (DMSO), 61 ± 1 % (dioxane), 53 ± 2 % (toluene), 30 ± 3 % 
(DMF) and 81 ± 1 % (benzonitrile). In accordance with the report of Ohno and Tsuji, 
reaction solutions remained homogeneous in benzonitrile, whereas in the other 
solvents, precipitation of the brick red complex was observed within the first 
5 minutes. Furthermore, TLC analysis revealed the formation of a radioactive polar 
complex commencing at the beginning of the reaction and resulting in the 
consumption of 30 ~ 60 % of the 18F-labeled benzaldehyde after 20 min in all 
solvents except benzonitrile. In the latter solvent, the radioactive polar by-product 
was detected in yields < 5 % at the end of the reaction. 
0 10 20 30 40 50 60
0
20
40
60
80
100
R
C
Y 
/ %
Time / min
 benzonitrile
 DMSO
 dioxane
 toluene
 DMF
 
Figure 3-30. Decarbonylation yield of 8-18F in different solvents with 2 molar eq. catalyst 
(molar eq. based on quantity of 8-F) at 150 ºC 
In the case of 2-[18F]fluoro-4,5-dimethoxy-benzaldehyde (5-18F), a yield of 84 ± 5 % 
was reported35 for the decarbonylation using 2 molar equivalents of the catalyst in 
dioxane as solvent at 150 °C after 15 min. Another group,108 however, using the 
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same reaction protocol, obtained only 59 % yield as was also observed in our 
experiments.  
The data of Ohno and Tsuji and those presented in this study clearly demonstrate 
that benzonitrile is the solvent of choice in order to obtain an efficient decarbonylation 
with Wilkinson's catalyst. 
3.3.1.3 Influence of temperature 
In the case of decarbonylating 8-18F, the influence of the temperature was evaluated 
by using 1 mL of benzonitrile as the solvent and 2 molar equivalents of Wilkinson´s 
catalyst. A change of temperature between 100 ºC and 180 ºC clearly enhanced the 
decarbonylation yield (Figure 3-31). At 180 ºC, the reaction was finished with 
maximum yield of 89 ± 1 % within 10 min. 
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Figure 3-31. Temperature dependence of decarbonylation yield of 8-18F in 1mL benzonitrile with 
2 molar eq.cat (molar eq. based on quantity of 8-F) 
3.3.1.4 Effect of catalyst concentration 
In a strict definition, a catalyst accelerates a reaction without being consumed. In a 
homogeneous hydrogenation, the active form of Wilkinson's catalyst (RhCl(PPh3)2S, 
S = solvent) enters a catalytic cycle and is regenerated each time. In contrast, in the 
decarbonylation of aldehydes the active species becomes transformed in a 
stoichiometric reaction to a rhodium carbonyl complex (RhCl(PPh3)2CO), which is 
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unable to mediate further decarbonylation.109 Therefore, the minimum requirements 
for the decarbonylation of an aldehyde are equimolar amounts of the rhodium 
complex. 
Compound 8-18F was reacted in benzonitrile at 150 °C in the presence of 1, 2 and 
3 molar equivalents of RhCl(PPh3)3 (molar equivalents of catalyst were based on the 
quantity of the labeling precursor, Figure 3-32). When 1 molar equivalent catalyst 
was used, only 4 % of the product was formed after 30 min. When the catalyst 
concentration was increased, a marked increase of the yield was observed. With 
2 molar equivalents of catalyst, the decarbonylation yield was 81 ± 1 % after 20 min, 
and with 3 molar equivalents the reaction resulted in 90 ± 0.3 % of decarbonylation 
after 7 min. 
As pointed out before, the decarbonylation of aldehydes by Wilkinson's catalyst 
requires stoichiometric amounts of the complex. When investigating the reaction of 
8-18F in benzonitrile at 150 °C, a distinct yield dependence of the decarbonylation 
product on the molar equivalents of the rhodium complex was found (Figure 3-32). 
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Figure 3-32. Decarbonylation yield of 8-18F with different catalyst concentrations 
(molar eq. based on quantity of 8-F) in 1mL benzonitrile at 150 ºC 
For compound 8-18F, maximum decarbonylation yields of 90 ± 0.3 % or 89 ± 1 % 
were obtained with 3 molar eq. of catalyst at 150 ºC, or with 2 molar eq. catalyst at 
180 ºC in benzonitrile after 10 min, respectively. However, performing the 
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decarbonylation with 2 molar equivalents of the catalyst in 1 mL benzonitrile at 
150 °C facilitated the analytical control of the reaction progress. Therefore, these 
conditions were chosen for further investigation. 
3.3.1.5 Decarbonylation of multiply-substituted model compounds under 
optimized condition 
Three kinds of methyl-substituted model compounds were applied with methoxy 
groups in different positions (Figure 3-28, Table 3-13). The reaction conditions 
described above were utilized in the decarbonylation of compound 8-18F, 9-18F and 
11-18F. After 30 min the decarbonylation yield reached 85 ± 1 % of 4-[18F]fluoro-3-
methylanisole (modeling [18F]fluoro-m-tyrosine). The yield of 3-[18F]fluoro-4-
methylanisole (modeling [18F]fluoro-p-tyrosine) was 87 ± 3 % from 9-F; 89 ± 1 % from 
9-NO2; 87 ± 2 % from 9-Cl and 89 ± 3 % from 9-Br. For 4,5-dimethoxy-2-
[18F]fluorotoluene (modeling [18F]FDOPA), the yield was 92 ± 2 %. Thus, the 
presence of even two methoxy substituents appears to have no effect on the ease of 
decarbonylation. 
  
Table 3-13. Radiochemical yield of model compounds with substitution patterns (8, 9 and 11) in radiolabeling and decarbonylation 
Radiolabeling* Decarbonylation** 
Precursor Product RCY(%)  in DMF 
RCY(%)  
in DMSO Product 
Y(%)  
at 20min 
Y(%)  
at 30min 
O
CH3
O
F
CH3  
8-F 
CH3
F18
O
O
CH3
 
8-18F 
73 ± 4 -- 
CH3
F18
O
CH3
 
81 ± 1 85 ± 1 
9-F (LG = F) 85 ± 5 -- 87 ± 2 87 ± 3 
9-NO2 (LG = NO2) 52 ± 6 33 ± 9 88 ± 2 89 ± 1 
9-Cl (LG = Cl) 9 ± 2 -- 85 ± 3 87 ± 2 LG
OO
CH3
CH3  9-Br (LG = Br) 
CH3
F18
OO
CH3
 
9-18F 29 ± 2 -- CH3
F18
O
CH3
 85 ± 3 89 ± 3 
O
CH3
F
O
CH3
CH3
O
 
11-F 
CH3
F18
O
CH3
O
CH3 O
 
11-18F 
76 ± 6 -- 
CH3
F18
O
CH3
O
CH3
 
89 ± 2 92 ± 2 
*: 0.05 mmol precursor in 1 mL of labeling solvent at 140 ºC. 
**: 2 molar eq. RhCl(PPh3)3 (based on labeling precursor), 150 ºC, 1 mL benzonitrile. 
Maximum RCY and decarbonylation yield are presented in the Table. 
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3.3.2 Decarbonylation of model compounds with dialdehydic functions 
In paragraph 3.2.4, the 18F-labeling reaction of the precursor with dialdehydic 
substituents was discussed. When both aldehydic functions were placed ortho or 
para to the nitro group, high RCYs were observed. As important results, it can be 
seen that both aldehydic groups can be efficiently decarbonylated in one synthetic 
step.  
In this part, based on the optimized decarbonylation conditions of the 
monoaldehydes, the decarbonylation of dialdehydes was performed in benzonitrile at 
120 - 150 °C with different amounts of Wilkinson's catalyst (3 or 4 molar eq. based on 
the quantity of the labeling precursor), and 23-18F was chosen as a model compound 
for this investigation.  
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Figure 3-33. Decarbonylation yield of 23-18F with different catalyst concentrations and 
temperatures in 1mL benzonitrile 
In Figure 3-33, with larger amount of catalyst and at higher temperatures, the yield of 
decarbonylation was increased. This is in accordance with the study of the 
decarbonylation of monoaldehydic compounds. For 23-18F, maximum 
decarbonylation yields of 67 ± 3 % were obtained with 4 molar eq. of catalyst at 
150 ºC. 
F18
O
CH3
O
O
23-18F
84 RESULTS AND DISCUSSION 
 
3.4 Synthesis of [18F]fluoro-m-tyrosine by a new developed 
strategy  
In chapter 2, it was mentioned that 18F-labeled aromatic amino acids can be 
produced by different strategies. One of these includes three synthetic steps: 
18F-labeling reaction, decarbonylation and hydrolysis (see Figure 2-2). In order to 
facilitate the systematic study on the 18F-labeling reaction (see paragraph 3.2) and 
decarbonylation (see paragraph 3.3), the experiments were carried out with model 
compounds in which the position of the molecule that was thought to carry protected 
amino acid residue was represented by a methyl group. In this part, the complete 
synthesis of [18F]fluoro-m-tyrosine started with a precursor already containing 
protected amino acid residue. Therefore, the suitable protective group for the glycine 
residue should meet the following requirements: 
(1) This protective group should not have acidic protons, because they deactivate 
18F- ion by hydrogen bonding.  
(2) The stability of protective groups should be good under the labeling conditions 
(temperature 100 - 140 °C, pH 8 - 12). 
(3) The precursor containing the protective glycine residue should show high 
enantiomeric purity, and its deprotection should be possible without partial 
racemization. 
Because of these demands, most protective groups for glycine are ruled out, and the 
range of options is very narrow. In this work, two kinds of protecting groups were 
chosen (Figure 3-34). 
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O
CH3
N
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H
N
N CH3
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OCH3
O CH3
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protected glycine 1
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18F-m-tyrosine precursor
R1 = H, R2 = -OMe, 
18F-p-tyrosine precursor
R1, R2 = -OMe, 
18FDOPA precursor
LG = NO2, F
protected glycine 2
 
Figure 3-34. The precursors containing protected glycine part for 18F-labeled 
aromatic amino acids 
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In the project for [18F]fluoro-m-tyrosine, compound 27-F was obtained by multi-step 
organic synthesis (see paragraph 3.1.4). The labeling results are presented in 
Figure 3-35.  
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Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 
140 °C, within 30 min. 
Figure 3-35. RCY in 18F-labeling reaction of fluoro-m-tyrosine precursor 
containing protected glycine 1 
Compared to the RCY (80 %) of model compound 8-F, the RCY of 27-F decreased to 
5 %. One of the reasons is the decomposition of the protected glycine. Following, a 
series of test reactions has been performed. At first, some precursors (5-NO2 and 
6-NO2) with known RCYs were labeled in the presence of one molar eq. of protected 
glycine 1 or protected glycine 2. It was found that the RCYs were decreased in the 
case of adding protected glycine 1, whereas the addition of protected glycine 2 did 
not show any negative effect on the RCYs. (Table 3-14).  
27-F
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Table 3-14. 18F-labeling reaction in presence of protected glycine derivatives 
RCY(%) 
 No addition of 
protected glycine 
With protected 
glycine 1 
With protected 
glycine 2 
O
CH3
O
CH3
N
+
O
-
O
O
 
5-NO2 
87 ± 2 30 ± 3 82 ± 3 
N
+
O
-
O
CH3
O
 
6-NO2 
48 ± 5 22 ± 6 45 ± 3 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C, 
within 30 min. Protected glycine derivatives were simultaneously added with molar eq. precursor. 
Maximum RCY is presented. 
Therefore, protected glycine 2 was a promising option for the 18F-labeling reaction. 
However, as described in paragraph 3.1.4, the synthesis of compound 28-F failed in 
the last synthetic step (formylation).  
In another parallel project,73 the complete synthesis of [18F]fluoro-p-tyrosine was 
carried out from compound 2-fluoro-3-[(5-isopropyl-3,6-dimethoxy-2,5-
dihydropyrazin-2-yl)methyl]-6-methoxybenzaldehyde (Figure 3-36). The experiment 
was performed with a small scale of radioactivity (ca. 500 MBq), and the overall yield 
of three-step radiosynthesis was 2.8 % (d.c.). This is only the first attempt at the 
synthesis, and the RCY could be improved after further optimization of every single 
step.  
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Figure 3-36. The entire synthesis for [18F]fluoro-p-tyrosine73 
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In summary, the pilot study on the synthesis of [18F]fluoro-p-tyrosine proved that the 
type of protection for amino acid (protected glycine 2) is suitable for syntheses of 
18F-labeled aromatic amino acids by this three-step strategy (18F-labeling, 
decarbonylation and hydrolysis). The further optimization of the organic synthesis of 
the precursor for [18F]fluoro-m-tyrosine (28-F) and radiochemical synthesis of 
[18F]fluoro-p-tyrosine has not been undertaken within the scope of this thesis. 
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3.5 Automated synthesis of n.c.a. [18F]FDOPA via nucleophilic 
aromatic substitution 
As mentioned in the introduction (paragraph 1.5), a reliable, efficient and safe PET 
radiopharmaceutical production needs the development of automated radiochemical 
synthesis systems. For PET studies [18F]FDOPA is used mostly for clinical 
investigations of cerebral disorders such as Parkinson's disease. Therefore, research 
is directed towards developing commercial production methods that can be applied to 
large scale production suitable for multi-medicinal analyses. 
The preparation of [18F]FDOPA can be accomplished by either electrophilic or 
nucleophilic procedures, but both of them have limitations. For the electrophilic 
syntheses, the main disadvantage is the low specific activity of the product 
(Table 3-15), as this can limit the utility of [18F]FDOPA. Moreover, since F2 (as carrier) 
is added in the production of [18F]F2, the maximum substitution yield can only reach 
50 %. In addition, selective electrophilic radiofluorination on the benzene ring is 
performed by fluorodemetallation, but this method brings the risk of potentially toxic 
metals in the final dose. 
Table 3-15. [18F]FDOPA production from the literature reports 
[18F]FDOPA Product Type of Fluorination  Yield Radioactivity Specific activity 
SNAr110 23 ± 6 % a 32 ± 8.5 mCi 835 ± 280 mCi/µmol 
SNAr111 6.5 ~ 13.6 % b 105 ± 35 mCi 2000 mCi/µmol 
SNAr108 2 % a --- 5400 mCi /µmol 
S-E111 8.2 % b 16-19 mCi 0.07 mCi/µmol 
S-E113 8.3 % b 3 mCi 0.12 mCi/µmol 
S-E114 9 % b 9 mCi 0.22 mCi/µmol 
S-E115 8 % b 4.8 mCi 0.68 mCi/µmol 
S-E116 26 % a 23-27 mCi 0.12 mCi/µmol 
SNAr: Nucleophilic aromatic substitution, S-E: Electrophic substitution 
a: decay corrected, b: decay uncorrected 
Nucleophilic methods using no-carrier-added [18F]fluoride ion have the potential to 
provide a higher specific activity and higher absolute yields. Several groups have 
attempted to synthesize [18F]FDOPA by this more promising method (Figure 3-37). 
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Figure 3-37. The strategies for synthesis of [18F]FDOPA via SNAr99, 108, 110 
In method A, the amino acid residue is introduced in the aromatic part after the 
18F-labeling reaction. Lemaire, C. and co-workers have reported a chiral catalytic 
phase-transfer procedure in which 90 ~ 98 % enantiomeric purity of L-[18F]FDOPA 
can be provided. However, there are still three synthetic steps after incorporating 18F 
into the precursor. This complex multi-step synthesis makes automated production 
more difficult. Only one semi-automated synthesis of [18F]FDOPA by this method has 
been accomplished.111 In method B, the protecting amino acid residue has been 
already included in the precursor molecule before the 18F-labeling reaction. Therefore, 
the radiochemical synthesis was simplified. However, the lower enantiomeric purity of 
L-[18F]FDOPA (80 %) was obtained because of the basic conditions in the labeling 
procedure.99 So method B is not considered for automated synthesis. In the method 
C, an enzymatic synthesis for building amino acid chains was developed, but the low 
radiochemical yield and complicated synthetic procedure became the limitation in this 
method. 
In summary, when transferring the multi-step synthesis of [18F]FDOPA to a 
completely automated synthesis, the main problem is to have the remote controlled 
system functioning in a reliable way. Therefore, in this paragraph an improved 
automated synthesis of n.c.a. [18F]FDOPA via nucleophilic aromatic substitution is 
studied. According to the above discussion about nucleophilic substitution methods, 
method A was chosen for developing the [18F]FDOPA production. Based on the 
program (GE Medical Systems), the synthesis procedure was brought into 
automation and a synthetic module was built in the laboratory of radiopharmacy 
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department (Figure 3-38). The complete synthesis can be divided into four parts: 
fluorination, reductive iodination, alkylation and hydrolysis. The improvement of the 
automated synthesis was focused on chemical optimization (increased radiochemical 
yields for every single synthetic step) and technical optimization (e. g. to prevent 
marked radioactivity losses during the entire process).  
  
 
Figure 3-38. Scheme for the automated synthesis of [18F]FDOPA via SNAr
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3.5.1 Fluorination 
The first step of the entire synthesis is 18F-fluorination of precursor 4,5-dimethoxy-
2-nitrobenzaldehyde (5-NO2). The optimized labeling reaction conditions were 
discussed in paragraph 3.2.1 and directly applied in the automated synthesis. The 
precursor was labeled with activated nucleophilic 18F- ion at 140 °C in DMF for 10 min, 
and 5-18F was obtained in RCY of 71 ± 4 % (n = 40). This is clearly better than the 
reported results in DMSO (23 ~ 55 %).35, 84, 95, 96, 108, 110, 117 
After the labeling reaction, the solution was cooled down and transferred into a 
vessel with 10 mL of water. It was found that there was always some radioactivity left 
on the wall of the labeling reactor, even after washing with water. Therefore, the 
relationship between reactor material and radioactivity loss during the transferring 
was investigated. In Table 3-16, when a glassy carbon reactor was used, the 
radioactivity loss during this step can be reduced to 2 % compared to normal glass 
(16 %). In the literature,89 the influence of different reactor materials (polycarbonate, 
pyrex, Teflon and glassy carbon) on 18F-labeling reactions has been reported. When 
the polycarbonate vessel was used, there was no radioactivity loss on the wall of 
vessel, however, a much lower RCY was observed. In this study, with the glassy 
carbon vessel, satisfying results were obtained for both RCY and radioactivity loss. 
Therefore, no further optimization of reactor material was developed.  
Table 3-16. Effect of material of labeling reactor in fluorination 
Material of labeling 
reactor Normal glass Glassy carbon 
Radioactivity loss 16 ± 6 %, n = 10 2.0 ± 0.7 %, n = 10 
Optimized fluorination conditions: 18F-, K2.2.2-K+, 5 mg precursor in 1 mL DMF at 140 °C for 10 min. 
Before the next synthetic step, the radiochemical pure 5-18F has to be separated from 
the labeling reaction solution. This separation was performed by a combination of 
three different kinds of cartridges. A Sep-Pak© Light Alumina N cartridge can be used 
to removed the residual 18F- ion in the labeling reaction; a Sep-Pak© Plus C18 
cartridge was used for trapping 5-18F and this product was eluted with DCM; the 
utility of an Na2SO4 cartridge is to absorb the water traces in the DCM eluent of 5-18F 
because the following reductive iodination reaction is very sensitive to water. After 
purification by cartridges. the radiochemical purity of the 5-18F (≥ 95 %) was found by 
radio-TLC analysis.  
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3.5.2 Reductive iodination 
The second step is to convert 2-[18F]fluoro-4,5-dimethoxybenzaldehyde (5-18F) to 
2-[18F]fluoro-4,5-dimethoxybenzyl iodide via reductive iodination by using the newly 
prepared diiodosilane (Figure 3-39). In this reaction, a strong deviation of the yield 
was observed. The reason might be that the newly prepared diiodosilane is 
extremely unstable, even at room temperature, it can decompose very fast.118 
Therefore, the effect of the storage time for diiodosilane on the reductive iodination 
yield was investigated (in Table 3-17). When the freshly prepared diiodosilane was 
used immediately, a reproducible and high yield was obtained. In the automatic 
synthesis, the iodine was loaded in the iodination vessel before starting the whole 
synthesis. Phenylsilane and ethyl acetate were introduced into this vessel just before 
the C18 cartridge trapping 5-18F was eluted by DCM. After 10 seconds of stirring at 
room temperature, the diiodosilane was formed and the DCM eluent came in 
immediately. 
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Figure 3-39. Reductive iodination in automatic synthesis of [18F]FDOPA 
Table 3-17. Effect of the storage time for newly prepared diiodosilane on the yield 
in reductive iodination 
Diiodosilane Preparation * 3 h 1 h 10 min 0 min 
Yield 23 % n = 1 
53 ± 12 % 
n = 9 
62 ± 12 % 
n = 16 
78 ± 4 % 
n = 23 
Optimized reductive iodination condition: Fresh diiodosilane (250 µL phenylsilane 250 mg I2 and 15 µL 
ethylacetate mixed at r.t.) with 5-18F stirred for 10 min at r.t. 
*: The storage time of newly prepared diiodosilane. 
Because the following alkylation reaction can be disturbed by diiodosilane, which was 
used in excess in the reductive iodination reaction, [18F]fluorobenzyl iodide had to be 
purified. This purification was also performed by cartridges. Different types of 
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cartridge were tested (Table 3-18). The results showed that the alkylation yield was 
strongly affected by the purification of the [18F]fluorobenzyl iodide (yield in range of 
42 % ~ 78 %). The combination of different types of cartridges was examined. The 
silica cartridge was used for trapping the iodinated product and the other cartridge 
was used for trapping the excessive iodination reagents. The utility of basic type 
Sep-Pak© cartridge (diol (D) or NH2 (A)) showed a better yield in the alkylation 
reaction than did the acidic type Sep-Pak© cartridge (Accell CM (CM)). However, the 
value of standard deviation in the alkylation yields was very large. In fact, when the 
diiodosilane or phenylsilane passed through the silica cartridge, they decomposed. 
Thus, only the Sep-Pak© Plus silica cartridges were used for further optimization in 
the purification, and different numbers of silica cartridges were tested. The results 
showed that the stable and highest alkylation yields (78 ± 4 %, n = 23) were obtained 
when three silica cartridges were used. In practice, the reductive iodination reaction 
solution passed through three combined silica cartridges, and then the cartridges 
were dried under a stream of argon for 5 min. Finally, the [18F]fluorobenzyl iodide 
trapped on the cartridge was eluted with DCM (7 mL). During the purification, the 
radioactivity loss of iodinated product was less than 5 %. In addition, the 
radiochemical purity of iodinated product was more than 95 % by Radio-TLC analysis.  
Table 3-18. Purification of [18F]fluorobenzyl iodide by cartridges and yields in alkylation 
Reductive iodination solution 
Cartridge1 S CM D A A S S 
Cartridge2 --- S S S A S S 
Cartridge3 --- --- --- --- S --- S 
Alkylation * 
Yield  42 ± 6 % n = 3 
47 % 
n = 1 
56 % 
n = 1 
60 % 
n = 1 
53 ± 22 % 
n = 5 
60 ± 8 % 
n = 20 
78 ± 6 % 
n = 15 
S = Sep-Pak© Plus Silica, CM = Sep-Pak© Accell Plus CM, A = Sep-Pak© Light NH2, D = Sep-Pak© 
Light Diol 
*: 250 mg CsOH, 40 mg PTC and 45 mg glycinate with 2-[18F]fluoro-4,5-dimethoxybenzyl iodide stirred 
for 10 min at r.t. 
3.5.3 Alkylation  
The third step is to couple the 2-[18F]fluoro-4,5-dimethoxybenzyl iodide with the 
protected glycine derivative by enantioselective synthesis. In practice, the 18F-labeled 
alkylation product was synthesized in a two-phase mixture containing 18F-labeled 
benzyl iodide, N-(diphenylmethylene)glycine tert-butyl ester, PTC (O-allyl-N-
(9-anthracenylmethyl)cinchonidinium)64 and cesium hydroxide in DCM. In the 
literature, this enantioselective catalytic phase-transfer alkylation is conducted 
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at -78 °C and high enantioselectivity is observed (> 95 %). However, this low 
temperature is not feasible for automated radiosynthesis. In radiochemistry, the 
reaction kinetics can be different from those in normal organic chemistry because of 
the extremely low concentration of the educt (at subnanomolar levels). In particular, 
Lemaire, C. et al. has reported that high enantiomeric purity (> 90 %) can be 
achieved even at 20 °C as reaction temperature in this enantioselective synthesis.64 
Therefore, in this study the alkylation reaction was carried out at room temperature in 
DCM, and the optimization of the amount of alkylation reagent was studied. In 
Table 3-19, when the ratio of reagents was fixed, the yield was improved by 
increasing the amount of reagent (from 43 % to 70 %). If larger amounts of reagents 
were used, continuously higher yields were observed. However, more reagent will 
cause difficulty in the filtration step before the preparative HPLC separation. 
Therefore, in the automated synthesis, 250 mg of CsOH, 40 mg of PTC and 45 mg of 
N-(diphenylmethylene)glycine tert-butyl ester were loaded in the alkylation vessel, 
and when the DCM eluent from the silica cartridges reached this vessel, the reaction 
solution was stirred at room temperature for 10 min. The reaction mixture was 
passed through a filter back into the fluorination reactor for the next step. 
Table 3-19. Optimization for the amount of reagent in alkylation 
Amount of alkylation reagent 
CsOH PTC glycine tert-butyl ester 
Yield 
100 mg 15 mg 20 mg 43 %, n = 1 
200 mg 30 mg 40 mg 70 ± 8 %, n = 8 
250 mg 40 mg 45 mg 78 ± 6 %, n = 15 
3.5.4 Hydrolysis 
In the entire synthesis, the last synthetic step is the hydrolysis for cleaving the 
protected groups in the molecule of 18F-labeled alkylation product. In the literature,64, 
66, 96, 110, 111 this step was usually performed under acidic conditions i.e. 57 % HI at 
150 °C for 10 min. However, in our case, a lower hydrolysis yield (37 %) was 
obtained under the reported conditions. With 48 % HBr and KI, a better yield of 76 % 
was achieved. Furthermore, the crude [18F]FDOPA product from hydrolysis reaction 
had to be purified by HPLC. In practice, the [18F]FDOPA which was obtained by using 
HI as the hydrolysis reagent was not stable (Table 3-20). A reason might be that the 
trace impurities still remain in the product solution even after HPLC purification.  
96 RESULTS AND DISCUSSION 
 
Table 3-20 Comparison of different reagent in the hydrolysis reaction 
Reagent in Hydrolysis 57 % HI 48 % HBr and KI 
Yield in Hydrolysis 37 ± 9 % n = 3 76 ± 10 % n = 12 
Stability of [18F]FDOPA  Decomposed 0.5 h after EOS 
7 h after EOS 
Radiochemical purity > 90 % 
Optimized hydrolysis condition: 500 µL of 48 % HBr and 10mg KI at 150 °C for 10 min 
In the automatic synthesizer, after the hydrolysis the reaction solution was adjusted 
to pH = 2-3 by adding 6 N NaOH, this mixed solution was introduced into a 
preparative HPLC. Before the purification on HPLC, a filtration step was necessary 
for removing the fine precipitates in the solution. However, the entire synthesis was 
often blocked because the filter was plugged by this solution. Therefore, several 
different types of filters were tested (Table 3-21). The best filtration was achieved 
with a microglass fiber filter (diameter 13 mm, pore size 1.6 µm).  
Table 3-21. Filtration test before preparative HPLC 
CN (Milipore) PTFE (CS)  micro glass fiber (WHATMAN) 
pore size diameter pore size diameter pore size diameter 
Filter 
2.5 µm 3 mm 0.45 µm 13 mm 1.6 µm 13 mm 
Filtration blocked > 10 min < 2 min 
3.5.5 Overall synthesis 
After optimization for every single synthetic step, the complete four-step synthesis of 
[18F]FDOPA was primarily performed with small scale radioactivity (200-400 MBq) in 
the automatic synthesizer (Figure 3-40).  
According to the optimized yield for the single steps, the calculated yield for the final 
product should be 32 % (d.c.), but in the real synthesis (n = 17), 20 ± 4 % (d.c.) of 
[18F]FDOPA was found. That means that there might be about 10 % radioactivity loss 
during the synthetic steps. 
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Figure 3-40. Data of single synthetic step in the [18F]FDOPA automatic synthesis 
The large scale production of [18F]FDOPA was carried out five times in the improved 
automated synthesizer. The reaction parameters are presented in Table 3-22. 
Table 3-22. Reaction parameter in the production of [18F]FDOPA by an automatic synthesizer 
Irradiation  120 min; 35 µA 
Reaction time 120 min 
Yield c.a. 20 % (d.c.) 
[18F]FDOPA at EOS 9064 ± 3076 MBq (n = 5) 
Radiochemical purity 95 % (7 h after EOS > 90 %) 
specific activity ca. 50 GBq/µmol at EOS 
enantiomeric excess (ee %)  95 % 
All other quality parameters were according to Ph. Eur. 
In conclusion, the routine production of n.c.a. [18F]FDOPA, suitable for multimedicinal 
analyses, was synthesized reliably in an automated synthesizer via a 4-step 
procedure including nucleophilic aromatic substitution. 
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4 SUMMARY 
The objective in this work was to develop a new strategy aimed at the syntheses of 
n.c.a. (no-carrier-added) 18F-labeled aromatic amino acids via nucleophilic aromatic 
substitution (SNAr). The reason for choosing a SNAr reaction to introduce 18F is that 
the electrophilic aromatic substitution method cannot provide labeling products with 
high specific activities as needed for clinical PET applications. Fluorine-18 (n.c.a.) is 
easily and efficiently produced at a cyclotron via the 18O(p,n)18F nuclear reaction 
yielding the radionuclide as [18F]fluoride ion. That implies that the nucleophilic 
substitution is used as the only type of reaction for labeling with fluorine-18. However, 
since the amino acids of clinical interest are principally not suited to undergo SNAr 
due to their phenolic structure, this has been a challenging task for more than two 
decades. Therefore, this study emphasized the evaluation of SNAr on aromatic 
compounds multiply-substituted with both electron withdrawing and electron donating 
groups. Consequently, the study focused on the following parts: 
• A systematic investigation on nucleophilic aromatic substitution using a variety 
of model compounds exhibiting different substitution patterns with both +M 
and -M substituents. 
• Evaluation of decarbonylation of the 18F-labeled arenes, as it is an important 
intermediate synthetic step in the syntheses of 18F-labeled aromatic amino 
acids. 
• A pilot study to suggest a new synthetic strategy for 18F-labeled aromatic 
amino acids i.e. the precursor includes the protected amino acid residue 
(Figure 2-2). 
• An improved automated synthesis of [18F]FDOPA by a reported synthetic 
strategy, i.e. n.c.a. 18F-labeling and subsequent addition of the amino acid 
residue (Figure 2-1). 
The first part of the thesis dealt with the integrated effects of three different types of 
substituents on the benzene ring in the nucleophilic aromatic 18F-fluorination. The 
first type of substituent was the leaving group, i.e. NO2, F, Br, Cl and N+Me3TfO-. The 
second type of substituent was the aldehydic function as an auxiliary group for 
decreasing the electron density of the reactive center. The third type of substituent 
was the methoxy or methyl group. The methoxy group was used as masked phenolic 
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hydroxyl group and the methyl group was used for mimicking the protected amino 
acid residue. 
For n.c.a. 18F-labeling, the reaction conditions were determined by using model 
compounds with only two substituents (leaving group and aldehydic function, see 
paragraph 3.2.1). As had previously been observed, DMF was superior to DMSO, 
which is usually used as the solvent for the labeling reaction. Partial DMSO-mediated 
oxidation of the aldehydes could be identified as a reason for the poor yields 
obtained in this solvent. For the precursors 2-bromobenzaldehyde (1-Br), 
2-nitrobenzaldehyde (1-NO2) and 4-nitrobenzaldehyde (2-NO2), 95 %, 10 % and 
55 % of the precursor was oxidized in DMSO after 3 min of reaction time, resulting in 
RCYs of 1 %, 68 % and 40 %, respectively. However, in DMF less than 5 % of these 
three precursors were oxidized after 3 min of reaction time, and higher RCYs of 73 % 
(1-Br), 84 % (1-NO2) and 81 % (2-NO2) were observed.  
In case of the nucleophilic 18F-fluorination of methoxylated o-nitrobenzaldehydes, 
twelve different compounds were studied (see paragraph 3.2.2). Most surprisingly, 
the RCYs were not decreased with increasing numbers of methoxy substituents. The 
threefold and fourfold methoxylated precursors (19-NO2 and 20-NO2) showed even 
better RCYs (82 % and 48 %, respectively) than some of the mono- or 
di-methoxylated precursors. Additionally, the SNAr reaction remained dominant in 
most cases, although some side reactions, such as demethylation and intramolecular 
redox-processes of the precursor, were observed. These observations prompted 
further studies to evaluate the dependence of SNAr reaction rates (determined at one 
minute of reaction) on the deshielding of the particular carbon atom bearing -NO2 
(chemical shifts of 13C NMR). The correlation (R2 = 0.89) illustrated the influences 
originated by the methoxy substituents on the substitution reaction. 
In the study of the model compounds with the methyl substituent (see 
paragraph 3.2.3), a strong competition reaction, i.e. condensation reaction, was 
observed if the precursor contained the o-nitrotoluene structure. When the precursor 
showed lower reactivity towards the SNAr reaction (methoxy substituent para to the 
nitro group), this side reaction became the dominant process, resulting in low RCYs. 
Although this side reaction does not take place for the precursors with halogens as 
leaving groups, the RCYs for halogen precursor were relatively low except in case of 
isotopic exchange. The increase of RCY from 7 % (7-NO2) to 69 % (7-N+Me3TfO-) 
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showed that N+Me3TfO- as a leaving group was a promising option for avoiding 
condensation side reactions while maintaining a high RCY.  
Throughout this study, the aldehydic function was used as an auxiliary group in order 
to facilitate the SNAr reaction. For gaining a more intensive effect, compounds with 
two aldehydic functions were studied (see paragraph 3.2.4). When both aldehydic 
functions were located in the ortho/para position to the LG, the RCYs were always 
high (> 80 %) and the reaction rates were improved significantly, so that 21-NO2 was 
labeled in an RCY of 78 %, even at room temperature within 10 min.  
When aiming at the development of a new strategy for syntheses of 18F-labeled 
aromatic amino acids, the aldehydic function as a necessary auxiliary group has to 
be removed fast and efficiently after 18F-labeling. The decarbonylation of 18F-labeled 
aromatic substrates was therefore studied in detail (see paragraph 3.3). It was found 
that the reaction could be carried out smoothly without by-products in benzonitrile by 
using Wilkinson's catalyst. A fast decarbonylation was achieved with higher 
concentrations of the catalyst or at higher temperatures. Decarbonylation of the 
multi-substituted compound 11-18F (modeling [18F]FDOPA) or dialdehydic substituted 
compound 23-18F (modeling [18F]fluoro-m-tyrosine) was efficiently performed in good 
yields of 89 % and 67 % under the optimized conditions i.e. using 1mL of benzonitrile 
with 2 molar eq. of catalyst (based on the amount of –CHO) at 150 ºC within 20 min. 
Thus far, all the information from these results guided the further studies on the 
syntheses of 18F-labeled aromatic amino acids (see paragraph 3.4). Compound 27-F 
with a protected glycine residue (glycine derivative 1) was taken as an example for 
testing the synthesis of [18F]fluoro-m-tyrosine by the newly-developed synthetic 
strategy (18F-labeling, decarbonylation and hydrolysis). In the 18F-labeling, a low RCY 
(4 %) was obtained because of decomposition of the protected glycine residue. An 
alternative protected glycine residue (glycine derivative 2) was used in another 
parallel project for the synthesis of [18F]fluoro-p-tyrosine by the same strategy, and a 
pilot experiment showed that the RCY of 18F-labeling was improved to 40 %, after the 
other two step synthesis, [18F]fluoro-p-tyrosine was achieved with an overall yield of 
3 %. This result proved the three-step synthetic strategy to be suitable for syntheses 
of 18F-labeled aromatic amino acids. However, in the case of the precursor with low 
reactivity ([18F]fluoro-m-tyrosine and [18F]FDOPA), further optimization of the organic 
synthesis of the precursor has to be performed out of the scope of this thesis. 
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In the last part, an automated synthesis of [18F]FDOPA over four steps (fluorination, 
reductive iodination, alkylation and hydrolysis), as described in the literature, was 
brought into routine application for the first time. Every single synthetic step was 
optimized in detail (see paragraph 3.5). In this improved automated synthesis, 
9064 ± 3076 MBq of [18F]FDOPA could be produced within 120 min of production 
time from EOB (n = 5). The radiochemical purity and enantiomeric excess were both 
95 %. The specific activity was ca. 50 GBq/µmol at EOS.  
102 EXPERIMENTAL 
 
5 EXPERIMENTAL 
5.1 General 
Chemicals and solvents for organic synthesis and 18F-radiochemical synthesis were 
obtained from the following companies: Aldrich (Germany), Sigma (Germany), 
Riedel-de Haёn (Germany), Fluka (Germany), Merck (Germany), Lancaster 
(England), ABCR (England). The chemicals were reagent grade or better and were 
directly used in the synthesis without further purification. 
The fluorination reactor in the automated synthesis of [18F]FDOPA: Glassy carbon 
reactor (HTW, Germany) and Normal glass reactor (GE Medical Systems, USA). 
Cartridge: Sep-Pak© Light QMA, Sep-Pak© Light Alumina N, Sep-Pak© Plus C18, 
Sep-Pak© Accell Plus CM, Sep-Pak© Light NH2, Sep-Pak© Light Diol, Sep-Pak© Plus 
Silica were obtained from Waters (USA). Na2SO4 cartridge (38 mm, 2.2 GM) was 
purchased from VARIAN (Germany). 
Thin-layer chromatography (TLC) was carried out with silica gel plates 
(Polygram Silica G/UV254, 8 × 4 cm, Macherey Nagel, Germany) visualized under an 
UV-lamp (254 nm).  
The employed high performance liquid chromatography (HPLC) consists of a 
Hewlett-Packard Model 1050 equipped with an UV/Vis detector.  
Middle pressure liquid chromatography system (MPLC, Büchi, Switzerland) was 
applied for the purification in the organic synthesis. Silica gel 60 (0.040 – 0.063 mm, 
Merck) or reverse phase material (POLYGOPREP 60-50, C18, MN, Germany) was 
used as immobile phase. Eluents were mixtures of petroleum ether (60/90 °C) and 
ethyl acetate or water and acetonitrile (given as v/v ratio). 
LC/MS measurements were performed on a quadrupole LC/MS (Agilent 
Technologies, Model 6120) with an HPLC (Agilent Technologies, Model 1200). All 
solvents (methanol and water) were of HPLC-grade purity. 
Melting points (m.p.) were determined using Gallenkamp device (MPG 350, USA) 
and were uncorrected.  
IR spectra were carried out on spectrum-one FT-IR spectrometer (Perkin-Elmer, 
Boston, USA).  
MS spectra were measured by using Triple Stage Quadrupole TSQ 70 Finnigan 
MAT – Massenspektrometer (Finnigan-MAT, Bremen, Germany). 
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1H NMR, 13C NMR and 19F NMR were carried out on Avance 400 (Bruker, USA) 
operating at 400 or 100 MHz. For measurements, as internal standards the 
deuterated solvents were used (DMSO-d6: δ = 2.49 in 1H and δ = 39.5 in 13C; CDCl3: 
δ = 7.25 in 1H and δ = 77.0 in 13C). The chemical shift δ in ppm was referred to the 
internal standard. 
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5.2 Organic syntheses of precursors and standards for SNAr with 
[18F]fluoride ion 
5.2.1 Model compounds as building blocks for 18F-labeled aromatic 
amino acids 
5.2.1.1 4-Formylphenyl-trimethylammonium triflate (2-N+Me3TfO-) 
To a stirred solution of p-dimethylaminobenzaldehyde (1.00 g, 6.71 mmol) in DCM 
(15 mL) was added methyl trifluoromethanesulfonate (0.88 mL, 7.78 mmol). The 
solution was stirred for 3 h at room temperature under argon. The suspension was 
filtered and the obtained solid product was crystallized from methanol and 
diisopropylether (20:80, v/v) to give 0.95 g 2-N+Me3TfO- as grey crystals (39 %). 
4-Formylphenyl-trimethylammonium triflate 
5
4
6
3
1
2
N
+
7
O
CH38
CH3
9CH3
10
CF3SO3
-
 
m.p. 111 - 112 °C (reported119 108 - 110 °C). 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.10 (s, 1H, H-(C-7)), 8.17 (dd, 4JH,H = 7.2 Hz, 3JH,H = 9.1 Hz, 4H, Harom), 
3.64 (s, 9H, -N-(CH3)3). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 56.9, 121.7, 130.9, 136.7, 151.0, 192.1. 
MS-FAB (70 eV) 
m/z: 164 ([M]+·, C10H14NO, 100 %), 154 (38 %), 136 ([M – CO]+, C9H14N, 32 %), 107 
(11 %). 
IR  
ν /cm-1 (T %): 3046 (93 %), 2941 (93 %), 2835 (92 %), 2298 (98 %), 1701 (97 %), 
1609 (96 %), 1497 (80 %), 1483 (84 %), 1474 (84 %), 1457 (88 %), 1416 (88 %), 
1368 (86 %), 1317 (91 %), 1252 (28 %), 1223 (41 %), 1195 (63 %), 1160 (48 %), 
1119 (71 %), 1099 (52 %), 1078 (56 %), 1051 (51 %), 1025 (29 %), 984 (53 %), 958 
(67 %), 940 (69 %), 909 (70 %), 890 (85 %), 848 (64 %), 818 (65 %), 757 (77 %), 
744 (92 %), 710 (89 %). 
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5.2.1.2 5-Methoxy-2-nitrobenzaldehyde (3-NO2)  
To a stirred suspension of 5-hydroxy-2-nitrobenzaldehyde (3.99 g, 23.89 mmol) and 
K2CO3 (3.18 g, 23.04 mmol) in DMF (40 mL), MeI (1.49 mL, 23.92 mmol) was added 
dropwise at 0 °C. After this addition, the suspension was stirred at room temperature 
and monitored by TLC. The starting compound was completely reacted after 3 h, the 
resulting mixture was poured into 100 mL water and extracted with diethyl ether (3 × 
50 mL). The combined organic layers were washed with 100 mL water and dried over 
Na2SO4. After evaporation of solvent, the residue was purified by using MPLC 
(petroleum ether / ethyl acetate, 1:1) to yield 3.77 g 3-NO2 as yellow crystal (87 %). 
5-Methoxy-2-nitrobenzaldehyde 
1
2
6
3
5
4
7
O
O
CH3
8
N
+ O
O
-  
m.p. 81 - 82 °C (reported120 83 °C). 
1H NMR (CDCl3, 250 MHz)  
δ (ppm) = 10.46 (s, 1H, H-(C-7)), 8.13 (d, 3JH,H = 9.1 Hz, 1H, H-(C-3) or H-(C-4)), 
7.30 (s, 1H, H-(C-6)), 7.13 (d, 3JH,H = 9.1 Hz, 1H, H-(C-3) or H-(C-4)), 3.94 (s, 3H, 
H-(C-8)). 
13C NMR (CDCl3, 60 MHz)  
δ (ppm) = 55.6, 113.5, 118.9, 127.5, 134.6, 142.5, 164.3, 188.8.  
HRMS (EI)  
m/z measured: 181.03488 ([M]+·, C8H7NO4).  
m/z calculated: 181.037486. 
MS-EI (70 eV) 
m/z: 181 ([M]+·, C8H7NO4, 10 %), 180 ([M – H]+, C8H6NO4, 29 %), 163 ([M – H2O]+·, 
C8H5NO3, 5 %), 151 ([M – NO]+, C8H7O3, 41 %), 133 ([M – H2O – NO]+·, C8H5O2, 
21 %), 123 (32 %), 108 (65 %), 95 (54 %), 77 ([C6H5]+, 24 %), 64 (37 %), 63 ([C5H3]+, 
100 %), 52 ([C4H4]+·, 21 %), 49 (14 %). 
IR  
ν /cm-1 (T %): 3102 (81 %), 2982 (82 %), 2946 (79 %), 2845 (82 %), 2666 (83 %), 
2166 (87 %), 1922 (87 %), 1689 (37 %), 1609 (77 %), 1580 (29 %), 1499 (31 %), 
1479 (47 %), 1459 (61 %), 1442 (47 %), 1419 (51 %), 1390 (45 %), 1326 (24 %), 
1286 (25 %), 1233 (29 %), 1187 (41 %), 1159 (33 %), 1079 (39 %), 1024 (38 %), 
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1001 (48 %), 963 (66 %), 929 (27 %), 892 (28 %), 847 (31 %), 834 (22 %), 771 
(52 %), 741 (23 %), 688 (42 %), 667 (45 %). 
5.2.1.3 2-Chloro-5-methoxybenzaldehyde (3-Cl)  
To a stirred suspension of 4-chloro-3-methylanisole (4.00 g, 25.64 mmol) in CCl4 
(20 mL) were added N-bromosuccinimide (5.00 g, 28.09 mmol) and a catalytic 
amount of AIBN (0.11 g). The reaction was refluxed for 1 h, the reaction suspesion 
was filtered off and the filtrate was evaporated to afford 5.80 g crude 4-chloro-
3-bromomethylanisole, which was used directly in the next synthesis step without 
further purification. 
A stirred suspension of crude 4-chloro-3-bromomethylanisole (5.80 g), DMSO (30 mL) 
and Na2CO3 (5.30 g, 50.00 mmol) was heated to 50 °C under argon overnight. Then 
this reaction suspension was cooled down and partitioned between diethyl ether 
(200 mL) and water (100 mL). The organic layer was separated, dried over Na2SO4 
and reduced to crude product. After purification by using MPLC (petroleum ether / 
ethyl acetate, 1:1), 1.60 g 3-Cl was obtained as white substance (36 % based on 
4-chloro-3-methylanisole).  
2-Chloro-5-methoxybenzaldehyde 
1
2
6
3
5
4
7
O
O
CH3
8
Cl 
m.p. 62 - 63 °C (reported121 62 - 64 °C). 
1H NMR (CDCl3, 250 MHz)  
δ (ppm) = 10.41 (s, 1H, H-(C-7)), 7.71 (d, 4JH,H = 3.3 Hz, 1H, H-(C-6)), 7.30 (d, 3JH,H = 
8.8 Hz, 1H, H-(C-3)), 7.07 (dd, 4JH,H = 3.3 Hz, 3JH,H = 8.8 Hz, 1H, H-(C-4)), 3.82 (s, 
3H, H-(C-8)). 
13C NMR (CDCl3, 60 MHz)  
δ (ppm) = 55.7, 111.9, 122.7, 129.6, 131.4, 132.9, 158.6, 189.6.  
MS-EI (70 eV) 
m/z: 172 ([M]+·, C8H737ClO2, 29 %), 169 ([M – H]+, C8H635ClO2, 100 %), 155 ([M – 
OH]+, C8H637ClO, 22 %), 141 (17 %), 126 (10 %), 99 (13 %), 98 (3 %), 77 ([C6H5]+, 
10 %), 63 ([C5H3]+, 12 %), 62 (4 %). 
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IR  
ν /cm-1 (T %): 3099 (86 %), 3076 (86 %), 3010 (79 %), 2979 (84 %), 2944 (78 %), 
2890 (79 %), 2844 (78 %), 2766 (86 %), 2042 (89 %), 1894 (87 %), 1694 (48 %), 
1679 (31 %), 1603 (53 %), 1573 (43 %), 1475 (40 %), 1443 (50 %), 1417 (50 %), 
1396 (44 %), 1300 (54 %), 1281 (37 %), 1243 (44 %), 1195  (31 %), 1170 (46 %), 
1137 (54 %), 1122 (53 %), 1069 (48 %), 1017 (43 %), 931 (22 %), 889 (57 %), 867 
(40 %), 821 (25 %), 756 (38 %), 687 (69 %), 660 (29 %).  
5.2.1.4 2-Bromo-5-methoxybenzaldehyde (3-Br)  
To a stirred solution of 3-methoxybenzaldehyde (3.00 mL, 24.62 mmol) in CHCl3 
(40 mL, absoluted) bromine (1.89 mL, 3.69 mmol) was introduced slowly over 20 min. 
Following, the reaction solution was stirred at room temperature for 0.5 h. The 
resulting solution was poured into diethyl ether (100 mL) and the mixture was 
washed with Na2S2O3 (2 × 50 mL) and 50 mL water. The organic layer was 
separated and dried over Na2SO4. After evaporation of the solvent under reduced 
pressure, the crude product was purified by using MPLC (petroleum ether / ethyl 
acetate, 1:1). 4.37 g 3-Br was obtained (82 %). 
2-Bromo-5-methoxybenzaldehyde 
1
2
6
3
5
4
7
O
O
CH3
8
Br 
m.p. 77 °C (reported122 75 - 76 °C). 
1H NMR (CDCl3, 400 MHz)  
δ (ppm) = 10.30 (s, 1H, H-(C-7)), 7.50 (d, 3JH,H = 8.6 Hz, 1H, H-(C-3)), 7.39 (d, 4JH,H = 
3.3 Hz, 1H, H-(C-6)), 7.02 (dd, 3JH,H = 8.7 Hz, 4JH,H = 3.1 Hz, 1H, H-(C-4)), 3.83 (s, 
3H, H-(C-8)). 
13C NMR (CDCl3, 100 MHz)  
δ (ppm) = 55.7, 112.6, 117.9, 123.1, 133.9, 134.5, 159.2, 191.7.  
MS-EI (70 eV) 
m/z: 216 ([M]+·, C8H781BrO2, 95 %), 215 ([M – H]+, C8H681BrO2, 87 %), 214 ([M]+·, 
C8H779BrO2, 100 %), 213 ([M – H]+, C8H779BrO2, 90 %), 185 ([M – CHO]+, C7H679BrO, 
14 %), 170 (10 %), 143 (11 %), 134 ([M – H79/81Br]+, C8H7O2, 6 %), 106 (12 %), 77 
([C6H5]+, 5 %), 63 ([C5H3]+, 15 %), 50 (2 %). 
108 EXPERIMENTAL 
 
IR  
ν /cm-1 (T %): 3094 (81 %), 3073 (81 %), 3007 (73 %), 2943 (73 %), 2875 (64 %), 
2842 (72 %), 2745 (79 %), 2580 (82 %), 2069 (82 %), 1895 (82 %), 1673 (25 %), 
1599 (50 %), 1569 (40 %), 1469 (36 %), 1440 (50 %), 1417 (46 %), 1382 (42 %), 
1366 (65 %), 1300 (47 %), 1278 (29 %), 1241 (39 %), 1198 (30 %), 1169 (42 %), 
1134 (52 %), 1116 (58 %), 1060 (43 %), 1012 (39 %), 931 (17 %), 864 (27 %), 819 
(17 %), 753 (37 %), 684 (63 %).  
5.2.1.5 2-Iodo-5-methoxybenzaldehyde (3-I)  
To a vigorous stirring suspension of I2 (4.06 g, 15.98 mmol) in CHCl3 (50 mL) were 
added dropwise 3-methoxybenzyl alcohol (2.00 mL, 16.11 mmol) and CF3COOAg 
(3.56 g, 16.11 mmol) under argon within 30-40 min. The reaction mixture was stirred 
at room temperature for 20 h. The resulting suspension was filtered and the filter 
cake was washed with CHCl3 (50 mL), the CHCl3 solution was concentrated and 
purified by using MPLC (petroleum ether / ethyl acetate, 1:1) to afford 2.03 g 2-iodo-
5-methoxybenzyl alcohol (48 %).  
2-Iodo-5-methoxybenzyl alcohol (1.79 g, 6.78 mmol) and PDC (5.00 g, 13.3 mmol) 
were suspended in DCM (20 mL). The reaction mixture was stirred at room 
temperature for 2 h. The resulting mixture was filtered and DCM was evaporated. To 
the residue diethyl ether (100 mL) was given and the mixture was put in an ultrasonic 
bath. The suspension was filtered and the filtrate solution was washed by 1 N HCl 
(50 mL) to remove pyridinium. The diethyl ether solution was dried over Na2SO4 and 
evaporated. The residue was purified by using MPLC (petroleum ether / ethyl acetate, 
1:1) to give 1.50 g 3-I as white crystals (84 % based on 2-iodo-5-methoxybenzyl 
alcohol). 
2-Iodo-5-methoxybenzaldehyde 
1
2
6
3
5
4
7
O
O
CH3
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I  
m.p. 115 - 116 °C (reported123 114 - 115 °C). 
1H NMR (CDCl3, 250 MHz)  
δ (ppm) = 10.01 (s, 1H, H-(C-7)), 7.77 (d, 3JH,H =8.5 Hz, 1H, H-(C-3)), 7.40 (d, 4JH,H = 
3.1 Hz, 1H, H-(C-6)), 6.91 (dd, 3JH,H = 8.7 Hz, 4JH,H = 3.0 Hz, 1H, H-(C-4)), 3.83 (s, 
3H, H-(C-8)). 
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13C NMR (CDCl3, 60 MHz)  
δ (ppm) = 56.1, 90.1, 114.1, 123.9, 136.2, 141.5, 160.8, 196.1.  
MS-EI (70 eV) 
m/z: 262 ([M]+·, C8H7IO2, 100 %), 233 ([M – CHO]+, C7H6IO, 7 %), 203 (2 %), 147 
(4 %), 134 ([M – HI]+·, C8H6O2, 17 %), 107 (3 %), 106 (13 %), 77 ([C6H5]+, 6 %), 63 
([C5H3]+, 10 %), 62 (3 %). 
IR 
ν /cm-1 (T %): 3322 (78 %), 3068 (78 %), 3004 (72 %), 2976 (75 %), 2937 (71 %), 
2860 (69 %), 2838 (70 %), 2743 (75 %), 2573 (78 %), 1980 (80 %), 1897 (79 %), 
1667 (38 %), 1592 (47 %), 1562 (41 %), 1465 (39 %), 1412 (46 %), 1381 (44 %), 
1298 (46 %), 1276 (30 %), 1242 (39 %), 1197 (35 %), 1166 (42 %), 1131 (53 %), 
1111 (58 %), 1052 (40 %), 1006 (42 %), 931 (25 %), 864 (29 %), 818 (26 %), 748 
(38 %), 682 (54 %).   
5.2.1.6 5-Methoxy-2-trimethylammoniumbenzaldehyde triflate 
(3-N+Me3TfO-) 
5-Methoxy-2-dimethylaminobenzaldehyde 
2-Fluoro-5-methoxybenzaldehyde (1.42 g, 9.22 mmol), dimethylamine hydrochloride 
(1.10 g, 13.50 mmol) and K2CO3 (1.80 g, 13.04 mmol) were stirred and heated under 
reflux in a mixture of DMSO (20 mL) and water (8 mL). After there was no 2-fluoro-5-
methoxybenzaldehyde left as checked by TLC (petroleum ether / ethyl acetate, 5:1), 
the saturated aqueous K2CO3 solution (100 mL) was added to cooled reaction 
solution. This mixture was extracted with diethyl ether (2 × 50 mL). The organic layer 
was dried over Na2SO4. After evaporation of solvent, the residue was purified by 
using MPLC (petroleum ether / ethyl acetate, 5:1) and 0.97 g 5-methoxy-2-
dimethylaminobenzaldehyde was obtained as yellow oil (59 %). 
5-Methoxy-2-dimethylaminobenzaldehyde 
1
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1H NMR (DMSO-d6, 250 MHz)  
δ (ppm) = 10.24 (s, 1H, H-(C-7)), 7.21 (m, 3H, Harom), 3.75 (s, 3H, H-(C-8)), 2.82 (s, 
6H, H-(C-9) and H-(C-10)). 
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13C NMR (DMSO-d6, 60 MHz)  
δ (ppm) = 46.1, 55.4, 79.1, 111.5, 120.6, 122.0, 128.2, 150.6, 154.2, 190.7. 
MS-EI (70 eV) 
m/z: 179 ([M]+·, C10H13NO2, 100 %), 164 ([M – CH3]+, C9H10NO2, 56 %), 150 (21 %), 
136 (21 %), 121 (23 %), 118 (9 %), 65 (6 %), 44 (2 %). 
IR  
ν /cm-1 (T %): 2944 (85 %), 2834 (79 %), 2789 (86 %), 1676 (32 %), 1607 (76 %), 
1572 (87 %), 1494 (25 %), 1453 (56 %), 1415 (59 %), 1381 (61 %), 1301 (57 %), 
1275 (34 %), 1234 (45 %), 1185 (63 %), 1164 (59 %), 1151 (44 %), 1089 (72 %), 
1034 (35 %), 950 (66 %), 937 (65 %), 926 (63 %), 869 (68 %), 822 (57 %), 774 
(55 %), 729 (90 %), 687 (53 %).  
5-Methoxy-2-trimethylammoniumbenzaldehyde triflate 
To a stirred solution of 5-methoxy-2-dimethylaminobenzaldehyde (0.97 g, 5.42 mmol) 
in DCM (10 mL) was added methyl trifluoromethanesulfonate (1.10 mL, 9.73 mmol). 
The solution was stirred for 3 h at room temperature under argon. The reaction 
solvent was concentrated and the residue was crystallized in a mixture of 
diisopropylether and DCM (1:10, v/v). 1.40 g 3-N+Me3TfO- was obtained as white 
crystals (78 %). 
5-Methoxy-2-trimethylammoniumbenzaldehyde triflate 
1
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m.p. 112 - 113 °C (reported72 114 - 115 °C). 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.19 (s, 1H, H-(C-7)), 8.00 (d, 3JH,H = 8.7 Hz, 1H, H-(C-3)), 7.87 (d, 4JH,H = 
3.5 Hz, 1H, H-(C-6)), 7.46 (dd, 4JH,H = 3.5 Hz, 3JH,H = 8.5 Hz, 1H, H-(C-4)), 4.00 (s, 
3H, H-(C-8)), 3.71 (s, 9H, -N-(CH3)3). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 56.3, 57.0, 118.7, 124.3, 126.0, 131.1, 137.0, 160.1, 193.0.  
MS-FAB (70 eV) 
m/z: 194 ([M]+·, C11H16NO2, 100 %), 179 ([M – CH3]+, C10H13NO2, 14 %),164 (8 %), 
150 (6 %), 136 (8 %). 
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IR  
ν /cm-1 (T %): 3085 (93 %), 3045 (92 %), 2985 (94 %), 2951 (94 %), 2851 (95 %), 
2287 (96 %), 1700 (67 %), 1686 (62 %), 1609 (89 %), 1585 (61 %), 1493 (77 %), 
1462 (82 %), 1447 (82 %), 1407 (86 %), 1309 (83 %), 1255 (17 %), 1221 (37 %), 
1203 (70 %), 1146 (31 %), 1082 (86 %), 1029 (18 %), 956 (72 %), 942 (75 %), 922 
(52 %), 901 (64 %), 830 (51 %), 770 (69 %), 754 (65 %), 690 (84 %), 660 (83 %). 
5.2.1.7 4-Methoxy-2-nitrobenzaldehyde (4-NO2)  
4-Bromo-3-nitroanisol (1.75 g, 7.54 mmol) and THF (80 mL, absoluted) were added 
to a dried flask while stirring under argon stream. The solution was cooled down 
to -78 ºC, and phenyllithium (4.00 mL, 7.60 mmol, 1.9 M in dibutyl ether) was added 
dropwise. Then the reaction mixture was stirred at -70 - -90 ºC for 2 h and DMF 
(1.50 mL, 21.63 mmol) was added dropwise. After this addtion the reaction solution 
was kept stirring at -70 - -90 ºC for another 1 h and was allowed to reach 0 ºC within 
1 h. This mixture was quenched by adding acetic acid (5 mL, concentrated) and 
partitioned between diethyl ether (100 mL) and water (50 mL). The organic layer was 
washed with satured NaHCO3 solution (50 mL), water (50 mL) and brine (50 mL), 
dried over Na2SO4 and concentrated to afford a crude product, which was purified by 
using MPLC (petroleum ether / ethyl acetate, 9:1) to yield 0.90 g 4-NO2 as yellow 
crystals (65 %). 
4-Methoxy-2-nitrobenzaldehyde 
1
2
6
3
5
4
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O
N
+
O
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O
O
CH3
8  
m.p. 95 - 96 °C (reported124 96 - 97 °C). 
1H NMR (DMSO-d6, 400 MHz)  
δ = 10.28 (s, 1H, H-(C-7)), 7.96 (d, 3JH,H = 8.5 Hz, 1H, H-(C-5) or H-(C-6)), 7.50 (d, 
4JH,H = 2.6 Hz, 1H, H-(C-3)), 7.22 (d, 3JH,H = 8.8 Hz, 1H, H-(C-5) or H-(C-6)), 3.95 (s, 
3H, H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ = 56.3, 109.5, 119.1, 123.4, 131.4, 151.6, 163.7, 186.9.  
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HRMS (EI)  
m/z measured: 181.03411 ([M]+·, C8H7NO4).  
m/z calculated: 181.037486. 
MS-EI (70 eV) 
m/z: 181 ([M]+·, C8H7NO4, 4 %), 151 ([M – NO]+, C8H7O3, 100 %), 134 (21 %), 119 
(4 %), 108 (18 %), 106 (26 %), 95 (22 %), 92 (12 %), 77 ([C6H5]+, 8 %), 63 ([C5H3]+, 
23 %), 50 (3 %). 
IR  
ν /cm-1 (T %): 3104 (85 %), 3066 (82 %), 2945 (84 %), 2841 (85 %), 1679 (56 %), 
1600 (59 %), 1564 (77 %), 1524 (41 %), 1500 (56 %), 1458 (74 %), 1435 (70 %), 
1403 (79 %), 1353 (52 %), 1320 (60 %), 1282 (54 %), 1241 (38 %), 1200 (65 %), 
1184 (52 %), 1140 (59 %), 1067 (48 %), 1025 (44 %), 963 (78 %), 910 (56 %), 897 
(47 %), 825 (29 %), 775 (57 %), 758 (54 %), 698 (76 %), 675 (73 %), 655 (62 %).   
5.2.2 Methyl-substituted model compounds  
5.2.2.1 3-Methyl-2-nitrobenzaldehyde (6-NO2)  
The compound 1-bromo-3-methyl-2-nitrobenzene was formylated by the analogous 
method described in the preparation of 4-NO2 (see paragraph 5.2.1.7).  
Phenyl lithium (6.29 mL, 10.06 mmol, 1.6 M in dibutyl ether solution) and 1-bromo-3-
methyl-2-nitrobenzene (2.00 g, 9.26 mmol) in THF (50 mL) were stirred for 2 h 
at -70 - -90 ºC under argon. Then piperidine-1-carbaldehyde (1.20 mL, 10.72 mmol) 
was added dropwise and the solution was allowed to reach room temperature within 
1 h. After workup and purification by using MPLC (petroleum ether / ethyl acetate, 
3:1), 1.00 g 6-NO2 was obtained (66 %) as slightly yellow crystals. 
3-Methyl-2-nitrobenzaldehyde 
1
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6
3
5
4
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N
+
O
-
O
CH3
8  
m.p. 62 - 64 °C (reported125 59 - 61 °C). 
1H NMR (CDCl3, 250 MHz)  
δ (ppm) = 9.93 (s, 1H, H-(C-7)), 7.59 (dd, 3JH,H = 9.2 Hz, 3JH,H = 9.2 Hz, 1H, H-(C-5)), 
7.57 (d, 3JH,H = 9.0 Hz, 2H, H-(C-4) and H-(C-6)), 2.38 (s, 3H, H-(C-8)). 
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13C NMR (CDCl3, 60 MHz)  
δ (ppm) = 16.9, 127.6, 128.6, 130.7, 131.0, 137.0, 150.5, 186.9.  
MS-FAB (70 eV) 
m/z: 166 ([M + H]+·, C8H8NO3, 100 %), 154 (89 %), 136 ([M + H – NO]+, C8H8O2, 
97 %), 107 (34 %), 89 (43 %), 77 ([C6H5]+, 56 %), 65 (22 %). 
IR  
ν /cm-1 (T %): 2869 (89 %), 2758 (94 %), 1701 (33 %), 1604 (57 %), 1585 (78 %), 
1527 (20 %), 1463 (61 %), 1433 (68 %), 1368 (30 %), 1320 (80 %), 1304 (76 %), 
1262 (47 %), 1233 (49 %), 1174 (66 %), 1131 (88 %), 1073 (85 %), 1044 (66 %), 960 
(52 %), 853 (39 %), 782 (27 %), 758 (40 %), 744 (55 %), 724 (64 %).  
5.2.2.2 2-Chloro-3-methylbenzaldehyde (6-Cl)  
6-Cl was synthesized by bromination and oxidation according to the above 
mentioned procedure for 3-Cl (see paragraph 5.2.1.3).  
2-Chloro-1,3-dimethylbenzene (4.85 g, 34.64 mmol), N-bromosuccinimide (6.77 g, 
38.03 mmol) and a catalytic amount of AIBN (0.11 g) in CCl4 (50 mL) were refluxed 
for 1 h. 6.70 g Crude 2-chloro-3-bromomethyltoluene was obtained and used directly 
in the next synthesis step. 
A stirred suspension of 6.70 g crude 2-chloro-3-bromomethyltoluene, DMSO (30 mL) 
and Na2CO3 (6.50 g, 61.32 mmol) was heated to 50 °C under argon overnight. After 
workup and purification by using MPLC, 1.60 g 6-Cl (33 % based on 2-chloro-1,3-
dimethylbenzene) was obtained as white crystals. 
2-Chloro-3-methylbenzaldehyde 
1
2
6
3
5
4
7
O
CH3
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m.p. 36 - 37 °C (reported126 37 °C). 
1H NMR (DMSO-d6, 400 MHz) 
δ (ppm) = 10.37 (s, 1H, H-(C-7)), 7.67 (m, 2H, H-(C-4) and H-(C-6)), 7.41 (dd, 3JH,H = 
7.4 Hz, 3JH,H = 7.4 Hz, 1H, H-(C-5)), 2.38 (s, 3H, H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 19.3, 127.2, 127.2, 132.2, 136.4, 136.7, 137.4, 190.3.  
114 EXPERIMENTAL 
 
MS-EI (70 eV) 
m/z: 156 ([M]+·, C8H637ClO, 26 %), 154 ([M]+·, C8H735ClO, 64 %), 153 ([M – H]+, 
C8H635ClO, 100 %), 127 ([M – CHO]+, C7H637Cl, 11 %), 125 ([M – CHO]+, C8H635Cl, 
30 %), 118 (2 %), 101 (2 %), 99 (4 %), 91 (11 %), 89 (20 %), 75 (3 %), 65 (4 %), 63 
([C5H3]+,10 %), 40 (5 %), 39 (6 %). 
IR  
ν /cm-1 (T %): 3346 (83 %), 2986 (78 %), 2921 (83 %), 2876 (75 %), 2745 (83 %), 
1952 (83 %), 1891 (84 %), 1831 (85 %), 1747 (90 %), 1701 (68 %), 1678 (14 %), 
1578 (39 %), 1452 (38 %), 1421 (68 %), 1378 (28 %), 1286 (78 %), 1242 (26 %), 
1169 (54 %), 1107 (65 %), 1046 (30 %), 1012 (58 %), 978 (71 %), 916 (42 %), 781 
(12 %), 714 (33 %), 703 (29 %).   
5.2.2.3 2-Bromo-3-methylbenzaldehyde (6-Br)  
The synthesis of 6-Br was similar to preparation of 6-Cl (see paragraph 5.2.2.2) 
After bromination by N-bromosuccinimide, 2-bromo-1,3-dimethylbenzene (4.38 g, 
23.68 mmol) gave 6.47 g crude 2-bromo-3-bromomethylanisole which was directly 
oxidized in DMSO in the presence of Na2CO3. After workup and purification by using 
MPLC (petroleum ether / ethyl acetate, 5:1), 2.50 g 6-Br was obtained as white 
crystals (53 % based on 2-bromo-1,3-dimethylbenzene). 
2-Bromo-3-methylbenzaldehyde 
1
2
6
3
5
4
7
O
CH3
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Br
 
m.p. 53 - 54 °C (reported127 53 - 54 °C). 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.29 (s, 1H, H-(C-7)), 7.66 (m, 2H, H-(C-4) and H-(C-6)), 7.44 (dd, 3JH,H = 
7.6 Hz, 3JH,H = 7.6 Hz, 1H, H-(C-5)), 2.42 (s, 3H, H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 22.3, 127.4, 127.8, 128.3, 133.6, 136.6, 139.3, 192.3.  
MS-EI (70 eV) 
m/z: 200 ([M]+·, C8H781BrO, 68 %), 199 ([M – H]+, C8H681BrO, 95 %), 198 ([M]+·, 
C8H779BrO, 69 %), 197 ([M – H]+, C8H779BrO, 100 %), 172 (3 %), 171 ([M – CHO]+, 
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C7H681Br, 22 %), 170 (4 %), 169 ([M – CHO]+, C7H779Br, 24 %), 118 ([M – H79/81Br]+·, 
C8H6O, 5 %), 98 (2 %), 91 (12 %), 89 (23 %), 74 (2 %), 63 (12 %), 39 (5 %). 
IR  
ν /cm-1 (T %): 3340 (80 %), 2982 (74 %), 2867 (71 %), 2735 (80 %), 1952 (81 %), 
1889 (82 %), 1825 (83 %), 1725 (87 %), 1696 (52 %), 1674 (17 %), 1584 (70 %), 
1572 (39 %), 1449 (43 %), 1418 (65 %), 1373 (32 %), 1280 (75 %), 1263 (76 %), 
1238 (31 %), 1168 (52 %), 1105 (61 %), 1031 (35 %), 1006 (49 %), 977 (68 %), 911 
(39 %), 779 (13 %), 701 (41 %), 689 (34 %). 
5.2.2.4 2-Fluoro-3-methylbenzaldehyde (6-F)  
To a stirred solution of t-BuOK (1.00 g, 8.93 mmol) in dry THF (20 mL) n-BuLi 
(5.70 mL, 9.12 mmol, 1.6 M in hexane) was added dropwise at -80 °C under argon. 
After 5 min further stirring, 1-fluoro-2-methylbenzene (1.00 g, 9.09 mmol) was 
introduced and the reaction was carried out for 2 h at -80 °C. DMF (0.80 mL, 
10.04 mmol) was added dropwise, then the solution was allowed to reach room 
temperature within 1 h. This reaction solution was quenched by adding acetic acid 
(5 mL, concentrated) and the resulting mixture was added into diethyl ether (100 mL). 
This solution was washed with satured aqueous NaHCO3 solution (50 mL), water 
(50 mL) and brine (50 mL) respectively, then the organic layer was dried over 
Na2SO4 and concentrated to afford a yellow oil, which was purified by using MPLC 
(petroleum ether / ethyl acetate, 4:1) to yield 0.77 g 6-F (62 %) as white crystals. 
2-Fluoro-3-methylbenzaldehyde  
1
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m.p. 36 - 37 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.22 (s, 1H, H-(C-7)), 7.63 (m, 2H, Harom), 7.27 (m, 1H, Harom), 2.28 (d, 
4JH,F = 2.0 Hz, 3H, H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 13.7 (d, 3JC,F = 3.6 Hz, C-8), 123.6 (d, 2JC,F = 8.8 Hz, C-1 or C-3), 124.5 (d, 
3JC,F = 3.7 Hz, C-4 or C-6), 125.8 (d, 2JC,F = 16.1 Hz, C-1 or C-3), 126.7 (d, 4JC,F = 
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1.5 Hz, C-5), 137.9 (d, 3JC,F = 6.6 Hz, C-4 or C-6), 161.9 (d, 1JC,F = 256.2 Hz, C-2), 
188.1 (d, 3JC,F = 6.6 Hz, C-7).  
HRMS (EI)  
m/z measured: 138.04527 ([M]+·, C8H7FO).  
m/z calculated: 138.048085. 
MS-EI (70 eV) 
m/z: 138 ([M]+·,.C8H7FO, 53 %), 137 ([M – H]+, C8H6FO, 53 %), 109 ([M – CHO]+, 
C7H6F, 40 %), 89 (3 %), 83 (12 %), 63 ([C5H3]+, 3 %), 39 (2 %).  
IR  
ν /cm-1 (T %): 2861 (93 %), 2759 (95 %), 1697 (34 %), 1678 (49 %), 1615 (68 %), 
1585 (52 %), 1474 (53 %), 1397 (59 %), 1382 (78 %), 1307 (90 %), 1252 (30 %), 
1228 (77 %), 1194 (43 %), 1164 (89 %), 1090 (87 %), 1074 (84 %), 1006 (93 %), 953 
(91 %), 922 (68 %), 820 (69 %), 780 (41 %), 760 (42 %), 721 (48 %), 684 (79 %). 
5.2.2.5 3-Methyl-4-nitrobenzaldehyde (7-NO2) 
The solution of 3-methyl-4-nitrobenzoic acid (4.50 g, 24.86 mmol) in THF (40 mL) 
was stirred in ice bath and 1 N BH3·THF (60 mL, 60 mmol) was added slowly into this 
solution. The ice bath was removed and the reaction solution was kept stirring for 
36 h. Methanol (50 mL) was added slowly to quench the reaction. The mixture was 
filtered and the filtrate was evaporated under reduced pressure. The residue was 
dissolved in ethyl acetate (100 mL) and washed with water (25 mL). Then the organic 
layer was separated, dried over Na2SO4, and evaporeated to afford 4.20 g crude 
(3-methyl-4-nitrophenyl)methanol as yellow solid. This crude product was used 
directly in the next synthesis step without further purification. 
(3-Methyl-4-nitrophenyl)methanol was oxidised to 7-NO2 by PDC according to the 
procedure described in the preparation for 3-I (see paragraph 5.2.1.5). 4.20 g Crude 
(3-methyl-4-nitrophenyl)methanol gave 3.12 g 7-NO2 (76 % based on 3-methyl-4-
nitrobenzoic acid) after purification by using MPLC (petroleum ether / ethyl acetate, 
5:1). 
3-Methyl-4-nitrobenzaldehyde 
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m.p. 72 - 74 °C (reported128 68 °C). 
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1H NMR (DMSO-d6, 250 MHz)  
δ (ppm) = 10.07 (s, 1H, H-(C-7)), 8.13 (d, 3JH,H = 8.3 Hz, 1H, H-(C-2) or H-(C-3)), 
8.00 (s, 1H, H-(C-6)), 7.94 (d, 3JH,H = 8.4 Hz, 1H, H-(C-2) or H-(C-3)), 2.54 (s, 3H, 
H-(C-8)). 
13C NMR (DMSO-d6, 60 MHz)  
δ (ppm) = 18.9 (C-8), 125.0 (H-Carom), 128.0 (H-Carom), 133.3 (C-5), 133.6 (H-Carom), 
138.4 (C-1), 152.2 (C-4), 192.2 (C-7).  
MS-EI (70 eV) 
m/z: 165 ([M]+·, C8H7NO3, 9 %), 148 ([M – OH]+, C8H6NO2, 100 %), 120 ([M – OH –
 CO]+, C7H6NO, 7 %), 106 (6 %), 92 (23 %), 91 (21 %), 77 ([C6H5]+, 12 %), 65 (50 %), 
51 (10 %), 39 (16 %). 
IR  
ν /cm-1 (T %): 3378 (88 %), 3104 (83 %), 3078 (85 %), 3042 (86 %), 2996 (87 %), 
2857 (82 %), 2744 (86 %), 1916 (90 %), 1782 (93 %), 1699 (60 %), 1606 (71 %), 
1586 (74 %), 1511 (40 %), 1458 (73 %), 1416 (73 %), 1382 (60 %), 1358 (47 %), 
1306 (59 %), 1270 (72 %), 1226 (61 %), 1148 (56 %), 1082 (69 %), 1038 (77 %), 
1007 (69 %), 963 (64 %), 952 (68 %), 889 (69 %), 831 (36 %), 757 (58 %), 734 
(45 %), 694 (66 %), 678 (64 %).   
5.2.2.6 4-Bromo-3-methylbenzaldehyde (7-Br) 
The synthesis of 7-Br was similar to the preparation of 7-NO2 (see paragraph 5.2.2.5). 
4-Bromo-3-methylbenzoic acid (2.10 g, 9.77 mmol) gave 2.20 g crude (4-bromo-3-
methylphenyl)methanol. This intermediate was directly oxidized by using PDC and 
1.14 g 7-Br (58 % based on 4-bromo-3-methylbenzoic acid) was obtained as yellow 
oil after purification by using MPLC (petroleum ether / ethyl acetate, 5:1). 
4-Bromo-3-methylbenzaldehyde 
3
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 9.95 (s, 1H, H-(C-7)), 7.85 (d, 4JH,H =1.3 Hz, 1H, H-(C-6)), 7.83 (d, 3JH,H 
=7.9 Hz, 1H, H-(C-3)), 7.64 (dd, 3JH,H =8.3 Hz, 4JH,H =1.7 Hz, 1H, H-(C-2)), 2.42 (s, 
3H, H-(C-8)). 
118 EXPERIMENTAL 
 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 22.3, 128.4, 131.1, 131.5, 133.1, 135.4, 138.5, 192.4.  
MS-EI (70 eV) 
m/z: 200 ([M]+·, C8H781BrO, 62 %), 199 ([M – H]+, C8H681BrO, 97 %), 198 ([M]+·, 
C8H779BrO, 64 %), 197 ([M – H]+, C8H779BrO, 100 %), 172 (4 %), 171 ([M – CHO]+, 
C7H681Br, 26 %), 170 (4 %), 169 ([M – CHO]+, C7H779Br, 30 %), 118 ([M – H79/81Br]+·, 
C8H6O, 2 %), 91 (8 %), 89 (18 %), 74 (2 %), 63 (11 %), 39 (5 %). 
IR  
ν /cm-1 (T %): 3378 (99 %), 2954 (96 %), 2923 (96 %), 2833 (92 %), 2722 (94 %), 
1698 (32 %), 1686 (34 %), 1590 (43 %), 1568 (51 %), 1469 (75 %), 1445 (78 %), 
1410 (87 %), 1383 (68 %), 1365 (72 %), 1291(72 %), 1279 (78 %), 1227 (50 %), 
1164 (80 %), 1153 (70 %), 1140 (84 %), 1024 (27 %), 948 (51 %), 924 (54 %), 892 
(78 %), 815 (48 %), 775 (45 %), 736 (38 %), 699 (77 %), 673 (81 %), 666 (82 %).  
5.2.2.7 3-Methyl-4-trimethylammoniumbenzaldehyde triflate (7-N+Me3TfO-) 
The synthetic procedure was the same as described in the preparation of 
3-N+Me3TfO- (see paragraph 5.2.1.6)  
3-Methyl-4-dimethylaminobenzaldehyde 
4-Fluoro-3-methylbenzaldehyde (0.95 g, 6.88 mmol), dimethylamine hydrochloride 
(1.40 g, 17.28 mmol) and K2CO3 (2.37 g, 17.17 mmol) were stirred in a mixture of 
DMSO (50 mL) and water (20 mL) and refluxed for 12 h. After workup and 
purification by using MPLC (petroleum ether / ethyl acetate, 5:1 ), 0.84 g 3-methyl-4-
dimethylaminobenzaldehyde was obtained as yellow oil (68 %). 
3-Methyl-4-dimethylaminobenzaldehyde 
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1H NMR (DMSO-d6, 400 MHz)  
δ = 9.79 (s, 1H, H-(C-7)), 7.65 (m, 2H, Harom), 7.07 (d, 3JH,H = 8.3 Hz, 1H, Harom), 2.77 
(s, 6H, H-(C-9) and H-(C-10)), 2.30 (s, 3H, H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ = 19.2, 59.7, 117.3, 128.9, 129.4, 129.7, 132.4, 157.9, 170.2, 191.2.   
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MS-EI (70 eV) 
m/z: 163 ([M]+·, C10H13NO, 100 %), 148 ([M – CH3]+, C9H10NO, 50 %), 132 (28 %), 
118 (14 %), 91 (14 %), 65 (7 %). 
IR  
ν /cm-1 (T %): 2946 (85 %), 2834 (83 %), 2791 (82 %), 2722 (90 %), 1679 (29 %), 
1594 (22 %), 1565 (55 %), 1500 (45 %), 1476 (79 %), 1445 (64 %), 1418 (76 %), 
1372 (72 %), 1333 (55 %), 1313 (58 %), 1230 (30 %), 1186 (62 %), 1156 (56 %), 
1137 (61 %), 1099 (27 %), 1053 (66 %), 1004 (87 %), 956 (43 %), 933 (75 %), 897 
(76 %), 821 (48 %), 778 (51 %), 744 (68 %), 731 (60 %), 703 (80 %).  
3-Methyl-4-trimethylammoniumbenzaldehyde triflate 
To a stirred solution of 3-methyl-4-dimethylaminobenzaldehyde (0.95 g, 5.83 mmol) 
in DCM (5 mL) was added methyl trifluoromethanesulfonate (0.78 mL, 6.90 mmol). 
The solution was stirred for 3 h at room temperature under argon. The reaction 
solvent was concentrated and the residue was crystallized in mixture of 
diisopropylether and DCM (1:10, v/v). 0.92 g 7-N+Me3TfO- was obtained as white 
crystals (74 %). 
3-Methyl-4-trimethylammoniumbenzaldehyde triflate 
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m.p. 113 - 115 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ = 10.06 (s, 1H, H-(C-7)), 8.10 (d, 4JH,H = 8.8 Hz, 1H, Harom), 7.99 (m, 2H, Harom), 
3.71 (s, 9H, -N-(CH3)3), 2.82 (s, 3H, H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ = 22.6 (C-8), 56.5(-N-(CH3)3), 122.7 (H-Carom), 128.4 (H-Carom), 132.0 (C-5), 136.2 
(H-Carom), 136.6 (C-1), 149.0 (C-4), 192.0 (C-7).  
MS-FAB (70 eV) 
m/z: 178 ([M]+·, C11H16NO, 100 %), 164 ([M – CH3]+, C10H13NO, 34 %), 136 ([M – CH3 
– CO]+, C9H13NO, 26 %), 107 (8 %). 
IR  
ν /cm-1 (T %): 3052 (93 %), 2296 (98 %), 1691 (60 %), 1609 (93 %), 1584 (88 %), 
1496 (76 %), 1480 (81 %), 1389 (90 %), 1376 (90 %), 1315 (92 %), 1255 (26 %), 
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1223 (30 %), 1197 (76 %), 1147 (33 %), 1092 (78 %), 1067 (60 %), 1026 (20 %), 962 
(80 %), 947 (58 %), 820 (73 %), 777 (65 %), 756 (72 %), 739 (90 %), 679 (86 %).  
5.2.2.8 2-Fluoro-5-methoxy-3-methylbenzaldehyde (8-F)  
2.45 g 8-F was obtained as white crystals (70 %) from 4-fluoro-3-methylanisole 
(3.00 mL, 17.14 mmol). The synthetic procedure was carried out according to 
described in the synthesis of 6-F (see paragraph 5.2.2.4). 
2-Fluoro-5-methoxy-3-methylbenzaldehyde 
1
2
6
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CH3
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m.p. 41 - 42 ºC. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.18 (s, 1H, H-(C-7)), 7.21 (dd, 4JH,H = 3.3 Hz, 4JH,F = 6.6 Hz, 1H, H-(C-4) 
or H-(C-6)), 7.07 (dd, 4JH,H = 3.8 Hz, 4JH,F = 5.1 Hz, 1H, H-(C-4) or H-(C-6)), 3.76 (s, 
3H, -OCH3), 2.25 (d, 4JH,F = 2.0 Hz, 3H, H-(C-8)).  
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 13.9 (d, 3JC,F = 3.7 Hz, C-8), 55.7 (C-9), 108.7 (d, 3JC,F = 2.9 Hz, C-4 or 
C-6), 123.7 (d, 2JC,F = 10.2 Hz, C-1 or C-3), 124.1 (d, 3JC,F = 5.9 Hz, C-4 or C-6), 
127.2 (d, 2JC,F = 18.2 Hz, C-1 or C-3), 155.1 (d, 4JC,F = 2.2 Hz, C-5), 156.8 (d, 1JC,F = 
249.6 Hz, C-2), 187.8 (d, 3JC,F = 5.9 Hz, C-7).  
HRMS (EI)  
m/z measured: 168.05987 ([M]+·, C9H9FO2).  
m/z calculated: 168.058645. 
MS-EI (70 eV) 
m/z: 168 ([M]+·, C9H9FO2, 100 %), 153 (3 %), 139 ([M – CHO]+, C8H8FO, 22 %), 109 
(9 %), 97 (7 %), 77 ([C6H5]+, 4 %), 57 (2 %), 51 ([C4H3]+, 6 %). 
IR  
ν /cm-1 (T %): 2941 (92 %), 2860 (92 %), 1690 (32 %), 1600 (65 %), 1478 (41 %), 
1444 (70 %), 1399 (52 %), 1382 (76 %), 1333 (56 %), 1290 (55 %), 1232 (52 %), 
1200 (34 %), 1149 (45 %), 1055 (43 %), 1010 (81 %), 967 (76 %), 946 (62 %), 857 
(58 %), 794 (72 %), 764 (88 %), 705 (64 %), 696 (63 %), 674 (30 %).  
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5.2.2.9 5-Methoxy-3-methyl-2-nitrobenzaldehyde (8-NO2) 
Synthetic pathway 1 
2-(5-Methoxy-2-nitrophenyl)-1,3-dioxolane 
In the Dean-Stark-Trap 5-methoxy-2-nitrobenzaldehyde (3.97 g, 21.93 mmol), 
ethylene glycol (2.20 mL, 39.49 mmol) and toluene-4-sulfonic acid (0.25 g, 
1.32 mmol) were mixed in toluene (55 mL). This solution was refluxed at 130 °C for 
6 h. The resulting mixture was washed with 3 % aqueous NaHCO3 solution (50 mL), 
then the toluene layer was dried over Na2SO4. After evaporation of solvent, the 
residue was purified by using MPLC (petroleum ether / ethyl acetate, 5:1). The 
collected product from MPLC was crystallized in diisopropyl ether to yield 4.51 g 
2-(5-methoxy-2-nitrophenyl)-1,3-dioxolane as white needle crystal (71 %). 
2-(5-Methoxy-2-nitrophenyl)-1,3-dioxolane 
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m.p. 52 - 54 °C. 
1H NMR (CDCl3, 250 MHz)  
δ (ppm) = 8.04 (d, 3JH,H = 9.1 Hz, 1H, H-(C-3’)), 7.29 (d, 4JH,H = 3.0 Hz, 1H, H-(C-6’)), 
6.90 (dd, 3JH,H = 9.1 Hz, 4JH,H = 2.8 Hz, 1H, H-(C-4’)), 6.55 (s, 1H, H-(C-2)), 4.04 (m, 
4H, H-(C-4) and H-(C-5)), 3.89 (s, 3H, H-(C-7)). 
13C NMR (CDCl3, 60 MHz)  
δ (ppm) = 55.9 (C-7), 65.3 (C-4 and C-5), 99.5 (C-2), 112.7 (C-6’), 113.9 (C-4’), 127.5 
(C-3’), 136.2 (C-1’), 141.5 (C-2’), 163.2 (C-5’).  
HRMS (EI)  
m/z measured: 225.06277 ([M]+·, C10H11NO5).  
m/z calculated: 225.063696. 
MS-FAB (70 eV) 
m/z: 226 ([M + H]+·, C10H12NO5, 100 %), 208 ([M – OH]+, C10H10NO4, 28 %), 178 
(100 %), 164 (12 %), 150 (16 %), 134 (53 %), 121 (46 %), 106 (89 %), 92 (10 %), 73 
(18 %), 63 ([C5H3]+, 14 %), 45 (8 %). 
IR  
ν /cm-1 (T %): 3122 (84 %), 3105 (86 %), 3081 (85 %), 2974 (83 %), 2948 (81 %), 
2897 (73 %), 2839 (86 %), 2617 (90 %), 2479 (91 %), 2055 (92 %), 1941 (90 %), 
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1812 (93 %), 1736 (94 %), 1689 (94 %), 1603 (61 %), 1589 (50 %), 1504 (49 %), 
1489 (41 %), 1473 (54 %), 1466 (55 %), 1457 (55 %), 1417 (80 %), 1392 (49 %), 
1317 (38 %), 1286 (39 %), 1240 (41 %), 1192 (41 %), 1177 (38 %), 1153 (59 %), 
1133 (70 %), 1100 (46 %), 1058 (29 %), 1026 (36 %), 982 (38 %), 957 (23 %), 938 
(29 %), 867 (30 %), 852 (29 %), 841 (34 %), 775 (50 %), 756 (46 %), 721 (47 %), 
695 (56 %). 
2-(5-Methoxy-3-methyl-2-nitrophenyl)-1,3-dioxolane 
To a stirred solution of 2-(5-methoxy-2-nitrophenyl)-1,3-dioxolane (0.30 g, 1.33 mmol) 
in THF (10 mL, absolute) at -80 °C MeMgBr (1.40 mL, 4.20 mmol, 3 M in diethyl 
ether) was added dropwise. After 30 min, the solution of KMnO4 (0.51 g, 3.23 mmol) 
in water and acetone (10 mL, 1:1, v/v) was introduced into the mixture which was 
then stirred another 1 h without cooling bath. 0.1 N HCl (25 mL) was added and the 
mixture was extracted with DCM (2 × 50 mL), the combined extracts were washed, 
dried over Na2SO4 and evaporated to leave a residue, which was subjected by using 
MPLC (petroleum ether / ethyl acetate, 5:1). 0.12 g 2-(5-methoxy-3-methyl-2-
nitrophenyl)-1,3-dioxolane was obtained as yellow oil (39 %). 
2-(5-Methoxy-3-methyl-2-nitrophenyl)-1,3-dioxolane 
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1H NMR (CDCl3, 250 MHz)  
δ = 7.00 (d, 4JH,H = 2.7 Hz, 1H, H-(C-4’) or H-(C-6’)), 6.74 (d, 4JH,H = 2.8 Hz, 1H, 
H-(C-4’) or H-(C-6’)), 6.10 (s, 1H, H-(C-2)), 3.99 (m, 4H, H-(C-4) and H-(C-5)), 3.83 (s, 
3H, H-(C-8)), 2.33 (s, 3H, H-(C-7)). 
13C NMR (CDCl3, 60 MHz)  
δ = 18.2 (C-7), 55.6 (C-8), 65.2 (C-4 and C-5), 99.8 (C-2), 109.9 (C-4’ or C-6’), 116.6 
(C-4’ or C-6’), 133.0 (C-3’), 133.3 (C-1’), 134.5 (C-2’), 160.3 (C-5’).  
MS-FAB (70 eV) 
m/z: 240 ([M + H]+·, C11H14NO5, 100 %), 219 (18 %), 196 ([M + H – CH2CH2O]+·, 
C9H10NO4, 45 %), 178 (16 %), 163 (18 %), 154 (78 %), 136 (15 %), 120 (25 %), 107 
(29 %), 89 (28 %), 77 ([C6H5]+, 38 %), 73 (35 %), 57 (18 %). 
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IR  
ν /cm-1 (T %): 2967 (90 %), 2892 (88 %), 1735 (96 %), 1595 (54 %), 1521 (35 %), 
1468 (64 %), 1360 (49 %), 1332 (56 %), 1316 (59 %), 1283 (56 %), 1233 (74 %), 
1195 (61 %), 1167 (47 %), 1123 (50 %), 1096 (33 %), 1052 (58 %), 1022 (53 %), 935 
(49 %), 863 (58 %), 840 (45 %), 753 (80 %), 722 (83 %), 678 (80 %).  
5-Methoxy-3-methyl-2-nitrobenzaldehyde 
To solution of 2-(5-methoxy-3-methyl-2-nitrophenyl)-1,3-dioxolane (0.40 g, 1.67 mmol) 
in THF (5 mL) was added 1 N HCl (5 mL). This solution was stirred at room 
temperature overnight. After workup and purification by using MPLC (petroleum ether 
/ ethyl acetate, 5:1), 0.24 g 8-NO2 was obtained as yellow substance (70 %).  
5-Methoxy-3-methyl-2-nitrobenzaldehyde 
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m.p. 114 - 116 °C. 
1H NMR (CDCl3, 250 MHz)  
δ (ppm) = 9.94 (s, 1H, H-(C-7)), 7.23 (s, 1H, H-(C-4) or H-(C-6)), 6.99 (s, 1H, H-(C-4) 
or H-(C-6)), 3.89 (s, 3H, H-(C-9)), 2.42 (s, 3H, H-(C-8)). 
13C NMR (CDCl3, 60 MHz)  
δ (ppm) = 18.3 (C-8), 56.0 (C-9), 111.4 (C-4 or C-6), 122.1 (C-4 or C-6), 130.9 (C-1), 
134.2 (C-3), 144.9 (C-2), 160.9 (C-5), 187.0 (C-7).  
HRMS (EI)  
m/z measured: 195.05047 ([M]+·, C9H9NO4).  
m/z calculated: 195.053136. 
MS-EI (70 eV) 
m/z: 195 ([M]+·, C9H9NO4, 11 %), 178 ([M – OH]+, C9H8NO3, 6 %), 167 ([M – CO]+·, 
C8H9NO3, 5 %), 165 ([M – NO]+, C9H9O3, 11 %), 162 (21 %), 149 ([M – NO2]+, 
C9H9O2, 100 %), 137 (9 %), 134 (16 %), 122 (8 %), 121 (41 %), 107 (9 %), 106 
(50 %), 95 (7 %), 78 (10 %), 73 (18 %), 63 ([C5H3]+, 9 %), 62 (4 %), 51 ([C4H3]+, 9 %), 
39 (6 %). 
IR  
ν /cm-1 (T %): 2941 (90 %), 1702 (63 %), 1593 (58 %), 1519 (38 %), 1468 (62 %), 
1360 (58 %), 1327 (49 %), 1289 (41 %), 1237 (67 %), 1194 (64 %), 1167 (52 %), 
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1112 (59 %), 1097 (53 %), 1052 (66 %), 1029 (62 %), 966 (69 %), 938 (60 %), 863 
(63 %), 841 (51 %), 730 (76 %), 692 (74 %).  
Synthetic pathway 2 
3-Methoxy-5-methylbenzaldehyde 
3,5-Dimethylphenol (18.00 g, 147.54 mmol) was methoxylated with MeI to give 
18.60 g crude 1-methoxy-3,5-dimethylbenzene. The synthetic procedure was the 
same as described in the preparation of 3-NO2 (see paragraph 5.2.1.2). 
13.00 g Crude 1-methoxy-3,5-dimethylbenzene was brominated with 
N-bromosuccinimide and the intermediate was submitted to oxidation under basic 
condition, 3.00 g 3-methoxy-5-methylbenzaldehyde (30 % based on 
1-(bromomethyl)-5-methoxy-3-methylbenzene) was obtained after purification by 
using MPLC (petroleum ether / ethyl acetate, 9:1). The synthetic procedure was the 
same as described in the synthesis of 3-Cl (see paragraph 5.2.1.3). 
3-Methoxy-5-methylbenzaldehyde 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 9.92 (s, 1H, H-(C-7)), 7.31 (s, 1H, Harom), 7.21 (s, 1H, Harom), 7.09 (s, 1H, 
Harom), 3.79 (s, 3H, H-(C-8)), 2.35 (s, 3H, H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 20.7, 55.3, 110.3, 121.3, 123.1, 137.5, 140.2, 159.7, 192.9.  
HRMS (EI)  
m/z measured: 150.06764 ([M]+·, C9H10O2).  
m/z calculated: 150.068671. 
MS-EI (70 eV) 
m/z: 150 ([M]+·, C9H10O2, 100 %), 135 ([M – CH3]+, C8H7O2, 1 %), 121 ([M – CHO]+, 
C7H6O, 34 %), 105 (6 %), 91 (20 %), 78 (8 %), 77 ([C6H5]+, 17 %), 63 ([C5H3]+, 6 %), 
51 (7 %), 38 (6 %). 
IR  
ν /cm-1 (T %): 2940 (91 %), 2841 (90 %), 2731 (94 %), 1696 (32 %), 1594 (45 %), 
1465 (58 %), 1385 (63 %), 1330 (54 %), 1292 (24 %), 1261 (85 %), 1232 (92 %), 
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1193 (67 %), 1155 (45 %), 1148 (45 %), 1064 (44 %), 1005 (80 %), 992 (84 %), 965 
(77 %), 935 (80 %), 918 (78 %), 845 (43 %), 770 (92 %), 705 (45 %), 678 (42 %).  
5-Methoxy-3-methyl-2-nitrobenzaldehyde 
3-Methoxy-5-methylbenzaldehyde (3.00 g, 20.00 mmol) was added to 90 % HNO3 
(10 mL) in several portions while stirring at 0 °C. After 1 h TLC analysis showed that 
the starting compound was completely converted and there were 3 different kinds of 
products in the solution. The resulting mixture was poured into water (100 mL) and 
extracted with diethyl ether (2 × 100 mL). The organic layer was washed with 
statured. NaHCO3  solution (2 × 50 mL) and brine (50 mL), dried over Na2SO4 and 
evaporated. After purification by using the MPLC (petroleum ether / ethyl acetate, 
5:1), 1.30 g 8-NO2 (30 %) was obtained as yellow substance. 
The analytic data (MS, NMR and IR) matched that of 8-NO2 in synthetic pathway 1. 
Synthetic pathway 3 
3,5-Dimethyl-4-nitrophenol  
Concentrated HCl (30 mL) was added dropwise into a stirred solution of 
3,5-dimethylphenol (40.40 g, 331.15 mmol) and NaNO3 (28.20 g, 331.76 mmol) in 
diethyl ether (250 mL) and water (250 mL). The solution was kept stirring at room 
temperature overnight. The resulting mixture was extracted with diethyl ether (2 × 
150 mL) and the combined organic extracts were washed with satured aqueous 
NaHCO3 solution (2 × 150 mL), water (2 × 200 mL) and brine (100 mL), then dried 
over Na2SO4 and concentrated to afford a crude mixed product (3,5-dimethyl-4-
nitrophenol and 3,5-dimethyl-2-nitrophenol). These two compounds were separated 
by steam distillation. 15.90 g 3,5-dimethyl-4-nitrophenol was obtained as yellow 
powder (29 %). 
3,5-Dimethyl-4-nitrophenol 
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m.p. 107 - 108 °C (reported129 107 - 108 °C). 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 6.59 (s, 2H, H-(C-2) and H-(C-6)), 2.19 (s, 6H, H-(C-7) and H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 17.6, 115.2, 132.0, 143.7, 158.6.  
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MS-EI (70 eV) 
m/z: 167 ([M]+·, C8H7NO4, 85 %), 150 ([M – OH]+, C8H6NO3, 100 %), 137 ([M – NO]+, 
C8H7O3, 11 %), 122 (14 %), 95 (9 %), 91 (26 %), 77 ([C6H5]+, 31 %), 65 (8 %). 
IR  
ν /cm-1 (T %): 3345 (61 %), 2974 (85 %), 2935 (85 %), 2868 (88 %), 2195 (93 %), 
1589 (38 %), 1506 (27 %), 1466 (35 %), 1438 (40 %), 1381 (73 %), 1350 (53 %), 
1306 (25 %), 1277 (29 %), 1232 (44 %), 1181 (36 %), 1172 (37 %), 1097 (39 %), 
1030 (54 %), 971 (67 %), 868 (56 %), 845 (34 %), 838 (37 %), 764 (66 %), 699 
(48 %).   
3,5-Dimethyl-4-nitroanisole  
The methoxylation of 3,5-dimethyl-4-nitrophenol was similar to the procedure 
described in the preparation of 3-NO2 (see paragraph 5.2.1.2). 
A mixture of 3,5-dimethyl-4-nitrophenol (1.25 g, 7.49 mmol), K2CO3 (1.03 g, 
7.46 mmol) and MeI (0.47 mL, 7.55 mmol) was stirred in 40 mL DMF at room 
temperature for 4 h. After workup and purification by using MPLC (petroleum ether / 
ethyl acetate, 3:1), 1.13 g 3,5-dimethyl-4-nitroanisole was obtained as a yellow 
substance (81 %). 
3,5-Dimethyl-4-nitroanisole 
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m.p. 56 - 58 °C (reported130 52 °C). 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 6.82 (s, 2H, H-(C-2) and H-(C-6)), 3.78 (s, 3H, H-(C-9)), 2.24 (s, 6H, 
H-(C-7) and H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 17.6, 55.6, 114.0, 131.8, 144.8, 159.8. 
MS-EI (70 eV) 
m/z: 181 ([M]+·, C9H11NO3, 95 %), 164 ([M – OH]+, C9H10NO2, 100 %), 151 ([M – NO]+, 
C9H11O2, 19 %), 121 (11 %), 109 (22 %), 91 (35 %), 77 ([C6H5]+, 30 %), 65 ([C5H5]+, 
15 %), 51 ([C4H3]+, 6 %). 
IR  
ν /cm-1 (T %): 3022 (88 %), 2974 (85 %), 2942 (80 %), 2842 (87 %), 2623 (92 %), 
1802 (95 %), 1716 (94 %), 1594 (40 %), 1505 (27 %), 1479 (41 %), 1441 (58 %), 
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1422 (65 %), 1379 (59 %), 1355 (44 %), 1325 (34 %), 1295 (45 %), 1189 (45 %), 
1168 (45 %), 1108 (48 %), 1057 (55 %), 1040 (66 %), 1004 (53 %), 964 (75 %), 943 
(53 %), 850 (50 %), 834 (24 %), 759 (71 %), 703 (56 %).   
5-Methoxy-3-methyl-2-nitrobenzaldehyde  
According to the procedure described in the preparation of 3-Cl (see paragraph 
5.2.1.3), 8-NO2 was synthesized from 3,5-dimethyl-4-nitroanisole (1.02 g, 5.64 mmol) 
by bromination and following oxidation. After workup and purification by using MPLC 
(petroleum ether / ethyl acetate, 5:1), 0.33 g 8-NO2 was obtained (30 % based on 
3,5-dimethyl-4-nitroanisole) as slightly yellow needles. 
The analytic data (MS, NMR and IR) matched that of 8-NO2 in synthetic pathway 1. 
5.2.2.10 2-Bromo-5-methoxy-3-methylbenzaldehyde (8-Br) 
2-Bromo-5-methoxy-1,3-dimethylbenzene  
1-Methoxy-3,5-dimethylbenzene (5.2.2.9, synthetic pathway 2) was brominated as 
described in the preparation of 3-Br (see paragraph 5.2.1.4). 
1-Methoxy-3,5-dimethylbenzene (3.00 g, 22.06 mmol) and Br2 (1.25 mL, 24.30 mmol) 
was stirred in CHCl3 (50 mL) at room temperature for 0.5 h. After purification by using 
MPLC (petroleum ether / ethyl acetate, 5:1), 3.90 g 2-bromo-5-methoxy-1,3-
dimethylbenzene (85 %) was obtained as colourless oil. 
2-Bromo-5-methoxy-1,3-dimethylbenzene 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 6.78 (s, 2H, H-(C-2) and H-(C-6)), 3.71 (s, 3H, H-(C-7)), 2.31 (s, 6H, 
H-(C-8) and H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 23.4, 55.1, 114.0, 117.2, 138.4, 157.8.  
MS-EI (70 eV) 
m/z: 217 ([M]+·, C9H1181BrO, 11 %), 216 ([M – H]+, C9H1081BrO, 94 %), 215 ([M]+·, 
C9H1179BrO, 13 %), 214 ([M – H]+, C9H1079BrO, 100 %), 201 ([M – CH3]+, C8H881BrO, 
10 %), 199 ([M – CH3]+, C8H879BrO, 12 %), 173 ([M – CH3 – CO]+, C7H881Br, 22 %), 
171 ([M – CH3 – CO]+, C7H879Br, 24 %), 135 ([M – H79/81Br]+·, C9H10O, 22 %), 119 
(3 %), 105 (11 %), 91 (23 %), 77 ([C6H5]+, 6 %). 
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IR  
ν /cm-1 (T %): 2953 (89 %), 2836 (92 %), 1585 (56 %), 1465 (49 %), 1437 (69 %), 
1407 (75 %), 1377 (83 %), 1318 (26 %), 1280 (82 %), 1236 (92 %), 1214 (90 %), 
1194 (49 %), 1160 (23 %), 1098 (85 %), 1075 (51 %), 1030 (67 %), 1016 (49 %), 997 
(71 %), 956 (91 %), 933 (77 %), 851 (58 %), 831 (60 %), 692 (73 %).    
2-Bromo-5-methoxy-3-methylbenzaldehyde 
According to the procedure described in the preparation of 3-Cl (see paragraph 
5.2.1.3), 8-Br was synthesized from 2-bromo-5-methoxy-1,3-dimethylbenzene 
(2.08 g, 9.63 mmol) by bromination and following oxidation. After workup and 
purification by using MPLC (petroleum ether / ethyl acetate, 5:1), 0.85 g 8-Br was 
obtained (39 % based on 2-bromo-5-methoxy-1,3-dimethylbenzene) as white needle 
crystals. 
2-Bromo-5-methoxy-3-methylbenzaldehyde 
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m.p. 94 - 95 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.24 (s, 1H, H-(C-7)), 7.29 (d, 4JH,H = 3.1 Hz, 1H, H-(C-4) or H-(C-6)), 
7.14 (d, 4JH,H = 3.0 Hz, 1H, H-(C-4) or H-(C-6)), 3.79 (s, 3H, H-(C-9)), 2.38 (s, 3H, 
H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 22.2 (C-8), 55.6 (C-9), 115.1 (C-4 or C-6), 119.2 (C-2), 123.0 (C-4 or C-6), 
134.1 (C-1), 140.6 (C-3), 158.3 (C-5), 192.0 (C-7). 
HRMS (EI)  
m/z measured: 227.98030 ([M]+·, C9H9BrO2).  
m/z calculated: 227.978542. 
MS-EI (70 eV) 
m/z: 230 ([M]+·, C9H981BrO2, 95 %), 229 ([M – H]+, C9H881BrO2, 95 %), 228 ([M]+·, 
C9H979BrO2, 100 %), 227 ([M – H]+, C9H879BrO2, 95 %), 202 (7 %), 201 ([M – CHO]+·, 
C8H881BrO, 25 %), 200 (9 %), 199 ([M – CHO]+·, C8H879BrO, 26 %), 185 (10 %), 157 
(6 %), 148 ([M – H79/81Br]+·, C9H8O2, 7 %), 134 (2 %), 120 (15 %), 105 (8 %), 91 
(17 %), 77 ([C6H5]+, 24 %), 63 ([C5H3]+, 10 %), 51 ([C4H3]+, 18 %). 
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IR  
ν /cm-1 (T %): 3339 (87 %), 3071 (81 %), 3016 (79 %), 2978 (76 %), 2938 (77 %), 
2888 (75 %), 2841 (78 %), 2604 (85 %), 2166 (88 %), 1762 (90 %), 1674 (32 %), 
1587 (46 %), 1578 (49 %), 1461 (40 %), 1428 (49 %), 1386 (42 %), 1375 (33 %), 
1311 (26 %), 1283 (37 %), 1231 (47 %), 1198 (43 %), 1158 (24 %), 1101 (70 %), 
1074 (32 %), 1020 (45 %), 969 (52 %), 937 (30 %), 881 (51 %), 867 (30 %), 714 
(49 %), 687 (53 %). 
5.2.2.11 2-Chloro-5-methoxy-3-methylbenzaldehyde (8-Cl)  
2-Chloro-5-methoxy-1,3-dimethylbenzene 
4-Chloro-3,5-dimethylphenol was methoxylated according to the procedure described 
in the synthesis of 3-NO2 (see paragraph 5.2.1.2). 
4-Chloro-3,5-dimethylphenol (13.80 g, 88.46 mmol), K2CO3 (14.60 g, 105.80 mmol) 
and MeI (6.60 mL, 105.97 mmol) were stirred in DMF (100 mL) at room temperature 
overnight. After workup and purification by using MPLC (petroleum ether / ethyl 
acetate, 5:1), 14.10 g 2-chloro-5-methoxy-1,3-dimethylbenzene was obtained as 
colourless oil (94 %).  
2-Chloro-5-methoxy-1,3-dimethylbenzene 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 6.76 (s, 2H, H-(C-2) and H-(C-6)), 3.70 (s, 3H, H-(C-7)), 2.27 (s, 6H, 
H-(C-8) and H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 20.4, 55.2, 114.1, 124.9, 136.5, 157.3.  
MS-EI (70 eV) 
m/z: 172 ([M]+·, C9H1137ClO, 34 %), 170 ([M]+·, C9H1135ClO, 100 %), 157 ([M – CH3]+, 
C8H837ClO, 9 %), 155 ([M – CH3]+, C8H937ClO, 23 %), 135 ([M – 35/37Cl]+, C9H11O, 
38 %), 127 (22 %), 105 (14 %), 91 (21 %), 77 ([C6H5]+, 10 %), 65 ([C5H3]+, 7 %), 39 
(5 %). 
IR  
ν /cm-1 (T %): 2953 (88 %), 2837 (91 %), 1715 (96 %), 1592 (57 %), 1471 (52 %), 
1438 (72 %), 1413 (76 %), 1377 (87 %), 1322 (29 %), 1281 (82 %),1237 (91 %), 
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1194 (50 %), 1160 (21 %), 1082 (62 %), 1039 (44 %), 998 (77 %), 957 (90 %), 936 
(79 %), 853 (60 %), 834 (63 %), 697 (73 %). 
2-Chloro-5-methoxy-3-methylbenzaldehyde  
According to the procedure described in the synthesis of 3-Cl (see 
paragraph 5.2.1.3), 2-chloro-5-methoxy-1,3-dimethylbenzene (5.70 g, 33.14 mmol) 
was brominated and oxidized. 0.92 g 8-Cl was obtained (15 % based on 2-chloro-5-
methoxy-1,3-dimethylbenzene) as white needle crystals after workup and purification 
by using MPLC (petroleum ether / ethyl acetate, 5:1). 
2-Chloro-5-methoxy-3-methylbenzaldehyde 
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m.p. 88 - 90 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.31 (s, 1H, H-(C-7)), 7.27 (d, 4JH,H = 3.1 Hz, 1H, H-(C-4) or H-(C-6)), 
7.15 (d, 4JH,H = 3.3 Hz, 1H, H-(C-4) or H-(C-6)), 3.78 (s, 3H, H-(C-9)), 2.34 (s, 3H, 
H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 19.3 (C-8), 55.6 (C-9), 110.6 (C-4 or C-6), 123.1 (C-4 or C-6), 128.2 (C-2), 
132.8 (C-3), 138.8 (C-1), 157.7 (C-5), 190.0 (C-7).  
HRMS (EI)  
m/z measured: 184.028585 ([M]+·, C9H9ClO2).  
m/z calculated: 184.029095. 
MS-EI (70 eV) 
m/z:186 ([M]+·, C9H937ClO2, 34 %), 185 ([M – H]+, C9H837ClO2, 42 %), 184 ([M]+·, 
C9H935ClO2, 93 %), 183 ([M – H]+, C9H835ClO2, 100 %), 158 (2 %), 157 ([M – CHO]+, 
C8H837ClO, 6 %), 156 (5 %), 155 ([M – CHO]+, C8H835ClO, 18 %), 141 (3 %), 127 
(2 %), 125 (4 %), 113 (3 %), 99 (2 %), 91 (6 %), 89 (5 %), 77 ([C6H5]+, 10 %), 63 
([C5H3]+, 4 %), 51 (6 %), 39 (3 %). 
IR  
ν /cm-1 (T %): 3345 (90 %), 3074 (85 %), 3019 (82 %), 2982 (80 %), 2941 (80 %), 
2891 (78 %), 2844 (83 %), 1766 (92 %), 1678 (38 %), 1594 (50 %), 1463 (42 %), 
1450 (53 %), 1433 (46 %), 1388 (44 %), 1376 (46 %), 1315 (33 %), 1284 (39 %), 
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1229 (53 %), 1196 (50 %), 1159 (30 %), 1081 (45 %), 1036 (38 %), 1013 (64 %), 970 
(56 %), 940 (39 %), 884 (58 %), 870 (32 %), 727 (58 %), 695 (56 %).  
5.2.3 The precursors for further systematic study of nucleophilic 
aromatic 18F-fluorination 
5.2.3.1 5-Ethoxy-2-nitrobenzaldehyde (12-C2H5) 
Compounds 12-C2H5, 12-C3H7 and 12-C4H9 were synthesized by the analogous 
method described in methoxylation of 3-NO2 (see paragraph 5.2.1.2):  
5-Hydroxy-2-nitrobenzaldehyde (0.37 g, 2.22 mmol), K2CO3 (0.37 g, 2.68 mmol) and 
C2H5I (0.21 mL, 2.69 mmol) in DMF (5 mL) were stirred at room temperature for 12 h, 
0.41 g 12-C2H5 (95 %) was obtained after purification by using MPLC (petroleum 
ether / ethyl acetate, 4:1). 
5-Ethoxy-2-nitrobenzaldehyde 
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m.p. 69 - 70 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.27 (s, 1H, H-(C-7)), 8.17 (d, 3JH,H = 9.1 Hz, 1H, H-(C-3)), 7.34 (dd, 3JH,H 
= 9.1 Hz, 4JH,H = 2.8 Hz, 1H, H-(C-4)), 7.21 (d, 4JH,H = 3.0 Hz, 1H, H-(C-6)), 4.24 (q, 
3JH,H = 7.1 Hz, 2H, H-(C-8)), 1.37 (t, 3JH,H = 7.0 Hz, 3H, H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 14.2 (C-9), 64.7 (C-8), 113.9 (C-6), 118.4 (C-4), 127.2 (C-3), 134.3 (C-1), 
141.6 (C-2), 162.8 (C-5), 189.9 (C-7).  
MS-EI (70 eV) 
m/z: 195 ([M]+·, C9H9NO4, 16 %), 167 ([M – C2H4]+·, C7H5NO4, 100 %), 150 ([M – 
C2H4 – OH]+, C7H4NO3, 12 %), 137 ([M – C2H4 – NO]+, C7H5O3, 28 %), 123 (29 %), 
109 (54 %), 92 (14 %), 81 (50 %), 69 (14 %), 63 ([C5H3]+, 15 %), 53 (18 %), 39 
(16 %). 
IR  
ν /cm-1 (T %): 3107 (96 %), 2986 (90 %), 2939 (93 %), 2899 (93 %), 2661 (98 %), 
1693 (44 %), 1579 (38 %), 1512 (30 %), 1486 (63 %), 1473 (62 %), 1425 (72 %), 
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1386 (56 %), 1327 (22 %), 1285 (22 %), 1232 (19 %), 1161 (57 %), 1111 (68 %), 
1079 (48 %), 1070 (43 %), 1034 (41 %), 993 (81 %), 974 (80 %), 882 (59 %), 842 
(32 %), 821 (56 %), 766 (77 %), 743 (37 %), 674 (61 %).  
5.2.3.2 2-Nitro-5-propoxybenzaldehyde (12-C3H7) 
5-Hydroxy-2-nitrobenzaldehyde (1.00 g, 5.99 mmol), K2CO3 (1.00 g, 7.25 mmol) and 
C3H7I (0.70 mL, 7.23 mmol) in DMF (15 mL) were stirred at room temperature for 
48 h, 0.90 g 12-C3H7 (72 %) was obtained after purification by using MPLC 
(petroleum ether / ethyl acetate, 3:1). 
2-Nitro-5-propoxybenzaldehyde 
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m.p. 63 - 65 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.28 (s, 1H, H-(C-7)), 8.17 (d, 3JH,H = 8.9 Hz, 1H, H-(C-3)), 7.35 (dd, 3JH,H 
= 8.9 Hz, 4JH,H = 2.8 Hz, 1H, H-(C-4)), 7.22 (d, 4JH,H = 2.8 Hz, 1H, H-(C-6)), 4.13 (t, 
3JH,H = 6.6 Hz, 2H, H-(C-8)), 1.80 (m, 2H, H-(C-9)), 0.99 (t, 3JH,H = 7.3 Hz, 3H, 
H-(C-10)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 10.1 (C-10), 21.7 (C-9), 70.4 (C-8), 114.0 (C-6), 118.4 (C-4), 127.2 (C-3), 
134.3 (C-1), 141.6 (C-2), 163.0 (C-5), 189.9 (C-7).   
MS-EI (70 eV) 
m/z: 209 ([M]+·, C10H11NO4, 2 %), 167 ([M – C3H6]+·, C7H5NO4, 100 %), 137 ([M – 
C3H6 – NO]+, C7H5O3, 18 %), 123 (23 %), 109 (30 %), 92 (6 %), 81 (22 %), 63 
([C5H3]+, 15 %), 43 (40 %). 
HRMS (EI)  
m/z measured: 209.07177 ([M]+·, C10H11NO4).  
m/z calculated: 209.068786. 
IR  
ν /cm-1 (T %): 3106 (96 %), 2969 (85 %), 2939 (87 %), 2881 (88 %), 2660 (97 %), 
1695 (49 %), 1579 (38 %), 1512 (33 %), 1484 (65 %), 1471 (67 %), 1425 (72 %), 
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1385 (60 %), 1327 (25 %), 1284 (24 %), 1231 (22 %), 1162 (59 %), 1071 (46 %), 
1042 (77 %), 1013 (71 %), 997 (72 %), 932 (69 %), 916 (71 %), 887 (72 %), 870 
(73 %), 846 (39 %), 789 (74 %), 744 (49 %), 674 (65 %).  
5.2.3.3 5-Butoxy-2-nitrobenzaldehyde (12-C4H9) 
5-Hydroxy-2-nitrobenzaldehyde (1.00 g, 5.99 mmol), K2CO3 (1.00 g, 7.25 mmol) and 
C4H9I (0.80 mL, 7.25mmol) in DMF (15 mL) were stirred at room temperature for 48 h, 
0.94 g 12-C4H9 (70 %) was obtained after purification by using MPLC (petroleum 
ether / ethyl acetate, 3:1). 
5-Butoxy-2-nitrobenzaldehyde 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.27 (s, 1H, H-(C-7)), 8.17 (d, 3JH,H = 9.1 Hz, 1H, H-(C-3)), 7.35 (dd, 3JH,H 
= 9.1 Hz, 4JH,H = 3.0 Hz, 1H, H-(C-4)), 7.22 (d, 4JH,H = 3.0 Hz, 1H, H-(C-6)), 4.17 (t, 
3JH,H = 6.6 Hz, 2H, H-(C-8)), 1.72 (m, 2H, H-(C-9)), 1.43 (m, 2H, H-(C-10)), 0.94 (t, 
3JH,H = 7.5 Hz, 3H, H-(C-11)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 13.6 (C-11), 18.5 (C-10), 30.3 (C-9), 68.7 (C-8), 114.0 (C-6), 118.4 (C-4), 
127.3 (C-3), 134.3 (C-1), 141.6 (C-2), 163.0 (C-5), 189.9 (C-7).  
MS-EI (70 eV) 
m/z: 223 ([M]+·, C11H13NO4, 2 %), 167 ([M – C4H8]+·, C7H5NO4, 100 %), 137 ([M – 
C4H8 – NO]+, C7H5O3, 33 %), 123 (53 %), 109 (42 %), 92 (8 %), 81 (24 %), 57 (50 %), 
41 (70 %). 
HRMS (EI)  
m/z measured: 223.08570 ([M]+·, C11H13NO4).  
m/z calculated: 223.084436. 
IR  
ν /cm-1 (T %): 3106 (96 %), 2960 (81 %), 2936 (84 %), 2874 (85 %), 2662 (97 %), 
1695 (52 %), 1579 (42 %), 1513 (36 %), 1485 (68 %), 1467 (69 %), 1425 (74 %), 
1385 (62 %), 1327 (24 %), 1282 (24 %), 1242 (35 %), 1233 (31 %), 1162 (62 %), 
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1124 (88 %), 1071 (49 %), 1022 (72 %), 934 (73 %), 887 (76 %), 873 (74 %), 840 
(44 %), 768 (78 %), 746 (50 %), 674 (67 %).  
5.2.3.4 5-(Benzyloxy)-2-nitrobenzaldehyde (12-Bn) 
A mixture of K2CO3 (3.95 g, 28.62 mmol), MeOH (35 mL) and CHCl3 (70 mL) was 
heated to reflux for 15 min. 5-Hydroxy-2-nitrobenzaldehyde (1.04 g, 6.23 mmol) and 
BnBr (1.07 g, 6.26 mmol) were added into the reaction solution and it was kept 
refluxing for 20 h. The reaction mixture was partitioned between diethyl ether 
(200 mL) and water (200 mL). The diethyl ether layer was separated and washed 
with satured NaHCO3 solution (100 mL), water (100 mL) and brine (100 mL). The 
extracted organic phase was dried over Na2SO4 and concentrated to afford a crude 
product, which was purified by using MPLC (petroleum ether / ethyl acetate, 5:1) to 
yield 1.12 g 12-Bn as yellow crystals (70 %). 
5-(Benzyloxy)-2-nitrobenzaldehyde 
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m.p. 77 - 79 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.28 (s, 1H, H-(C-7)), 8.19 (d, 3JH,H = 8.9 Hz, 1H, Harom), 7.48 (m, 7H, 
Harom), 5.31 (s, 2H, H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 70.4 (C-8), 114.4 (H-Carom), 118.9 (H-Carom), 127.2 (H-Carom), 127.8 
(H-Carom), 128.2 (H-Carom), 128.5 (H-Carom), 134.2 (C-1), 135.7 (C-9), 141.9 (C-2), 
162.5 (C-5), 189.8 (C-7).  
MS-EI (70 eV) 
m/z: 257 ([M]+·, C14H11NO4, 26 %), 227 ([M – NO]+, C14H11O3, 36 %), 181 ([M – 
C6H4]+·, C8H7NO4, 28 %), 163 (14 %), 152 ([M – C6H4 – CHO]+, C7H6NO3, 90 %), 136 
(100 %), 108 (36 %), 91 (99 %), 65 (6 %). 
IR  
ν /cm-1 (T %): 3380 (86 %), 3102 (83 %), 3072 (84 %), 3035 (84 %), 2920 (84 %), 
2663 (86 %), 2240 (87 %), 1743 (85 %), 1695 (61 %), 1584 (56 %), 1512 (52 %), 
1499 (61 %), 1485 (62 %), 1455 (67 %), 1417 (73 %), 1392 (62 %), 1330 (44 %), 
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1277 (54 %), 1246 (46 %), 1187 (64 %), 1160 (54 %), 1117 (70 %), 1069 (55 %), 
1030 (69 %), 1003 (50 %), 987 (56 %), 961 (65 %), 906 (67 %), 887 (57 %), 842 
(42 %), 774 (69 %), 750 (48 %), 734 (37 %), 694 (40 %).  
5.2.3.5 2-Nitro-5-(trifluoromethoxy)benzaldehyde (12-CF3) 
3-(Trifluoromethoxy)benzaldehyde (0.50 g, 2.63 mmol) was added portion by portion 
to a mixture of 100 % HNO3 (4 mL) and 97 % H2SO4 (1 mL) while stirring at 25 °C. 
Afterward, the reaction solution was kept stirring at 25 °C for 1 h. The resulting 
mixture was poured into water (100 mL) and extracted with diethyl ether (100 mL). 
The diethyl ether layer was washed with statured NaHCO3 solution (2 × 50 mL) and 
brine (50 mL). Then the organic phase was separated, dried over Na2SO4 and 
evaporated to give a yellow oil. After purification by using MPLC (petroleum ether / 
ethyl acetate, 2:1) 0.50 g 12-CF3 was obtained (81 %). 
2-Nitro-5-(trifluoromethoxy)benzaldehyde 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.22 (s, 1H, H-(C-7)), 8.32 (d, 3JH,H = 8.9 Hz, 1H, H-(C-3) or H-(C-4)), 
7.90 (d, 3JH,H = 8.8 Hz, 1H, H-(C-3) or H-(C-4)), 7.80 (s, 1H, H-(C-6)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 118.4 (C-8), 121.0 (C-8), 121.2 (H-Carom), 125.5 (H-Carom), 127.4 (H-Carom), 
133.1 (C-1), 147.2 (C-2), 151.2 (C-5), 188.5 (C-7) 
MS-EI (70 eV) 
m/z: 235 ([M]+·, C8H4F3NO4, 15 %), 205 ([M – NO]+, C8H4F3O3, 100 %), 188 (25 %), 
177 ([M – NO – CO]+, C7H4F3O2, 10 %), 160 (40 %),149 (8 %), 132 (5 %), 110 (21 %), 
95 (15 %), 83 (54 %), 69 (40 %), 63 ([C5H3]+, 46 %), 52 ([C4H4]+·, 8 %), 50 (8 %). 
HRMS (EI)  
m/z measured: 235.00715 ([M]+·, C8H4F3NO4).  
m/z calculated: 235.00921. 
IR  
ν /cm-1 (T %): 3371 (97 %), 3111 (86 %), 3073 (91 %), 2913 (94 %), 2869 (95 %), 
2646 (96 %), 2431 (96 %), 2083 (97 %), 1941 (96 %), 1789 (97 %), 1690 (32 %), 
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1618 (93 %), 1584 (49 %), 1519 (26 %), 1476 (65 %), 1424 (64 %), 1392 (75 %), 
1359 (84 %), 1323 (51 %), 1282 (48 %), 1244 (47 %), 1199 (22 %), 1144 (3 %), 1081 
(36 %), 1001 (44 %), 986 (33 %), 893 (30 %), 876 (47 %), 846 (22 %), 789 (45 %), 
749 (31 %), 707 (41 %), 681 (41 %).  
5.2.3.6 2-Methoxy-6-nitrobenzaldehyde (13-NO2)  
To a stirred solution of hexamethylenetetraamine (3.63 g, 25.92 mmol) in 
trifluoroacetic acid (35 mL) 3-nitrophenol (3.00 g, 21.58 mmol) was added. The 
reaction solution was refluxed at 130 °C under argon. After 27 h, TLC analysis 
showed complete conversion of the starting compound. The reaction solution was 
cooled down and quenched by adding 6 N HCl (120 mL). After 20 min stirring, the 
resulting solution was extracted with DCM (2 × 100 mL). The combined organic layer 
was washed with satured NaHCO3 solution (2 × 50 mL), water (50 mL) and brine 
(50 mL). Then this organic phase was separated and dried over Na2SO4. After 
evaporation of solvent, 1.50 g crude products (2-hydroxy-6-nitrobenzaldehyde and 
2-hydroxy-4-nitrobenzaldehyde) were obtained. This crude intermediate compound 
was directly submitted to the methoxylation. The procedure was the same as 
described in synthesis of 3-NO2 (see paragraph 5.2.1.2). 
1.45 g Crude intermediate compounds, K2CO3 (1.38 g, 10.00 mmol) and MeI 
(0.62 mL, 9.95 mmol) in DMF (17 mL) were stirred at room temperature for 3 h, two 
pure products were obtained after purification by using MPLC (petroleum ether / ethyl 
acetate, 1:1): 
0.33 g 2-methoxy-4-nitrobenzaldehyde (9 % based on 3-nitrophenol) 
0.59 g 2-methoxy-6-nitrobenzaldehyde (16 % based on 3-nitrophenol) 
2-Methoxy-6-nitrobenzaldehyde 
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m.p. 108 - 109 °C (reported131 110 - 111 °C). 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.36 (s, 1H, H-(C-7)), 7.59 (m, 1H, H-(C-4)), 7.42 (d, 3JH,H = 8.1 Hz, 1H, 
H-(C-3) or H-(C-5)), 7.22 (d, 3JH,H = 8.3 Hz, 1H, H-(C-3) or H-(C-5)), 3.94 (s, 3H, 
H-(C-8)). 
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13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 55.6, 115.4, 116.0 120.4, 133.5, 148.1, 159.7, 187.6. 
HRMS (EI)  
m/z measured: 181.03436 ([M]+·, C8H7NO4).  
m/z calculated: 181.037486. 
MS-EI (70 eV) 
m/z: 181 ([M]+·, C8H7NO4, 10 %), 163 ([M – H2O]+·, C8H5NO3, 10 %), 151 ([M – NO]+, 
C8H7O3, 100 %), 136 (66 %), 133 ([M – H2O – NO]+, C8H5O2, 17 %), 119 (11 %), 108 
(41 %), 92 (18 %), 77 ([C6H5]+, 27 %), 76 (38 %), 63 ([C5H3]+, 19 %), 50 (6 %), 43 
(5 %). 
IR  
ν /cm-1 (T %): 3092 (86 %), 3034 (87 %), 2954 (86 %), 2879 (82 %), 1959 (88 %), 
1706 (42 %), 1609 (67 %), 1527 (34 %), 1468 (50 %), 1437 (59 %), 1388 (73 %), 
1353 (42 %), 1309 (62 %), 1269 (37 %), 1208 (57 %), 1190  (58 %), 1162  (51 %), 
1048 (38 %), 971 (62 %), 900 (58 %), 833 (50 %), 804 (41 %), 792 (33 %), 733 
(30 %). 
5.2.3.7 3,6-Dimethoxy-2-nitrobenzaldehyde (16-NO2)  
To a stirred solution of 2,5-dimethoxybenzaldehyde (1.00 g, 6.02 mmol) in AcOH 
(5 mL) was added 70 % HNO3 (1-1.5 molar eq. based on 
2,5-dimethoxybenzaldehyde) at 0 °C within 5 min and then this reaction solution was 
kept stirring at room temperature for 1 h. The resulting mixture was poured into water 
(50 mL) and was extracted with diethyl ether (2 × 50 mL). The combined diethyl ether 
layer was washed with satured NaHCO3 solution (50 mL) and brine (50 mL). Then 
the organic layer was separated, dried over Na2SO4 and concentrated under reduced 
pressure. 0.53 g 16-NO2 was obtained as yellow crystals (42 %) after purification by 
using MPLC (petroleum ether / ethyl acetate, 2:1). 
3,6-Dimethoxy-2-nitrobenzaldehyde 
1
2
6
3
5
4
N
+
O
-
O
7
OO
CH3
9
O
CH3
8  
m.p. 172 °C (reported132 171 - 172 °C). 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.24 (s, 1H, H-(C-7)), 7.67 (d, 3JH,H = 9.3 Hz, 1H, H-(C-4) or H-(C-5)), 
7.45 (d, 3JH,H = 9.3 Hz, 1H, H-(C-4) or H-(C-5)), 3.94 (s, 3H, H-(C-8) or H-(C-9)), 3.85 
(s, 3H, H-(C-8) or H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 57.2, 57.3, 114.9, 116.0, 121.7, 137.1, 143.7, 155.1, 186.7.  
MS-EI (70 eV) 
m/z: 211 ([M]+·, C9H9NO5, 18 %), 194 ([M – OH]+, C9H8NO4, 3 %), 176 (5 %), 166 ([M 
– OH – CO]+, C8H8NO3, 100 %), 165 (40 %), 149 (22 %), 136 (41 %), 135 (46 %), 
119 (38 %), 107 (23 %), 106 (14 %), 93 (13 %), 77 ([C6H5]+, 22 %), 65 (25 %), 51 
([C4H3]+, 12 %), 50 (7 %). 
IR  
ν /cm-1 (T %): 3099 (92 %), 2946 (92 %), 2898 (90 %), 2844 (92 %), 1893 (96 %), 
1691 (67 %), 1611 (81 %), 1577 (84 %), 1535 (57 %), 1488 (61 %), 1450 (66 %), 
1443 (70 %), 1432 (66 %), 1399 (83 %), 1368 (74 %), 1269 (46 %), 1186 (59 %), 
1087 (64 %), 1049 (62 %), 948 (60 %), 921 (74 %), 824 (58 %), 803 (65 %), 715 
(55 %). 
5.2.3.8 3,5-Dimethoxy-2-nitrobenzaldehyde (17-NO2)  
3,5-Dimethoxybenzaldehyde (2.00 g, 12.05 mmol) was added to 90 % HNO3 (10 mL) 
in several portion while stirring at 0 °C. After this addition, the reaction solution was 
kept stirring at 0 °C and monitored by TLC. When the starting compound was 
completely converted, the resulting mixture was poured into water (100 mL) and 
extracted with diethyl ether (100 mL). The organic layer was washed with satured 
NaHCO3 solution (2 × 50 mL) and brine (50 mL), dried over Na2SO4 and 
concentrated. 0.41 g 17-NO2 (17 %) was obtained as yellow crystals after separation 
on the MPLC (petroleum ether / ethyl acetate, 1:1). 
3,5-Dimethoxy-2-nitrobenzaldehyde 
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m.p. 104 - 106 °C (reported133 104 - 106 °C). 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 9.92 (s, 1H, H-(C-7)), 6.94 (d, 4JH,H = 2.5 Hz, 1H, H-(C-4) or H-(C-6)), 6.75 
(d, 4JH,H = 2.8 Hz, 1H, H-(C-4) or H-(C-6)), 3.92 (s, 3H, H-(C-8) or H-(C-9)), 3.90 (s, 
3H, H-(C-8) or H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 56.1, 56.8, 104.0, 104.9, 130.6, 133.4, 153.2, 162.1, 186.7.  
MS-EI (70 eV) 
m/z: 211 ([M]+·, C9H9NO5, 48 %), 194 ([M – OH]+, C9H8NO4, 10 %), 179 (16 %), 164 
(97 %), 151 (100 %), 136 (81 %), 123 (43 %), 95 (77 %), 77 ([C6H5]+, 53 %), 69 
(35 %), 51 ([C4H3]+, 22 %). 
IR  
ν /cm-1 (T %): 3094 (91 %), 2989 (89 %), 2953 (86 %), 2847 (83 %), 2746 (92 %), 
2652 (93 %), 2060 (95 %), 1700 (24 %), 1590 (36 %), 1529 (24 %), 1492 (62 %), 
1458 (32 %), 1430 (53 %), 1386 (58 %), 1369 (46 %), 1334 (22 %), 1311 (20 %), 
1231 (44 %), 1198 (23 %), 1185 (41 %), 1166 (27 %), 1118 (45 %), 1112 (45 %), 
1031 (50 %), 956 (22 %), 942 (42 %), 931 (43 %), 852 (52 %), 840 (18 %), 831 
(19 %), 775 (54 %), 735 (71 %), 695 (55 %).  
5.2.3.9 2-Bromo-3,5-dimethoxybenzaldehyde (17-Br) 
2-Bromo-3,5-dimethoxybenzaldehyde was synthesized according to the procedure 
described in the bromination of 3-methoxybenzaldehyde (see paragraph 5.2.1.4). 
To a stirred solution of 3,5-dimethoxybenzaldehyde (1.50 g, 9.04 mmol) in dry CHCl3 
(10 mL/mmol) the bromine (0.60 mL, 11.66 mmol) was introduced slowly over 20 min. 
Then the reaction solution was stirred at room temperature for 0.5 h. After workup 
and purification by using MPLC (petroleum ether / ethyl acetate, 5:1), 1.86 g 17-Br 
was obtained (84 %). 
2-Bromo-3,5-dimethoxybenzaldehyde 
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m.p. 114 - 115 °C (reported134 115 - 116 °C). 
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1H NMR (CDCl3, 250 MHz)  
δ (ppm) = 10.24 (s, 1H, H-(C-7)), 6.97 (d, 4JH,H = 2.8 Hz, 1H, H-(C-4) or H-(C-6)), 
6.93 (d, 4JH,H = 2.7 Hz, 1H, H-(C-4) or H-(C-6)), 3.89 (s, 3H, H-(C-8) or H-(C-9)), 3.82 
(s, 3H, H-(C-8) or H-(C-9)). 
13C NMR (CDCl3, 60 MHz)  
δ (ppm) = 55.8, 56.8, 104.4, 105.7, 107.0, 134.3, 156.9, 159.7, 191.7.  
MS-EI (70 eV) 
m/z: 246 ([M]+·, C9H981BrO3, 97 %), 245 ([M – H]+, C9H881BrO3, 46 %), 244 ([M]+·, 
C9H979BrO3, 100 %), 243 ([M – H]+, C9H879BrO3, 38 %), 217 ([M – CHO]+, C8H881BrO2, 
2 %), 215 ([M – CHO]+, C8H879BrO2, 6 %), 202 (15 %), 200 (15 %), 173 (8 %), 157 
(3 %), 135 ([M – CHO – H81Br]+, C8H7O2, 5 %), 122 (3 %), 134 (2 %), 106 (18 %), 79 
(4 %), 77 ([C6H5]+, 8 %), 63 ([C5H3]+, 8 %), 51 (2 %). 
IR  
ν /cm-1 (T %): 3329 (91 %), 3077 (87 %), 3024 (88 %), 2975 (86 %), 2943 (85 %), 
2895 (86 %), 2837 (87 %), 2625 (89 %), 2299 (91 %), 1980 (91 %), 1673 (50 %), 
1584 (54 %), 1448 (54 %), 1431 (73 %), 1391 (59 %), 1333 (56 %), 1290 (47 %), 
1224 (57 %), 1199 (54 %), 1159 (50 %), 1076 (56 %), 1067 (61 %), 1021 (49 %), 970 
(64 %), 918 (57 %), 860 (62 %), 848 (63 %), 832 (55 %), 718 (63 %), 693 (77 %).  
5.2.3.10 3,4-Dimethoxy-2-nitrobenzaldehyde (18-NO2) 
Into the stirred solution of 4-formyl-2-methoxy-3-nitrophenyl benzenesulfonate 
(2.80 g, 8.31 mmol) in ethanol (70 mL) 2 mL of NaOH aqueous solution (1 g/mL) was 
added. This solution was refluxed for 0.5 h. After the ethanol was evaporated, 
100 mL water was added to the residue and the pH value was adjusted to 6 by 
adding 2 N HCl. The resulting mixture was extracted with diethyl ether (200 mL) and 
the separated organic layer was washed with satured aqueous NaHCO3 solution 
(50 mL), water (50 mL) and brine (50 mL) respectively, then dried over Na2SO4 and 
concentrated to afford 0.86 g 4-hydroxy-3-methoxy-2-nitrobenzaldehyde, which was 
used directly in further synthetic procedure. 
The methoxylation of 4-hydroxy-3-methoxy-2-nitrobenzaldehyde was similar to the 
procedure described in the preparation of 3-NO2 (see paragraph 5.2.1.2). 
0.86 g 4-Hydroxy-3-methoxy-2-nitrobenzaldehyde, K2CO3 (0.72 g, 5.22 mmol) and 
MeI (0.32 mL, 5.14 mmol) were stirred in DMF (15 mL) at room temperature for 2 h. 
After workup and purification by using MPLC (petroleum ether / ethyl acetate, 1:1), 
EXPERIMENTAL 141 
 
0.81 g 18-NO2 was obtained (46 % based on 4-formyl-2-methoxy-3-nitrophenyl 
benzenesulfonate). 
3,4-Dimethoxy-2-nitrobenzaldehyde 
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m.p. 60 - 62 °C (reported135 58 - 61 °C). 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 9.79 (s, 1H, H-(C-7)), 7.90 (d, 3JH,H = 8.6 Hz, 1H, H-(C-5) or H-(C-6)), 7.51 
(d, 3JH,H = 8.6 Hz, 1H, H-(C-5) or H-(C-6)), 4.01 (s, 3H, H-(C-8) or H-(C-9)), 3.83 (s, 
3H, H-(C-8) or H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 57.2, 62.0, 114.2, 119.5, 131.3, 140.2, 142.3, 158.1, 188.3. 
MS-EI (70 eV) 
m/z: 211 ([M]+·, C9H9NO5, 18 %), 194 ([M – OH]+, C9H8NO4, 2 %), 176 (2 %), 166 ([M 
– OH – CO]+, C8H8NO3, 100 %), 165 (43 %), 151 (21 %), 136 (32 %), 135 (38 %), 
119 (36 %), 107 (23 %), 93 (14 %), 77 ([C6H5]+, 34 %), 65 (42 %), 51 ([C4H3]+, 16 %), 
50 (10 %). 
IR  
ν /cm-1 (T %): 3363 (95 %), 3088 (93 %), 2997 (90 %), 2940 (85 %), 2857 (86 %), 
2604 (93 %), 2030 (95 %), 1908 (95 %), 1688 (34 %), 1596 (41 %), 1536 (44 %), 
1501 (33 %), 1454 (36 %), 1435 (63 %), 1422 (53 %), 1398 (65 %), 1373 (50 %), 
1321 (81 %), 1279 (24 %), 1248 (34 %), 1211 (43 %), 1189 (60 %), 1171 (61 %), 
1071 (41 %), 1045 (36 %), 1007 (72 %), 960 (31 %), 901 (45 %), 829 (40 %), 802 
(51 %), 780 (64 %), 743 (46 %), 698 (78 %), 663 (72 %).  
5.2.3.11 2,3,4-Trimethoxy-6-nitrobenzaldehyde (19-NO2) 
The compound 2,3,4-trimethoxybenzaldehyde was nitrated according to the 
procedure decribed in the nitration of 2,5-dimethoxybenzaldehyde (see 
paragraph 5.2.3.7).  
2,3,4,-Trimethoxybenzaldehyde (2.00 g, 10.20 mmol) and 10 mL mixture of 100 % 
HNO3 and 100 % AcOH (50:50) were stirred at 0 °C for 10 min. After workup and 
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purification by using MPLC (petroleum ether / ethyl acetate, 3:1), 1.62 g 19-NO2 was 
obtained as yellow crystals (66 %).  
2,3,4,-Trimethoxy-6-nitrobenzaldehyde 
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m.p. 85 - 86 °C (reported136 80 - 82 °C). 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.12 (s, 1H, H-(C-7)), 7.51 (s, 1H, H-(C-5)), 3.94 (s, 3H, -OCH3), 3.93 (s, 
3H, -OCH3), 3.86 (s, 3H, -OCH3). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 57.4, 60.9, 62.7, 104.2, 117.3, 143.8, 144.7, 153.8, 156.7, 187.4. 
MS-EI (70 eV) 
m/z: 241 ([M]+·, C10H11NO6, 34 %), 224 ([M – OH]+, C10H10NO5, 8 %), 211 ([M – NO]+, 
C10H11O5, 100 %), 196 (99 %), 181 (43 %), 168 (65 %), 153 (56 %), 137 (18 %), 125 
(16 %), 123 (14 %), 109 (10 %), 93 (16 %), 77 ([C6H5]+, 17 %), 66 (13 %), 53 (11 %). 
IR  
ν /cm-1 (T %): 3081 (85 %), 3018 (88 %), 3000 (88 %), 2946 (78 %), 2866 (84 %), 
2752 (89 %), 2642 (90 %), 1946 (93 %), 1704 (51 %), 1607 (79 %), 1560 (84 %), 
1521 (55 %), 1485 (51 %), 1454 (59 %), 1429 (76 %), 1389 (61 %), 1323 (51 %), 
1301 (41 %), 1253 (49 %), 1207 (57 %), 1196 (59 %), 1119 (33 %), 1048 (52 %), 
1030 (54 %), 977 (66 %), 962 (50 %), 918 (50 %), 885 (41 %), 800 (67 %), 766 
(45 %), 759 (47 %), 731 (58 %), 675 (62 %).   
5.2.3.12 6-Fluoro-2,3,4-trimethoxybenzaldehyde (19-F) 
A mixture of KF (0.24 g, 4.14 mmol, spray dried) and Kryptofix 222 (1.16 g, 
6.32 mmol) was heated at 140 °C under argon for 20 min, then 19-NO2 (0.50 g, 
2.07 mmol) in DMF (20 mL) was added and the reaction solution was heated for 
another 15 min. The reaction solution was poured into water (25 mL) and this mixture 
was extracted with diethyl ether (2 × 25 mL). The combined organic layer was 
washed with 25 mL of 1 N NaOH (This basic washing solution was kept for isolation 
of phenolic by-product), water (25 mL) and brine (25 mL), then was dried over 
Na2SO4 and concentrated to afford 0.22 g crude product. After purification by using 
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MPLC (POLYGOPREP 60-50, C18, CH3CN / water, 3:7) 0.025 g product was 
obtained. This product was purified again on preparative HPLC (Luna, phenyl-hexyl 
5 µm, 150 mm × 10 mm, Phenomenex, USA; CH3CN / water, 3:1; 5 mL/min) to give 
0.012 g pure 19-F (1.3 %). 
6-Fluoro-2,3,4-trimethoxybenzaldehyde 
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1H NMR (CDCl3, 400 MHz)  
δ = 10.21 (s, 1H, H-(C-7)), 6.45 (d, 3JH,F = 8.4 Hz, 1H, H-(C-5)), 3.99 (s, 3H, -OCH3), 
3.90 (s, 3H, -OCH3), 3.82 (s, 3H, -OCH3).  
13C NMR (CDCl3, 100 MHz)  
δ = 56.3 (-OCH3), 61.1 (-OCH3), 62.2 (-OCH3), 96.1 (d, 2JC,F = 26.3 Hz, C-5), 112.0 (d, 
2JC,F = 8.8 Hz, C-1), 138.4 (d, 4JC,F = 3.7 Hz, C-3), 156.0 (d, 3JC,F = 7.3 Hz, C-2 or 
C-4), 159.3 (d, 3JC,F = 13.9 Hz, C-2 or C-4), 159.9 (d, 1JC,F = 259.8 Hz, C-6), 186.3 (d, 
3JC,F = 3.7 Hz, C-7). 
19F NMR (CDCl3, 400 MHz)  
117.1 (F-(C-6)). 
MS-EI (70 eV) 
m/z: 214 ([M]+·, C10H11FO4, 100 %), 199 ([M – CH3]+, C9H8FO4, 79 %), 181 ([M – CH3 
– H2O]+, C9H6FO3, 66 %), 171 ([M – CH3 – CO]+, C8H8FO3, 16 %), 153 (30 %), 138 
(18 %), 113 (8 %), 97 (8 %), 83 (9 %), 57 (10 %). 
HRMS (EI)  
m/z measured: 214.06256 ([M]+·, C10H11FO4).  
m/z calculated: 214.064116. 
IR  
ν /cm-1 (T %): 2942 (95 %), 1691 (82 %), 1604 (76 %), 1574 (91 %), 1492 (88 %), 
1457 (88 %), 1404 (92 %), 1386 (87 %), 1342 (83 %), 1251 (84 %), 1198 (87 %), 
1134 (80 %), 1096 (85 %), 1028 (91 %), 989 (88 %), 925 (95 %), 820 (94 %), 800 
(92 %).  
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Phenolic by-product 
The basic washing solution was acidified by adding 2 N HCl (50 mL) and extracted 
with diethyl ether (2 × 50 mL). The ether layer was washed with water (50 mL) and 
brine (50 mL), dried over Na2SO4, and concentrated to afford 0.080 g phenolic 
by-product. The position of the phenolic hydroxyl substituent was not determined. 
1H NMR (DMSO-d6, 400 MHz)  
δ = 10.13 (s, 1H, -CHO), 7.23 (s, 1H, Harom), 3.92 (s, 3H, -OCH3), 3.77 (s, 3H, -OCH3).  
13C NMR (DMSO-d6, 100 MHz)  
δ = 56.9 (-OCH3), 60.6 (-OCH3), 100.9 (Carom-H), 109.9 (Carom-CHO), 138.9 
(Carom-NO2), 145.5 (Carom-OCH3 or Carom-OH), 154.1 (Carom-OH or Carom-OCH3), 156.6 
(Carom-OCH3 or Carom-OH), 188.2 (-CHO). 
IR  
ν /cm-1 (T %): 3095 (84 %), 2948 (75 %), 2850 (81 %), 2324 (91 %), 1632 (45 %), 
1508 (35 %), 1460 (54 %), 1445 (49 %), 1416 (56 %), 1389 (35 %), 1317 (38 %), 
1283 (33 %), 1250 (21 %), 1203 (29 %), 1139 (18 %), 1035 (42 %), 982 (42 %), 961 
(29 %), 896 (32 %), 856 (41 %), 775 (23 %), 728 (32 %), 686 (40 %). 
5.2.3.13 6-Bromo-2,3,4-trimethoxybenzaldehyde (19-Br) 
5-Bromo-2,3-dimethoxyphenol was synthesized from 5-bromo-2,3-
dimethoxybenzaldehyde by baeyer villiger reaction.137 A mixture of 30 % H2O2 (4 mL) 
and formic acid (11 mL) with catalytic mount of concentrated H2SO4 was stirred at 
room temperature for 1 h. A solution of 5-bromo-2,3-dimethoxybenzaldehyde (4.05 g, 
16.40 mmol) in formic acid (25 mL) was added dropwise in above solution at 0 °C, 
then the mixture was kept stirring overnight. When TLC analysis indicated complete 
conversion of the starting compound, the reaction was quenched with water (50 mL) 
and extracted by diethyl ether (200 mL). The diethyl ether layer was washed by 
satured NaHCO3 (100 mL), and brine (50 mL). The organic phase was separated, 
dried over Na2SO4, and concentrated to afford 5.50 g 5-bromo-2,3-dimethoxyphenol 
crude product as red oil which was used directly in the next synthesis step.  
5-Bromo-2,3-dimethoxyphenol was formylated according to the procedure described 
in formylation of 3-nitrophenol (see paragraph 5.2.3.6).  
4.00 g Crude 5-bromo-2,3-dimethoxyphenol and hexamethylentetramine (2.30 g, 
17.22 mmol) were refluxed at 130 °C in trifluoroacetic acid (40 mL) for 4 h. After 
workup, crude product 6-bromo-2-hydroxy-3,4-dimethoxybenzaldehyde (1.55 g) was 
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obtained and submitted directly to the methoxylation. The procedure was the same 
as described in the synthesis of 3-NO2 (see paragraph 5.2.1.2).  
1.55 g Crude 6-bromo-2-hydroxy-3,4-dimethoxybenzaldehyde, K2CO3 (0.80 g, 
5.80 mmol) and MeI (0.36 mL, 5.78 mmol) were stirred in DMF (20 mL) at room 
temperature for 3 h. After workup and purification by using MPLC (petroleum ether / 
ethyl acetate, 2:1), 0.41 g 19-Br was obtained (13 % based on 5-bromo-2,3-
dimethoxybenzaldehyde). 
6-Bromo-2,3,4-trimethoxybenzaldehyde 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.09 (s, 1H, H-(C-7)), 7.19 (s, 1H, H-(C-5)), 3.90 (s, 3H, -OCH3), 3.86 (s, 
3H, -OCH3), 3.76 (s, 3H, -OCH3). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 56.7, 60.6, 62.4, 113.9, 117.6, 120.9, 141.4, 156.5, 157.8, 188.8. 
MS-EI (70 eV) 
m/z: 276 ([M]+·, C10H1181BrO4, 93 %), 275 ([M – H]+, C10H1081BrO4, 32 %), 274 ([M]+·, 
C10H1179BrO4, 100 %), 273 ([M – H]+, C10H1079BrO4, 18 %), 261 ([M – CH3]+, 
C9H881BrO4, 57 %), 260 (12 %), 259 ([M – CH3]+, C9H879BrO4, 82 %), 258 (37 %), 246 
(13 %), 245 (20 %), 244 (17 %), 243 (61 %), 231 (21 %), 230 (36 %), 229 (18 %), 
238 (38 %), 215 (38 %), 198 (28 %), 178 (34 %), 165 (8 %), 137 (10 %), 124 (12 %), 
109 (23 %), 93 (18 %), 77 ([C6H5]+, 15 %), 55 (10 %), 43 (24 %). 
IR  
ν /cm-1 (T %): 2940 (84 %), 2851 (89 %), 2768 (96 %), 2586 (97 %), 1689 (42 %), 
1574 (31 %), 1483 (46 %), 1447 (56 %), 1430 (62 %), 1370 (36 %), 1296 (31 %), 
1244 (35 %), 1194 (58 %), 1110 (17 %), 1033 (62 %), 1009 (43 %), 961 (58 %), 947 
(44 %), 906 (60 %), 818 (59 %), 787 (57 %), 764 (59 %), 717 (72 %).  
5.2.3.14 2,3,4,5-Tetramethoxy-6-nitrobenzaldehyde (20-NO2) 
2-Hydroxy-3,4,5-trimethoxybenzaldehyde  
2-Hydroxy-3,4,5-trimethoxybenzaldehyde was synthesized by baeyer villiger reaction, 
the experiment was performed by the synthetic procedure described in 
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paragraph 5.2.3.13. 30 % H2O2 (15 mL) was added to a stirred solution of 
2,3,4-trimethoxybenzaldehyde (7.50 g, 38.26 mmol) in methanol (75 mL) with a 
catalytic mount of concentrated H2SO4 (0.2 mL). The reaction was carried out at 
room temperature for 2 h. After workup and purification by using MPLC (petroleum 
ether / ethyl acetate, 2:1) to afford 4.44 g 2,3,4-trimethoxyphenol and used directly in 
the next synthesis step. 
3.40 g 2,3,4-Trimethoxyphenol and Hexamethylentetramine (3.15 g, 22.52 mmol) 
were refluxed at 130 °C in TFA (20 mL) for 24 h. After extraction with DCM, the crude 
product was purified by using MPLC (petroleum ether / ethyl acetate, 2:1) to give 
2.00 g 2-hydroxy-3,4,5-trimethoxybenzaldehyde as colourless oil (51 % based on 
2,3,4-trimethoxyphenol). 
2-Hydroxy-3,4,5-trimethoxybenzaldehyde 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.12 (s, 1H, H-(C-7)), 7.01 (s, 1H, H-(C-6)), 3.87 (s, 3H, -OCH3), 3.77 (s, 
3H, -OCH3), 3.76 (s, 3H, -OCH3). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 55.9, 60.7, 60.9, 105.6, 117.1, 141.4, 146.0, 149.0, 150.0, 190.6.  
MS-EI (70 eV) 
m/z: 212 ([M]+·, C10H12O5, 100 %), 197 ([M – CH3]+, C9H9O5, 28 %), 182 ([M – 
CH2O]+·, C9H7O4, 6 %), 169 ([M – CH3 – CO]+, C8H4O4, 23 %), 151 (22 %), 126 (9 %), 
111 (10 %), 97 (13 %), 83 (18 %), 69 (35 %), 55 (38 %), 44 (37 %). 
IR  
ν /cm-1 (T %): 2947 (73 %), 2841 (82 %), 1639 (43 %), 1585 (72 %), 1488 (48 %), 
1453 (41 %), 1431 (41 %), 1393 (39 %), 1319 (23 %), 1272 (23 %), 1217 (62 %), 
1198 (49 %), 1189 (52 %), 1139 (20 %), 1096 (25 %), 1031 (28 %), 987 (24 %), 935 
(30 %), 896 (31 %), 843 (44 %), 781 (28 %), 732 (28 %). 
2,3,4,5-Tetramethoxybenzaldehyde  
The synthetic procedure was the same as described in the synthesis of 3-NO2 (see 
paragraph 5.2.1.2).  
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A mixture of 2-hydroxy-3,4,5-trimethoxybenzaldehyde (1.70 g, 8.02 mmol), K2CO3 
(1.24 g, 8.99 mmol) and MeI (0.56 mL, 8.99 mmol) was stirred in DMF (30 mL) at 
room temperature overnight. After extraction with diethyl ether and purification by 
using MPLC (petroleum ether / ethyl acetate, 2:1), 1.45 g 2,3,4,5-
tetramethoxybenzaldehyde was obtained (80 % based on 2-hydroxy-3,4,5-
trimethoxybenzaldehyde). 
2,3,4,5-Tetramethoxybenzaldehyde 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.17 (s, 1H, H-(C-7)), 7.02 (s, 1H, H-(C-6)), 3.88 (s, 3H, -OCH3), 3.86 (s, 
3H, -OCH3), 3.85 (s, 3H, -OCH3), 3.80 (s, 3H, -OCH3). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 55.9, 60.8, 61.1, 62.8, 103.7, 123.7, 146.5, 148.8, 149.6, 151.5, 188.4. 
MS-EI (70 eV) 
m/z: 226 ([M]+·, C11H14O5, 100 %), 211 ([M – CH3]+, C10H8O5, 49 %), 193 (23 %), 178 
(12 %), 165 (16 %), 140 (10 %), 125 (8 %), 110 (2 %), 97 (6 %), 93 (3 %), 69 (4 %), 
53 (4 %). 
IR  
ν /cm-1 (T %): 2940 (83 %), 2844 (89 %), 1679 (45 %), 1591 (65 %), 1481 (57 %), 
1467 (41 %), 1412 (41 %), 1385 (45 %), 1338 (35 %), 1280 (61 %), 1252 (68 %), 
1213 (62 %), 1197 (51 %), 1127 (28 %), 1076 (22 %), 1034 (46 %), 999 (39 %), 981 
(54 %), 924 (59 %), 881 (76 %), 852 (64 %), 787 (83 %), 757 (62 %), 705 (82 %), 
686 (82 %). 
2,3,4,5-Tetramethoxy-6-nitrobenzaldehyde  
2,3,4,5-Tetramethoxybenzaldehyde (0.50 g, 2.21 mmol) and 70 % HNO3 (0.16 mL, 
2.75 mmol) were stirred in acetic acid (5 mL, concentrated) at 0 °C for 10 min, then 
the ice bath was removed and the reaction solution was stirred for another 1 h at 
room temperature. After extraction with diethyl ether and purification by using MPLC 
(petroleum ether / ethyl acetate, 3:1), 0.23 g 20-NO2 was obtained as yellow crystals 
(39 % based on 2,3,4,5-tetramethoxybenzaldehyde). 
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2,3,4,5-Tetramethoxy-6-nitrobenzaldehyde 
1
6
2
5
3
4
7
O
N
+
O
-
O
O
CH3
8
O
CH3
9
O
CH3
10
O
CH3
11  
m.p. 67 - 70 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.09 (s, 1H, H-(C-7)), 4.03 (s, 3H, -OCH3), 3.98 (s, 3H, -OCH3), 3.92 (s, 
3H, -OCH3), 3.81 (s, 3H, -OCH3). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 61.4 (-OCH3), 61.5 (-OCH3), 62.6 (-OCH3), 63.0 (-OCH3), 115.0 (C-1), 
137.8 (C-6), 140.9 (CH3O-Carom), 148.0 (CH3O-Carom), 152.7 (CH3O-Carom), 153.1 
(CH3O-Carom), 186.2 (C-7).  
HRMS (EI)  
m/z measured: 271.07104 ([M]+·, C11H13NO7).  
m/z calculated: 271.069167. 
MS-EI (70 eV) 
m/z: 271 ([M]+·, C11H13NO7, 31 %), 254 ([M – OH]+, C11H12NO6, 100 %), 224 (30 %), 
211 (82 %), 195 (42 %), 181 (46 %), 167 (27 %), 152 (33 %), 137 (35 %), 127 (19 %), 
125 (16 %), 95 (10 %), 93 (8 %), 65 ([C5H5]+, 5 %), 53 (10 %). 
IR  
ν /cm-1 (T %): 2998 (87 %), 2952 (77 %), 2876 (80 %), 1692 (26 %), 1591 (60 %), 
1537 (39 %), 1465 (28 %), 1444 (48 %), 1404 (32 %), 1383 (29 %), 1364 (29 %), 
1336 (17 %), 1267 (44 %), 1194 (44 %), 1125 (34 %), 1082 (22 %), 1054 (21 %), 
1011 (17 %), 963 (25 %), 943 (30 %), 901 (47 %), 878 (44 %), 823 (50 %), 787 
(54 %), 745 (35 %), 684 (59 %).  
5.2.3.15 2-Bromo-3,4,5,6-tetramethoxybenzaldehyde (20-Br) 
20-Br was synthesized by bromination of 2,3,4,5-tetramethoxybenzaldehyde. 
Into the solution of 2,3,4,5-tetramethoxybenzaldehyde (0.89 g, 3.94 mmol) in 
trifluoroacetic acid (5 mL) N-bromosuccinimide (0.84 g, 4.72 mmol) was added over 
15 min at 0 °C. The reaction was monitored by TLC. After 0.5 h the starting 
compound was completely consumed, the reaction was stopped. The resulting 
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mixture was poured into water and extracted with diethyl ether (100 mL). The organic 
layer was washed with water (100 mL) and dried over Na2SO4. After evaporation of 
solvent, the residue was purified by using MPLC (petroleum ether / ethyl acetate, 5:1) 
to yield 0.91 g 20-Br as yellow oil (75 %).  
2-Bromo-3,4,5,6-tetramethoxybenzaldehyde 
1
2
6
3
5
4
7
O
Br
O
CH3
11
O
CH3
10
O
CH3
9
O
CH3
8  
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.13 (s, 1H, H-(C-7)), 3.96 (s, 3H, -OCH3), 3.85 (s, 3H, -OCH3), 3.84 (s, 
3H, -OCH3), 3.75 (s, 3H, -OCH3). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 60.8, 61.1, 61.3, 62.5, 111.7, 123.6, 146.2, 147.1, 151.8, 152.8, 189.5. 
MS-EI (70 eV) 
m/z: 306 ([M]+·, C11H1381BrO5, 95 %), 305 ([M – H]+, C11H1281BrO5,18 %), 304 ([M]+·, 
C11H1379BrO5, 100 %), 303 ([M – H]+, C11H1279BrO5, 4 %), 291 ([M – CH3]+, 
C10H1081BrO5, 80 %), 290 (12 %), 289 ([M – CH3]+, C10H1079BrO5, 91 %), 288 (18 %), 
276 (10 %), 275 (14 %), 274 (16 %), 273 (48 %), 261 (17 %), 260 (14 %), 259 (10 %), 
258 (26 %), 246 (23 %), 245 (24 %), 244 (7 %), 243 (22 %), 231 (20 %), 210 ([M – 
CH3 – H81Br]+, C10H9O5, 10 %), 203 (15 %), 195 (29 %), 167 (17 %), 139 (21 %), 93 
(6 %), 83 (14 %), 59 (20 %), 43 (41 %). 
IR  
ν /cm-1 (T %): 2939 (81 %), 2860 (89 %), 1696 (41 %), 1563 (71 %), 1458 (44 %), 
1404 (48 %), 1380 (20 %), 1319 (32 %), 1251 (76 %), 1195 (61 %), 1119 (44 %), 
1076 (33 %), 1032 (39 %), 1001 (29 %), 962 (40 %), 938 (43 %), 891 (77 %), 797 
(65 %), 765 (71 %).  
5.2.3.16 2-Nitroisophthalaldehyde (21-NO2) 
2-Nitroisophthalic acid 
2-Nitro-1,3-xylene (15.00 g, 99.33 mmol) was added to the solution of KMnO4 
(63.00 g, 39.87 mmol) and KOH (13.20 g, 235.71 mmol) in water (400 mL), and the 
mixture was refluxed with vigorous stirring for 21 h. Afterward, manganese dioxide in 
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reaction suspension was filtered off and the filtrate was carefully neutralized with 3 N 
HCl. This solution was extracted with DCM to remove any monobasic acids, and the 
water layer was acidified to pH = 2 to precipitate 2-nitroisophthalic acid. After 
washing with diethyl ether and drying, 12.90 g 2-Nitroisophthalic acid was obtained 
(63 %). 
2-Nitroisophthalic acid 
1
2
6
3
5
4
7
O
OH
8
OOH
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+
O
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O
 
m.p. 313 - 315 °C 
1H NMR (DMSO-d6, 250 MHz)  
δ (ppm) = 8.17 (d, 3JH,H = 8.0 Hz, 2H, H-(C-4) and H-(C-6)), 7.80 (m, 1H, H-(C-5)). 
13C NMR (DMSO-d6, 60 MHz)  
δ (ppm) = 124.8, 131.1, 134.5, 148.7, 164.0. 
MS-EI (70 eV) 
m/z: 211 ([M]+·, C8H5NO6, 17 %), 194 ([M – OH]+, C8H4NO5, 4 %), 181 ([M – NO]+, 
C8H5O5, 20 %), 167 ([M – CO2]+·, C7H5NO3, 78 %), 149 ([M – CO2 – H2O]+·, C7H3NO2, 
100 %), 147 (66 %), 135 (26 %), 119 (54 %), 107 (22 %), 91 (54 %), 75 (12 %), 63 
([C5H3]+, 14 %), 45 (10 %), 43 (19 %). 
IR  
ν /cm-1 (T %): 3405 (79 %), 2870 (70 %), 2825 (69 %), 2658 (70 %), 2534 (68 %), 
2004 (89 %), 1954 (90 %), 1811 (90 %), 1694 (38 %), 1604 (44 %), 1556 (28 %), 
1467 (72 %), 1413 (41 %), 1376 (51 %), 1306 (54 %), 1268 (32 %), 1166 (45 %), 
1068 (66 %), 905 (32 %), 854 (51 %), 837 (54 %), 783 (67 %), 767 (27 %), 735 
(63 %), 683 (23 %).  
1,3-Dihydroxymethyl-2-nitrobenzene 
This compound was synthesized according to the procedure described in the 
synthesis of (3-methyl-4-nitrophenyl)methanol (see paragraph 5.2.2.5): 
2-nitroisophthalic acid (12.90 g, 61.14 mmol) and THF (60 mL) were stirred in an ice 
bath, 1 N BH3·THF (300 mL, 300 mmol) was added slowly. The ice bath was 
removed and the reaction solution was kept stirring for 36 h. To quench the reaction 
methanol (50 mL) was added slowly. After workup and crystallization from diisopropyl 
ether, 9.90 g 1,3-dihydroxymethyl-2-nitrobenzene was obtained (90 %).  
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1,3-Dihydroxymethyl-2-nitrobenzene 
1
2
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5
4
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OH
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m.p. 98 - 99 °C (reported138 100 - 101 °C). 
1H NMR (DMSO-d6, 250 MHz)  
δ (ppm) = 7.55 (m, 3H, Harom), 4.53 (d, 4JH,H = 4.4 Hz, 2H, H-(C-7) and H-(C-8)). 
13C NMR (DMSO-d6, 60 MHz)  
δ (ppm) = 59.2, 127.5, 130.7, 134.2, 147.4. 
MS-EI (70 eV) 
m/z: 165 ([M – H2O]+·, C8H7NO3, 46 %), 148 ([M – H2O – OH]+, C8H6NO2, 100 %), 
146 (29 %), 133 (14 %), 120 (38 %), 105 (20 %), 91 (61 %), 77 ([C6H5]+, 52 %), 63 
([C5H3]+, 8 %), 51 (13 %), 39 (8 %). 
IR  
ν /cm-1 (T %): 3202 (60 %), 2925 (72 %), 2862 (75 %), 1967 (90 %), 1909 (91 %), 
1828 (91 %), 1709 (92 %), 1602 (82 %), 1580 (83 %), 1517 (26 %), 1470 (64 %), 
1444 (66 %), 1429 (63 %), 1352 (41 %), 1322 (48 %), 1286 (63 %), 1255 (62 %), 
1235 (58 %), 1173 (69 %), 1063 (33 %), 1040 (32 %), 995 (60 %), 982 (56 %), 912 
(74 %), 901 (73 %), 856 (57 %), 794 (39 %), 751 (42 %), 714 (43 %), 664 (41 %).  
2-Nitroisophthalaldehyde 
1,3-Dihydroxymethyl-2-nitrobenzene was oxidized to 21-NO2 by PDC using analogy 
method in the oxidation of 2-iodo-5-methoxybenzyl alcohol (see paragraph 5.2.1.5). 
To the stirred suspension of 1,3-dihydroxymethyl-2-nitrobenzene (0.90 g, 4.92 mmol) 
and sodium acetate (1.00 g, 12.19 mmol) in DCM (30 mL) in an ice bath, PDC 
(2.13 g, 5.65 mmol) was introduced slowly over 15 min. When TLC analysis showed 
that the starting compound was completely converted, the reaction was stopped. 
After workup, these crude mixture products were purified by using MPLC (DCM 
containing 1 % MeOH)  
0.21 g 21-NO2 (23 % based on 1,3-dihydroxymethyl-2-nitrobenzene) and 0.49 g 
3-(hydroxymethyl)-2-nitrobenzaldehyde (54 % based on 1,3-dihydroxymethyl-2-
nitrobenzene) were obtained. 
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2-Ntroisophthalaldehyde 
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m.p. 128 - 129 °C  
1H NMR (DMSO-d6, 250 MHz)  
δ (ppm) = 10.01 (s, 2H, H-(C-7) and H-(C-8)), 8.39 (d, 3JH,H = 7.9 Hz, 2H, H-(C-4) and 
H-(C-6)), 8.08 (dd, 3JH,H = 7.9 Hz, 3JH,H = 7.9 Hz, 1H, H-(C-5)). 
13C NMR (DMSO-d6, 60 MHz)  
δ (ppm) = 126.9 (C-1 and C-3), 132.2 (C-5), 137.9 (C-4 and C-6), 149.9 (C-2), 188.9 
(C-7 and C-8). 
MS-EI (70 eV) 
m/z: 180 ([M + H]+·, C8H6NO4, 13 %), 161 ([M – OH]+, C8H4NO3, 31 %), 147 (11 %), 
133 ([M – OH – CO]+, C7H4NO2, 28 %), 119 (6 %), 103 (100 %), 91 (9 %), 77 ([C6H5]+, 
33 %), 65 (29 %), 51 (26 %), 39 (10 %). 
IR  
ν /cm-1 (T %): 3391 (90 %), 3102 (91 %), 3077 (88 %), 3023 (91 %), 2871 (85 %), 
2761 (90 %), 2247 (93 %), 2010 (95 %), 1941 (95 %), 1701 (23 %), 1593 (40 %), 
1536 (23 %), 1394 (66 %), 1360 (53 %), 1309 (58 %), 1233 (45 %), 1165 (50 %), 
1128 (78 %), 1113 (78 %), 1068 (75 %), 1013 (28 %), 938 (70 %), 863 (74 %), 857 
(74 %), 801 (32 %), 773 (45 %), 747 (51 %), 721 (46 %).  
3-(Hydroxymethyl)-2-nitrobenzaldehyde 
1
2
6
3
5
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O
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O
OH  
1H NMR (DMSO-d6, 250 MHz)  
δ (ppm) = 9.97 (s, 1H, H-(C-7)), 7.98 (m, 2H, Harom), 7.84 (m, 1H, Harom), 4.56 (d, 4JH,H 
= 4.4 Hz, 2H, H-(C-8)). 
13C NMR (DMSO-d6, 60 MHz)  
δ (ppm) = 58.3, 127.2, 131.5, 131.6, 134.3, 135.0, 146.6, 189.4. 
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MS-EI (70 eV) 
m/z: 182 ([M + H]+·, C8H8NO4, 3 %), 164 ([M – OH]+, C8H6NO3, 7 %), 146 ([M – OH – 
H2O]+, C8H6NO3, 44 %), 133 (32 %), 118 (34 %), 105 (69 %), 91 (100 %), 77 ([C6H5]+, 
82 %), 63 ([C5H3]+, 10 %), 51 (36 %), 39 (10 %). 
IR  
ν /cm-1 (T %): 3387 (88 %), 3086 (95 %), 2880 (92 %), 1700 (40 %), 1600 (69 %), 
1579 (82 %), 1528 (22 %), 1466 (76 %), 1363 (46 %), 1308 (75 %), 1238 (57 %), 
1170 (71 %), 1076 (56 %), 1039 (53 %), 1017 (53 %), 968 (69 %), 919 (76 %), 852 
(58 %), 788 (46 %), 754 (59 %), 722 (68 %), 687 (66 %).  
5.2.3.17 2-Fluoroisophthalaldehyde (21-F) 
2-(2-Fluorophenyl)-1,3-dioxolane 
The synthetic procedure was the same as described in the synthesis of 
2-(5-methoxy-2-nitrophenyl)-1,3-dioxolane (see paragraph 5.2.2.9, synthetic 
pathway 1). 
A mixture of 2-fluorobenzaldehyde (5.00 g, 40.32 mmol), ethylene glycol (3.95 mL, 
70.72 mmol) and toluene-4-sulfonic acid (0.46 g, 2.35 mmol) in toluene (70 mL) was 
refluxed in a Dean-Stark-Trap at 130 °C for 6 h. After workup and purification by 
using MPLC (petroleum ether / ethyl acetate, 5:1), 5.97 g 2-(2-fluorophenyl)-
1,3-dioxolane was afforded as colourless oil (81 %). 
2-(2-Fluorophenyl)-1,3-dioxolane 
1'
2'
6'
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O
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1H NMR (CDCl3, 400 MHz)  
δ (ppm) = 7.53 (m, 1H, Harom), 7.33 (m, 1H, Harom), 7.15 (m, 1H, Harom), 7.06 (m, 1H, 
Harom), 6.09 (s, 1H, H-(C-2)), 4.09 (m, 4H, H-(C-4) and H-(C-5)). 
13C NMR (CDCl3, 100 MHz)  
δ (ppm) = 65.4 (C-4 and C-5), 98.9 (d, 3JC,F = 5.1 Hz, C-2), 115.6 (d, 2JC,F = 20.5 Hz, 
C-3’), 124.0 (d, 4JC,F = 2.2 Hz, C-5’), 125.1 (d, 2JC,F = 11.7 Hz, C-1’), 127.7 (d, 3JC,F = 
5.1 Hz, C-6’ or C-4’), 130.8 (d, 3JC,F = 7.3 Hz, C-6’ or C-4’), 161.0 (d, 1JC,F = 249.6 Hz, 
C-2’).  
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MS-EI (70 eV) 
m/z: 168 ([M]+·, C9H9FO2, 18 %), 167 ([M – H]+, C9H8FO2, 100 %), 149 ([M – F]+, 
C9H9O2, 8 %), 137 (11 %), 123 ([M – H – CH2CH2O]+, C7H4FO, 27 %), 108 (9 %), 95 
(5 %), 73 (10 %), 45 (2 %). 
IR  
ν /cm-1 (T %): 2956 (93 %), 2889 (86 %), 1619.47 (79 %), 1593 (84 %), 1490 (65 %), 
1458 (68 %), 1398 (72 %), 1300 (90 %), 1276 (77 %), 1232 (58 %), 1185 (68 %), 
1153 (81 %), 1112 (58 %), 1071 (30 %), 1030 (61 %), 966 (57 %), 940 (38 %), 874 
(83 %), 845 (78 %), 809 (67 %), 756 (16 %). 
3-(1,3-Dioxolan-2-yl)-2-fluorobenzaldehyde 
According to the procedure described in the preparation of 6-F (see paragraph 
5.2.2.4), 3-(1,3-Dioxolan-2-yl)-2-fluorobenzaldehyde was prepared by following 
procedure: To a stirred solution of t-BuOK (0.80 g, 7.14 mmol) in THF (20 mL, 
absoluted) n-BuLi (4.50 mL, 7.20 mmol, 1.6 M in hexane) was added dropwise 
at -78 °C under argon. After 5 min further stirring, 2-(2-fluorophenyl)-1,3-dioxolane 
(1.00 g, 5.95 mmol) was added and the reaction was carried out for another 2 h 
at -78 °C. DMF (2.00 mL, 26.03 mmol) was added dropwise and the solution was 
warmed up to room temperature within 1 h. The reaction was quenched by adding 
acetic acid (5 mL, concentrated). After workup and purification by using MPLC 
(petroleum ether / ethyl acetate, 5:1), 0.44 g 3-(1,3-dioxolan-2-yl)-2-
fluorobenzaldehyde was obtained (37 %). 
3-(1,3-Dioxolan-2-yl)-2-fluorobenzaldehyde 
1'
2'
6'
3'
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1H NMR (CDCl3, 250 MHz)  
δ (ppm) = 10.37 (s, 1H, H-(C-6)), 7.83 (m, 2H, H-(C-4’) and H-(C-6’)), 7.26 (dd, 3JH,H 
= 7.7 Hz, 3JH,H = 7.7 Hz, 1H, H-(C-5’)), 6.11 (s, 1H, H-(C-2)), 4.11 (m, 4H, H-(C-4) 
and H-(C-5)). 
13C NMR (CDCl3, 60 MHz)  
δ (ppm) = 65.6 (C-4 and C-5), 98.5 (d, 3JC,F = 4.8 Hz, C-2), 124.5 (d, 3JC,F = 4.7 Hz, 
C-6’ or C-4’), 126.8 (d, 2JC,F = 12.4 Hz, C-1’), 129.6 (d, 2JC,F = 12.8 Hz, C-3’), 131.1 
EXPERIMENTAL 155 
 
(C-5’), 134.2 (d, 3JC,F = 4.8 Hz, C-6’ or C-4’), 162.8 (d, 1JC,F = 211.7 Hz, C-2’), 186.8 
(d, 3JC,F = 4.4 Hz, C-6).  
MS-EI (70 eV) 
m/z: 196 ([M]+·, C10H9FO3, 100 %), 195 ([M – H]+, C10H8FO3, 100 %), 167 ([M – 
CHO]+, C9H8FO2, 19 %), 151 ([M – H – CH2CH2O]+, C8H4FO2, 94 %), 140 (18 %), 
123 (39 %), 107 (24 %), 101 (18 %), 95 (12 %), 73 (32 %), 59 (28 %), 45 (2 %). 
IR  
ν /cm-1 (T %): 2968 (93 %), 2891 (86 %), 2767 (96 %), 1692 (39 %), 1617 (62 %), 
1588 (75 %), 1460 (70 %), 1398 (58 %), 1299 (87 %), 1249 (54 %), 1218 (68 %), 
1198 (63 %), 1166 (84 %), 1098 (32 %), 1026 (62 %), 966 (55 %), 946 (54 %), 907 
(71 %), 830 (55 %), 784 (53 %), 762 (60 %), 740 (59 %), 684 (71 %). 
2-Fluoroisophthalaldehyde 
The dioxolane group in 3-(1,3-Dioxolan-2-yl)-2-fluorobenzaldehyde was cleaved by 
the same procedure as described in the deprotection of 2-(5-methoxy-3-methyl-2-
nitrophenyl)-1,3-dioxolane (see paragraph 5.2.2.9, synthetic pathway 1). 
3-(1,3-Dioxolan-2-yl)-2-fluorobenzaldehyde (1.30 g, 6.63 mmol) was stirred in the 
solution mixture of THF (10 mL) and 1 N HCl (10 mL) at room temperature overnight. 
After workup and purification by using MPLC (petroleum ether / ethyl acetate, 5:1), 
0.61 g 2-fluoroisophthalaldehyde was obtained (61 %).  
2-Fluoroisophthalaldehyde 
1
2
6
3
5
4
7
O
F
8
O  
m.p. 92 - 93 °C. 
1H NMR (CDCl3, 250 MHz)  
δ (ppm) = 10.26 (s, 2H, H-(C-7) and H-(C-8)), 8.13 (m, 2H, H-(C-4) and H-(C-6)), 
7.55 (dd, 3JH,H = 7.7 Hz, 3JH,H = 7.7 Hz, 1H, H-(C-5)). 
13C NMR (CDCl3, 60 MHz)  
δ (ppm) = 124.7 (d, 2JC,F = 8.1 Hz, C-1 or C-3), 125.5 (d, 3JC,F = 4.4 Hz, C-4 or C-6), 
135.2 (d, 4JC,F = 2.9 Hz, C-5), 164.2 (d, 1JC,F = 270.8 Hz, C-2), 187.2 (d, 3JC,F = 
5.9 Hz, C-7 or C-8).  
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HRMS (EI)  
m/z measured: 152.02645 ([M]+·, C8H5FO2).  
m/z calculated: 152.027345. 
MS-EI (70 eV) 
m/z: 152 ([M]+·, C8H5FO2, 68 %), 151 ([M – H]+, C8H4FO2, 100 %),123 ([M – CHO]+, 
C7H4FO, 6 %), 95 ([M – CHO – CO]+, C6H4F, 10 %), 75 (7 %). 
IR  
ν /cm-1 (T %): 3354 (88 %), 3089 (88 %), 3059 (87 %), 3018 (87 %), 2890 (85 %), 
2775 (88 %), 1708 (70 %), 1679 (60 %), 1606 (64 %), 1578 (65 %), 1492 (86 %), 
1460 (62 %), 1447 (67 %), 1395 (60 %), 1309 (77 %), 1244 (56 %), 1199 (58 %), 
1166 (75 %), 1083 (79 %), 1060 (83 %), 1010 (84 %), 913 (59 %), 828 (69 %), 798 
(53 %), 777 (64 %), 724 (65 %), 706 (51 %). 
5.2.3.18 2-Nitroterephthalaldehyde (22-NO2) 
The synthetic procedure for this compound was the same as described in the 
synthesis of 21-NO2 (see paragraph 5.2.3.16). 
1,4-Dihydroxymethyl-2-nitrobenzene 
2-Nitroterephthalic acid (3.82 g 18.10 mmol) and THF (50 mL) were stirred in ice bath, 
1 N BH3·THF (100 mL, 100 mmol) was added slowly. The ice bath was removed and 
the reaction solution was kept stirring for 36 h. After workup and crystallization from 
diisopropylether, 3.15 g 1,4-dihydroxymethyl-2-nitrobenzene was obtained (96 %). 
1,4-Dihydroxymethyl-2-nitrobenzene 
1
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m.p. 106 - 108 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 7.97 (s, 1H, H-(C-3)), 7.77 (d, 3JH,H = 7.8 Hz, 1H, H-(C-5) or H-(C-6)), 7.68 
(d, 3JH,H = 7.8 Hz, 1H, H-(C-5) or H-(C-6)), 4.80 (d, 4JH,H = 5.2 Hz, 2H, H-(C-7) or 
H-(C-8)), 4.59 (d, 4JH,H = 5.2 Hz, 2H, H-(C-7) or H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 59.8 (C-7), 61.5 (C-8), 121.7 (C-3), 128.2 (C-5 or C-6), 131.4 (C-5 or C-6), 
136.8 (C-1), 142.9 (C-4), 146.7 (C-2). 
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MS-EI (70 eV) 
m/z: 166 ([M – H2O]+·, C8H7NO3, 35 %), 150 (16 %), 136 ([M – H2O – CO]+·, C7H7NO2, 
13 %), 120 ([M – H2O – NO2]+·, C8H7O, 24 %), 109 (48 %), 92 (50 %), 89 (52 %), 77 
([C6H5]+, 100 %), 65 (30 %), 50 (38 %), 37 (20 %). 
IR  
ν /cm-1 (T %): 3228 (59 %), 3088 (70 %), 2923 (78 %), 2857 (79 %), 2035 (90 %), 
1932 (90 %), 1810 (91 %), 1715 (90 %), 1625 (89 %), 1567 (81 %), 1521 (43 %), 
1488 (61 %), 1424 (56 %), 1334 (42 %), 1295 (49 %), 1253 (62 %), 1225 (65 %), 
1213 (63 %), 1189 (60 %), 1146 (78 %), 1080 (64 %), 1018 (23 %), 991 (39 %), 967 
(57 %), 905 (57 %), 832 (51 %), 814 (35 %), 748 (41 %), 677 (40 %).  
2-Nitroterephthalaldehyde 
To a stirred suspension of 1,4-dihydroxymethyl-2-nitrobenzene (1.75 g, 9.51 mmol) 
and sodium acetate (1.00 g, 12.20 mmol) in DCM (80 mL) at 0 °C, PCC (8.20 g, 
38.14 mmol) was introduced slowly over 15 min. The reaction solution was stirred at 
room temperature for 3 h. After workup, the mixture of products was purified by using 
MPLC (petroleum ether / ethyl acetate, 2:1) to give 1.10 g 22-NO2 (64 % based on 
3-methyl-4-nitrobenzoic acid).  
2-Nitroterephthalaldehyde 
1
2
6
3
5
4
7
O
8
O
N
+
O
-
O
 
m.p. 100 - 101°C (reported139 96 - 97 °C). 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.31 (s, 1H, H-(C-7) or H-(C-8)), 10.16 (s, 1H, H-(C-7) or H-(C-8)), 8.60 (d, 
4JH,H = 1.6 Hz, 1H, H-(C-3)), 8.37 (dd, 4JH,H = 1.8 Hz, 3JH,H = 7.5 Hz, 1H, H-(C-5)), 
8.06 (d, 3JH,H = 7.9 Hz, 1H, H-(C-6)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 124.8 (C-6), 130.6 (C-3), 133.9 (C-5), 134.4 (C-1), 139.3 (C-4), 149.3 (C-2), 
189.7 (C-7), 191.3 (C-8).  
MS-EI (70 eV) 
m/z: 180 ([M + H]+·, C8H6NO4, 28 %), 163 ([M + H – OH]+, C8H5NO3, 6 %), 149 ([M – 
NO]+, C8H5O2, 100 %), 133 (5 %), 132 (22 %), 121 (55 %), 103 (100 %), 93 (8 %), 77 
([C6H5]+, 6 %), 65 (30 %), 51 (20 %), 39 (11 %). 
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IR  
ν /cm-1 (T %): 3396 (91 %), 3367 (91 %), 3082 (83 %), 3058 (88 %), 3041 (89 %), 
2933 (88 %), 2868 (74 %), 2742 (91 %), 1983 (95 %), 1811 (96 %), 1690 (10 %), 
1615 (78 %), 1566 (57 %), 1528 (22 %), 1483 (39 %), 1416 (60 %), 1391 (47 %), 
1376 (76 %), 1351 (19 %), 1313 (52 %), 1267 (36 %), 1181 (17 %), 1140 (61 %), 
1068 (67 %), 1009 (71 %), 999 (59 %), 921 (60 %), 911 (47 %), 856 (35 %), 828 
(39 %), 794 (22 %), 751 (19 %), 717 (31 %), 670 (54 %).  
5.2.3.19 2-Fluoroterephthalaldehyde (22-F) 
2-(4-Bromo-3-fluorophenyl)-1,3-dioxolane 
4-Bromo-3-fluorobenzaldehyde (5.50 g, 27.09 mmol) was reacted with ethylene 
glycol to give 6.20 g 2-(4-bromo-3-fluorophenyl)-1,3-dioxolane (92 %). The 
experiment was performed by the synthetic procedure described in the synthesis of 
2-(2-fluorophenyl)-1,3-dioxolane (see paragraph 5.2.2.9, synthetic pathway 1). 
2-(4-Bromo-3-fluorophenyl)-1,3-dioxolane 
4'
3'
5'
2'
6'
1'
F
Br
2
O
1
O
3
5
4
 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 7.73 (m, 1H, Harom), 7.39 (m, 1H, Harom), 7.23 (m, 1H, Harom), 5.75 (s, 1H, 
H-(C-2)), 3.99 (m, 4H, H-(C-4) and H-(C-5)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 64.9 (C-5 and C-4), 101.3 (d, 4JC,F = 1.5 Hz, C-2), 108.6 (d, 2JC,F = 20.5 Hz, 
C-4’), 114.7 (d, 2JC,F = 23.4 Hz, C-2’), 124.2 (d, 3JC,F = 3.7 Hz, C-5’), 133.5 (C-6’), 
140.8 (d, 3JC,F = 6.6 Hz, C-1’), 158.1 (d, 1JC,F = 245.2 Hz, C-3’). 
HRMS (EI)  
m/z measured: 245.97209 ([M]+·, C9H8BrFO2).  
m/z calculated: 245.969117. 
MS-EI (70 eV) 
m/z: 248 ([M]+·, C9H881BrFO2, 100 %), 246 ([M]+·, C9H879BrFO2, 99 %), 227 (6 %), 203 
([M – H – CH2CH2O]+, C6H381BrFO, 28 %), 201 ([M – H – CH2CH2O]+, C6H479BrFO, 
27 %), 187 (6 %), 174 (14 %), 167 ([M – H79/81Br]+·, C9H7FO2, 22 %), 137 (4 %), 123 
(10 %), 107 (14 %), 94 (9 %), 73 (12 %), 57 (2 %), 45 (6 %). 
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IR  
ν /cm-1 (T %): 2956 (93 %), 2888 (85 %), 1726 (97 %), 1581 (83 %), 1483 (68 %), 
1424 (67 %), 1397 (71 %), 1277 (81 %), 1241 (73 %), 1165 (59 %), 1135 (84 %), 
1082 (35 %), 1039 (51 %), 967 (59 %), 942 (47 %), 873 (50 %), 819 (54 %), 779 
(57 %), 739 (79 %), 722 (74 %), 695 (82 %), 667 (75 %).  
2-Fluoroterephthalaldehyde 
Following the same synthetic procedure as described in the formylation of 4-bromo-
3-nitroanisol (see paragraph 5.2.1.7), 2-(4-bromo-3-fluorophenyl)-1,3-dioxolane 
(2.25 g, 9.07 mmol) gave 3.50 g crude 4-(1,3-dioxolan-2-yl)-2-fluorobenzaldehyde 
which was directly submitted to hydrolysis without further purification. 
3.50 g Crude 4-(1,3-dioxolan-2-yl)-2-fluorobenzaldehyde was stirred in a mixture of 
THF (10 mL) and 1 N HCl (10 mL) at room temperature overnight. After workup and 
purification by using MPLC (petroleum ether / ethyl acetate, 3:1), 1.10 g 22-F was 
obtained (77 % based on 2-(4-bromo-3-fluorophenyl)-1,3-dioxolane). 
2-Fluoroterephthalaldehyde 
1
2
6
3
5
4
7
O
8
O
F
 
m.p. 91 - 92 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.27 (s, 1H, H-(C-8)), 10.07 (d, 4JH,F = 1.5 Hz, 1H, H-(C-7)), 8.05 (m, 1H, 
Harom), 7.88 (m, 2H, Harom). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 117.0 (d, 2JC,F = 21.2 Hz, C-3), 125.5 (d, 3JC,F = 3.7 Hz, C-6), 127.4 (d, 
2JC,F = 10.3 Hz, C-1), 130.3 (d, 4JC,F = 2.2 Hz, C-5), 141.8 (d, 3JC,F = 5.9 Hz, C-4), 
163.3 (d, 1JC,F = 259.1 Hz, C-2), 187.8 (d, 3JC,F = 5.1 Hz, C-7), 191.9 (d, 4JC,F = 
2.2 Hz, C-8). 
HRMS (EI)  
m/z measured: 152.02661 ([M]+·, C8H5FO2).  
m/z calculated: 152.027345. 
MS-EI (70 eV) 
m/z: 152 ([M]+·, C8H5FO2, 75 %), 151 ([M – H]+, C8H4FO2, 100 %), 123 ([M – CHO]+, 
C7H4FO, 40 %), 95 (28 %), 75 (18 %), 50 (6 %). 
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IR  
ν /cm-1 (T %): 3372 (90 %), 3114 (90 %), 3081 (87 %), 3062 (86 %), 3044 (82 %), 
2885 (83 %), 2847 (83 %), 2778 (88 %), 2742 (88 %), 1992 (92 %), 1936 (93 %), 
1802 (93 %), 1723 (86 %), 1682 (33 %), 1615 (65 %), 1577 (62 %), 1492 (65 %), 
1430 (49 %), 1401 (60 %), 1384 (51 %), 1314 (51 %), 1280 (80 %), 1259 (57 %), 
1238 (56 %), 1185 (48 %), 1133 (46 %), 1104 (58 %), 1002 (82 %), 968 (61 %), 948 
(81 %), 897 (65 %), 822 (43 %), 807 (46 %), 750 (28 %), 706 (71 %), 665 (70 %).  
5.2.3.20 5-Methoxy-2-nitroisophthalaldehyde (23-NO2) 
The synthetic procedure for this compound was the same as described in the 
synthesis of 21-NO2 (see paragraph 5.2.3.16). 
5-Methoxy-2-nitroisophthalic acid 
3.00 g 5-methoxy-2-nitroisophthalic acid was produced from 5-methoxy-2-nitro-
1,3-xylene (41 %). 
5-Methoxy-2-nitroisophthalic acid 
1
2
6
3
5
4
7
O
OH
9
OOH
O
CH3
8
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+
O
-
O
 
m.p. 222 - 224 °C. 
1H NMR (DMSO-d6, 250 MHz)  
δ (ppm) = 7.51 (s, 2H, H-(C-4) and H-(C-6)), 3.90 (s, 3H, H-(C-8)). 
13C NMR (DMSO-d6, 60 MHz)  
δ (ppm) = 56.5 (C-8), 118.1  (C-4 and C-6), 127.8 (C-1 and C-3), 141.8 (C-2), 159.9 
(C-5), 164.3 (C-7 and C-9). 
MS-EI (70 eV) 
m/z: 241 ([M]+·, C9H7NO7, 62 %), 225 (4 %), 211 ([M – NO]+, C9H7O6, 100 %), 193 
([M – NO – H2O]+, C9H5O5, 3 %), 177 (24 %), 165 (6 %), 149 (18 %), 139 (48 %), 111 
(35 %), 93 (42 %), 79 (8 %), 62 (12 %), 53 (6 %). 
IR  
ν /cm-1 (T %): 3607 (81 %), 3396 (82 %), 3096 (80 %), 2389 (81 %), 1903 (83 %), 
1715 (59 %), 1673 (67 %), 1589 (60 %), 1552 (47 %), 1466 (62 %), 1456 (62 %), 
1441 (61 %), 1373 (60 %), 1325 (63 %), 1267 (49 %), 1192 (46 %), 1152 (52 %), 
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1091 (52 %), 1033 (53 %), 933 (69 %), 904 (61 %), 891 (47 %), 837 (52 %), 798 
(40 %), 764 (64 %), 732 (56 %), 674 (48 %).  
5-Methoxy-1,3-dihydroxymethyl-2-nitrobenzene 
5-Methoxy-2-nitroisophthalic acid (2.50 g, 10.37 mmol) and THF (20 mL) were stirred 
in an ice bath, 1 N BH3·THF (65 mL, 65 mmol) was added slowly. The ice bath was 
removed and the reaction solution was kept stirring for 36 h. After workup and 
crystallization in diisopropyl ether, 1.45 g 1,3-dihydroxymethyl-2-nitrobenzene was 
obtained (53 %). 
5-Methoxy-1,3-dihydroxymethyl-2-nitrobenzene 
1
2
6
3
5
4
7
OH
8
OH
O
CH3
9
N
+
O
-
O
 
m.p. 127 - 129 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ = 7.07 (s, 2H, H-(C-4) and H-(C-6)), 4.55 (s, 4H, H-(C-7) and H-(C-8)), 3.85 (s, 3H, 
H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ = 55.7 (C-9), 59.5 (C-7 and C-8), 111.7 (C-4 and C-6), 138.2 (C-1 and C-3), 140.1 
(C-2), 160.7 (C-5). 
HRMS (EI)  
m/z measured: 213.06506 ([M]+·, C9H11NO5).  
m/z calculated: 213.063696. 
MS-EI (70 eV) 
m/z: 213 ([M]+·, C9H11NO5, 18 %), 195 ([M – H2O]+·, C9H9NO4, 12 %), 178 ([M – H2O 
– OH]+, C9H8NO3, 100 %), 149 ([M – H2O – NO2]+·, C9H9O2, 26 %), 134 (12 %), 121 
(43 %), 106 (17 %), 95 (30 %), 77 ([C6H5]+, 22 %), 65 (17 %), 39 (7 %). 
IR  
ν /cm-1 (T %): 3206 (62 %), 2944 (83 %), 2256 (96 %), 1707 (94 %), 1594 (55 %), 
1511 (63 %), 1409 (29 %), 1327 (19 %), 1280 (25 %), 1231 (47 %), 1193 (56 %), 
1165 (47 %), 1109 (37 %), 1050 (41 %), 961 (58 %), 881 (59 %), 864 (58 %), 840 
(55 %), 783 (46 %), 764 (40 %), 688 (53 %). 
5-Methoxy-2-nitroisophthalaldehyde  
To a stirred suspension of 5-methoxy-1,3-dihydroxymethyl-2-nitrobenzene (1.45 g, 
6.81 mmol) and sodium acetate (1.00 g, 12.20 mmol) in DCM (30 mL) at 0 °C, PDC 
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(2.70 g, 7.18 mmol) was introduced slowly over 15 min. After 3 h stirring at room 
temperature, the reaction mixture was worked up and the crude products was 
purified by using MPLC (petroleum ether / ethyl acetate, 3:1).  
0.33 g 23-NO2 (22 % based on 5-methoxy-1,3-dihydroxymethyl-2-nitrobenzene) and 
0.72 g 5-methoxy-3-(hydroxymethyl)-2-nitrobenzaldehyde (49 % based on 
5-methoxy-1,3-dihydroxymethyl-2-nitrobenzene) were obtained. 
5-Methoxy-2-nitroisophthalaldehyde 
1
2
6
3
5
4
7
O
8
O
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+
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O
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9
 
m.p. 152 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.01 (s, 2H, H-(C-7) and H-(C-8)), 7.74 (s, 2H, H-(C-4) and H-(C-6)), 3.98 
(s, 3H, H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 56.8 (C-9), 121.1 (C-4 and C-6), 130.4 (C-1 and C-3), 140.3 (C-2), 161.2 
(C-5), 189.0 (C-7 and C-8). 
HRMS (EI)  
m/z measured: 209.03456 ([M]+·, C9H7NO5).  
m/z calculated: 209.032396. 
MS-EI (70 eV) 
m/z: 209 ([M]+·, C9H7NO5, 5 %), 191 ([M – H2O]+·, C9H5NO4, 10 %), 176 ([M – H2O – 
CH3]+, C8H2NO4, 6 %), 163 ([M – H2O – CO]+·, C8H5NO3, 54 %), 148 ([M – H2O – CO 
– CH3]+, C7H2NO3, 9 %), 133 (100), 119 (10 %), 105 (52 %), 92 (22 %), 77 ([C6H5]+, 
19 %), 63 ([C5H3]+, 66 %), 52 (14 %), 50 (10 %). 
IR  
ν /cm-1 (T %): 3370 (87 %), 3077 (78 %), 2990 (85 %), 2951 (85 %), 2917 (85 %), 
2876 (85 %), 2633 (87 %), 2233 (89 %), 1791 (92 %), 1699 (48 %), 1595 (66 %), 
1583 (48 %), 1540 (50 %), 1504 (52 %), 1477 (68 %), 1465 (55 %), 1438 (68 %), 
1425 (64 %), 1389 (62 %), 1370 (63 %), 1328 (50 %), 1295 (42 %), 1237 (56 %), 
1193 (67 %), 1170 (69 %), 1113 (57 %), 1034 (65 %), 1020 (42 %), 992 (62 %), 966 
(65 %), 936 (42 %), 904 (53 %), 885 (32 %), 845 (59 %), 838 (58 %), 781 (74 %), 
763 (64 %), 713 (54 %), 683 (58 %).  
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5-Methoxy-3-(hydroxymethyl)-2-nitrobenzaldehyde 
1
2
6
3
5
4
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OH  
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 9.97 (s, 1H, H-(C-7)), 7.44 (d, 4JH,H = 2.7 Hz, 1H, H-(C-4) or H-(C-6)), 7.38 
(d, 4JH,H = 2.7 Hz, 1H, H-(C-4) or H-(C-6)), 4.61 (d, 4JH,H = 5.1 Hz, 2H, H-(C-8)), 3.91 
(s, 3H, H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 56.3 (C-8), 58.9 (C-9), 114.5 (C-4 or C-6), 117.8 (C-4 or C-6), 131.4 (C-1), 
139.1 (C-2), 140.6 (C-3), 161.1 (C-5), 189.4 (C-7). 
MS-EI (70 eV) 
m/z: 211 ([M]+·, C9H9NO5, 7 %), 194 ([M – H2O]+·, C9H7NO4, 6 %), 176 (14 %), 163 
(7 %), 147 (14 %), 134 (48 %), 121 (100 %), 106 (46 %), 92 (42 %), 77 ([C6H5]+, 
38 %), 63 ([C5H3]+, 23 %), 51 (13 %), 39 (11 %). 
IR  
ν /cm-1 (T %): 3513 (79 %), 3369 (80 %), 3079 (83 %), 2987 (87 %), 2949 (84 %), 
2847 (87 %), 1693 (43 %), 1585 (35 %), 1500 (34 %), 1463 (42 %), 1422 (50 %), 
1393 (45 %), 1359 (58 %), 1320 (34 %), 1284 (15 %), 1229 (48 %), 1195 (50 %), 
1162 (52 %), 1108 (31 %), 1064 (30 %), 1031 (31 %), 974 (41 %), 962 (49 %), 936 
(38 %), 894 (46 %), 878 (40 %), 844 (35 %), 773 (69 %), 720 (46 %), 704 (47 %), 
657 (55 %).  
5.2.3.21 2-Fluoro-5-methoxyisophthalaldehyde (23-F) and 
2-fluoro-5-methoxyterephthalaldehyde (24-F) 
3-(1,3-Dioxolan-2-yl)-4-fluoroanisole 
3-(1,3-Dioxolan-2-yl)-4-fluoroanisole was synthesized according to decribed in 
synthesis of 2-(2-fluorophenyl)-1,3-dioxolane (see paragraph 5.2.2.9, synthetic 
pathway 1). 2-Fluoro-5-methoxybenzaldehyde (5.80 g, 37.66 mmol) gave 6.74 g 
3-(1,3-dioxolan-2-yl)-4-fluoroanisole (90 %).  
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3-(1,3-Dioxolan-2-yl)-4-fluoroanisole 
3
4
2
5
1
6
2'
O
1'
O
3'
5'
4'
O
CH3
7
F  
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 7.16 (m, 1H, Harom), 6.97 (m, 2H, Harom), 5.93 (s, 1H, H-(C-2’)), 4.00 (m, 4H, 
H-(C-4’) and H-(C-5’)), 3.73 (s, 3H, H-(C-7)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 55.6 (C-7), 64.8 (C-4’ and C-5’), 97.9 (d, 3JC,F = 3.7 Hz, C-2’), 112.4 (d, 
3JC,F = 3.7 Hz, C-2), 115.9 (d, 3JC,F = 7.3 Hz, C-6), 116.3 (d, 2JC,F = 22.7 Hz, C-5), 
125.8 (d, 2JC,F = 13.9 Hz, C-3), 155.2 (d, 4JC,F = 2.2 Hz, C-1), 155.6 (d, 1JC,F = 
240.1 Hz, C-4). 
HRMS (EI)  
m/z measured: 198.06757 ([M]+·, C10H11FO3).  
m/z calculated: 198.069206. 
MS-EI (70 eV) 
m/z: 198 ([M]+·, C10H11FO3, 90 %), 197 ([M – H]+, C10H10FO3, 90 %), 179 ([M – OH]+, 
C10H8FO2, 22 %), 167 (70 %), 153 ([M – H – CH2CH2O]+, C8H6FO2, 86 %), 137 
(22 %), 126 (55 %), 109 (20 %), 95 (12 %), 83 (14 %), 73 (56 %), 56 (8 %), 43 (18 %). 
IR  
ν /cm-1 (T %): 2957 (90 %), 2890 (87 %), 2838 (93 % ),1598 (91 %), 1496 (37 %), 
1466 (73 %), 1431 (73 %), 1400 (68 %), 1302 (77 %), 1273 (60 %), 1253 (80 %), 
1199 (41 %), 1160 (47 %), 1114 (74 %), 1068 (37 %), 1032 (43 %), 961 (54 %), 947 
(54 %), 879 (65 %), 865 (65 %), 814 (55 %), 753 (78 %), 731 (54 %), 696 (59 %). 
4-(1,3-Dioxolan-2-yl)-5-fluoro-2-methoxybenzaldehyde and 
3-(1,3-dioxolan-2-yl)-2-fluoro-5-methoxybenzaldehyde 
A solution of 3-(1,3-dioxolan-2-yl)-4-fluoroanisole (4.70 g, 23.74 mmol) and TMEDA 
(3.6 mL, 23.80 mmol) in THF (100 mL) was chilled to -78 °C in a CO2/acetone bath. 
sec-BuLi (21.90 mL, 28.49 mmol, 1.3 M in cyclohexane) was added into this cold 
solution and it was kept stirring for 2 h at -78 °C. DMF (4 mL, 50.20 mmol) was 
added dropwise. Afterward, the reaction solution was warmed up to room 
temperature within 1 h and 5 mL water was added to quench the reaction. The 
reaction mixture was extracted with diethyl ether (2 × 200 mL). The combined organic 
layer was washed with water (100 mL), satured NaHCO3 solution (100 mL), brine 
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(100 mL) and dried over Na2SO4. After evaporation of the solvent, the residue was 
purified by using MPLC (petroleum ether / ethyl acetate, 4:1) to yield 0.53 g 
4-(1,3-dioxolan-2-yl)-5-fluoro-2-methoxybenzaldehyde (10 %) and 2.00 g 
3-(1,3-dioxolan-2-yl)-2-fluoro-5-methoxybenzaldehyde (37 %). 
3-(1,3-Dioxolan-2-yl)-2-fluoro-5-methoxybenzaldehyde 
3
2
4
1
5
6
2'
O
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O
3'
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4'
O
CH3
8
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O  
m.p. 83 - 85 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.19 (s, 1H, H-(C-7)), 7.31 (m, 2H, H-(C-4) and H-(C-6)), 6.02 (s, 1H, 
H-(C-2’)), 4.02 (m, 4H, H-(C-4’) and H-(C-5’)), 3.80 (s, 3H, H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 55.9 (C-8), 65.0 (C-4’ and C-5’), 97.6 (d, 3JC,F = 2.9 Hz, C-2’), 112.3 (d, 
3JC,F = 2.9 Hz, C-4), 120.0 (d, 3JC,F = 5.1 Hz, C-6), 124.5 (d, 2JC,F = 9.5 Hz, C-1), 
128.0 (d, 2JC,F = 13.9 Hz, C-3), 155.3 (d, 4JC,F = 2.2 Hz, C-5), 156.2 (d, 1JC,F = 
254.7 Hz, C-2), 187.4 (d, 3JC,F = 5.1 Hz, C-7). 
HRMS (EI)  
m/z measured: 226.06312 ([M]+·, C11H11FO4).  
m/z calculated: 226.064116. 
MS-EI (70 eV) 
m/z: 226 ([M]+·, C11H11FO4, 68 %), 225 ([M – H]+, C11H10FO4, 52 %), 198 ([M – CO]+·, 
C10H11FO3, 8 %), 181 ([M – H – CH2CH2O]+, C9H6FO3, 98 %), 165 (14 %), 153 
(53 %), 141 (8 %), 109 (8 %), 95 (10 %), 73 (100 %), 57 (2 %), 45 (17 %). 
IR  
ν /cm-1 (T %): 3345 (95 %), 3090 (93 %), 3025 (94 %), 2967 (87 %), 2943 (86 %), 
2899 (78 %), 2843 (87 %), 2283 (97 %), 2091 (96 %), 2010 (96 %), 1727 (93 %), 
1678 (20 %), 1646 (88 %), 1600 (69 %), 1470 (30 %), 1439 (50 %), 1416 (40 %), 
1371 (62 %), 1364 (64 %), 1334 (29 %), 1297 (78 %), 1275 (53 %), 1229 (44 %), 
1199 (38 %), 1159 (52 %), 1134 (68 %), 1102 (21 %), 1046 (42 %), 1023 (40 %), 991 
(65 %), 963 (56 %), 945 (33 %), 930 (26 %), 905 (40 %), 880 (60 %), 864 (30 %), 
814 (77 %), 768 (58 %), 726 (52 %). 
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4-(1,3-Dioxolan-2-yl)-5-fluoro-2-methoxybenzaldehyde 
4
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O  
m.p. 113 - 115 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.28 (d, 3JH,H = 3.0 Hz, 1H, H-(C-7)), 7.42 (d, 3JH,F = 9.9 Hz, 1H, H-(C-6)), 
7.26 (d, 4JH,F = 5.3 Hz, 1H, H-(C-3)), 6.00 (s, 1H, H-(C-2’)), 4.04 (m, 4H, H-(C-4’) and 
H-(C-5’)), 3.92 (s, 3H, H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 56.6 (C-8), 65.1 (C-4’ and C-5’), 97.6 (d, 3JC,F = 2.9 Hz, C-2’), 112.0 (d, 
3JC,F = 3.7 Hz, C-3), 113.8 (d, 2JC,F = 23.4 Hz, C-6), 125.3 (d, 3JC,F = 5.9 Hz, C-1), 
132.9 (d, 2JC,F = 14.6 Hz, C-4), 154.3 (d, 1JC,F = 243.0 Hz, C-5), 157.7 (d, 4JC,F = 
1.5 Hz, C-2), 188.1 (d, 4JC,F = 1.5 Hz, C-7). 
HRMS (EI)  
m/z measured: 226.06256 ([M]+·, C11H11FO4).  
m/z calculated: 226.064116. 
MS-EI (70 eV) 
m/z: 226 ([M]+·, C11H11FO4, 90 %), 225 ([M – H]+, C11H10FO4, 76 %), 208 ([M – H2O]+·, 
C11H8FO3, 17 %), 203 ([M – CHO]+, C10H10FO3, 47 %), 181 ([M – H – CH2CH2O]+, 
C9H6FO3, 76 %), 165 (33 %), 153 (48 %), 137 (38 %), 123 (16 %), 109 (22 %), 95 
(14 %), 73 (100 %), 57 (7 %), 45 (26 %). 
IR  
ν /cm-1 (T %): 3347 (95 %), 3054 (92 %), 2967 (87 %), 2901 (81 %), 2879 (81 %), 
2770 (93 %), 2277 (97 %), 1980 (96 %), 1678 (40 %), 1622 (69 %), 1590 (90 %), 
1488 (43 %), 1466 (40 %), 1419 (42 %), 1400 (33 %), 1384 (43 %), 1281 (53 %), 
1235 (52 %), 1202 (61 %), 1187 (45 %), 1155 (28 %), 1117 (61 %), 1068 (27 %), 
1024 (55 %), 1002 (28 %), 957 (38 %), 943 (31 %), 891 (21 %), 867 (33 %), 790 
(71 %), 723 (40 %), 689 (30 %), 666 (40 %).  
2-Fluoro-5-methoxyisophthalaldehyde and 
2-fluoro-5-methoxyterephthalaldehyde 
3-(1,3-dioxolan-2-yl)-2-fluoro-5-methoxybenzaldehyde (0.17 g, 0.75 mmol) was 
hydrolyzed in a mixed solution of 1 N HCl and THF (50:50) to give 0.12 g 23-F (88 %).  
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By the same procedure, 4-(1,3-dioxolan-2-yl)-5-fluoro-2-methoxybenzaldehyde 
(0.20 g, 0.88 mmol) was hydrolyzed in a mixed solution of 1 N HCl and THF (50:50) 
to give 0.13 g 2-fluoro-5-methoxyterephthalaldehyde (80 %).  
2-Fluoro-5-methoxyisophthalaldehyde 
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m.p. 98 - 100 °C. 
1H-NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.22 (s, 2H, H-(C-7) and H-(C-8)), 7.58 (d, 4JH,F = 5.3 Hz, 2H, H-(C-4) and 
H-(C-6)), 3.85 (s, 3H, H-(C-9)). 
13C-NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 56.2 (C-9), 119.2 (d, 3JC,F = 2.9 Hz, C-4 and C-6), 125.5 (d, 2JC,F = 9.5 Hz, 
C-1 and C-3), 155.6 (d, 4JC,F = 2.2 Hz, C-5),158.6 (d, 1JC,F = 263.5 Hz, C-2), 187.2 (d, 
3JC,F = 5.9 Hz, C-7 and C-8).  
HRMS (EI)  
m/z measured: 182.03754 ([M]+·, C9H7FO3).  
m/z calculated: 182.037906. 
MS-EI (70 eV) 
m/z: 182 ([M]+·, C9H7FO3, 100 %), 153 ([M – CHO]+, C8H6FO2, 61 %), 138 (8 %), 125 
(10 %), 110 (7 %), 83 (48 %),71 (22 %), 55 (31 %), 43 (87 %). 
IR  
ν /cm-1 (T %): 3353 (89 %), 3073 (82 %), 3018 (86 %), 2980 (84 %), 2957 (83 %), 
2897 (79 %), 2849 (82 %), 2770 (87 %), 2619 (89 %), 2092 (92 %), 1810 (93 %), 
1682 (38 %), 1598 (54 %), 1495 (77 %), 1469 (38 %), 1463 (39 %), 1442 (49 %), 
1431 (42 %), 1392 (35 %), 1322 (53 %), 1290 (42 %), 1227 (41 %), 1197 (35 %), 
1156 (53 %), 1045 (43 %), 1008 (72 %), 972 (64 %), 945 (39 %), 894 (34 %), 810 
(67 %), 724 (56 %), 705 (52 %), 661 (32 %).  
2-Fluoro-5-methoxyterephthaldehyde 
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m.p. 127 - 128 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.32 (s, 1H, H-(C-7) or H-(C-8)), 10.23 (s, 1H, H-(C-7) or H-(C-8)), 7.58 (s, 
1H, H-(C-6)), 7.54 (d, 3JH,F = 5.5 Hz, 1H, H-(C-3)), 3.97 (s, 3H, H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 56.1 (C-9), 112.6 (d, 3JC,F = 2.2 Hz, C-6), 115.3 (d, 2JC,F = 23.4 Hz, C-3), 
128.2 (d, 2JC,F = 10.2 Hz, C-1), 128.9 (d, 3JC,F = 6.6 Hz, C-4), 157.1 (d, 1JC,F = 
251.8 Hz, C-2), 157.4 (d, 4JC,F = 1.4 Hz, C-5), 187.5 (d, 3JC,F = 4.4 Hz, C-7), 188.2 (d, 
4JC,F = 1.4 Hz, C-8).  
HRMS (EI)  
m/z measured: 182.03624 ([M]+·, C9H7FO3).  
m/z calculated: 182.037906. 
MS-EI (70 eV) 
m/z: 182 ([M]+·, C9H7FO3, 92 %), 164 ([M – H2O]+·, C9H5FO2, 74 %) 153 ([M – CHO]+, 
C8H6FO2, 30 %), 138 (100 %), 123 (73 %), 121 (56 %), 109 (40 %), 95 (34 %), 83 
(26 %), 62 (10 %), 56 (16 %), 48 (10 %). 
IR  
ν /cm-1 (T %): 3365 (91 %), 3109 (90 %), 3052 (83 %), 2995 (89 %), 2960 (81 %), 
2929 (83 %), 2871 (73 %), 2769 (84 %), 1998 (92 %), 1726 (78 %), 1697 (53 %), 
1683 (43 %), 1619 (80 %), 1581 (87 %), 1478 (53 %), 1465 (50 %), 1414 (46 %), 
1402 (38 %), 1390 (41 %), 1296 (52 %), 1279 (44 %), 1234 (53 %), 1200 (55 %), 
1190 (47 %), 1166 (59 %), 1131 (36 %), 1072 (67 %), 1040 (78 %), 999 (38 %), 903 
(45 %), 883 (39 %), 783 (73 %), 742 (78 %), 710 (81 %), 678 (40 %), 657 (32 %).  
5.2.3.22 5-Methoxy-2-nitroterephthalaldehyde (24-NO2) 
2,5-Dimethyl-4-nitrophenol  
2,5-Dimethylphenol was nitrated according to the nitration of 3,5-dimethylphenol (see 
paragraph 5.2.2.9). 2,5-dimethylphenol (5.07 g, 41.56 mmol) gave 2.50 g 
2,5-dimethyl-4-nitrophenol (36 %). 
2,5-Dimethyl-4-nitrophenol 
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m.p. 117 - 119 °C (reported140 117 - 119 °C). 
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1H NMR (DMSO-d6, 250 MHz)  
δ (ppm) = 7.87 (s, 1H, H-(C-3) or H-(C-6)), 6.74 (s, 1H, H-(C-3) or H-(C-6)), 2.45 (s, 
3H, H-(C-7) or H-(C-8)), 2.13 (s, 3H, H-(C-7) or H-(C-8)). 
13C NMR (DMSO-d6, 60 MHz)  
δ (ppm) = 15.1, 20.6, 117.5, 123.2, 127.7, 133.8, 139.8, 160.4.  
MS-EI (70 eV) 
m/z: 167 ([M]+·, C8H9NO3, 50 %), 150 ([M – OH]+, C8H8NO2, 100 %), 122 (30 %), 106 
(12 %), 95 (18 %), 91 (41 %), 77 (35 %), 65 (11 %), 50 (11 %). 
IR 
ν /cm-1 (T %): 3345 (64 %), 2977 (79 %), 2933 (77 %), 2307 (87 %), 1778 (93 %), 
1746 (93 %), 1670 (85 %), 1622 (59 %), 1578 (57 %), 1519 (45 %), 1481 (39 %), 
1460 (47 %), 1440 (52 %), 1406 (64 %), 1375 (49 %), 1314 (31 %), 1262 (27 %), 
1219 (32 %), 1173 (38 %), 1047 (38 %), 1016 (38 %), 903 (53 %), 889 (33 %), 853 
(27 %), 785 (57 %), 757 (36 %), 729 (55 %), 712 (52 %).  
2,5-Dimethyl-4-nitroanisole 
2,5-Dimethyl-4-nitrophenol was methoxylated according to the method described in 
synthesis of 3-NO2 (see paragraph 5.2.1.2). 2.30 g 2,5-Dimethyl-4-nitroanisole was 
obtained (85 %) from 2,5-dimethyl-4-nitrophenol (2.50 g, 14.97 mmol). 
2,5-Dimethyl-4-nitroanisole 
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m.p. 94 - 97 °C (reported141 91 - 92 °C). 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 7.88 (s, 1H, H-(C-3) or H-(C-6)), 6.99 (s, 1H, H-(C-3) or H-(C-6)), 3.88 (s, 
3H, H-(C-7)), 2.54 (s, 3H, H-(C-8) or H-(C-9)), 2.15 (s, 3H, H-(C-8) or H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 15.2 (C-8 or C-9), 20.7 (C-8 or C-9), 56.1 (C-7), 113.7 (C-3 or C-6), 124.7 
(C-2 or C-5), 126.8 (C-3 or C-6), 134.2 (C-2 or C-5), 140.8 (C-4), 161.0 (C-1). 
MS-EI (70 eV) 
m/z: 181 ([M]+·, C9H11NO3, 40 %), 164 ([M – OH]+, C9H10NO2, 100 %), 149 (7 %), 136 
(20 %), 109 (28 %), 91 (38 %), 77 (14 %), 65 (8 %), 50 (8 %). 
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IR 
ν /cm-1 (T %): 3056 (89 %), 3009 (88 %), 2974 (83 %), 2932 (75 %), 2849 (84 %), 
2736 (90 %), 2593 (90 %), 2514 (90 %), 2321 (91 %), 2052 (91 %), 1980 (92 %), 
1802 (93 %), 1725 (93 %), 1643 (89 %), 1618 (57 %), 1572 (49 %), 1513 (42 %), 
1496 (33 %), 1473 (51 %), 1462 (49 %), 1441 (49 %), 1394 (73 %), 1372 (60 %), 
1334 (32 %), 1322 (26 %), 1255 (15 %), 1197 (54 %), 1175 (40 %), 1062 (25 %), 999 
(44 %), 937 (71 %), 898 (42 %), 862 (47 %), 852 (49 %), 787 (46 %), 758 (44 %), 
720 (71 %).  
Compound 2,5-dimethyl-4-nitroanisole was oxidized to benzoic acid and reduced to 
benzyl alcohol, then followed by oxidation with PDC to give 24-NO2. The synthetic 
procedure was similar to described in the synthesis of 21-NO2 (see 
paragraph 5.2.3.16). 
5-Methoxy-2-nitroterephthalic acid 
2,5-Dimethyl-4-nitroanisole (2.00 g, 11.05 mmol) gave 1.04 g 5-methoxy-
2-nitroterephthalic acid (40 %). 
5-Methoxy-2-nitroterephthalic acid 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 8.31 (s, 1H, H-(C-3) or H-(C-6)), 7.14 (s, 1H, H-(C-3) or H-(C-6)), 3.98 (s, 
3H, H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 57.2 (C-9), 112.6 (C-3 or C-6), 117.4 (C-1 or C-4), 127.1 (C-3 or C-6), 
134.1 (C-1 or C-4), 138.4 (C-2), 161.6 (C-5), 164.8 (C-7 or C-8), 166.1 (C-7 or C-8). 
MS-EI (70 eV) 
m/z: 241 ([M]+·, C9H7NO7, 44 %), 227 (22 %), 212 ([M – CHO]+, C8H6NO6, 100 %), 
209 (69 %), 194 ([M – CHO – H2O]+, C8H4O4, 26 %), 179 (14 %), 150 (11 %), 135 
(8 %), 107 (14 %), 79 (10 %), 63 (14 %). 
IR  
ν /cm-1 (T %): 2852 (71 %), 2638 (74 %), 1695 (32 %), 1620 (56 %), 1567 (52 %), 
1531(55 %), 1489 (50 %), 1474 (59 %), 1413 (50 %), 1336 (31 %), 1297 (50 %), 
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1239 (24 %), 1153 (52 %), 1115 (47 %), 1034 (37 %), 977 (62 %), 926 (56 %), 877 
(39 %), 855 (41 %), 789 (47 %), 776 (48 %), 758 (38 %), 741 (39 %), 672 (45 %).  
5-Methoxy-2-nitroterephthalaldehyde 
5-Methoxy-2-nitroterephthalic acid (1.00 g, 4.15 mmol) was treated with 1 N BH3·THF 
(20 mL) to give 1.30 g crude 5-methoxy-1,4-dihydroxymethyl-2-nitrobenzene which 
was submitted to oxidation by PDC. 0.38 g 24-NO2 was obtained (44 % based on 
5-methoxy-2-nitroterephthalic acid). 
5-Methoxy-2-nitroterephthalaldehyde 
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m.p. 149 - 150 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.34 (s, 1H, H-(C-7) or H-(C-8)), 10.32 (s, 1H, H-(C-7) or H-(C-8)), 8.36 (s, 
1H, H-(C-3) or H-(C-6)), 7.52 (s, 1H, H-(C-3) or H-(C-6)), 4.11 (s, 3H, H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 57.5 (C-9), 113.3 (C-3 or C-6), 124.9 (C-3 or C-6), 125.7 (C-1 or C-4), 
138.0 (C-1 or C-4), 141.5 (C-2), 164.4 (C-5), 187.6 (C-7 or C-8), 189.7 (C-7 or C-8). 
HRMS (EI)  
m/z measured: 209.03132 ([M]+·, C9H7NO5).  
m/z calculated: 209.032396. 
MS-EI (70 eV) 
m/z: 209 ([M]+·, C9H7NO5, 56 %), 195 ([M – CH3]+, C8H4NO5, 14 %), 179 ([M – NO]+, 
C9H7O4, 100%), 151 ([M – NO – CO]+, C8H7O3, 70 %), 135 (56 %), 119 (60 %), 105 
(40 %), 91 (28 %), 77 ([C6H5]+, 45 %), 57 (36 %), 43 (29 %). 
IR  
ν /cm-1 (T %): 3387 (86 %), 3102 (82 %), 3038 (79 %), 3002 (83 %), 2956 (80 %), 
2899 (81 %), 2650 (85 %), 1882 (90 %), 1735 (84 %), 1704 (56 %), 1681 (48 %), 
1608 (56 %), 1567 (51 %), 1513 (52 %), 1466 (47 %), 1457 (54 %), 1389 (44 %), 
1330 (42 %), 1268 (42 %), 1244 (35 %), 1188 (60 %), 1141 (44 %), 1056 (45 %), 
1015 (63 %), 987 (47 %), 941 (47 %), 894 (44 %), 872 (39 %), 817 (51 %), 773 
(62 %), 741 (35 %), 690 (61 %).  
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5.2.4 The precursors with protected glycine derivative 
5.2.4.1 Methyl N-(diphenylmethylene)-2-fluoro-3-formyl-
5-methoxyphenylalaninate (27-F) 
3-(1,3-Dioxolan-2-yl)-2-fluoro-5-methoxybenzyl alcohol 
To a solution of 2-(2-fluoro-5-methoxyphenyl)-1,3-dioxolane (2.00 g, 8.85 mmol) in 
MeOH (50 mL) in an ice bath, NaBH4 (0.70 g, 18.92 mmol) was added and the 
resulting mixture was stirred at room temperature for 3 h. The progress of the 
reaction was monitored by TLC. After completion of the reaction, AcOH (4 mL, 
concentrated) was added to adjust pH to 6. Then the reaction solution was poured 
into water (200 mL) and extracted with DCM (2 × 100 mL). The combined organic 
layer was washed with satured NaHCO3 solution (100 mL) and brine (100 mL), dried 
over Na2SO4. After evaporation of the solvent, the residue was purified by using 
MPLC (petroleum ether / ethyl acetate, 1:1) and 1.52 g product was obtained as 
colourless oil (76 %). 
3-(1,3-Dioxolan-2-yl)-2-fluoro-5-methoxybenzyl alcohol 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 7.01 (s, 1H, H-(C-4) or H-(C-6)), 6.87 (s, 1H, H-(C-4) or H-(C-6)), 5.93 (s, 
1H, H-(C-2’)), 4.52 (d, 4JH,F = 5.3 Hz, 2H, H-(C-7)), 4.00 (m, 4H, H-(C-4’) and 
H-(C-5’)), 3.73 (s, 3H, H-(C-8)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 55.5 (C-8), 56.7 (d, 3JC,F = 4.4 Hz, C-7), 64.8 (C-4’ and C-5’), 98.0 (d, 3JC,F 
= 3.7 Hz, C-2’), 110.5 (d, 3JC,F = 3.7 Hz, C-4 or C-6), 114.5 (d, 3JC,F = 4.4 Hz, C-4 or 
C-6), 125.5 (d, 2JC,F = 13.9 Hz, C-1 or C-3), 130.6 (d, 2JC,F = 16.1 Hz, C-1 or C-3), 
151.8 (d, 1JC,F = 240.8 Hz, C-2), 154.9 (d, 4JC,F = 1.5 Hz, C-5). 
MS-EI (70 eV) 
m/z: 228 ([M]+·, C11H13FO4, 85 %), 227 ([M – H]+, C11H12FO4, 74 %), 206 (8 %), 197 
([M – H – CH2O]+, C10H10FO3, 40 %), 183 ([M – H – CH2CH2O]+, C9H8FO3, 55 %), 
163 (19 %), 156 (64 %), 135 (13 %), 127 (30 %), 112 (13 %), 109 (12 %), 73 (81 %), 
71 (100 %), 59 (7 %), 45 (17 %), 43 (32 %). 
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IR  
ν /cm-1 (T %): 3421 (89 %), 2950 (89 %), 2891 (85 %), 1707 (95 %), 1606 (86 %), 
1472 (55 %), 1442 (72 %), 1396 (61 %), 1325 (67 %), 1246 (81 %), 1194 (46 %), 
1154 (61 %), 1100 (29 %), 1045 (47 %), 1026 (51 %), 997 (52 %), 946 (46 %), 859 
(53 %), 800 (76 %), 754 (70 %), 728 (71 %), 683 (64 %).  
3-(Bromomethyl)-2-fluoro-5-methoxybenzaldehyde 
Following the method in the synthesis of 23-F and 24-F (see paragraph 5.2.3.21), 
3-(1,3-dioxolan-2-yl)-2-fluoro-5-methoxybenzyl alcohol (1.52 g, 6.67 mmol) was 
hydrolyzed under acidic condition to afford 1.15 g 2-fluoro-3-(hydroxymethyl)-5-
methoxybenzaldehyde which was used directly in the further synthesis. 
To a solution of 2-fluoro-3-(hydroxymethyl)-5-methoxybenzaldehyde (1.15 g) in 
15 mL of dioxane BMDAB (1.82 g, 8.52 mmol) was added. This procedure was 
carried out under argon. This mixture was kept strong stirring at 70 °C. After 
completion of the reaction as checked by TLC, the reaction solution was poured into 
DCM (100 mL). The organic layer was washed with water (50 mL), satured NaHCO3 
solution (50 mL), brine (50 mL) and dried over Na2SO4. After evaporation of solvent, 
the residue was crystallized in diisopropyl ether to give 1.25 g 3-(bromomethyl)-2-
fluoro-5-methoxybenzaldehyde (76 % based on 3-(1,3-dioxolan-2-yl)-2-fluoro-5-
methoxybenzyl alcohol). 
3-(Bromomethyl)-2-fluoro-5-methoxybenzaldehyde 
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m.p. 77 - 78 °C. 
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.19 (s, 1H, H-(C-7)), 7.49 (dd, 4JH,H = 3.6 Hz, 4JH,F = 6.1 Hz, 1H, H-(C-4) 
or H-(C-6)), 7.26 (dd, 4JH,H = 3.8 Hz, 4JH,F = 5.3 Hz, 1H, H-(C-4) or H-(C-6)), 4.71 (s, 
2H, H-(C-8)), 3.80 (s, 3H, H-(C-9)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 25.8 (d, 3JC,F = 4.4 Hz, C-8), 55.9 (C-9), 112.2 (d, 3JC,F = 3.7 Hz, C-4 or 
C-6), 123.5 (d, 3JC,F = 3.7 Hz, C-4 or C-6), 124.5 (d, 2JC,F = 9.5 Hz, C-1 or C-3), 127.9 
(d, 2JC,F = 16.1 Hz, C-1 or C-3), 155.3 (d, 4JC,F = 2.9 Hz, C-5), 156.1 (d, 1JC,F = 
254.7 Hz, C-2), 187.3 (d, 3JC,F = 5.9 Hz, C-7).  
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MS-EI (70 eV) 
m/z: 248 ([M]+·, C9H881BrFO2, 14 %), 246 ([M]+·, C9H879BrFO2, 14 %), 167 ([M – 
79/81Br]+, C9H8FO2, 100 %), 137 (6 %), 123 (6 %), 109 (13 %), 96 (6 %), 57 (2 %), 40 
(2 %). 
IR  
ν /cm-1 (T %): 3376 (89 %), 3068 (84 %), 3027 (85 %), 2979 (85 %), 2941 (82 %), 
2867 (78 %), 2844 (83 %), 2767 (84 %), 2630 (89 %), 2280 (89 %), 2078 (90 %), 
1987 (91 %), 1776 (88 %), 1693 (40 %), 1613 (77 %), 1598 (59 %), 1476 (41 %), 
1430 (59 %), 1394 (45 %), 1325 (49 %), 1300 (48 %), 1244 (56 %), 1219 (49 %), 
1201 (32 %), 1153 (47 %), 1121 (52 %), 1039 (38 %), 983 (54 %), 949 (46 %), 898 
(77 %), 880 (26 %), 798 (68 %), 729 (50 %), 672 (39 %).  
Methyl N-(diphenylmethylene)-2-fluoro-3-formyl-5-methoxyphenylalaninate 
A solution of lithiumdiisopropylamine (0.85 mL, 1.53 mmol, 1.8 M in THF) in THF 
(5 mL, absoluted) was chilled to -78 °C in a CO2/acetone bath. To this solution 
N-(diphenylmethylen)glycine-methylester (0.39 g, 1.52 mmol) dissolved in THF (5 mL, 
absoluted) was added dropwise. Then DMPU (0.18 mL, 1.52 mmol) was added. After 
15 min stirring, the solution of 3-(bromomethyl)-2-fluoro-5-methoxybenzaldehyde 
(0.38 g, 1.53 mmol) in THF (5 mL) was introduced. The reaction mixture was stirred 
at -80 °C for 1 h and was warmed up to -30 °C by storing in refrigerator. 100 mL 
water was added to quench the reaction and the mixture was extracted with diethyl 
ether (2 × 100 mL). The combined organic layer was washed with brine (2 × 50 mL) 
and dried over Na2SO4. After evaporation of solvent, the residue was purified by 
using MPLC (petroleum ether / ethyl acetate, 5:1), 0.28 g 27-F as white powder was 
obtained (44 %).  
Methyl N-(diphenylmethylene)-2-fluoro-3-formyl-5-methoxyphenylalaninate 
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1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 10.06 (s, 1H, H-(C-11)), 7.39 (m, 8H, Harom), 7.11 (m, 1H, Harom), 7.07 (m, 
1H, Harom), 6.62 (m, 2H, Harom), 4.29 (m, 1H, H-(C-8)), 3.67 (s, 6H, H-(C-10) and 
H-(C-12)), 3.25 (m, 1H, H-(C-7)), 3.17 (m, 1H, H-(C-7)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 30.6 (C-7), 31.8 (C-7), 52.2 (C-10), 55.7 (C-12), 64.5 (C-8), 110.2 (d, 3JC,F 
= 2.2 Hz, C-4 or C-6), 123.8 (d, 2JC,F = 10.3 Hz, C-1 or C-3), 124.5 (d, 2JC,F = 7.3 Hz, 
C-1 or C-3), 127.1 (Carom), 127.2 (Carom), 127.2 (d, 3JC,F = 2.2 Hz, C-4 or C-6), 127.3 
(Carom), 128.2 (Carom), 128.3 (Carom), 128.4 (Carom), 128.8 (Carom), 130.7 (Carom), 134.9 
(Carom), 138.6 (Carom), 155.0 (d, 4JC,F = 1.5 Hz, C-5), 156.8 (d, 1JC,F = 250.0 Hz, C-2), 
170.3 (C-13), 171.0 (C-9), 187.6 (d, 3JC,F = 5.9 Hz, C-11).  
MS-EI (70 eV) 
m/z: 420 ([M + H]+·, C25H23FNO4, 3 %), 419 ([M]+·, C25H22FNO4, 2 %), 360 ([M – 
COOMe]+, C23H22FNO2, 22 %), 252 (C16H14NO2, 100 %), 192 (C14H10N, 58 %), 165 
(25 %). 
HRMS (EI)  
m/z measured: 419.15215 ([M]+·, C25H22FNO4).  
m/z calculated: 419.153261. 
IR  
ν /cm-1 (T %): 3058 (95 %), 3002 (95 %), 2951 (92 %), 1738 (58 %), 1712 (77 %), 
1691 (51 %), 1617 (77 %), 1598 (72 %), 1576 (85 %), 1474 (55 %), 1444 (67 %), 
1398 (71 %), 1316 (71 %), 1278 (64 %), 1244 (61 %), 1202 (50 %), 1175 (61 %), 
1149 (60 %), 1058 (65 %), 1029 (72 %), 999 (76 %), 982 (74 %), 954 (72 %), 861 
(75 %), 801 (74 %), 781 (66 %), 766 (68 %), 695 (33 %).  
5.2.4.2 2-(2-Fluoro-5-methoxybenzyl)-5-isopropyl-3,6-dimethoxy-2,5-
dihydropyrazine (28-F) 
3-(Bromomethyl)-4-fluoroanisole 
Following the method in the synthesis of compound 3-Cl (see paragraph 5.2.1.3), 
4.50 g 3-(Bromomethyl)-4-fluoroanisole was obtained as colourless oil (55 %) by 
bromination of 4-fluoro-3-methylanisole (5.26 g, 37.57 mmol) with NBS in CCl4. 
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3-(Bromomethyl)-4-fluoroanisole 
5
4
6
3
1
2
F
O
CH3
7
8
Br  
1H NMR (DMSO-d6, 400 MHz)  
δ (ppm) = 7.17 (m, 2H, Harom), 6.94 (m, 1H, Harom), 4.64 (s, 2H, H-(C-8)), 3.73 (s, 3H, 
H-(C-7)). 
13C NMR (DMSO-d6, 100 MHz)  
δ (ppm) = 27.0, 27.1, 55.6, 115.7, 115.8, 115.9, 116.0, 116.2, 116.4, 125.6, 125.8, 
153.3, 155.3, 155.4, 155.7.  
MS-EI (70 eV) 
m/z: 220 ([M]+·, C8H881BrFO, 39 %), 218 ([M]+·, C8H879BrFO, 39 %), 139 ([M – 81/79Br]+, 
C8H8FO, 100 %), 109 (32 %), 96 (18 %), 83 (6 %), 57 (3 %). 
IR  
ν /cm-1 (T %): 3004 (95 %), 2958 (93 %), 2836 (93 %), 1737 (98 %), 1613 (93 %), 
1596 (90 %), 1497 (22 %), 1463 (69 %), 1422 (66 %), 1321 (77 %), 1283 (59 %), 
1256 (86 %), 1221 (35 %), 1208 (23 %), 1155 (55 %), 1100 (82 %), 1033 (38 %), 931 
(78 %), 878 (75 %), 853 (75 %), 808 (46 %), 766 (70 %), 725 (61 %), 710 (37 %).  
2-(2-Fluoro-5-methoxybenzyl)-5-isopropyl-3,6-dimethoxy-2,5-dihydropyrazine 
A solution of (2R)-(-)-2,5-dihydro-3,6-dimethoxy-2-isopropylpyrazine (3.53 g, 
19.22 mmol) in THF (40 mL) was chilled to -78 °C in a CO2/acetone bath. n-BuLi 
(12.00 mL, 19.20 mmol, 1.6 M in hexane) was added into this cold solution and it was 
kept stirring 15 min at -78 °C. Then the solution of 3-(bromomethyl)-4-fluoroanisole 
(3.85 g, 17.50 mmol) in THF (15 mL) was added dropwise. Afterward, the reaction 
was stirred at -78 °C for 2 h. Then the reaction solution was warmed up to room 
temperature within 1 h and extracted with diethyl ether (2 × 100 mL). The combined 
organic layer was washed with water (50 mL), satured NaHCO3 solution (50 mL), 
brine (50 mL) and dried over Na2SO4. After evaporation of the solvent, the residue 
was purified by using MPLC (petroleum ether / ethyl acetate, 6:1) to yield 5.20 g 28-F 
(91 %) as slightly yellow oil. 
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2-(2-Fluoro-5-methoxybenzyl)-5-isopropyl-3,6-dimethoxy-2,5-dihydropyrazine 
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1H NMR (CDCl3, 400 MHz)  
δ (ppm) = 6.87 (m, 1H, Harom), 6.67 (m, 2H, Harom), 4.30 (m, 1H, H-(C-2)), 3.72 (s, 3H, 
H-(C-12) or H-(C-8)), 3.71 (s, 3H, H-(C-12) or H-(C-8)), 3.65 (s, 3H, H-(C-7’)), 3.48 
(m, 1H, H-(C-5)), 3.20 (m, 1H, H-(C-7)), 2.99 (m, 1H, H-(C-7)), 2.17 (s, 1H, H-(C-9)), 
0.97 (d, 3JH,H = 6.8 Hz, 3H, H-(C-10) or H-(C-11)), 0.62 (d, 3JH,H = 6.8 Hz, 3H, 
H-(C-10) or H-(C-11)). 
13C NMR (CDCl3, 100 MHz)  
δ (ppm) = 16.3 (C-10 or C-11), 19.0 (C-10 or C-11), 31.2 (C-7), 33.5 (C-9), 52.1 (C-8 
or C-12), 52.2 (C-8 or C-12), 55.6 (C-7’), 56.0 (C-2), 60.3 (C-5), 113.2 (d, 3JC,F = 
8.1 Hz, C-4’ or C-6’), 115.3 (d, 2JC,F = 24.9 Hz, C-3’), 116.7 (d, 3JC,F = 5.1 Hz, C-4’ or 
C-6’), 125.3 (d, 2JC,F = 17.6 Hz, C-1’), 154.9 (d, 4JC,F = 2.2 Hz, C-5’), 156.1 (d, 1JC,F = 
237.9 Hz, C-2’), 162.5 (C-3 or C-6), 164.0 (C-3 or C-6).  
MS-EI (70 eV) 
m/z: 322 ([M]+·, C17H23FN2O3, 10 %), 279 ([M – C3H7]+, C14H16FN2O3, 10 %), 183 
(C9H15N2O2, 57 %), 141 (C8H10FO, 100 %), 109 (6 %), 96 (3 %), 55 (2 %), 43 (4 %). 
HRMS (EI)  
m/z measured: 322.16812 ([M]+·, C17H23FN2O3).  
m/z calculated: 322.169246. 
IR  
ν /cm-1 (T %): 2945 (83 %), 2871 (92 %), 2842 (95 %), 1693 (42 %), 1593 (95 %), 
1499 (52 %), 1463 (76 %), 1435 (70 %), 1382 (88 %), 1365 (86 %), 1336 (89 %), 
1307 (77 %), 1277 (81 %), 1236 (35 %), 1195 (48 %), 1150 (73 %), 1141 (74 %), 
1113 (71 %), 1063 (84 %), 1040 (63 %), 1011 (54 %), 917 (89 %), 876 (91 %), 852 
(85 %), 804 (75 %), 784 (78 %), 747 (74 %), 722 (67 %), 712 (72 %), 686 (90 %), 
660 (88 %).  
178 EXPERIMENTAL 
 
5.3 Radiosyntheses 
5.3.1 Production of [18F]fluoride ion 
No-carrier-added (n.c.a.) [18F]fluoride ion was produced at the PET trace cyclotron 
(General Electric Healthcare, Uppsala, Sweden) via the 18O(p,n)18F nuclear reaction 
by irradiating 1.5 mL of > 95 % enriched [18O]water (Rotem, Israel) with 16.5 MeV 
protons. 
5.3.2 18F-labeling reaction  
n.c.a. 18F-fluorination: 
A 5 mL glass vial (Supelco, graduated screw top V-Vials®, autoclavable borosilicate 
USP Type 1 glass) equipped with triangle stirring bar and a silicone septum sealed 
lid, into which two needles were stuck, connecting the outlet and the argon gas line, 
was evacuated and flushed with argon three time. From the aqueous n.c.a. 
[18F]fluoride solution, 50 to 100 MBq was introduced into this sealed vial containing 
100 µL of 3.5 % aqueous K2CO3 and 15.0 mg Kryptofix 222. The [18F]fluoride solution 
was dried for 20 min under a mild stream of argon (ca. 2 mL/min) at 140 °C by 
azeotropic distillation with acetonitrile (2 × 1 mL). Then, this reaction vial containing 
the [K2.2.2-K]+18F- complex was adjusted to the reaction temperature and 10 mg of 
precursor dissolved in 1.0 mL of solvent were added into. For Radio-TLC analysis, 
the reaction samples were withdrawn at 1, 3, 7, 10, 20 and 30 min. For Radio-HPLC 
analysis, the reaction sample was taken at the reaction time when the maximum 
RCY was observed by Radio-TLC. 
For a number of experiments (n = 20), the amount of radioactivity that remained 
adsorbed in the reaction vial after removing the reaction solution and washing with 
water (3 × 3 mL) was determined as 12 ± 8 % (based on the total radioactivity in the 
vial after labeling). 
c.a.18F fluorination: 
The [18F]fluoride solution was introduced into a 5.0 mL sealed vial containing 50 µL of 
1 % aqueous K19F, 100 µL of 3.5 % aqueous K2CO3 and 15.0 mg Kryptofix 222, the 
following step was the same as n.c.a. 18F-fluorination. 
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5.3.3 Decarbonylation of 18F-labeled product with (Ph3P)3RhCl 
After 18F-radiolabeling reaction, the reaction solution was cooled down in an ice bath 
for 2 min and diluted with water (10 mL) and 0.1 N HCl (5 mL). Then this reaction 
mixture was passed through a combination of cartridges (Sep-Pak© Light Alumina N 
and Sep-Pak© Plus C18 in series) and the 18F-labeled product was trapped by the 
Sep-Pak© C18 cartridge. This C18 cartridge was eluted with DCM (4 mL) and the 
elution passed through a Na2SO4 cartridge to a glass vessel. After the solvent was 
evaporated at 70 °C under argon, the radiochemical pure 18F-labeled product was 
obtained. 
To this residue, 1 mL of decarbonylation solvent was added and the solution was 
transferred into a sealed vial (same as 18F-labeling reaction vial) containing 
RhCl(PPh3)3. Then, the mixture was heated in an aluminium block at 100 °C, 120 °C, 
150 °C or 180 °C. Aliquots of the solution were taken out at different times for 
analysis (Radio-TLC and Radio-HPLC, the procedure was the same as that in the 
18F-labeling reaction). Amounts of catalyst used are based on quantity of labeling 
precursor. 
5.3.4 Synthesis of [18F]FDOPA by an automatic module  
The automated synthesis was carried out in the synthetic module which was built in 
our laboratory (Figure 3-38). The remote operation was controlled by PC and the 
operation program was developed from GE Medical Systems. All of the chemicals 
and solvents were loaded before the [18F]fluoride solution was delivered into the 
synthetic module. 
The automated synthesis procedure was described by following: The [18F]fluoride 
solution was trapped on a Sep-Pak© Light QMA and eluted with 1 mL of solution 
(containing 900 µL acetonitrile,100 µL of 3.5 % K2CO3 and 15.0 mg Kryptofix 222) 
into the fluorination reactor. This mixture was dried for 10 min under a stream of 
argon (ca. 96 bar in vial) at 140 oC by azeotropic distillation with acetonitrile (1 mL). 
Precursor (5 mg) dissolved in DMF (1 mL) was added to the dry residue of the 
complex [K2.2.2-K]+18F-. Following, the fluorination reaction vial was kept heating at 
140 oC for 10 min. The reaction solution was cooled down to 40 °C and diluted with 
15 mL water, then this solution passed through combination of two cartridges 
(Sep-Pak© Light Alumina N and Sep-Pak© Plus C18). The Sep-Pak© Plus C18 
cartridge trapping the 18F-labeled product was washed with DCM (4 mL) and this 
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eluent was passed though a Na2SO4 cartridge into the reductive iodination reaction 
vial in which the diiodosilane was prepared in situ (250 µL phenylsilane, 250 mg I2 
and 15 µL ethylacetate mixed at room temperature.). The reductive iodination 
reaction was carried out at room temperature for 10 min. Then this iodinated product 
was trapped on Sep-Pak© Plus Silica and eluted with DCM (7 mL) into the next reaci-
vial in which 250 mg CsOH, 40 mg PTC and 45 mg N-(diphenylmethylene)glycine 
tert-butyl ester were loaded. After 10 min alkylation at room temperature, this 
reaction solution was transferred back into the fluorination reaction vial and DCM was 
evaporated. Into the residue 48 % HBr (500 µL) containing KI (10 mg) was added 
and the hydrolysis was performed at 150 °C for 10 min. The reaction mixture was 
cooled down to 40 °C and NaOH (500 µL, 6 N) was added. The mixed solution was 
loaded into a HPLC injection loop after on-line filtration through a micro glass fiber 
filter (WHATMAN). Preparative purification was performed with a precolumn 
(Phenomenex, Luna, C18 (2), 5µ, 50 mm × 10 mm) and a reverse phase column 
(Phenomenex, Luna, C18 (2), 5µ, 250 mm × 10 mm) with 0.1 % AcOH and 200 mg/L 
ascorbic acid in water as an eluent at a flow rate of 5.0 mL/min. The fraction 
corresponding to [18F]FDOPA (retention time 9-11 min) was collected and sterile 
filtered (Millex GV, Millipore, USA). 
All of the reaction parameters used above were already optimized results. In the 
optimization of every single synthetic step, the other reaction parameters were tested 
(see paragraph 3.5). 
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5.4 Analytic methods 
For examining the identification and purity of the 18F-labeled product both Radio-TLC 
and Radio-HPLC were used. [18F]Fluorobenzene was a volatile product and not 
suitable for Radio-TLC, thus this compound was only analysed by Radio-HPLC. In 
most cases, 18F-labeled compounds were identified by their non-radioactive 
reference compounds via comparison of the UV-signals with the radioactive signals. 
In few cases non-radioactive reference compounds were not available, the 
developed methods (LC/MS analysis for c.a. 18F-fluorination or comparison of the 
18F-labeled products from the precursor with the same substitution pattern but 
different LGs, see paragraph 3.2.1.6) were applied. 
5.4.1 Analyses in 18F-labeling reaction and decarbonylation  
5.4.1.1 Radio thin layer chromatography 
An aliquot of the reaction solution (1-5 µL) was given on a silica gel plate (Polygram 
Silica G/UV254, 8 × 4 cm, Macherey&Nagel, Germany) and this plate was developed 
in the appropriate solvent mixture. The radioactive spots were quantitatively 
assessed by means of electronic autoradiography (Instant Imager, Canberra Packard, 
USA). The Rf values are listed in Table 5-1 (18F-fluorination) and in Table 5-2 
(decarbonylation) along with solvent system (given as v/v ratios). The size of the TLC 
plate and the location of the reference standard were marked by radioactive spots on 
the plate, thus a correlation between radioactive labeled product and non-radioactive 
standards was assured. 
5.4.1.2 Radio high performance liquid chromatography 
Radio-HPLC was performed on the same system as described in paragraph 5.1 for 
non-radioactive HPLC. For the measurement of radioactivity, the outlet of the UV/Vis 
detector was connected to a NaI(Tl)-scintillation detector. The aliquots of 18F-labeling 
reaction solution (10 µL) were analyzed by reverse phase Radio-HPLC using an 
appropriate column and acetonitrile / water in various concentration ratios containing 
0.1 % KF as mobile phase. KF was added to the eluent as carrier in order to assure 
radioactive [18F]fluoride ions to be eluted as a sharp peak (k’ = 1.0). The flow rate 
was varied from 1 to 2 mL/min. All measurements were performed at room 
temperature. Individual k’-values of the reference compounds and retention times of 
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18F-labeled products are given in Table 5-1 (18F-fluorination) and in Table 5-2 
(decarbonylation). 
The data of compounds 1-F, 1-Cl, 2-F, 2-Cl and 2-Br are presented in a previous 
report,67 and the data of compounds with substitution pattern 5, 9 and 10 are shown 
in a parallel work.73 
For more precise control of RCY, during Radio-HPLC analysis the 18F-labeled 
product fraction was collected and measured by means of a gamma-counter 
(1480 Wallac WIZARD 3'', PerkinElmer, USA). The radiochemical yield was 
calculated by relating the radioactivity of the product peak with the amount of 
radioactivity injected into the column. 
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Table 5-1. Rf and Rt for the reference compounds and 18F-labeled products in 18F-fluorination 
Rf (Radio-TLC) * Rt (Radio-HPLC) 
Precursors [19F]fluoro 
standard 
18F-labeled 
product 
[19F]fluoro 
standard(min) 
18F-labeled 
product (min) k’ 
1-NO2 0.69 0.69 7.49 8.02 a 2.94 
1-Br 0.69 0.69 7.49 8.01 a 2.94 
1-N+Me3TfO- 0.69 0.69 7.49 8.05 b 2.94 
2-NO2 0.63 0.63 7.21 7.73 b 2.79 
3-NO2 0.68 0.68 8.82 9.36 b 3.64 
3-F 0.68 0.68 8.74 9.29 b 3.6 
3-Cl 0.68 0.68 8.72 9.29 b 3.58 
3-Br 0.68 0.68 8.82 9.37 b 3.64 
3-I 0.68 0.68 8.77 9.33 b 3.61 
3-N+Me3TfO- 0.68 0.68 5.68 5.94 c 2.93 
4-NO2 0.61 0.61 7.94 8.47 b 3.17 
6-NO2 0.71 0.71 10.55 10.98 b 4.55 
6-F 0.71 0.71 10.61 11.04 b 4.58 
6-Cl 0.71 0.71 10.54 10.94 b 4.54 
6-Br 0.71 0.71 10.58 11.00 b 4.56 
7-NO2 0.67 0.67 8.51 8.91 b 3.47 
7-F 0.67 0.67 8.51 -- -- 
7-N+Me3TfO- 0.67 0.67 8.58 9.03 b 3.51 
8-NO2 0.65 0.65 11.76 12.23 b 5.18 
8-F 0.65 0.65 11.85 12.33 b 5.23 
8-Cl 0.65 0.65 11.77 12.27 b 5.19 
8-Br 0.65 0.65 5.76 6.00 d 2.84 
12-C2H5 -- 0.72 -- 12.63 b -- 
12-C3H7 -- 0.72 -- 17.03 b -- 
12-C4H9 -- 0.72 -- 20.55 b -- 
12-CF3 -- 0.67 -- 16.49 b -- 
12-Bn -- 0.63 -- 27.72 b -- 
13-NO2 0.44 0.44 6.44 7.00 b 2.38 
14-NO2 0.59 0.59 7.75 8.28 b 3.07 
15-NO2 0.40 0.40 10.45 10.74 e 5.96 
15-Br 0.40 0.40 10.45 10.78 e 5.96 
16-NO2 0.26 0.26 -- 9.71 e -- 
17-NO2 0.61 0.61 -- 17.86 e -- 
17-Br 0.61 0.61 -- 17.87 e -- 
18-NO2 -- 0.30 -- 9.48 e -- 
19-NO2 0.52 0.52 7.49 8.05 b 2.94 
19-Br 0.52 0.52 7.49 8.05 b 2.94 
20-NO2 0.54 0.54 -- 10.15 b -- 
20-Br 0.54 0.54 -- 10.16 b -- 
21-NO2 0.51 0.51 7.56 7.98 f 2.97 
22-NO2 0.49 0.49 8.93 9.18 g 4.91 
23-NO2 0.70 0.70 7.70 8.11 h 4.13 
24-NO2 0.48 0.48 8.78 9.19 h 4.85 
27-F 0.45 0.45 5.56 5.81 d 2.70 
3-nitrobenzaldehyde 0.58 0.58 15.40 15.83 i 9.19 
nitrobenzene -- -- 10.11 10.52 j 5.74 
4-nitroanisole 0.79 0.79 10.16 i -- 5.77 
*: Petroleum ether / ethyl acetate (3:1, v/v). Except the case of 23-NO2: Petroleum ether / ethyl acetate 
(1:1, v/v). 
a Column: C18, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / water 
(50:50) containing 0.1 % acetic acid and 0.1 % KF. Flow rate: 1 mL/min. UV: at 254 nm. 
b Column: C18, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / water 
(50:50) containing 0.1 % KF. Flow rate: 1 mL/min. UV: at 254 nm. 
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c Column: phenylhexyl, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / 
water (40:60) containing 0.1 % KF. Flow rate: 2 mL/min. UV: at 254 nm. 
d Column: C18, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / water 
(50:50) containing 0.1 % KF. Flow rate: 2 mL/min. UV: at 254 nm. 
e Column: C18, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / water 
(30:70) containing 0.1 % KF. Flow rate: 2 mL/min. UV: at 254 nm. 
f Column: C18, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / water (40:60) 
containing 10 mM Na2HPO4 and 0.1 % KF Flow rate: 1 mL/min. UV: at 254 nm. 
g Column: phenylhexyl, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / 
water (20:80) containing 10 mM Na2HPO4 and 0.1 % KF. Flow rate: 2 mL/min. UV: at 254 nm. 
h Column: C18, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / water 
(30:70) containing 10 mM Na2HPO4 and 0.1 % KF. Flow rate: 2 mL/min. UV: at 254 nm. 
i Column: phenylhexyl, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / 
water (20:80) containing 0.1 % KF. Flow rate: 2 mL/min. UV: at 254 nm. 
j Column: C18, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / water (40:60) 
containing 0.1 % KF. Flow rate: 2 mL/min. UV: at 254 nm. 
Table 5-2. Rf and Rt for the reference compounds and 18F-labeled products in decarbonylation 
Rf (Radio-TLC)* Rt (Radio-HPLC) 
Precursors [19F]fluoro 
standard 
18F-labeled 
product 
[19F]fluoro 
standard(min) 
18F-labeled 
product (min) k’ 
4-[18F]fluoro-3-
methylanisole 0.70 0.70 8.12 8.40
 a 4.41 
3-[18F]fluoro-4-
methylanisole 0.77 0.77 8.97 9.20
 a 4.98 
5-dimethoxy-2-
[18F]fluorotoluene 0.57 0.57 7.04 7.28
 a 3.69 
4-[18F]fluoro-
anisole 0.79 0.79 12.17 12.61
 b 5.41 
*: Petroleum ether / ethyl acetate (3:1, v/v) 
a Column: C18, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / water 
(50:50). Flow rate: 2 mL/min. UV: at 254 nm. 
b Column: C18, 5 µm, 250 mm × 4.6 mm (Luna, Phenomenex, USA). Eluent: acetonitrile / water 
(50:50). Flow rate: 1 mL/min. UV: at 254 nm. 
In Table 5-1 and Table 5-2, The time delay between UV/Vis detector and Radioactive detector: 
0.2-0.3 min at 1 mL/min, 0.4-0.6 min at 2 mL/min. 
In addition, in the analyses of the oxidation by-products by using DMSO as solvent in 
labeling reaction (see paragraph 3.2.1.4), the integral of UV-signals obtained by the 
UV/Vis detector was proportional to the benzoic acids or benzaldehydes. The 
measured peak-areas were fitted by linear regression as functions of the amount of 
reference compounds and led to straight lines, which were used for calibration 
(Figure 5-1). 
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Figure 5-1. Integral of the UV-peak as a function of the quantity of 
benzoic acids or benzaldehydes 
Column: Luna C18, 5 µm, 250 mm × 4.6 mm, (Luna, Phenomenex, USA). Flow rate: 1 mL/min. Eluent: 
acetonitrile / water (50:50) containing 0.1 % acetic acid. UV: at 280 nm. 
1-NO2: Rt (6.86 min), k’ (2.61). 2-Nitrobenzoic acid: Rt (4.24 min), k’ (1.23).  
2-NO2: Rt (6.65 min), k’ (2.50). 4-Nitrobenzoic acid: Rt (4.85 min), k’ (1.55).  
1-Br: Rt (11.44 min), k’ (5.02). 2-Bromobenzoic acid: Rt (5.13 min), k’ (1.70). 
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5.4.1.3 LC/MS 
For identification of product in the c.a. 18F-labeling reaction (see paragraph 3.2.1.6, 
Method 2): 
The reaction sample from the c.a. labeling reaction was separated by Radio-HPLC at 
first. The fraction (50 µL) corresponding to the 18F-labeled product was injected into 
the LC/MS system. A HP ODS (100 × 2.1 mm, 5 µ) column was used. Eluent was 
methanol / water (40:60) buffered with ammonium acetate (144 mg/L). Compounds 
3-NO2, 5-NO2, 16-NO2, 18-NO2, 19-NO2 and 20-NO2 were identified by this method, 
the mass peaks in LC/MS analysis are listed in Table 5-3. 
Table 5-3. Identification of fluorinated products by LC/MS in c.a. 18F-fluorination 
Precursors 3-NO2 5-NO2 16-NO2 18-NO2 19-NO2 20-NO2 
Mass peak 
(ACPI (+) mode) M+1,M+15 M+1,M+15 M+1,M+15 M+1,M+15 M+1 M+1 
For the detection of by-product in the labeling reaction: 
The reaction sample (10 µL) from the labeling reaction (with or without addition of 
[18F]fluoride ion) was directly injected into the LC/MS system. 
A Phenomenex Luna (100 × 2.0 mm, 5 µ) C18 (2) column was used. Eluent was a 
gradient from 100 % water to 100 % methanol (within 30 min) buffered with 
ammonium acetate (144 mg/L). 
5.4.1.4 GC/MS 
In the 18F-labeling reaction with DMSO as solvent, the dimethylsulfide formed by 
oxidation (see paragraph 3.2.1.4) was analyzed by means of GC/MS 
(Hewlett-Packard 5890 Series II Plus). Samples were taken from the gas phase 
above the reaction solution at 30 min reaction time. Column: Chrompack Poraplot Q 
(27.5 m × 0.32 mm); He-flow: 9.6 mL/min; temperature program: 10 °C/min from 
85 °C to 200 °C. Rt (dimethylsulfide): 8.29 min. 
5.4.2 Analyses in the automated synthesis of [18F]FDOPA  
Radiochemical yields of the intermediate radioactive products were confirmed by 
radio-TLC. An aliquot of the intermediate product solution was applied to silica gel 
plates (Polygram Silica G/UV254, 8 × 4 cm, Macherey&Nagel, Germany) and 
development was carried out with solvent (petroleum ether / ethyl acetate, 2:1), the 
Rf values were 0.59, 0.73, 0.58 for compounds 2-fluoro-4,5-dimethoxybenzaldehyde, 
1-fluoro-2-(iodomethyl)-4,5-dimethoxybenzene, methyl N-(diphenylmethylene)-
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2-fluoro-5-methoxy-O-methyltyrosinate, respectively. All of these reference 
compounds were provided by my colleague Michael Übele.  
Determination of radiochemical purity of [18F]FDOPA were carried out with a reverse 
phase column (Phenomenex, Luna, C18 (2), 5µ, 250 mm × 4.6 mm, eluent: water 
containing 0.1 % AcOH and 200 mg/L ascorbic acid, flow rate: 1 mL/min). The 
enatiomeric excess of [18F]FDOPA was checked by a chiral column (Chirosil, 5µ, 
150 × 4.6 mm, eluent: methanol / Water (85:15) containing 6 mM AcOH, flow rate: 
0.6 mL/min). The retention time was 8.69 min ([18F]FDOPA on the reverse phase 
column) and 7.67 min ([18F]fluoro-L-DOPA on the chiral column). 
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7 APPENDICES 
Table 7-1. 18F-labeling RCY for precursors with substitution pattern 1 
LG
CHO
LG = NO2, 1-NO2; LG = Br, 1-Br; 
LG = Cl, 1-Cl
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
1-NO2 a 5 80.3 1.6 84.1 0.8 84.3 0.4 81.9 4.4 82.0 4.1 82.3 3.6 -- -- -- 
1-NO2 b 3 67.6 1.3 68.5 2.3 72.8 1.6 72.3 1.3 71.6 2.5 74.5 1.4 -- -- -- 
1-NO2 c 3 30.1 3.9 51.3 4.9 56.7 2.2 57.4 2.9 61.0 3.5 62.1 3.6 -- -- -- 
1-NO2 d 3 0.2 0.1 0.7 0.2 1.7 0.4 2.8 0.2 5.5 2.4 7.2 4.7 -- -- -- 
1-NO2 e 3 64.0 4.5 45.2 3.2 34.2 2.6 31.1 3.8 24.9 2.8 19.7 2.5 -- -- -- 
1-Br e 3 1.2 0.9 1.5 0.5 1.0 0.4 1.3 0.9 1.5 1.1 1.3 0.8 -- -- -- 
1-Cl e 3 0.3 0.3 0.6 0.3 0.2 0.1 0.3 0.1 0.3 0.2 0.1 0.1 -- -- -- 
Labeling condition: precursor (10 mg), solvent (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg). 
a: DMF, 140 °C; b: DMF, 100 °C; c: DMF, 60 °C; d: DMF, 25 °C; e: DMSO, 140 °C. 
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Table 7-2. 18F-labeling RCY for precursors with substitution pattern 2 
LG
OHC
LG = NO2, 2-NO2; LG = Br, 2-Br; LG = Cl, 2-Cl; 
LG = F, 2-F; LG = N+Me3TfO
-, 2-N+Me3TfO
-
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
2-NO2 a 4 12.2 1.2 25.5 1.5 35.0 1.0 39.9 3.0 38.2 3.3 34.3 2.0 -- -- -- 
2-Br a 3 0.5 0.6 0.5 0.4 0.8 0.6 0.4 0.3 0.6 0.4 0.5 0.4 -- -- -- 
2-Cl a 3 0.1 0.1 0.3 0.3 0.3 0.3 0.9 0.7 1.2 0.8 1.1 0.8 -- -- -- 
2-F a 4 55.9 4.3 48.9 4.2 41.4 2.5 36.3 5.5 29.4 5.2 12.2 8.2 -- -- -- 
2-N+Me3TfO- b 3 -- -- -- -- -- -- 89.3 0.6 -- -- -- -- 1 87.6 -- 
Labeling condition: precursor (10 mg), solvent (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 140 °C. 
a: DMSO, b: DMF. 
Table 7-3. 18F-labeling RCY for 4-NO2 
NO2MeO
CHO
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
4-NO2 4 86.5 0.6 88.3 1.8 89.0 2.4 86.3 4.2 87.0 3.7 86.6 3.3 1 85.5 -- 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 140 °C. 
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Table 7-4. 18F-labeling RCY for precursors with substitution pattern 3 
LG
CHOMeO
LG = NO2, 3-NO2; LG = Br, 3-Br; LG = Cl, 3-Cl; 
LG = F, 3-F; LG = I, 3-I; LG = N+Me3TfO
-, 3-N+Me3TfO
-
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
3-NO2 a 4 46.2 1.2 53.3 1.2 57.4 1.0 53.1 5.6 54.9 4.6 53.6 4.0 2 57.2 5.0 
3-NO2 b 3 6.2 0.9 14.4 0.8 23.8 0.8 29.8 4.0 31.3 1.9 27.3 1.3 1 27.7 -- 
3-NO2 c 3 0.7 0.5 2.2 1.1 2.9 0.3 3.9 0.7 3.5 0.8 2.5 0.5 -- -- -- 
3-NO2 d 2 31.6 10.0 53.1 7.6 57.6 0.8 56.9 0.3 56.8 1.2 54.1 0.1 1 60.3 -- 
3-NO2 e 2 41.4 0.2 51.3 0.3 56.1 2.2 58.6 0.9 54.9 3.7 49.8 2.3 2 56.8 2.2 
3-NO2 f 2 37.8 1.8 55.4 1.9 59.1 1.0 58.9 0.3 56.8 2.0 56.8 5.0 1 57.7 -- 
3-NO2 g 2 11.1 2.1 18.9 10.5 29.1 11.8 30.9 8.3 35.5 3.1 37.5 1.2 1 34.7 -- 
3-NO2 h 2 8.4 1.2 15.1 3.6 20.7 3.6 22.8 3.0 25.8 7.1 25.4 2.6 1 20.2 -- 
3-Br a 4 17.3 3.2 26.3 4.9 27.0 4.6 27.6 4.3 27.1 3.4 26.1 3.9 2 24.8 1.6 
3-Cl a 4 5.2 2.5 15.8 2.8 24.1 4.4 28.4 3.9 30.6 3.8 28.3 4.3 1 31.4 -- 
3-F a 3 78.4 0.7 82.1 1.5 83.2 2.8 80.9 1.8 75.5 2.4 71.2 2.5 1 76.5 -- 
3-I a 4 3.4 0.9 11.0 2.6 18.4 1.6 17.8 5.1 17.8 3.8 17.8 3.5 1 16.2 -- 
3- N+Me3TfO-
a 4 31.4 0.9 35.3 4.1 23.1 3.7 19.2 2.8 15.8 3.9 13.8 1.8 1 32.1 -- 
Labeling condition: precursor (10 mg), solvent (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg) at 140 °C. 
a: DMF; b: DMF, c.a. reaction; c: DMSO; d: DMF, addition of toluene; e: DMF, addition of nitrobenzene; f: DMF, addition of 4-nitroanisole; g: DMF, addition of 
o-nitrotoluene; h: DMF, addition of 4-nitro-3-methylanisole. 
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Table 7-5. 18F-labeling RCY for precursors with substitution pattern 5 
LG
MeO CHO
MeO
LG = NO2, 5-NO2; LG = Br, 5-Br O
O
CH3
N
H5C6 C6H5
H
H
H
N
N CH3
CH3
OCH3
O CH3
H
protected glycine 1 protected glycine 2
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
5-NO2 5 73.2 1.7 81.5 1.0 85.2 2.2 86.8 1.8 81.7 1.0 79.7 1.6 1 86.1 -- 
5-NO2 a 3 42.6 0.6 70.5 2.6 80.1 2.0 83.4 0.2 80.6 0.7 76.2 2.0 1 80.0 -- 
5-NO2 b 4 17.4 2.4 24.9 4.4 25.4 4.4 29.9 3.2 28.1 3.5 23.1 3.4 -- -- -- 
5-NO2 c 3 75.8 4.9 78.9 4.1 80.7 3.2 81.5 3.1 76.3 3.2 72.1 3.6 -- -- -- 
5-NO2 d 2 68.1 6.5 76.2 3.7 82.2 0.4 82.1 0.5 78.2 1.6 77.4 1.8 1 81.7 -- 
5-NO2 e 2 65.3 14.0 73.6 15.1 83.8 1.6 84.4 1.4 80.8 0.1 77.7 1.9 1 86.5 -- 
5-NO2 f 2 70.9 4.9 79.7 3.7 82.7 0.7 84.6 4.4 80.6 2.9 77.6 2.2 1 87.5 -- 
5-NO2 g 2 35.9 15.0 48.3 7.7 52.3 1.2 54.6 5.3 48.7 7.4 44.9 3.1 1 53.7 -- 
5-NO2 h 2 51.4 7.9 63.5 8.6 68.5 5.1 69.2 2.6 65.8 0.1 63.9 2.1 1 70.9 -- 
5-Br 3 12.4 1.2 26.1 3.2 35.7 1.8 34.4 2.1 33.9 3.7 32.4 1.7 1 36.7 -- 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C. 
a: c.a. reaction; b: addition of protected glycine 1; c: addition of protected glycine 2; d: addition of toluene; e: addition of nitrobenzene; f: addition of 4-nitroanisole; 
g: addition of o-nitrotoluene; h: addition of 4-nitro-3-methylanisole. 
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Table 7-6. 18F-labeling RCY for precursors with substitution pattern 6 
LG
CHO
CH3
LG = NO2, 6-NO2; LG = Br, 6-Br; 
LG = Cl, 6-Cl; LG = F, 6-F
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
6-NO2  6 -- -- -- -- 47.5* 7.1* 48.2 5.3 45.6 4.9 45.0 4.5 2 48.3 2.8 
6-NO2 a 2 -- -- -- -- 21.3* 4.5* 21.7 5.5 21.4 7.6 19.1 5.6 -- -- -- 
6-NO2 b 2 23.6 5.1 32.7 3.4 38.6 4.3 44.9 2.9 31.6 11.2 31.4 8.8 -- -- -- 
6-Br 5 17.7 0.9 34.0 4.6 45.0 6.8 51.6 2.0 51.0 3.0 50.0 4.5 1 55.9 -- 
6-Cl 5 27.6 2.1 43.9 4.6 54.9 8.2 57.8 8.2 61.8 8.8 60.6 8.1 1 64.5 -- 
6-F 4 45.8 7.7 79.2 2.8 78.7 2.2 75.3 2.2 65.7 2.3 60.5 1.4 2 81.0 1.8 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C.  
a: addition of protected glycine 1 (see Table 7-5); b: addition of protected glycine 2 (see Table 7-5); *: RCY at 5 min. 
Table 7-7. 18F-labeling RCY for precursors with substitution pattern 7 
LG
CH3
OHC
LG = NO2, 7-NO2; LG = N
+Me3TfO
-, 7-N+Me3TfO
-
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
7-NO2 4 4.5 0.7 7.5 0.7 7.5 0.7 5.6 2.0 5.4 2.3 4.0 1.6 -- -- -- 
7-N+Me3TfO- 3 58.2 3.6 68.8 1.3 64.2 5.2 62.6 3.6 54.7 6.1 53.1 7.5 2 69.6 1.4 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C. 
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Table 7-8. 18F-labeling RCY for precursors with substitution pattern 8 
LG
CHO
CH3
MeO
LG = NO2, 8-NO2; LG = Br, 8-Br; 
LG = Cl, 8-Cl; LG = F, 8-F
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
8-NO2 a 3 1.0 0.4 1.5 0.4 2.0 0.6 1.6 0.9 2.9 0.8 2.1 0.9 2 3.7 0.2 
8-NO2 b 3 0.1 0.1 0.1 0.1 0.4 0.1 0.5 0.1 0.5 0.2 0.6 0.2 -- -- -- 
8-NO2 c 2 1.4 0.1 1.9 0.2 3.0 0.1 2.6 0.4 0.5 0.2 1.9 0.4 -- -- -- 
8-NO2 d 2 1.0 0.1 1.7 0 1.1 0.4 1.3 0.4 1.7 0.2 1.4 0.4 -- -- -- 
8-NO2 e 3 1.2 0.4 1.4 0.7 1.6 1.0 1.7 1.0 1.9 0.6 1.7 1.2 -- -- -- 
8-NO2 f 2 1.1 0.2 1.6 1.1 1.2 0.7 1.1 0.3 1.6 0.6 1.9 0.6 -- -- -- 
8-NO2 g 3 0.2 0.2 0.4 0.1 1.5 0.1 1.4 0.3 2.3 0.8 1.7 0.8 -- -- -- 
8-NO2 h 2 0.3 0.1 0.7 0.4 0.7 0.3 0.6 0.1 1.4 0.1 0.9 0.2 -- -- -- 
8-NO2 i 2 0.1 0.2 0.4 0.2 0.8 0.1 0.6 0.1 0.6 0.1 0.6 0 -- -- -- 
8-Br a 3 3.6 0.2 8.4 1.1 8.6 0.9 9.7 1.5 9.0 0.2 8.4 0.8 1 12.9 -- 
8-Cl a 3 2.0 0.8 4.3 1.7 9.3 2.9 10.3 4.0 13.3 2.9 14.3 3.3 1 17.7 -- 
8-F a 4 60.9 3.6 69.0 1.0 74.6 2.4 73.2 3.1 66.1 2.6 62.2 2.5 3 78.4 3.6 
Labeling condition: precursor (10 mg), solvent (1 mL), base (25 µmol) and K2.2.2 (15 mg). 
a-e: base = K2CO3 
a: DMF, 140 °C; b: DMF, 120 °C; c: DMF, 160 °C; d: DMSO, 140 °C; e: DMAc, 140 °C; f: DMF, 140 °C, CeCO3; g: DMF, 140 °C, K2C2O4; h: K2C2O4 / K2CO3 = 33:1; 
i: DMF, 140 °C, K2C2O4 / K2CO3 = 1:1. 
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Table 7-9. 18F-labeling RCY for precursors with substitution pattern 12 
NO2
RO CHO
R = C2H5, 12-C2H5; R = C3H7, 12-C3H7; 
R = C4H9, 12-C4H9; R = Bn, 12-Bn; R = CF3, 12-CF3
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
12-C2H5 4 42.3 4.0 56.0 1.9 63.1 3.4 61.0 3.6 57.6 1.9 52.7 2.8 2 60.9 0.9 
12-C3H7 4 48.3 6.5 55.1 4.9 58.9 2.7 60.1 1.9 55.9 1.5 52.1 1.9 1 59.3 -- 
12-C4H9 4 34.4 0.2 56.6 1.6 59.7 2.5 59.6 2.7 56.9 1.2 54.9 2.1 1 61.5 -- 
12-Bn 3 14.0 2.4 33.1 1.3 46.1 0.5 49.5 0.6 48.6 3.0 46.9 2.3 1 48.3 -- 
12-CF3 4 56.1 5.4 59.6 0.8 56.7 2.4 57.6 3.9 52.4 6.2 47.1 7.1 1 61.4 -- 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C. 
Table 7-10. 18F-labeling RCY for 13-NO2 
NO2
CHO
OMe
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
13-NO2 4 69.5 0.4 72.3 1.1 77.6 1.4 78.5 3.5 78.9 4.0 78.7 3.1 1 75.5 -- 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C. 
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Table 7-11. 18F-labeling RCY for 14-NO2 
NO2
CHO
OMe  
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
14-NO2 4 45.7 3.1 64.3 2.1 70.1 3.1 67.4 5.0 67.4 2.8 66.5 4.7 1 59.2 -- 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C. 
Table 7-12. 18F-labeling RCY for precursors with substitution pattern 15 
LG
CHO
OMe
MeO
LG = NO2, 15-NO2; LG = Br, 15-Br
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
15-NO2 4 8.9 0.5 15.8 1.8 20.6 2.3 22.3 2.1 21.0 1.3 18.9 1.0 1 21.0 -- 
15-Br 4 3.5 1.0 6.4 0.5 8.8 0.8 8.2 0.7 7.5 0.9 6.6 1.2 -- -- -- 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C. 
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Table 7-13. 18F-labeling RCY for 16-NO2 
NO2
CHO
OMe
OMe
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
16-NO2 4 47.8 2.0 65.2 3.6 69.6 1.6 67.9 4.1 67.0 2.5 60.8 2.4 2 76.7 4.0 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C. 
Table 7-14. 18F-labeling RCY for precursors with substitution pattern 17 
LG
CHOMeO
OMe
LG = NO2, 17-NO2; LG = Br, 17-Br
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
17-NO2 4 1.4 0.2 6.0 0.9 11.2 0.2 13.0 1.5 11.8 1.6 10.4 0.7 2 17.4 1.7 
17-Br 4 1.4 0.4 3.9 0.7 5.3 1.4 5.8 1.9 5.2 1.1 4.6 0.5 1 6.8 -- 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C. 
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Table 7-15. 18F-labeling RCY for 18-NO2 
NO2
CHO
OMe
MeO
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
18-NO2 4 67.0 6.4 72.9 4.7 70.7 9.7 85.9 4.2 84.8 4.7 84.6 3.6 2 87.0 1.2 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C. 
Table 7-16. 18F-labeling RCY for precursors with substitution pattern 19 
LG
CHOMeO
MeO
OMe
LG = NO2, 19-NO2; LG = Br, 19-Br
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
19-NO2 4 66.3 2.0 73.8 6.0 80.4 4.3 81.5 2.4 74.0 4.8 65.9 4.1 3 79.0 5.9 
19-NO2
a 4 17.4 7.3 32.4 6.8 39.1 6.1 43.2 2.8 41.4 3.8 36.1 3.2 1 44.4 -- 
19-Br 4 2.9 0.4 8.7 1.0 15.1 1.2 18.2 1.5 18.7 1.2 19.0 1.4 1 18.0 -- 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C. 
a: c.a. reaction. 
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Table 7-17. 18F-labeling RCY for precursors with substitution pattern 20 
LG
CHOMeO
OMe
OMe
MeO
LG = NO2, 20-NO2; LG = Br, 20-Br
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
20-NO2 5 38.0 2.0 43.7 1.6 47.6 4.5 45.3 3.5 44.2 5.8 41.0 6.9 3 47.2 5.9 
20-NO2
a 4 7.5 1.1 19.1 2.1 27.1 3.3 31.4 3.4 30.1 3.1 23.7 3.7 1 26.8 -- 
20-Br 5 2.0 0.5 5.6 0.8 9.0 1.3 10.3 0.7 10.5 0.6 10.0 1.3 1 10.8 -- 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C.  
a: c.a. reaction. 
Table 7-18. 18F-labeling RCY for precursors with substitution pattern 22 or 24 
NO2
R1 CHO
OHC
R1 = H, 22-NO2; R1 = OMe, 24-NO2
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
Mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
22-NO2
a 4 36.5 2.1 56.7 5.6 59.8 3.0 56.9 3.1 35.8 6.3 5.4 2.8 3 59.3 5.5 
22-NO2
b 4 3.1 1.3 12.8 2.3 25.1 3.6 28.2 2.4 24.8 3.9 13.3 4.7 -- -- -- 
22-NO2
c 3 2.6 0.1 4.1 0.1 6.8 1.4 7.2 1.1 6.2 0.8 2.7 1.0 -- -- -- 
24-NO2
a 2 7.7 0.4 16.5 1.8 25.8 4.4 31.9 1.4 29.7 2.4 13.2 0.7 1 29.3 -- 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg). 
a: 140 °C; b: 120 °C; c: 100 °C. 
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Table 7-19. 18F-labeling RCY for precursors with substitution pattern 21 or 23 
NO2
R1 CHO
CHO
R2
R1, R2 = H, 21-NO2,
R1 = OMe, R2 = H, 23-NO2
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
21-NO2
a 3 83.9 3.2 69.7 2.7 44.8 2.6 22.9 2.1 1.0 0 0.8 0.3 1 84.9 -- 
21-NO2
b 3 83.1 3.0 82.3 2.9 70.7 3.4 68.0 5.0 59.1 6.0 47.8 4.2 -- -- -- 
21-NO2
c 4 86.7 3.7 85.6 4.7 82.1 5.1 80.5 6.6 80.8 5.8 79.7 6.5 -- -- -- 
21-NO2
d 4 68.1 1.6 75.7 5.1 78.2 3.0 78.1 1.3 77.5 3.1 77.6 2.2 2 83.2 0.7 
23-NO2
a 4 75.3 0.5 79.3 0.2 78.3 2.5 79.7 0.6 73.3 1.5 66.3 2.5 2 79.4 0.2 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg). 
a: 140 °C; b: 100 °C; c: 60 °C; d: 25 °C. 
Table 7-20. 18F-labeling RCY for 27-F 
F
CHO
CH2R
MeO
R = O
O
CH3
N
H5C6 C6H5
H
 
RCY/% (TLC) RCY/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min Time at max. RCY (TLC) 
Nr. 
n
mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
27-F 4 3.5 0.5 4.3 0.6 2.7 1.2 1.6 0.9 0.8 0.2 0.1 0 2 4.6 0.3 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), 140 °C. 
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Table 7-21. 18F-labeling RCY for nitrobenzene, 4-nitroanisole and 3-nitrobenzaldehyde 
RCY/% (HPLC) 
30 min Precursor n mean SD 
nitrobenzene 4 1.0 0.1 
4-nitroanisole 4 0 -- 
3-nitrobenzaldehyde 3 7.0* 1.0* 
Labeling condition: precursor (10 mg), DMF (1 mL), 3.5 % K2CO3 (100 µL) and K2.2.2 (15 mg), at 140 °C, after 30 min, the labeling solution was cooled down  
and 10 µL of this solution was injected into HPLC. 
*: reaction time 10 min. 
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Table 7-22. Decarbonylation yield for 8-18F 
F18
CHOMeO
CH3  
Yield/% (TLC) Yield/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min 60 min 30 min Nr. n mean SD Mean SD mean SD mean SD mean SD mean SD mean SD n mean SD 
8-F +, a 4 0.6 0.3 7.8 1.3 32.5 2.9 61.3 3.0 62.1 1.7 57.9 4.7 58.7 1.0 1 64.5 -- 
8-F +, b 4 1.0 0.2 19.2 6.2 52.5 1.1 69.4 1.8 81.0 0.8 84.6 1.0 88.7 3.0 1 92.4 -- 
8-F +, c 3 1.3 0 23.8 3.2 27.7 3.2 28.7 2.4 29.8 3.0 32.0 2.2 33.3 2.1 1 25 -- 
8-F +, d 3 0.4 0.5 23.0 0.6 54.4 1.6 63.7 1.4 64.7 1.3 64.4 1.9 61.6 2.0 1 57.5 -- 
8-F +, e 3 1.3 0.3 13.8 2.0 46.3 4.7 53.3 1.2 52.6 1.7 52.2 4.0 -- -- 1 51.8 -- 
8-F +, f 3 0.6 0.2 3.1 0.6 8.3 0.9 13.6 0.9 25.2 3.1 32.6 4.1 47.1 2.7 -- -- -- 
8-F +, g 4 1.0 0.2 7.4 0.8 28.0 3.2 38.4 4.7 62.4 4.3 69.5 5.4 76.9 7.9 1 72.7  
8-F +, h 3 5.2 1.6 78.7 0.6 85.5 2.4 89.1 1.3 88.1 1.0 88.6 2.9 90.2 3.7 2 95.5* 0.7 
8-F +, i 2 0.8 0.5 1.7 0.6 2.2 0.4 3.5 0 3.3 0.1 3.5 0.1 3.3 0.4 -- -- -- 
8-F +, j 3 1.2 0.7 30.2 10.4 90.4 0.3 88.3 1.4 86.5 1.3 87.2 0.7 -- -- 1 94.8** -- 
+: Precursor for 18F-labeling reaction. 
*: Decabonylation yield at 10 min, **: Decabonylation yield at 20 min. 
Decabonylation condition: 
a-e: in 1mL solvent with 2 molar eq.catalyst at 150 °C. a: dioxan, b: benzonitrile, c: DMF, d: DMSO, e: toluene. 
f-h: in 1mL benzonitrile with 2 molar eq.catalyst f: 100 °C, g: 120 °C, h: 180 °C. 
i-j: in 1mL benzonitrile with X molar eq.catalyst at 150 °C. i: 1 molar eq.catalyst, j: 3 molar eq.catalyst. 
(Amount of the catalyst was  based on quantity of labelling precursor) 
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Table 7-23. Decarbonylation yield for 9-18F 
F18
CHO
CH3
OMe
 
Yield/% (TLC) Yield/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min 60 min 30 min Nr. n mean SD mean SD mean SD mean SD mean SD mean SD mean SD n mean SD 
9-F+ 3 3.0 1.6 50.7 3.4 75.2 1.2 83.4 2.5 86.5 1.8 86.7 2.5 88.4 2.9 1 92.0 -- 
9-NO2+ 3 1.5 0.9 53.0 4.3 88.8 1.4 88.7 2.8 88.4 1.7 88.9 1.2 89.1 0.6 1 95.0 -- 
9-Br+ 3 4.7 1.5 68.4 1.9 81.0 3.9 82.0 2.9 84.7 2.5 88.7 3.3 88.4 1.6 1 90.8 -- 
9-Cl+ 3 2.6 0.2 55.8 2.9 78.2 2.3 84.7 2.5 85.2 2.5 86.9 2.3 88.0 3.4 -- -- -- 
+: Precursor with different LG for 18F-labeling reaction. 
Decabonylation condition: in 1mL benzonitrile with 2 molar eq.catalyst at 150 °C (Amount of the catalyst was  based on quantity of labelling precursor). 
Table 7-24. Decarbonylation yield for 11-18F 
F18
CHO
CH3
OMe
MeO
 
Yield/% (TLC) Yield/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min 60 min 30 min Nr. n mean SD mean SD mean SD mean SD mean SD mean SD mean SD n mean SD 
11-F+ 3 3.9 1.4 51.4 2.6 81.1 4.0 84.2 2.6 88.9 2.2 91.8 1.6 92.5 0.6 1 97.0 -- 
+: Precursor for 18F-labeling reaction. 
Decabonylation condition: in 1mL benzonitrile with 2 molar eq.cat at 150 °C (Amount of the catalyst was  based on quantity of labelling precursor). 
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Table 7-25. Decarbonylation yield for 23-18F 
F18
CHOMeO
CHO  
Yield/% (TLC) Yield/% (HPLC) 
1 min 3 min 7 min 10 min 20 min 30 min 60 min 
Time at 
max. RCY 
(TLC) 
Nr. 
n 
mean SD mean SD mean SD mean SD mean SD mean SD mean SD 
n 
mean SD 
23-NO2+, 
a 4 0 0 19.3 1.5 63.9 2.1 67.1 3.4 67.1 3.1 66.4 1.5 -- -- 2 66.9 0.2 
23-NO2+, 
b 3 0 0 18.8 2.2 35.0 2.9 50.1 0.8 60.3 3.7 62.6 0 -- -- 1 59.0 -- 
23-NO2+, 
c 2 0 0 4.2 1.4 26.6 0.9 42.2 1.0 52.2 1.4 61.0 1.3 -- -- 2 61.5 0.3 
+: Precursor for 18F-labeling reaction. 
Decabonylation condition: 1mL benzonitrile. a: 4 molar eq.catalyst at 150 °C; b: 4 molar eq.catalyst at 120 °C; c: 3 molar eq.catalyst at 150 °C. 
(Amount of the catalyst was  based on quantity of labelling precursor) 
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